
<html lang="en"     class="pb-page"  data-request-id="ae5595ff-d6c5-4af9-b5bb-5a3f9b9f26c8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.7b01370;issue:issue:10.1021/jmcmar.2018.61.issue-13;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease" /></meta><meta name="dc.Creator" content="Yinuo  Wu" /></meta><meta name="dc.Creator" content="Zhe  Li" /></meta><meta name="dc.Creator" content="Yi-You  Huang" /></meta><meta name="dc.Creator" content="Deyan  Wu" /></meta><meta name="dc.Creator" content="Hai-Bin  Luo" /></meta><meta name="dc.Description" content="Alzheimer’s disease (AD) is one of the greatest public health challenges. Phosphodiesterases (PDEs) are a superenzyme family responsible for the hydrolysis of two second messengers: cyclic adenosin..." /></meta><meta name="Description" content="Alzheimer’s disease (AD) is one of the greatest public health challenges. Phosphodiesterases (PDEs) are a superenzyme family responsible for the hydrolysis of two second messengers: cyclic adenosin..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 24, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01370" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01370" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01370" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01370" /></link>
        
    
    

<title>Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01370" /></meta><meta property="og:title" content="Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0010.jpeg" /></meta><meta property="og:description" content="Alzheimer’s disease (AD) is one of the greatest public health challenges. Phosphodiesterases (PDEs) are a superenzyme family responsible for the hydrolysis of two second messengers: cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Since several PDE subfamilies are highly expressed in the human brain, the inhibition of PDEs is involved in neurodegenerative processes by regulating the concentration of cAMP and/or cGMP. Currently, PDEs are considered as promising targets for the treatment of AD since many PDE inhibitors have exhibited remarkable cognitive improvement effects in preclinical studies and over 15 of them have been subjected to clinical trials. The aim of this review is to summarize the outstanding progress that has been made by PDE inhibitors as anti-AD agents with encouraging results in preclinical studies and clinical trials. The binding affinity, pharmacokinetics, underlying mechanisms, and limitations of these PDE inhibitors in the treatment of AD are also reviewed and discussed." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01370"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01370">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01370&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01370&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01370&amp;href=/doi/10.1021/acs.jmedchem.7b01370" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5467-5483</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00873" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b01413" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Yinuo Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yinuo Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yinuo++Wu">Yinuo Wu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhe Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhe Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhe++Li">Zhe Li</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yi-You Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yi-You Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yi-You++Huang">Yi-You Huang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deyan Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deyan Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deyan++Wu">Deyan Wu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Hai-Bin Luo</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hai-Bin Luo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#e78b92888f85d0d0a78a868e8bc9949e9492c9828392c98489"><span class="__cf_email__" data-cfemail="e38f968c8b81d4d4a38e828a8fcd909a9096cd868796cd808d">[email protected]</span></a>. Fax: +86-20-3994 3000.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hai-Bin++Luo">Hai-Bin Luo</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2163-0509" title="Orcid link">http://orcid.org/0000-0002-2163-0509</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01370&amp;href=/doi/10.1021%2Facs.jmedchem.7b01370" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5467–5483</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 24, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 September 2017</li><li><span class="item_label"><b>Published</b> online</span>24 January 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 July 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01370" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01370</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5467%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYinuo%2BWu%252C%2BZhe%2BLi%252C%2BYi-You%2BHuang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D13%26contentID%3Dacs.jmedchem.7b01370%26title%3DNovel%2BPhosphodiesterase%2BInhibitors%2Bfor%2BCognitive%2BImprovement%2Bin%2BAlzheimer%25E2%2580%2599s%2BDisease%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5483%26publicationDate%3DJuly%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01370"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4168</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">47</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01370" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yinuo&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Zhe&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yi-You&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Deyan&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Hai-Bin&quot;,&quot;last_name&quot;:&quot;Luo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5467-5483&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01370&quot;},&quot;abstract&quot;:&quot;Alzheimer’s disease (AD) is one of the greatest public health challenges. Phosphodiesterases (PDEs) are a superenzyme family responsible for the hydrolysis of two second messengers: cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Since several PDE subfamilies are highly expressed in the human brain, the inhibition of PDEs is involved in neurodegenerative processes by regulating the concentration of cAMP and/or cGMP. Currently, PDEs are considered as promising targets for the treatment of AD since many PDE inhibitors have exhibited remarkable cognitive improvement effects in preclinical studies and over 15 of them have been subjected to clinical trials. The aim of this review is to summarize the outstanding progress that has been made by PDE inhibitors as anti-AD agents with encouraging results in preclinical studies and clinical trials. The binding affinity, pharmacokinetics, underlying mechanisms, and limitations of these PDE inhibitors in the treatment of AD are also reviewe&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01370&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01370" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01370&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01370" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01370&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01370" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01370&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01370&amp;href=/doi/10.1021/acs.jmedchem.7b01370" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01370" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01370" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01370%26sid%3Dliteratum%253Aachs%26pmid%3D29363967%26genre%3Darticle%26aulast%3DWu%26date%3D2018%26atitle%3DNovel%2BPhosphodiesterase%2BInhibitors%2Bfor%2BCognitive%2BImprovement%2Bin%2BAlzheimer%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D13%26spage%3D5467%26epage%3D5483%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=290792" title="Circuits">Circuits</a>,</li><li><a href="/action/doSearch?ConceptID=290729" title="Nervous system diseases">Nervous system diseases</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/jmcmar.2018.61.issue-13/20180712/jmcmar.2018.61.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Alzheimer’s disease (AD) is one of the greatest public health challenges. Phosphodiesterases (PDEs) are a superenzyme family responsible for the hydrolysis of two second messengers: cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Since several PDE subfamilies are highly expressed in the human brain, the inhibition of PDEs is involved in neurodegenerative processes by regulating the concentration of cAMP and/or cGMP. Currently, PDEs are considered as promising targets for the treatment of AD since many PDE inhibitors have exhibited remarkable cognitive improvement effects in preclinical studies and over 15 of them have been subjected to clinical trials. The aim of this review is to summarize the outstanding progress that has been made by PDE inhibitors as anti-AD agents with encouraging results in preclinical studies and clinical trials. The binding affinity, pharmacokinetics, underlying mechanisms, and limitations of these PDE inhibitors in the treatment of AD are also reviewed and discussed.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11158" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11158" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most common type of dementia, which is characterized by progressive memory loss, a decline in language skills, and some other neurodegenerative disorders.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> According to the data provided by the Alzheimer’s Association (U.S.), approximately 46.8 million people worldwide are suffering from AD. The morbidity and mortality rates of patients with AD are high, especially for elderly individuals over the age of 60. The global societal economic cost for AD patients was estimated at $818 billion in 2015 and is expected to rise to $1 trillion in 2018 and $2 trillion in 2030.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Thus, AD has become one of the greatest public health challenges across the world and severely impacts individuals and their families.</div><div class="NLM_p">Currently, the clinically available anti-AD drugs are three acetylcholine inhibitors (donepezil, rivastigmine, and galantamine) and one <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor (NMDA) antagonist (memantine),<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and these drugs improve only cognition and the degree of dementia in AD patients but do not reverse the progression of AD. Thus, the need to develop novel anti-AD drugs is extremely compelling. While the pathogenic mechanism of AD is highly complicated and still not fully understood, several hypotheses about the pathophysiology of AD, including low levels of acetylcholine, deposition of β-amyloid (Aβ) plaques, aggregation of Tau protein, oxidative stress, and the accumulation of biometals, have been proposed to facilitate drug development.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Recently, the Aβ pathological hypothesis has attracted great interest from many studies, as Aβ-plaques and neurofibrillary tangles are two major hallmarks in the brains of AD patients. However, several promising candidates targeting Aβ, such as bapineuzumab and solanuzumab, have failed in phase III clinical trials.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Although limited information was obtained for the failure, one important possible reason is that treatment of symptomatic dementia such as β-amyloid (Aβ) plaques was too late to delay the progression of the AD.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Furthermore, approximately 20–25% of patients have been observed with the assistance of positron emission tomography imaging to be without Aβ burden.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Thus, the discovery of anti-AD agents, including non-Aβ-directed therapies, still has a long way to go.</div><div class="NLM_p">Phosphodiesterases (PDEs) are a superenzyme family that is responsible for the hydrolysis of two second messengers: cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The PDE superfamily is coded by 21 identified genes and can be divided into 11 subtypes (PDE1–11). Among these subtypes, PDEs 4, 7, and 8 specifically hydrolyze cAMP, whereas PDEs 5, 6, and 9 specifically hydrolyze cGMP. The remaining PDE families are capable of degrading both cGMP and cAMP.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> As cAMP and cGMP are essential in cellular signaling and function, PDE inhibitors are used to regulate many biological processes by increasing the cellular levels of cAMP and cGMP. Thus far, several PDE inhibitors have been approved as therapeutics for the treatment of erectile dysfunction, pulmonary hypertension, chronic obstructive pulmonary disease, and heart failure (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The most successful example of this drug class is sildenafil, a PDE5 inhibitor that is used for the treatment of male erectile dysfunction (Viagra) and pulmonary hypertension (Revatio).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. PDEs Inhibitors Approved on the Market</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">drug name</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">clinical use</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vinpocetine</td><td class="colsep0 rowsep0" align="left">Calan, Cavinton</td><td class="colsep0 rowsep0" align="left">PDE1</td><td class="colsep0 rowsep0" align="left">Parkinson’s disease</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Alzheimer disease</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cilostazol</td><td class="colsep0 rowsep0" align="left">Pletal, Pletaal</td><td class="colsep0 rowsep0" align="left">PDE3</td><td class="colsep0 rowsep0" align="left">antiplatelet, intermittent claudication</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">amrinone lactate</td><td class="colsep0 rowsep0" align="left">Inocor</td><td class="colsep0 rowsep0" align="left">PDE3</td><td class="colsep0 rowsep0" align="left">heart failure</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ilrinone lactate</td><td class="colsep0 rowsep0" align="left">Primacor</td><td class="colsep0 rowsep0" align="left">PDE3</td><td class="colsep0 rowsep0" align="left">congestive heart failure</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">roflumilast</td><td class="colsep0 rowsep0" align="left">Daxas, Daliresp</td><td class="colsep0 rowsep0" align="left">PDE4</td><td class="colsep0 rowsep0" align="left">chronic obstructive pulmonary disease</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">apremilast</td><td class="colsep0 rowsep0" align="left">Otezla</td><td class="colsep0 rowsep0" align="left">PDE4</td><td class="colsep0 rowsep0" align="left">psoriasis and psoriatic arthritis</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">crisaborole</td><td class="colsep0 rowsep0" align="left">Eucrisa</td><td class="colsep0 rowsep0" align="left">PDE4</td><td class="colsep0 rowsep0" align="left">allergic dermatitis</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sildenafil citrate</td><td class="colsep0 rowsep0" align="left">Viagra</td><td class="colsep0 rowsep0" align="left">PDE5</td><td class="colsep0 rowsep0" align="left">erectile dysfunction, pulmonary arterial hypertension</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tadalafil</td><td class="colsep0 rowsep0" align="left">Cialis</td><td class="colsep0 rowsep0" align="left">PDE5</td><td class="colsep0 rowsep0" align="left">erectile dysfunction, pulmonary arterial hypertension</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vardenafil hydrochloride</td><td class="colsep0 rowsep0" align="left">Vivanza</td><td class="colsep0 rowsep0" align="left">PDE5</td><td class="colsep0 rowsep0" align="left">erectile dysfunction</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">avanafil</td><td class="colsep0 rowsep0" align="left">Zepeed, Stendra</td><td class="colsep0 rowsep0" align="left">PDE5</td><td class="colsep0 rowsep0" align="left">erectile dysfunction</td></tr></tbody></table></div></div><div class="NLM_p">PDEs are highly expressed in the human brain, and their inhibitors regulate neurodegenerative processes by increasing the concentrations of cAMP and cGMP in brain tissue (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In general, cAMP is synthesized from ATP by adenylate cyclase (AC), activates protein kinase A (PKA), and phosphorylates cAMP-responsive element binding protein (CREB), which has been considered a molecular switch required for learning and memory. Several preclinical and clinical studies have demonstrated that impaired CREB phosphorylation plays an important role in neurodegenerative disorders, especially AD.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Decreasing the level of cAMP may cause a decreased concentration of CREB, which affects the transcription of genes related to synaptic plasticity and survival, such as brain-derived neurotrophic factor (BDNF), and results in the loss of synaptic plasticity and in memory decline in AD.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Similarly, cGMP, which is derived from GTP by guanylyl cyclase (GC), could be activated by nitric oxide (NO) via the NO/cGMP pathway, which activates protein kinase G (PKG) and subsequent CREB phosphorylation, thus increasing the level of the antiapoptotic protein Bcl-2.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Relation of PDE inhibition and the cAMP or cGMP signaling pathway in the brain: PDE, phosphodiesterase; AC, adenyl cyclase; GC, guanylyl cyclase; ATP, adenosine triphosphate; GTP, guanosine triphosphate; PKA, protein kinase A; PKG, protein kinase G; P, phosphorylated; CREB, cAMP response element binding protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since the first preclinical AD study on the PDE4 inhibitor rolipram, which indicated that the inhibition of PDEs might have promising effects on the improvement of the memory deficits in AD,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> several PDE inhibitors have exhibited remarkable effects in animal models related to AD, including the Morris water maze, passive avoidance, and object recognition tasks (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In view of the encouraging results obtained in preclinical studies, several PDE inhibitors have been subjected to clinical trials for the treatment of cognitive disorders in AD patients (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Most of these inhibitors exhibited outstanding safety and tolerability profiles in phase I studies. Furthermore, over 10 PDE inhibitors have been subjected to phase II/III/IV clinical trials. Thus, this review mainly focuses on the outstanding progress that has been made in the application of PDE inhibitors for memory enhancement effects for anti-AD purposes in preclinical or clinical trials.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. PDEs inhibitors studied in the animal models of Alzheimer’s disease</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd (no., its target)</th><th class="colsep0 rowsep0" align="center">subject</th><th class="colsep0 rowsep0" align="center">model</th><th class="colsep0 rowsep0" align="center">results</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">Vinpocetine (<b>1</b>, PDE1)</td><td class="colsep0 rowsep0" rowspan="4" align="left">Streptozotocin injected rats<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></td><td class="colsep0 rowsep0" align="left">Morris water maze, 10 mg/kg, icv;</td><td class="colsep0 rowsep0" align="left">Improve memory,</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Reduce oxidative–nitritive stress,</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Passive avoidance, 10 mg/kg, icv</td><td class="colsep0 rowsep0" align="left">Modulate cholinergic functions,</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Prevent neuronal damage.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ITI-214 (<b>2</b>, PDE1)</td><td class="colsep0 rowsep0" align="left">Rats<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></td><td class="colsep0 rowsep0" align="left">Object recognition, 0.3–3.0 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">Improve acquisition, consolidation, and retrieval memory.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BAY 60-7550 (<b>4</b>, PDE2)</td><td class="colsep0 rowsep0" align="left">Chronic stress-induced mice<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></td><td class="colsep0 rowsep0" align="left">Morris water maze, 3.0 mg/kg, ip;</td><td class="colsep0 rowsep0" rowspan="2" align="left">Reverse cognitive impairment via neuroplasticity-related NMDAR-CaMKII-cGMP/cAMP signaling.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Novel object recognition and location task, 3.0 mg/kg, ip</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left"> </td><td class="colsep0 rowsep0" rowspan="3" align="left">Rats and C57BL/6J mice<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></td><td class="colsep0 rowsep0" rowspan="3" align="left">Object recognition and social memory task, 1.0 mg/kg, po</td><td class="colsep0 rowsep0" align="left">Improve memory,</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Enhance LTP,</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Reversed MK801-induced deficits.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Aged rats<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></td><td class="colsep0 rowsep0" align="left">Object recognition task, 0.3 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">Improve cognition and memory through enhancing the nNOS activity.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">APP/PS1 mice<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></td><td class="colsep0 rowsep0" align="left">Object location test, 0.3 mg/kg, po;</td><td class="colsep0 rowsep0" rowspan="3" align="left">Improve memory without anxiety, depressive-like behavior, or hypothalamus–pituitary–adrenal axis regulation;</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Y- maze, 0.3 mg/kg, po;</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Forced swim test, 0.3 mg/kg, po;</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Elevated zero maze, 0.3 mg/kg, po</td><td class="colsep0 rowsep0" align="left">No changes on the level of Aβ, pCREB, BDNF or presynaptic density.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cilostazol (<b>8</b>, PDE3)</td><td class="colsep0 rowsep0" align="left">Aβ<sub>25–35</sub>-injected mice</td><td class="colsep0 rowsep0" align="left">Y-maze, 30 mg/kg, po;<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></td><td class="colsep0 rowsep0" rowspan="3" align="left">Improve memory possibly due to the prevention of oxidative damage<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> or by decreasing Aβ accumulation by the reduction of Aβ accumulation and Tau phosphorylation.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"> </td><td class="colsep0 rowsep0" align="left">Passive avoidance, 30 mg/kg, po;<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Morris water maze, 10 mg/kg, ip<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Rolipram (<b>9</b>, PDE4)</td><td class="colsep0 rowsep0" align="left">APP/PS1 mice<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></td><td class="colsep0 rowsep0" align="left">Morris water maze, 0.03 mg/kg, sc</td><td class="colsep0 rowsep0" align="left">Improve memory.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Radial-arm water maze, 0.03 mg/kg, sc</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Aβ<sub>25–35</sub> or Aβ<sub>40</sub> infused rats<a onclick="showRef(event, 'ref68 ref71'); return false;" href="javascript:void(0);" class="ref ref68 ref71">(68,71)</a></td><td class="colsep0 rowsep0" align="left">Morris water maze, 0.5 mg/kg, ip;</td><td class="colsep0 rowsep0" align="left">Improve memory;</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Passive avoidance, 0.5 and 1.25 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">Reduce oxidative–nitritive stress; Upregulate thioredoxin;</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Inhibit iNOS/NO pathway.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Streptozotocin injected and aged mice<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></td><td class="colsep0 rowsep0" align="left">Morris water maze, 0.05 mg/kg and 0.1 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">Improve memory probably due to its anti-cholinesterase, anti-amyloid, anti-oxidative, and anti-inflammatory effects</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Iron-impaired aged rat<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></td><td class="colsep0 rowsep0" align="left">Object recognition, 0.01–0.1 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">Improve memory.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Roflumilast (<b>10</b>, PDE4)</td><td class="colsep0 rowsep0" align="left">Mice<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></td><td class="colsep0 rowsep0" align="left">Object location, 0.03 mg/kg, sc;</td><td class="colsep0 rowsep0" align="left">Improve memory,</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Y-maze, 0.1 mg/kg, sc</td><td class="colsep0 rowsep0" rowspan="2" align="left">Increased emetic-like properties at a dose 100 times the memory-enhancing dose.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Xylazine/ketamine induced anesthesia.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Scopolamine-impaired rats<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></td><td class="colsep0 rowsep0" align="left">Object recognition, 0.1 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">No improvement on memory when given alone;</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Fully restored memory deficit when given in combination with donepezil (0.1 mg/kg, po).</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HT-0712 (<b>11</b>, PDE4)</td><td class="colsep0 rowsep0" align="left">Aged mice<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></td><td class="colsep0 rowsep0" align="left">Fear conditioning, 0.1 mg/kg, ip;</td><td class="colsep0 rowsep0" align="left">Enhance long-term memory;</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Morris water maze, 0.15 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">Facilitate expression of CREB-regulated genes in aged hippocampus.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MK-0952 (<b>12</b>, PDE4)</td><td class="colsep0 rowsep0" align="left">Rats<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></td><td class="colsep0 rowsep0" align="left">Object recognition, 0.01 mg/kg, ip;</td><td class="colsep0 rowsep0" align="left">Improve long-term recognition, memory and cognition</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Water maze delayed matching to position test, 0.3 mg/kg, ip</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FFPM (<b>14</b>, PDE4)</td><td class="colsep0 rowsep0" align="left">APP/PS1 mice<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></td><td class="colsep0 rowsep0" align="left">Morris water maze, 0.5 mg/kg, po</td><td class="colsep0 rowsep0" rowspan="2" align="left">Improve memory probably due to stimulation of the cAMP/PKA/CREB/BDNF pathway and anti-inflammatory effects;</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Passive avoidance, 0.5 mg/kg, po</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Xylazine/ketamine induced anesthesia.</td><td class="colsep0 rowsep0" align="left">Little emetic potential.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GEBR-7b (<b>15</b>, PDE4)</td><td class="colsep0 rowsep0" align="left">Mice<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></td><td class="colsep0 rowsep0" align="left">Object location and recognition, 0.003 mg/kg, sc</td><td class="colsep0 rowsep0" align="left">Improve memory at doses without emesis-like behavior.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Xylazine/ketamine induced anesthesia.</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D159687 (<b>17</b>, PDE4)</td><td class="colsep0 rowsep0" align="left">Scopolamine-injected mice<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></td><td class="colsep0 rowsep0" align="left">Y-maze, 0.001 mg/kg, iv</td><td class="colsep0 rowsep0" rowspan="3" align="left">Improve memory at doses without emesis-like behavior.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mice<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></td><td class="colsep0 rowsep0" align="left">Object recognition, 0.01 mg/kg, iv</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Xylazine/ketamine induced anesthesia.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Sildenafil (<b>19</b>, PDE5)</td><td class="colsep0 rowsep0" align="left">Tg2576 mice<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></td><td class="colsep0 rowsep0" align="left">Morris water maze, 15 mg/kg, ip;</td><td class="colsep0 rowsep0" rowspan="2" align="left">Reverse memory deficits by regulating the Akt/GSK3b and p25/CDK5 pathways.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Fear conditioning, 15 mg/kg, ip</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SAMP8 mice<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></td><td class="colsep0 rowsep0" align="left">Morris water maze, 7.5 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">Ameliorate age-dependent cognitive impairments,</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Reduce the Tau phosphorylation.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">APP/PS1 mice<a onclick="showRef(event, 'ref103 ref104'); return false;" href="javascript:void(0);" class="ref ref103 ref104">(103,104)</a></td><td class="colsep0 rowsep0" align="left">Fear conditioning, 3 mg/kg, ip</td><td class="colsep0 rowsep0" rowspan="2" align="left">Improve memory by a long-lasting reduction of Aβ levels.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Reversal Morris water maze, 3 mg/kg, ip</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Object recognition, 10 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">Restore cognitive deficits by the regulation of PKG/pCREB signaling, anti-inflammatory response, and reduction of Aβ levels.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SAMP8 and SAMR1 mice<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></td><td class="colsep0 rowsep0" align="left">Passive avoidance, 7.5 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">Improve memory by reducing APP processing, Aβ levels, and Tau hyperphosphorylation.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tadalafil (<b>20</b>, PDE5)</td><td class="colsep0 rowsep0" align="left">Aged J20-mice<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></td><td class="colsep0 rowsep0" align="left">Morris water maze, 15 mg/kg, po</td><td class="colsep0 rowsep0" align="left">Improve memory;</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Reduce Tau phosphorylation but not Aβ.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S14 (<b>23</b>, PDE7)</td><td class="colsep0 rowsep0" align="left">APP/PS1 mice<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a></td><td class="colsep0 rowsep0" align="left">Radial arm water maze, 3 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">Improve memory.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BAY 73-6691 (<b>24</b>, PDE9)</td><td class="colsep0 rowsep0" align="left">Scopolamine-injected rats<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></td><td class="colsep0 rowsep0" align="left">T-maze, 10 mg/kg, po</td><td class="colsep0 rowsep0" align="left">Improve long-term and short-term memory.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Passive avoidance, 10 mg/kg, po</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Rats<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></td><td class="colsep0 rowsep0" align="left">Social recognition, 0.3 mg/kg, po</td><td class="colsep0 rowsep0" align="left">Improve both early and late LTP.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Object recognition, 0.1 mg/kg, po</td><td class="colsep0 rowsep0" align="left">Transform early into late LTP.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tg2576 mice<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></td><td class="colsep0 rowsep0" align="left">Object location, 5 mg/kg, po</td><td class="colsep0 rowsep0" align="left">Improve memory;</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Restore Aβ induced impairment of long-term potentiation.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Aβ<sub>25–35</sub>-injected mice<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></td><td class="colsep0 rowsep0" align="left">Morris water maze, 1 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">Improve memory.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PF-04447943 (<b>25</b>, PDE9)</td><td class="colsep0 rowsep0" align="left">Scopolamine-injected rats<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></td><td class="colsep0 rowsep0" align="left">Conditioned avoidance attention, 3 mg/kg, ip</td><td class="colsep0 rowsep0" align="left">Improve learning and memory.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Object recognition,1 mg/kg, po</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mice<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></td><td class="colsep0 rowsep0" align="left">Social recognition, 1 mg/kg, po</td><td class="colsep0 rowsep0" align="left">Improve cognitive performance.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Y-maze, 1 mg/kg, po</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. PDEs Inhibitors in Clinical Trials for the Treatment of Alzheimer’s Disease or Related Diseases<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">condition</th><th class="colsep0 rowsep0" align="center">current status</th><th class="colsep0 rowsep0" align="center">clinical trial registry no.</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ITI-214 (<b>2</b>)</td><td class="colsep0 rowsep0" align="left">PDE1</td><td class="colsep0 rowsep0" align="left">Schizophrenia</td><td class="colsep0 rowsep0" align="left">Phase I, 2013, terminated</td><td class="colsep0 rowsep0" align="left">NCT01900522</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PF-0999</td><td class="colsep0 rowsep0" align="left">PDE2</td><td class="colsep0 rowsep0" align="left">Schizophrenia</td><td class="colsep0 rowsep0" align="left">Phase I, 2011, completed</td><td class="colsep0 rowsep0" align="left">NCT01429740</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(PF-05180999, <b>6</b>)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Healthy volunteers</td><td class="colsep0 rowsep0" align="left">Phase I, 2012, completed</td><td class="colsep0 rowsep0" align="left">NCT01530529</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TAK-915</td><td class="colsep0 rowsep0" align="left">PDE2</td><td class="colsep0 rowsep0" align="left">Healthy volunteers</td><td class="colsep0 rowsep0" align="left">Phase I, 2015, completed</td><td class="colsep0 rowsep0" align="left">NCT02584569</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Healthy volunteers</td><td class="colsep0 rowsep0" align="left">Phase I, 2015, completed</td><td class="colsep0 rowsep0" align="left">NCT02461160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cilostazol (<b>8</b>)</td><td class="colsep0 rowsep0" align="left">PDE3</td><td class="colsep0 rowsep0" align="left">Alzheimer’s disease</td><td class="colsep0 rowsep0" align="left">Phase IV, 2011, completed</td><td class="colsep0 rowsep0" align="left">NCT01409564</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mild cognitive impairment</td><td class="colsep0 rowsep0" align="left">Phase II, 2015, recruiting</td><td class="colsep0 rowsep0" align="left">NCT02491268</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Roflumilast (<b>10</b>)</td><td class="colsep0 rowsep0" align="left">PDE4</td><td class="colsep0 rowsep0" align="left">Dementia</td><td class="colsep0 rowsep0" align="left">Phase II, 2011, completed</td><td class="colsep0 rowsep0" align="left">NCT01433666</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Memory impairment, Alzheimer’s disease</td><td class="colsep0 rowsep0" align="left">Phase I,2014, completed</td><td class="colsep0 rowsep0" align="left">NCT02051335</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Alzheimer disease</td><td class="colsep0 rowsep0" align="left">Preclinical, 2016, recruiting</td><td class="colsep0 rowsep0" align="left">NCT02835716</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HT-0712 (<b>11</b>)</td><td class="colsep0 rowsep0" align="left">PDE4</td><td class="colsep0 rowsep0" align="left">Age-associated memory impairment</td><td class="colsep0 rowsep0" align="left">Phase II, 2013, completed</td><td class="colsep0 rowsep0" align="left">NCT02013310</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Healthy elderly volunteers</td><td class="colsep0 rowsep0" align="left">Phase I, 2010, terminated</td><td class="colsep0 rowsep0" align="left">NCT01215552</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MK-0952 (<b>12</b>)</td><td class="colsep0 rowsep0" align="left">PDE4</td><td class="colsep0 rowsep0" align="left">Alzheimer’s disease</td><td class="colsep0 rowsep0" align="left">Phase II, 2006, terminated</td><td class="colsep0 rowsep0" align="left">NCT00362024</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Etazolate (<b>13</b>) (EHT0202)</td><td class="colsep0 rowsep0" align="left">PDE4</td><td class="colsep0 rowsep0" align="left">Alzheimer’s disease</td><td class="colsep0 rowsep0" align="left">Phase II, 2009, completed</td><td class="colsep0 rowsep0" align="left">NCT00880412</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BPN14770 (<b>18</b>)</td><td class="colsep0 rowsep0" align="left">PDE4</td><td class="colsep0 rowsep0" align="left">Alzheimer disease</td><td class="colsep0 rowsep0" align="left">Phase I, 2017, ongoing but not recruiting participants</td><td class="colsep0 rowsep0" align="left">NCT03030105</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Alzheimer’s disease</td><td class="colsep0 rowsep0" align="left">Phase I, 2016, completed</td><td class="colsep0 rowsep0" align="left">NCT02840279</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Alzheimer’s disease</td><td class="colsep0 rowsep0" align="left">Phase I, 2016, completed</td><td class="colsep0 rowsep0" align="left">NCT02648672</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Sildenafil (<b>19</b>)</td><td class="colsep0 rowsep0" align="left">PDE5</td><td class="colsep0 rowsep0" align="left">Schizophrenia</td><td class="colsep0 rowsep0" align="left">Phase IV, 2007, completed</td><td class="colsep0 rowsep0" align="left">NCT00455715</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Parkinson’s disease</td><td class="colsep0 rowsep0" align="left">Phase IV, 2013</td><td class="colsep0 rowsep0" align="left">NCT01941732</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Parkinson’s disease</td><td class="colsep0 rowsep0" align="left">Phase II, 2007, terminated due to not enough subjects</td><td class="colsep0 rowsep0" align="left">NCT02162979</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tadalafil (<b>20</b>)</td><td class="colsep0 rowsep0" align="left">PDE5</td><td class="colsep0 rowsep0" align="left">Dementia, vascular</td><td class="colsep0 rowsep0" align="left">Phase II, 2017, recruting</td><td class="colsep0 rowsep0" align="left">NCT02450253</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PF-04447943 (<b>25</b>)</td><td class="colsep0 rowsep0" align="left">PDE9</td><td class="colsep0 rowsep0" align="left">Alzheimer’s disease</td><td class="colsep0 rowsep0" align="left">Phase II, 2009, completed</td><td class="colsep0 rowsep0" align="left">NCT00930059</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Alzheimer’s disease</td><td class="colsep0 rowsep0" align="left">Phase I, 2009, completed</td><td class="colsep0 rowsep0" align="left">NCT00988598</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Healthy</td><td class="colsep0 rowsep0" align="left">Phase I, 2010, completed</td><td class="colsep0 rowsep0" align="left">NCT01097876</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BI-409306</td><td class="colsep0 rowsep0" align="left">PDE9</td><td class="colsep0 rowsep0" align="left">Alzheimer’s disease</td><td class="colsep0 rowsep0" align="left">Phase II, 2014, recruiting</td><td class="colsep0 rowsep0" align="left">NCT02240693</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Alzheimer’s disease</td><td class="colsep0 rowsep0" align="left">Phase II, 2014, recruiting</td><td class="colsep0 rowsep0" align="left">NCT02337907</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PF-02545920 (<b>31</b>)</td><td class="colsep0 rowsep0" align="left">PDE10</td><td class="colsep0 rowsep0" align="left">Huntington’s disease</td><td class="colsep0 rowsep0" align="left">Phase II, 2015, terminated</td><td class="colsep0 rowsep0" align="left">NCT02342548</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Huntington’s disease</td><td class="colsep0 rowsep0" align="left">Phase II, 2014, completed</td><td class="colsep0 rowsep0" align="left">NCT02197130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TAK-063 (<b>32</b>)</td><td class="colsep0 rowsep0" align="left">PDE10</td><td class="colsep0 rowsep0" align="left">Schizophrenia</td><td class="colsep0 rowsep0" align="left">Phase II, 2015, terminated</td><td class="colsep0 rowsep0" align="left">NCT02477020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OMS643762</td><td class="colsep0 rowsep0" align="left">PDE10</td><td class="colsep0 rowsep0" align="left">Schizophrenia</td><td class="colsep0 rowsep0" align="left">Phase II, 2013, terminated</td><td class="colsep0 rowsep0" align="left">NCT01952132</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EVP-6308</td><td class="colsep0 rowsep0" align="left">PDE10</td><td class="colsep0 rowsep0" align="left">Schizophrenia</td><td class="colsep0 rowsep0" align="left">Phase I, 2014, completed</td><td class="colsep0 rowsep0" align="left">NCT02037074</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Information from <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">2.  PDE Inhibitors Studied for the Treatment of AD</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.1.  PDE1 Inhibitors</h3><div class="NLM_p">PDE1 is a Ca<sup>2+</sup>/calmodulin-dependent PDE family with three isoforms (PDE1A, -1B, and -1C) that hydrolyze both cGMP and cAMP.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> PDE1B and PDE1C are the two major isoforms existing in humans, while PDE1A has relatively low expression. Each isoform is also expressed in a tissue-specific manner. In the caudate nucleus and the nucleus accumbens, for example, PDE1B is the most abundant isoform among all PDE species, and the level of PDE1B is 10- and 100-fold higher than that of PDE1C and PDE1A, respectively. In the cortex and hippocampus, the levels of PDE1B and PDE1C are almost the same. In the periphery, PDE1C is the major isoform of PDE1 and mainly exists in the heart, bladder, and lungs (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01370/suppl_file/jm7b01370_si_001.pdf" class="ext-link">Figure S1 in Supporting Information</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Its specific distribution in the brain and its distinctive regulation by intracellular calcium and calmodulin make PDE1 an attractive target to improve cognitive impairments in neurodegenerative diseases, such as AD, schizophrenia, and Parkinson’s disease.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Vinpocetine (<b>1</b>), a derivative of the alkaloid vincamine, shows weak inhibition against PDE1 (IC<sub>50</sub> = 30 μM) and has been widely used for the treatment of cognitive dysfunction (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> In streptozotocin (STZ)-induced rat models, which closely simulate the clinical and pathologic features of sporadic AD<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), chronic treatment with <b>1</b> significantly improved learning and memory abilities in the Morris water maze and passive avoidance tests. Furthermore, the levels of malondialdehyde (MDA) and nitrite decreased, whereas that of glutathione (GSH) increased. The concentrations of acetylcholinesterase and lactate dehydrogenase were also regulated by <b>1</b>. These results suggested that its effect on memory impairment might be related to oxidative stress and cholinergic function mechanisms. Pharmacokinetics studies of patients with cerebrovascular disorders demonstrated that <b>1</b> is able to pass through the blood–brain barrier and reach the central nervous system.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> A clinical study of patients with mild to moderate organic psychosyndromes, including primary dementia, was carried out in 1991 to evaluate the efficacy and tolerance of orally administering <b>1</b>. The result showed that <b>1</b> could efficiently enhance the cognitive performance of these patients.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Current PDE1 inhibitors for the treatment of AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">ITI-214 (<b>2</b>), a PDE1 inhibitor reported by Intra-Cellular Therapies in 2012, had an IC<sub>50</sub> value of 0.058 nM against PDE1 and an excellent selectivity (>1000-fold) across other PDEs (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The good pharmacokinetic properties of <b>2</b> made it suitable as a CNS drug candidate. In a novel object recognition test in rats, with a single oral dose of 0.1–10 mg/kg, <b>2</b> could significantly enhance memory performance during acquisition and consolidation without changing exploratory behavior or basal locomotor activity. Furthermore, its administration did not change or have an effect on the antipsychotic activity or pharmacokinetic profile of risperidone in the conditioned avoidance response test.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Currently, <b>2</b> has already completed four phase I studies (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), including a single rising dose study in normal healthy volunteers and a multiple rising dose study once daily.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Its safety and tolerability in healthy volunteers and patients with schizophrenia have also been evaluated. Although this trial has been terminated due to a business decision, the obtained results proved that <b>2</b> might work as an efficient candidate for the treatment of cognitive dysfunction as seen in AD, schizophrenia, and Parkinson’s disease.</div><div class="NLM_p last">Most recently, a thienotriazolopyrimidinone PDE1 inhibitor, DNS-0056 (<b>3</b>), with good pharmacokinetic properties and brain penetration has been developed (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In a rat model of recognition memory, <b>3</b> significantly increased long-term memory without altering exploratory behavior in rats.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.2.  PDE2 Inhibitors</h3><div class="NLM_p">Similar to PDE1, PDE2 is another subfamily that hydrolyzes both cAMP and cGMP. Unlike other PDE families, in which activating cGMP signals could decrease the level of local cAMP, the inhibition of PDE2 selectively abolishes the negative effects of cGMP on cAMP.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> PDE2A is the only isoform of PDE2 that is highly expressed in most brain regions, including the caudate, nucleus accumbens, cortex, and hippocampus (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01370/suppl_file/jm7b01370_si_001.pdf" class="ext-link">Figure S2</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In most peripheral tissues, except the spleen, the level of PDE2 is relatively low. This spatial distribution makes PDE2 inhibitors ideal as therapeutic agents against cognitive disorder diseases but with less cardiovascular and other side effects that commonly exist in other PDE inhibitors.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">BAY-60-7550 (<b>4</b>) is a highly selective PDE2 inhibitor developed by Bayer with an IC<sub>50</sub> of 4.7 nM and up to 100-fold selectivity across other PDEs (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Its poor pharmacokinetic properties have limited its clinical use. Thus, this compound has usually worked as a tool medicine to investigate the potential therapeutic utility of PDE2 inhibitors. The inhibition of PDE2A by <b>4</b> enhanced the long-term potentiation of synaptic transmission without altering basal synaptic transmission. In addition, <b>4</b> improved memory performance in social and object recognition memory tasks and rescued deficits of spontaneous alternation in the T-maze induced by the <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) antagonist MK801.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Further study of object location and recognition tasks indicated that its role in memory improvement was probably due to the enhancement of memory consolidation instead of attention.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In memory-impaired, aged rats, <b>4</b> enhanced the impaired learning and recognition memory for objects at different ages and was accompanied by increased basal constitutive nitric oxide synthase activity in the hippocampus and striatum.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Another study discovered that the inhibition of PDE2 in the hydrolysis of both cGMP and cAMP using <b>4</b> improved spatial object memory consolidation in both early and late stages, whereas the vardenafil-induced inhibition of PDE5 in the hydrolysis of cGMP only enhanced the early stage, and the rolipram-induced inhibition of PDE4 in the hydrolysis of cAMP enhanced only the late stage.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In APP/PS1 mice, chronic treatment with <b>4</b> improved memory performance without causing anxiety, indicating that signaling pathways other than the NO/cAMP/CREB pathway might be responsible for its cognition-enhancing effects.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Most recently, another study demonstrated that <b>4</b> reduced stress-induced activation of an extracellularly regulated protein kinase and attenuated the loss of stress-induced transcription factors and plasticity-related proteins via the neuroplasticity-related NMDAR-CaMKII-cGMP/cAMP signaling pathway.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Current PDE2 inhibitors for the treatment of AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pharmaceutical study in rats revealed that the brain penetration of BAY 60-7550 was poor. The administration of BAY 60-7550 at the dose of 10 mg/kg only resulted in a brain concentration of 3.6 ng/g.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Thus, the main reason for the good memory improvement effects obtained by BAY 60-7550 is probably due to the highest expression of PDE2 in brain, where low brain concentrations of PDE2 inhibitor might be sufficient to activate the cAMP and cGMP signal, causing signal amplification for memory improvement.</div><div class="NLM_p">ND-7001 (<b>5</b>), developed by the Neuro3d company, showed an IC<sub>50</sub> of 50 nM against PDE2 and good selectivity over PDE3 and PDE4 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Its safety, tolerability, and pharmacokinetics were evaluated in phase I trials, which demonstrated that it was safe and well tolerated at high doses and produced no sedation, memory disturbance, or withdrawal effects.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> However, no further development has been reported since 2010.</div><div class="NLM_p">PF-999 (<b>6</b>, also named as PF-05180999), developed by Pfizer, showed remarkable inhibitory activity against PDE2 (IC<sub>50</sub> = 2.3 nM) and selectivity over other PDEs, as well as a reasonable free brain/plasma ratio in rats (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> PF-999 was found to increase the level of cGMP in the cerebrospinal fluid of rats, attenuate ketamine-induced memory deficits, and reverse spatial learning and memory in scopolamine-induced models.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In 2015, a study that explored the primarily presynaptic mechanism of PDE2A inhibition was also performed by using PF-999. The results showed that the inhibition of PDE2 might be involved in short-term synaptic plasticity by modulating the hydrolysis of cAMP to accommodate changes in cGMP levels associated with presynaptic short-term plasticity.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Currently, <b>6</b> has already completed two phase I clinical trials: one trial evaluated its safety, tolerability, and pharmacokinetics in healthy subjects, and the other evaluated the relative bioavailability of a modified-release formulation at 30 mg and 120 mg in patients with schizophrenia.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> However, no further information has been reported since 2012.</div><div class="NLM_p">Recently, compound <b>71</b> (<b>7</b>), developed by Pfizer, showed an IC<sub>50</sub> of 2 nM against PDE2 and selectivity of up to 4000-fold over other PDEs (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a><b>7</b> increased the level of cGMP in rodent brain regions expressing the highest levels of the PDE2A enzyme. In the radial arm maze, <b>7</b> significantly attenuated memory impairments induced by ketamine in rats. Furthermore, <b>7</b> reversed a maximum of 80% of the MK-801-induced local field potential disruption at a steady-state <i>C</i><sub>bu</sub> of 11 nM. These results indicated selective PDE2A inhibition in brain-potentiated, pharmacologically induced NMDA hypofunction in vivo and that it is suitable to be used in treating neurological and neuropsychiatric disorders associated with NMDA hypofunction, such as schizophrenia.</div><div class="NLM_p last">TAK-915, developed by Takeda with no structural or other information disclosed, has already finished two phase I clinical trials of healthy participants in 2015. One trial served to examine the degree and duration of brain PDE2A enzyme occupancy/target engagement after its administration in order to provide evidence of dosing and a schedule for future clinical studies of schizophrenia.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The other trial was conducted to characterize its safety, tolerability, and plasma pharmacokinetic properties when administered as single and multiple oral suspension doses at escalating dose levels in healthy participants, including elderly participants.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">2.3.  PDE3 Inhibitors</h3><div class="NLM_p">Similar to PDE1 and PDE2, PDE3 is another subfamily responsible for hydrolyzing both cAMP and cGMP and has two isoforms: PDE3A and PDE3B. In the brain, the expression of PDE3A and PDE3B is relatively low and is mainly in the cerebellum. In the periphery, the expression of PDE3A is mainly in the heart, while the expression of PDE3B is mostly in the lungs and liver (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01370/suppl_file/jm7b01370_si_001.pdf" class="ext-link">Figure S3</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> PDE3A variants have differential expression in cardiovascular tissues. Intracellularly, PDE3B is predominantly membrane-associated and localized to endoplasmic reticulum and microsomal fractions. Furthermore, although the concentration of PDE3 is low in brain compared with other PDE subfamilies, the inhibition of PDE3 might be sufficient to active the cAMP and cGMP signal, causing signal amplification for memory improvement.<a onclick="showRef(event, 'ref8 ref48'); return false;" href="javascript:void(0);" class="ref ref8 ref48">(8,48)</a></div><div class="NLM_p">AD and vascular dementia are two major types of dementia in elderly persons. A number of elderly people may suffer from both conditions. Cerebral white matter lesions have been demonstrated to be one important risk factor for transforming mild cognitive impairment to AD and are the main reason for the age-dependent coexistence of AD and cerebrovascular disease.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> The neurovascular dysfunction of aged AD is associated with cerebral ischemia and the accumulation of Aβ.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a></div><div class="NLM_p">Cilostazol (<b>8</b>) is a selective PDE3 inhibitor (IC<sub>50</sub> = 0.2 μM) that has been clinically used as an antiplatelet drug for the prevention of cerebrovascular disease (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Recently, therapy using <b>8</b> directed at both vascular and neurodegenerative aspects of dementia has been considered a more suitable approach for elderly patients with AD. In an Aβ<sub>25–35</sub>-injected mouse model of AD, repeated administration of <b>8</b> significantly attenuated impairment of spontaneous alternation and reversed the shortening of step-down latency induced by Aβ<sub>25–35</sub>. The increased level of MDA was completely prevented, indicating that <b>8</b> may reverse oxidative damage induced by Aβ<sub>25–35</sub>.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Another study demonstrated that <b>8</b> significantly attenuated Aβ accumulation and improved spatial learning and memory. The level of apolipoprotein E (ApoE), a protein associated with Alzheimer’s neurofibrillary tangles and Aβ protein, was decreased, resulting in reduced Aβ aggregation.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Selective PDE3 inhibitor, cilostazol, may be used to treat cerebrovascular diseases and AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A clinical study of 10 patients with moderate AD proved that <b>8</b> ameliorated cognitive decline efficiently when coadministered with donepezil after an average follow-up period. However, this combinatorial therapy had no effect on patients with moderate or severe dementia.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> A retrospective analysis revealed that <b>8</b> could significantly improve memory in patients with mild cognitive impairment, but no significant effect was observed in patients with normal cognitive function or dementia.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The clinical effects of monotherapy with galantamine or <b>8</b> added to combinatorial therapy in AD patients were also evaluated in a clinical study. Galantamine or <b>8</b> monotherapy increased the cognitive, affective, and activities of daily living functions in AD patients, while the combination of galantamine and <b>8</b> resulted in a better therapeutic effect than the monotherapy.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Most recently, a clinical study was performed in a large Asian population to investigate the potential risk and benefit of using <b>8</b> to reduce the risk of dementia (9148 participants free of dementia at 40 years or older). Patients given <b>8</b> had a significantly decreased risk of incident dementia compared with patients without the drug. Notably, the use of <b>8</b> had a dose-dependent association with the reduced rate of dementia emergence. Subgroup analysis identified a decrease in dementia in <b>8</b> users with diagnosed ischemic heart disease and cerebrovascular disease.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><div class="NLM_p last">Two clinical trials of <b>8</b> related to AD or dementia were registered at clinicaltrials.gov. A phase IV study was performed by Seoul National University Hospital in 2011 to examine the added effect of <b>8</b> with donepezil treatment using cognitive tasks and PET imaging in mild to moderate AD patients with subcortical white matter hyperintensities (WMHI).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> A phase II trial in patients with mild cognitive impairment was performed by the National Cerebral and Cardiovascular Center in 2015 to evaluate whether <b>8</b> could prevent the conversion from mild cognitive impairment to dementia.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">2.4.  PDE4 Inhibitors</h3><div class="NLM_p">PDE4 is a subfamily that hydrolyzes cAMP only. The four isoforms of PDE4 (PDE4A, PDE4B, PDE4C, and PDE4D) are widely expressed in the CNS and have been found to remain present in the aged and Alzheimer’s brain.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> PDE4B is highly expressed in most areas of brain except in the dorsal root ganglia, where the levels of all the PDE4 isoforms are low. The levels of PDE4A and PDE4B are equally high in the cortex, but PDE4A is 2- to 4-fold lower in other brain regions. PDE4C has very low expression in the brain. PDE4D has relatively high expression in the frontal cortex but is 3- to 10-fold lower than PDE4B in all CNS tissues. In the periphery, PDE4B and PDE4D are two major isoforms (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01370/suppl_file/jm7b01370_si_001.pdf" class="ext-link">Figure S4</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Currently, three PDE4 inhibitors, namely, roflumilast, crisaborole, and apremilast, have been approved on the market for the treatment of chronic obstructive pulmonary disease (COPD), atopic dermatitis, and psoriatic arthritis, respectively.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> In general, PDE4 inhibitors have been widely explored for the treatment of AD.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> However, most of the current PDE4 inhibitors may cause emetic side effects, limiting their usage in CNS diseases.</div><div class="NLM_p">Rolipram (<b>9</b>) is the first generation of PDE4 inhibitors with an IC<sub>50</sub> of 230 nM (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Compared with the approved drugs roflumilast and apremilast, rolipram has good brain penetration, or an ability to pass the blood–brain barrier. The concentration of <b>9</b> in the brain is twice as high as that in the plasma.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> However, low-dose administration of rolipram causes emesis. Currently, rolipram is widely used to investigate the underlying mechanisms of PDE4 inhibitors in AD.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Current PDE4 inhibitors for the treatment of AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The neuroprotective effect of rolipram in AD models was first demonstrated on hippocampal-dependent memory tasks in 1998, which suggested that the inhibition of PDE4 might decrease the threshold for generating long-lasting long-term potentiation (LTP) and increase behavioral memory through the cAMP pathway.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Gong and co-workers demonstrated that <b>9</b> improved cognitive deficits in both LTP and contextual learning in APP/PS1 mouse models. Notably, its effect on the improvement of LTP and basal synaptic transmission, as well as working, reference, and associative memory deficits, lasted at least 2 months after treatment.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The loss of dendritic spines and dystrophic neurites existed in the hippocampus of APP/PS1 transgenic mice and AD patients. Gong also demonstrated that <b>9</b> reversed spine density to a normal level in APP/PS1 mice and aged mice. The changes in dendritic structure and function caused by Aβ peptides were also reversed by rolipram.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> In Aβ<sub>25–35</sub>- or Aβ<sub>1–40</sub>-injected rats, chronic administration or repeated treatment with <b>9</b> reversed memory impairment, while acute treatment with <b>9</b> did not. Furthermore, the decreased levels of Pcreb and Bcl-2 and the increased level of NF-κB p65 and Bax in the hippocampus were regulated by <b>9</b> in a dose-dependent manner.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> These results indicated that the attenuation of neuronal inflammation and apoptosis mediated by cAMP/CREB signaling might be involved in the process, which is in accordance with a previous study showing that <b>9</b> reversed scopolamine-induced and time-dependent memory in object recognition tasks by elevating cAMP levels.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> Most recently, it has been proven that <b>9</b> significantly improved learning and memory ability in streptozotocin-induced and naturally aged mice.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Its potential for treatment of memory dysfunctions can probably be attributed to its anti-cholinesterase, anti-amyloid, anti-oxidative, and anti-inflammatory actions, and other effects.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72,73)</a></div><div class="NLM_p">Roflumilast (<b>10</b>, Daliresp or Daxas) was the first selective PDE4 inhibitor approved by the FDA for the treatment of COPD in 2011 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Compared with <b>9</b>, <b>10</b> showed a significantly better inhibitory affinity against PDE4 with decreased emetic properties and may be suitable as a candidate drug for the treatment of AD.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> A preclinical study demonstrated that both <b>10</b> and <b>9</b> have positive effects on memory improvement in an object location task in male C57BL/6NCrl mice. In the Y-maze test, <b>10</b> improved spatial memory performance, while <b>9</b> did not. More importantly, <b>10</b> produced emetic-like effects at a dose 100 times that of the memory-enhancing dose, indicating that it is relatively safe in AD treatment. A single administration of donepezil or <b>10</b> did not improve memory, while combining efficacious doses of both fully reversed scopolamine-induced memory deficits in object recognition tasks.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Its beneficial effect on memory and its nonemetic properties promoted <b>10</b> to clinical trials of AD. Currently, <b>10</b> has already finished one phase II study as a translational cognition enhancer<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> and one phase I study to evaluate whether coadministration of <b>10</b> and donepezil could attenuate scopolamine-induced cognitive impairment.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> A preclinical trial is underway to evaluate its effect on preventing the onset of AD in high-risk individuals.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Although the IC<sub>50</sub> of <b>10</b> is almost 1000 times higher than that of <b>9</b> in vitro, the effects obtained in memory improvement experiments by roflumilast are almost the same or even less than those of rolipram. The difference has been attributed to the relatively poor ability of roflumilast to penetrate the blood–brain barrier. Recent studies demonstrated that <b>10</b> efficiently reversed cognitive impairment induced by hypertension in rodents, even at low doses.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79,80)</a></div><div class="NLM_p">HT-0712 (<b>11</b>) was developed as a novel PDE4 inhibitor by Bourtchouladze and Scott (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Both <b>11</b> and <b>9</b> ameliorated long-term memory in a mouse model of Rubinstein–Taybi syndrome.<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81,82)</a> Currently, <b>11</b> has already completed a phase II trial to evaluate its efficacy in improving memory and cognitive performance in subjects with age-associated memory impairment (AAMI) and had positive results.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><div class="NLM_p">MK-0952 (<b>12</b>), developed by Merck, shows an IC<sub>50</sub> of 0.6 nM against PDE4 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> A phase II clinical trial with <b>12</b> was performed to determine its effect on improving cognitive impairments in patients in mild to moderate stages of AD.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p">Etazolate (<b>13</b>, also named as EHT0202) is a PDE4 inhibitor and a GABA-A receptor modulator (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Its underlying mechanism of memory improvement in AD might be cross-linked.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Currently, <b>13</b> has already finished one phase II trial to evaluate its safety and tolerability as an adjunctive therapy to acetylcholinesterase inhibitors in mild to moderate AD.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> The results showed that <b>13</b> was safe and generally well tolerated. Dose-dependent numbers of early withdrawal and central nervous system-related adverse events were observed.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div><div class="NLM_p">FFPM (<b>14</b>) is a novel PDE4 inhibitor that was developed by Ke and co-workers and that has an IC<sub>50</sub> of 26 nM and good selectivity over other PDEs (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Its effects on learning and memory were investigated by Xu and co-workers using the APP/PS1 mouse model of AD.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> After 3 weeks of treatment, the learning and memory abilities of APP/PS1 transgenic mice were significantly improved, as measured by the Morris water maze test and the step-down passive avoidance task. <b>14</b> had no significant effect on the duration of xylazine/ketamine anesthesia in mice, indicating that <b>14</b> might not cause emesis during the treatment of AD. Furthermore, <b>14</b> penetrated the blood–brain barrier quickly after oral administration, with a half-life in plasma of 1.5 h.</div><div class="NLM_p">PDE4D has been demonstrated to be the main subtype involved in the process of memory consolidation and LTP. The inhibition of PDE4 by <b>9</b> in PDE4D-deficient mice did not alter memory performance.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Thus, selective PDE4D inhibitors may have beneficial effects on cognition enhancement. However, the inhibition of PDE4D is also the main reason for the emetic side effects of a PDE4 inhibitor, as it may mimic the pharmacological actions of α2-adrenoceptor antagonists.<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93,94)</a></div><div class="NLM_p">GEBR-7b (<b>15</b>) is a selective PDE4D inhibitor, showing low inhibitory activities toward PDE4A4, PDE4B2, and PDE4C2 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> An in vivo study demonstrated that <b>15</b> improved spatial and object recognition memory in late-phase consolidation processes in object recognition and location tests. The level of cAMP in the hippocampus was increased without affecting the level of Aβ. The effect of <b>15</b> on memory was 3- to 10-fold more potent than that of <b>9</b>. In the xylazine/ketamine test, no emetic effect was observed in mice, even at doses of 30 times higher than those in the object location test for behavioral performance improvement. The greatly reduced emetic effect of <b>15</b> is probably due to the relatively low doses required to improve memory.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Most recently, the development of <b>15</b> led to a new molecule, <b>8a</b> (<b>16</b>), which showed good PDE4D3 selective inhibition and the ability to cross the blood–brain barrier.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> The brain/plasma ratio of <b>16</b> is 0.8, while those of roflumilast and rolipram are approximately 1 and 2, respectively. In the object recognition task, administration of <b>16</b> at a dose of 0.003 mg/kg significantly enhanced long-term memory performance and fully reversed the scopolamine induced short-term memory deficit without causing any emetic-like behavior. These results offered another strategy for the discovery of PDE4 inhibitors with nonemesis behavior for the treatment of AD.</div><div class="NLM_p">Recent studies demonstrated that allosteric modulators of PDE4D that do not completely inhibit enzymatic activity may enhance memory with reduced emetic effects. Unlike the usual PDE4 inhibitors, these PDE4D allosteric modulators form an allosteric binding to the specific phenylalanine in primates in the UCR2 region of PDE4D, resulting in its high affinity and selectivity. In the scopolamine-impaired mouse model, the PDE4D allosteric modulator D159687 (<b>17</b>), with an IC<sub>50</sub> of 27 nM against PDE4D and good selectivity, efficiently improved cognitive memory in novel object recognition and Y-maze tests (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Compared with <b>9</b>, <b>17</b> showed 100-fold less emetic in <i>S. murinus</i>, 3000-fold less in the beagle dog, and 500-fold less in monkey. Thus, <b>17</b> may work efficiently to improve memory with reduced emetic potential. The total brain/plasma AUC ratio for D159687 was above 1 across both rodents and primates.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></div><div class="NLM_p last">Another PDE4D allosteric modulator, BPN14770 (<b>18</b>), had IC<sub>50</sub> values of 8 and 130 nM against human and mouse PDE4D, respectively (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). This modulator also enhanced the long-term potential in hippocampal slices.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> In 2016, two clinical trials of <b>18</b> were conducted for the evaluation of its safety, tolerability, and pharmacokinetic profile in different subjects.<a onclick="showRef(event, 'ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref100 ref101">(100,101)</a> Another phase I trial to assess its effect on reversing scopolamine-induced cognitive impairment in healthy volunteers is in progress, with donepezil used as the positive control.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">2.5.  PDE5 Inhibitors</h3><div class="NLM_p">Phosphodiesterase-5 (PDE5) is a subfamily that hydrolyzes cGMP and has one isoform, PDE5A. Compared with other PDE subfamilies, the expression of PDE5A in the brain is relatively low. The levels of PDE5A mRNA are highest in the periphery, bladder, and lungs (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01370/suppl_file/jm7b01370_si_001.pdf" class="ext-link">Figure S5</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> However, several studies have demonstrated that PDE5 inhibitors have a potential therapeutic effect on the treatment of AD through stimulation of nitric oxide (NO)/cGMP signaling by elevating the level of cGMP. Currently, several PDE5 inhibitors, such as sildenafil and tadalafil, have been approved by the FDA for the treatment of erectile dysfunction and pulmonary arterial hypertension.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><div class="NLM_p">Sildenafil (<b>19</b>) has shown an IC<sub>50</sub> of 2.2 nM against PDE5A and moderate selectivity across other PDEs (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Its pharmaceutical properties, such as easily crossing the blood–brain barrier and lower toxicity, indicate that <b>19</b> is suitable as a candidate drug for the investigation of the effect and mechanism of PDE5 inhibitors in neurodegenerative processes.<a onclick="showRef(event, 'ref104 ref105 ref106 ref107 ref108 ref109'); return false;" href="javascript:void(0);" class="ref ref104 ref105 ref106 ref107 ref108 ref109">(104−109)</a><b>19</b> produced an immediate and long-lasting improvement of synaptic function, CREB phosphorylation, and memory in an APP/PS1 mouse model.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> In the same study, PDE5 inhibitor tadalafil and a highly selective PDE1 inhibitor IC354 (IC<sub>50</sub> = 80 nM) were also tested. Tadalafil (1 mg/kg, ip) did not improve either contextual fear conditioning or spatial working memory in APP/PS1 mice, and IC354 had no effect on the LTP amplitude in hippocampal slices. Further study proved that <b>19</b> regulates the level of Aβ possibly by modifying their production, metabolism, or clearance. The increased CREB phosphorylation might be due to the anti-inflammatory effect of <b>19</b> via the cGMP/PKG/pCREB signaling pathway.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Currently, <b>19</b> has already finished one phase IV trial for schizophrenia and one phase IV trial for Parkinson’s disease.<a onclick="showRef(event, 'ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref110 ref111">(110,111)</a> However, the clinical trial for AD has not been performed yet. It is worth mentioning that the selectivity of <b>19</b> for PDE1 and PDE6 is 180 and 12, respectively, and may cause mild vasodilatory effects and transiently disturb vision.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Current PDE5 inhibitors for the treatment of AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As is mentioned before, there are direct links between AD pathology with cerebrovascular disease. Compared to healthy controls, patients with AD usually have reduced cerebral blood flow (CBF), increased cerebrovascular resistance, and reduced cerebral metabolic rate. A clinical study on AD patients was performed in 2017, demonstrating that <b>19</b> could significantly improve the cerebral blood flow and oxygen consumption at a single dose of 50 mg. The cerebrovascular reactivity was decreased. This result indicated that the memory effect of PDE5 inhibitors may possibly be due to the increase in cerebral blood flow mediated by PDE5 expressed in endothelial brain tissue.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><div class="NLM_p">Tadalafil (<b>20</b>) is an efficient PDE5 inhibitor developed by Eli Lilly (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Compared with <b>19</b>, <b>20</b> has shown better selectivity against PDE6 and a longer half-life.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> These properties suggest that <b>20</b> might be more suitable than <b>19</b> as an anti-AD drug. However, the administration of <b>20</b> (1 mg/kg, ip) did not improve either contextual fear conditioning or spatial working memory in APP/PS1 mice, while <b>19</b> did.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> The main reason for this result has been attributed to the fact that <b>19</b> can cross the BBB, while <b>20</b> cannot. A further study in 2013 proved that 12% of tadalafil found in the bloodstream crosses the BBB and reaches the brain. Chronic treatment with <b>20</b> leads its accumulation in the brain of the J20 transgenic mouse model of AD, which reverses memory deficits. <b>20</b> is even more effective than <b>19</b> in the improvement of memory performance. The level of hyperphosphorylated  Tau protein decreased via activation of the pAkt/GSK3 pathway. Neither <b>20</b> nor <b>19</b> decreased the level of Aβ plaques, indicating that cognition enhancement by PDE5 inhibitors may occur without gross improvement of Aβ pathology.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Currently, a phase II clinical trial of tadalafil is underway in patients with cerebral small vessel disease, to identify whether tadalafil improves blood flow in deep brain tissue and potentially improves cognitive function<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><div class="NLM_p">A quinoline compound, <b>7a</b> (<b>21</b>), exhibited a higher inhibitory affinity (IC<sub>50</sub> = 0.27 nM) and better selectivity than <b>19</b>, vardenafil, and <b>20</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). In the APP/PS1 mouse model of AD, <b>21</b> crossed the blood–brain barrier readily and increased the level of cGMP in the mouse hippocampus, thus restoring synaptic plasticity and memory damage caused by the elevation of Aβ<sub>42</sub>.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a></div><div class="NLM_p last">The pathogenic mechanism of AD is complicated. A combination of multiple targets involved in AD has been considered more appropriate than individual ones. Histone deacetylase inhibitors (HDACIs) are potential modulators of cognitive impairment in AD. Administration of both the pan-HDACI vorinostat and PDE5 inhibitor <b>20</b> in aged Tg2576 mice effectively reversed the cognitive deficits and increased the reduced dendritic spine density in hippocampal neurons. The coadministration of these two drugs gave better and longer-lasting effects than each drug alone.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> On the basis of this result, CM-414 (<b>22</b>), an inhibitor acting on both PDE5 and HDAC, was developed with remarkable IC<sub>50</sub> values against PDE5 and moderate inhibition against HDAC class I (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a><b>22</b> was able to cross the blood–brain barrier, inducing AcH3K9 acetylation and CREB phosphorylation in the hippocampus and rescuing LTP in APP/PS1 mice. Chronic treatment of Tg2576 mice with <b>22</b> decreased the level of Aβ and Tau phosphorylation in the brain and increased the inactive form of GSK3β. Both the decrease in dendritic spine density in hippocampal neurons and the cognitive deficits were reversed. Thus, <b>22</b> may act as an efficient PDE5/HDAC dual inhibitor with a good safety profile, and it may be worth exploration in the clinical trials for AD patients.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.6.  PDE7 Inhibitors</h3><div class="NLM_p">PDE7 is a cAMP-specific subfamily composed of two isoforms, PDE7A and PDE7B. Compared with other PDEs, the expression of PDE7 is relatively low in all tissues. The expression of PDE7B is relatively higher than that of PDE7A in the CNS, such as in the caudate, nucleus accumbens, cortical tissues, and hippocampus. In the periphery, the level of PDE7A is higher than or equal to that of PDE7B in the heart, lungs, etc. (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01370/suppl_file/jm7b01370_si_001.pdf" class="ext-link">Figure S6</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Moreover, in situ hybridization demonstrated that the expression of PDE7B remained unchanged and that PDE7A was reduced in the hippocampal regions of advanced AD patients.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Several PDE7 inhibitors have been recently reported to be potential new agents for the treatment of brain diseases. However, investigation of PDE7 inhibitors for the treatment of AD is still limited.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div><div class="NLM_p">A quinazoline compound, S14 (<b>23</b>), was identified by the CODES program with IC<sub>50</sub> values of 4.7 and 8.8 μM against PDE7A and PDE7B, respectively, as well as good selectivity over the other five PDEs (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref122 ref123">(122,123)</a> In the APP/PS1 mouse, its administration reduced behavioral impairment in the T-maze via the cAMP/CREB signaling pathway. Moreover, <b>23</b> reduced the accumulation of Aβ deposits and modulated brain astrocyte distribution. Significant decreases in Tau phosphorylation, cell death, and proapoptotic protein expression were also observed.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Current PDE7 inhibitor for the treatment of AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">2.7.  PDE9 Inhibitors</h3><div class="NLM_p">PDE9 is a subfamily that hydrolyzes cGMP only. Among the 11 PDE subfamilies, PDE9 has the highest binding affinity for cGMP (<i>K</i><sub>m</sub> = 70 nM) with only isoform PDE9A.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> The expression of PDE9A occurs in most human tissues (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01370/suppl_file/jm7b01370_si_001.pdf" class="ext-link">Figure S8</a>). In the CNS, the highest levels of PDE9A are in the caudate nucleus and cerebellum. In the periphery, the highest level of PDE9 occurs in the bladder. PDE9 has been regarded as an important target since several efficient inhibitors are in clinical trials for the treatment of AD.</div><div class="NLM_p">In 2005, the first selective PDE9 inhibitor, BAY 73-6691 (<b>24</b>), was reported by Bayer. <b>24</b> showed an IC<sub>50</sub> of 55 nM against PDE9A and moderate selectivity over PDE1 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> A program was performed to investigate its potential treatment effect on neurological diseases, including AD, but was terminated in 2004 with no reason disclosed. Currently, <b>24</b> is often used as a tool in medicine to investigate the underlying mechanism of PDE9A inhibition in AD.<a onclick="showRef(event, 'ref127 ref128 ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref127 ref128 ref129 ref130">(127−130)</a><b>24</b> enhanced the ability of acquisition, consolidation, and retention of LTP in social and object recognition tasks in rodents, improving the scopolamine-induced passive avoidance deficit and the MK-801-induced short-term memory deficits.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Compared with donepezil, which only increased early LTP, <b>24</b> improved both early and late LTP, even transforming early into late LTP. These results indicated that PDE9 inhibition might have better therapeutic effects on AD patients than donepezil.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> In APP transgenic Tg2576 mice with Alzheimer’s plaque pathology, <b>24</b> restored Aβ<sub>42</sub> oligomer-induced LTP and improved memory performance.<a onclick="showRef(event, 'ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref129 ref130">(129,130)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Current PDE9 inhibitors for the treatment of AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">PF-04447943 (<b>25</b>) is a highly selective and brain penetrant PDE9A inhibitor that was developed by Pfizer in 2011, with an IC<sub>50</sub> of 8.3 nM against PDE9A and above 100-fold selectivity over other PDEs (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Compared with other current AD drugs, which only ameliorate learning and memory function, <b>25</b> was able to reverse scopolamine-induced deficits in both the Morris water maze and novel object recognition tests.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> In the Y-maze spatial recognition memory, social recognition memory, and scopolamine-deficit novel object recognition tasks, <b>25</b> significantly improved cognitive performance.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> In the Tg2576 mouse model of amyloid precursor protein (APP) overexpression, <b>25</b> regulated the dendritic spine density of hippocampal neurons.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a>A preclinical test proved that <b>25</b> has excellent tolerability, exposure, and a long half-life of 19–31 h. Currently, <b>25</b> has already completed six phase I trials and one phase II trial for AD. In the six phase I trials, its safety, tolerability, and blood level after multiple doses were evaluated in different subjects with good results. One phase I trial was performed to evaluate its safety when given in combination with donepezil in AD patients and to evaluate the absorption and distribution of both it and donepezil.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Its efficacy, safety, and pharmacokinetics were investigated in a phase II trial in subjects with mild to moderate probable AD.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> However, its administration over 2 weeks did not improve cognitive behavior or cause global changes with statistically significant differences compared with a placebo.</div><div class="NLM_p">BI-409306 was developed by Boehringer Ingelheim for the treatment of cognitive disorder diseases, such as AD and schizophrenia (IC<sub>50</sub> = 52 nM). Currently, BI-409306 has already completed 15 phase I trials. The safety, tolerability, and pharmacokinetics of BI-409306 were investigated in different subjects, including healthy males, CYP2C19-genotyped persons, and patients with AD. The results showed that BI-409306 was safe and well tolerated in most subjects. The most commonly experienced adverse effects were headache and photopsia, with mild to moderate intensity, which might be caused by the modulation of PDE9A of some processes in the retina. Furthermore, in a study aiming to assess its exposure in cerebrospinal fluid, BI-409306 was found to cross the blood–CSF barrier and be rapidly absorbed in plasma and distributed in CSF. The level of cGMP in CSF increased in a dose-dependent manner. Currently, two phase II trials for AD are in progress.<a onclick="showRef(event, 'ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref137 ref138">(137,138)</a> One trial aims to investigate its effect on cognitive impairment in AD patients in comparison with a placebo or donepezil. The other trial aims to explore the effect of different doses on the treatment of AD. IMR-687(<b>26</b>) and PF-4181366, developed by H. Lundbeck company and Pfizer, respectively were evaluated in preclinical and clinical trials of AD, but no progress has been reported.</div><div class="NLM_p last">A series of PDE9 inhibitors was reported by Luo’s group with the assistance of structure-based design and computational docking (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Compound <b>27</b> has an IC<sub>50</sub> of 21 nM against PDE9A and >150-fold selectivity over other PDEs. Further structural modification of compound <b>27</b> led to compound <b>3r</b> (<b>28</b>), with an improved IC<sub>50</sub> of 0.6 nM. However, these two compounds were designed for the treatment of diabetes, and thus, their physicochemical properties might be beyond the range of CNS drugs.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Compound <b>C33</b> (<b>29</b>), with an IC<sub>50</sub> value of 16 nM against PDE9 and moderate selectivity over other PDEs, could significantly improve memory and cognitive impairment induced by scopolamine or Aβ<sub>25–35</sub>.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> In 2015, Luo’s group used a combinatorial method to discover novel PDE9 inhibitors with new scaffolds rather than pyrazolopyrimidinones from the SPECS database.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Fifteen hits out of 29 molecules, with five novel scaffolds, were identified as PDE9 inhibitors. Further structural modification of compound AG-690/40135604 (IC<sub>50</sub> = 8.0 μM) led to a new compound <b>30</b>, with an improved inhibitory affinity of 2.1 μM. The five novel scaffolds discovered could be used for the rational design of PDE9 inhibitors with higher affinities.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">2.8.  PDE10 Inhibitors</h3><div class="NLM_p">PDE10A is a dual-specificity subfamily that hydrolyzes cAMP (<i>K</i><sub>m</sub> = 0.05 μM) and cGMP (<i>K</i><sub>m</sub> = 3 μM).<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> The highest expression of PDE10A in the brain is in the caudate nucleus, and it is also the most prevalent PDE species in this tissue, together with PDE1B. The level of PDE10A is relatively high in the nucleus accumbens. In other parts of the brain and the peripheral tissues examined, the level of PDE10 mRNA could be detected but was very low (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01370/suppl_file/jm7b01370_si_001.pdf" class="ext-link">Figure S8</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Furthermore, the level of PDE10A decreased in the striatum of patients with Huntington’s disease and immediately preceded the onset of motor symptoms.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Currently, PDE10 is considered a promising target for CNS diseases, especially for schizophrenia and Huntington’s disease.</div><div class="NLM_p">PF-02545920 (<b>31</b>, MP-10) was developed by Pfizer (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> After its safety, tolerability, and pharmacokinetics in different subjects were identified in five phase I trials, its efficacy in the treatment of schizophrenia was evaluated in three phase II trials. However, <b>31</b> failed to reach its primary efficacy end-point in a trial with schizophrenia patients in 2012, and thus, its condition was changed to Huntington’s disease, which was completed in 2014.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Another phase II trial in 2015 sought to investigate its long-term safety, tolerability, and efficacy in subjects with Huntington’s disease. However, this study was terminated in 2016 due to no significant difference being observed in the primary end point between <b>31</b> and placebo.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Current PDE10 inhibitors for the treatment of AD and other diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">TAK-063 (<b>32</b>), developed by Takeda by using structure-based drug design (SBDD) techniques, has an IC<sub>50</sub> of 0.30 nM against PDE10 (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Its selectivity over other PDEs could be up to 15 000-fold. Its pharmacokinetics were promising, including high brain penetration in mice.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> In vivo studies have demonstrated that <b>32</b> produced dose-dependent, antipsychotic-like effects in METH-induced hyperactivity and prepulse inhibition in rodents.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Furthermore, <b>32</b> attenuated both phencyclidine-induced working memory deficits in a Y-maze test in mice and MK-801-induced working memory deficits in an eight-arm radial maze task in rats.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Recently, <b>32</b> has been evaluated in a phase II trial for the treatment of acutely exacerbated schizophrenia.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a></div><div class="NLM_p last">OMS-824 (<b>33</b>, OMS643762), developed by Omeros Corporation, has finished one phase II trial that evaluated its safety, tolerability, and pharmacokinetics in psychiatrically stable schizophrenia patients (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Another phase I trial of <b>33</b> in subjects with Huntington’s disease has been suspended with no reason disclosed.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Another PDE10 inhibitor, EVP-6308, has finished a phase II trial in subjects with schizophrenia who are on a stable antipsychotic regimen.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">3.  Other PDE Subfamilies and Their Application</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11615" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11615" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PDE6 is an enzyme-specific hydrolyzing cGMP that is divided into three subtypes: PDE6A, -6B, and -6C. The retina is the only human tissue with high levels of PDE6A expression. PDE6 has not been detected in the CNS.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Currently, the purification of PDE6 enzyme is still a challenge, and no selective PDE6 inhibitor has been reported yet.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> The structural, biochemical, and pharmacologic properties of PDE6 are closely related to PDE5. PDE5 inhibitors, such as sildenafil, vardenafil, and tadalafil, have exhibited low selectivity toward PDE6, which may disturb the cGMP signaling pathway in the retina during treatment for other diseases and may cause side effects, including visual disturbances, blurry vision, and light sensitivity.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a></div><div class="NLM_p">PDE8 specifically hydrolyzes cAMP, which is coded by two genes: PDE8A and PDE8B. PDE8A exists throughout the brain and peripheral organs at low levels, while PDE8B is mainly expressed in the brain and thyroid.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> On the basis of its expression, PDE8 has been considered a target for the treatment of thyroid dysfunction and modulation of steroidogenesis in the testes and adrenal glands.<a onclick="showRef(event, 'ref157 ref158 ref159'); return false;" href="javascript:void(0);" class="ref ref157 ref158 ref159">(157−159)</a> Furthermore, the overexpression of PDE8B, as well as PDE7, has been observed in the brains of Alzheimer’s patients, indicating that the inhibition of PDE8B was able to enhance memory function by the activation of the cAMP signal pathway. However, only a few PDE8-selective inhibitors are available,<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> limiting the usage of PDE8.</div><div class="NLM_p last">PDE11A is the only isoform of PDE11 that hydrolyzes both cAMP and cGMP. PDE11A is expressed at relatively low levels in most tissues, especially in the cortex and the hippocampus.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Studies of PDE11 are few, and the biological roles of PDE11 are poorly understood due to the lack of selective inhibitors.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">4.  Prospective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05138" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05138" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In light of the recent high-profile phase III failures of several Aβ-targeting agents, such as bapineuzumab and solanuzumab, there has been a trend to refocus on the discovery of novel non-Aβ-directed, anti-AD drugs rather than acetylcholine inhibitors and NMDA antagonists, which still have a long way to go.</div><div class="NLM_p">Over the past 20 decades, great efforts have been made to understand the roles of PDEs and to discover effective inhibitors for cognitive improvement in AD. Compared with other hot research areas related to the deposition of Aβ or aggregation of Tau protein, PDE inhibitors hydrolyze two important second messengers (cAMP/cGMP), which can be used before the formation of amyloid plaques and neurofibrillary tangles, regulating central nervous system function such as emotion-related learning, memory, and neural regeneration. Alterations in the levels of cAMP and cGMP are due to the accumulation of cyclase and the degradation of PDE regulation. The regulation of the concentration of cAMP/cGMP makes PDEs promising drug targets. Until now, there have been many reports of PDE inhibitors with outstanding and remarkable effects on memory in AD in preclinical (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) or clinical (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) trials. The role of PDE inhibitors in improving learning and memory is gaining more and more data, but the underlying mechanisms are still not fully understood. Sufficient evidence has demonstrated that the cAMP-mediated PKA/CREB or cGMP-mediated PKG/CREB signaling pathways are involved in this process. In addition, enhanced cAMP/cGMP concentrations by several PDE inhibitors can significantly improve both early and late LTP, even transforming early into late LTP, which demonstrates that the inhibition of PDEs might have better therapeutic effects on AD patients than acetylcholine inhibitors and suggests a possible mechanism for the use of PDE inhibitors in the treatment of AD. This finding may lead to the development of drugs for treating cognitive dysfunctions, especially in AD.</div><div class="NLM_p last">As candidates for the treatment of AD, PDE inhibitors may cause several adverse reactions, which greatly limits their clinical applications. For example, most current PDE4 inhibitor including roflumilast may cause nausea, emesis, diarrhea, and headache, due to the inhibition of PDE4D subtype. PDE5 inhibitor sildenafil may cause visual abnormality as it inhibits PDE6 at the same time. Solutions for avoiding these side effects should be further studied through effective methods. Many studies used structure-based molecular design methods to discover highly selective PDE inhibitors. In addition, the discovery of novel allosteric modulators<a onclick="showRef(event, 'ref93 ref94 ref95 ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref93 ref94 ref95 ref96 ref97">(93−97)</a> based on the allosteric site of PDEs could significantly improve their selectivity and decrease the likelihood of side effects. Such allosteric modulators will provide a better basis for the development of future anti-AD drugs in the field of PDE inhibitors, but their role needs to be examined in further preclinical or clinical evaluations.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01370" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01370" class="ext-link">10.1021/acs.jmedchem.7b01370</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figures showing expression of mRNA for PDEs in human tissues (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01370/suppl_file/jm7b01370_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01370/suppl_file/jm7b01370_si_001.pdf">jm7b01370_si_001.pdf (421.43 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01370" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30456" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30456" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hai-Bin Luo</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2163-0509" title="Orcid link">http://orcid.org/0000-0002-2163-0509</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5539203a3d3762621538343c397b262c26207b3031207b363b"><span class="__cf_email__" data-cfemail="a1cdd4cec9c39696e1ccc0c8cd8fd2d8d2d48fc4c5d48fc2cf">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yinuo Wu</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhe Li</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi-You Huang</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deyan Wu</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51547" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51547" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Yinuo Wu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=BIO-d81e2709-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yinuo Wu</b> is currently an Assistant Professor in the School of Pharmaceutical Sciences at Sun Yat-sen University (SYSU). She received her Ph.D. degree at SYSU in 2011 and subsequently went to Hong Kong Polytechnic University as a postdoctoral fellow. Her research encompasses discovery of novel PDEs inhibitors and their applications in the treatment of neurological disorders.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Zhe Li</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=BIO-d81e2714-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zhe Li</b> is currently an Assistant Professor in the School of Pharmaceutical Sciences at Sun Yat-sen University (SYSU). He received his Ph.D. degree in Medicinal Chemistry from SYSU in 2017. During his Ph.D. study, he went to Prof. Chang-Guo Zhan’s group as an exchange student in University of Kentucky for two years. His research in medicinal chemistry focuses on the development of drug design methods and the applications of these methods in the development of novel PDEs inhibitors.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Yi-You Huang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=BIO-d81e2719-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yiyou Huang</b> is currently pursuing his Ph.D. in the School of Pharmaceutical Sciences at Sun Yat-sen University under the supervision of Prof. Hai-Bin Luo. He went to Prof. Hengming Ke’s group as a visiting scholar in the University of North Carolina at Chapel Hill from April 2017 to October 2017. His research focuses in structural biology and their applications on the design of novel PDE inhibitors.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Deyan Wu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=BIO-d81e2724-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Deyan Wu</b> is currently an Assistant Professor in the School of Pharmaceutical Sciences at Sun Yat-sen University (SYSU). He received his Ph.D. degree at East China University of Science & Technology in 2014 and subsequently worked at ChemPartner as a senior researcher. After one-year research, he joined Sun Yat-sen University as an Assistant Professor. His research is currently specialized in medicinal chemistry and total synthesis of natural products, focusing on the research and development of PDEs inhibitors for treatment of pulmonary arterial hypertension (PAH), erectile dysfunction (ED), chronic obstructive pulmonary disease (COPD), and structural modification of active natural products as novel PDEs inhibitors.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Hai-Bin Luo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=BIO-d81e2729-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Hai-Bin Luo</b> is currently a Full Professor and the Associate Dean of the School of Pharmaceutical Sciences at Sun Yat-sen University (SYSU). He received his Bachelor’s degree from Xiamen University in 1999 and Ph.D. degree from Hong Kong Baptist University in 2005. After one-year postdoctoral research, he joined Sun Yat-sen University as an Associate Professor. His research currently encompasses the rational design and discovery of novel PDEs inhibitors and their applications in the treatment of several diseases.</p></figure></div><div class="ack" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Key R&D Program of China (Grant 2017YFB0202600), Natural Science Foundation of China (Grants 21402243, 21572279, 81522041, 81373258, and 81602968), Science Foundation of Guangdong Province (Grants 2014A020210009 and 2016A030310144), Guangdong Province Higher Vocational Colleges & Schools Pearl River Scholar Funded Scheme (2016), and Foundation of Traditional Chinese Medicine, Bureau of Guangdong Province (Grant 20171049).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61808" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61808" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 160 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stopschinski, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, M. I.</span></span> <span> </span><span class="NLM_article-title">The prion model for progression and diversity of neurodegenerative diseases</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">332</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(17)30037-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2FS1474-4422%2817%2930037-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=28238712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=323-332&author=B.+E.+Stopschinskiauthor=M.+I.+Diamond&title=The+prion+model+for+progression+and+diversity+of+neurodegenerative+diseases&doi=10.1016%2FS1474-4422%2817%2930037-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The prion model for progression and diversity of neurodegenerative diseases</span></div><div class="casAuthors">Stopschinski, Barbara E.; Diamond, Marc I.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">323-332</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The neuropathol. of different neurodegenerative diseases begins in different brain regions, and involves distinct brain networks.  Evidence indicates that transcellular propagation of protein aggregation, which is the basis of prion disease, might underlie the progression of pathol. in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.  The prion model predicts specific patterns of neuronal vulnerability and network involvement on the basis of the conformation of pathol. proteins.  Indeed, evidence indicates that self-propagating aggregate conformers, or so-called strains, are assocd. with distinct neuropathol. syndromes.  The extension of this hypothesis to our understanding of common neurodegenerative disorders can suggest new therapeutic approaches, such as immunotherapy and small mols., to block transcellular propagation, and new diagnostic tools to detect early evidence of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnR2DhaWpjBbVg90H21EOLACvtfcHk0lhTXvNc2JcgAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGkt7w%253D&md5=e42b6241cba73884d43777c0bfc85b50</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2817%2930037-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252817%252930037-6%26sid%3Dliteratum%253Aachs%26aulast%3DStopschinski%26aufirst%3DB.%2BE.%26aulast%3DDiamond%26aufirst%3DM.%2BI.%26atitle%3DThe%2520prion%2520model%2520for%2520progression%2520and%2520diversity%2520of%2520neurodegenerative%2520diseases%26jtitle%3DLancet%2520Neurol.%26date%3D2017%26volume%3D16%26spage%3D323%26epage%3D332%26doi%3D10.1016%2FS1474-4422%2817%2930037-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span>Alzheimer’s
Disease International. World Alzheimer Report 2015. <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf" class="extLink">ps://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s%0ADisease+International.+World+Alzheimer+Report+2015.+ps%3A%2F%2Fwww.alz.co.uk%2Fresearch%2FWorldAlzheimerReport2015.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goedert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spillantini, M. G.</span></span> <span> </span><span class="NLM_article-title">A century of Alzheimer’s disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>314</i></span>,  <span class="NLM_fpage">777</span>– <span class="NLM_lpage">781</span>, <span class="refDoi"> DOI: 10.1126/science.1132814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1126%2Fscience.1132814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=17082447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKit73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=777-781&author=M.+Goedertauthor=M.+G.+Spillantini&title=A+century+of+Alzheimer%E2%80%99s+disease&doi=10.1126%2Fscience.1132814"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A Century of Alzheimer's Disease</span></div><div class="casAuthors">Goedert, Michel; Spillantini, Maria Grazia</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">5800</span>),
    <span class="NLM_cas:pages">777-781</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  One hundred years ago a small group of psychiatrists described the abnormal protein deposits in the brain that define the most common neurodegenerative diseases.  Over the past 25 years, it has become clear that the proteins forming the deposits are central to the disease process.  Amyloid-β and tau make up the plaques and tangles of Alzheimer's disease, where these normally sol. proteins assemble into amyloid-like filaments.  Tau inclusions are also found in a no. of related disorders.  Genetic studies have shown that dysfunction of amyloid-β or tau is sufficient to cause dementia.  The ongoing mol. dissection of the neurodegenerative pathways is expected to lead to a true understanding of disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlvQWrY5FMmrVg90H21EOLACvtfcHk0lhTXvNc2JcgAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKit73K&md5=6e152685c65d4a08e0b23c0807a35149</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1132814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1132814%26sid%3Dliteratum%253Aachs%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26atitle%3DA%2520century%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D777%26epage%3D781%26doi%3D10.1126%2Fscience.1132814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucke, L.</span></span> <span> </span><span class="NLM_article-title">Alzheimer mechanisms and therapeutic strategies</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1222</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.02.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.cell.2012.02.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=22424230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1CqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=1204-1222&author=Y.+Huangauthor=L.+Mucke&title=Alzheimer+mechanisms+and+therapeutic+strategies&doi=10.1016%2Fj.cell.2012.02.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer Mechanisms and Therapeutic Strategies</span></div><div class="casAuthors">Huang, Yadong; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1204-1222</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  There are still no effective treatments to prevent, halt, or reverse Alzheimer's disease, but research advances over the past three decades could change this gloomy picture.  Genetic studies demonstrate that the disease has multiple causes.  Interdisciplinary approaches combining biochem., mol. and cell biol., and transgenic modeling have revealed some of its mol. mechanisms.  Progress in chem., radiol., and systems biol. is beginning to provide useful biomarkers, and the emergence of personalized medicine is poised to transform pharmaceutical development and clin. trials.  However, investigative and drug development efforts should be diversified to fully address the multifactoriality of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx4Jw1D9na57Vg90H21EOLACvtfcHk0lhTXvNc2JcgAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1CqurY%253D&md5=4f44f2d5019321a668029282777946d1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.040%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DAlzheimer%2520mechanisms%2520and%2520therapeutic%2520strategies%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D1204%26epage%3D1222%26doi%3D10.1016%2Fj.cell.2012.02.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolgin, E.</span></span> <span> </span><span class="NLM_article-title">Failed Alzheimer’s trial does not kill leading theory of disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>540</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1038/nature.2016.21045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnature.2016.21045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=27905452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFylsLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=540&publication_year=2016&pages=15-16&author=A.+Abbottauthor=E.+Dolgin&title=Failed+Alzheimer%E2%80%99s+trial+does+not+kill+leading+theory+of+disease&doi=10.1038%2Fnature.2016.21045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Failed Alzheimer's trial does not kill leading theory of disease</span></div><div class="casAuthors">Abbott, Alison; Dolgin, Elie</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">540</span>
        (<span class="NLM_cas:issue">7631</span>),
    <span class="NLM_cas:pages">15-16</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Solanezumab flopped in a large clin. trial, but the drug or others like it could yet succeed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg8_Ct6Pm-f7Vg90H21EOLACvtfcHk0lh7hM_WG8eW0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFylsLjI&md5=32717907cf9871c72a44d373c5b45aa7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature.2016.21045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature.2016.21045%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DA.%26aulast%3DDolgin%26aufirst%3DE.%26atitle%3DFailed%2520Alzheimer%25E2%2580%2599s%2520trial%2520does%2520not%2520kill%2520leading%2520theory%2520of%2520disease%26jtitle%3DNature%26date%3D2016%26volume%3D540%26spage%3D15%26epage%3D16%26doi%3D10.1038%2Fnature.2016.21045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, M.</span></span> <span> </span><span class="NLM_article-title">Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010–2015</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1080/13543784.2017.1323868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1080%2F13543784.2017.1323868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=28460541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot1Shu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=735-739&author=D.+Mehtaauthor=R.+Jacksonauthor=G.+Paulauthor=J.+Shiauthor=M.+Sabbagh&title=Why+do+trials+for+Alzheimer%E2%80%99s+disease+drugs+keep+failing%3F+A+discontinued+drug+perspective+for+2010%E2%80%932015&doi=10.1080%2F13543784.2017.1323868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015</span></div><div class="casAuthors">Mehta, Dev; Jackson, Robert; Paul, Gaurav; Shi, Jiong; Sabbagh, Marwan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">735-739</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: There are dozens of drugs in development for AD with billions of dollars invested.  Despite the massive investment in AD drugs and a burgeoning pipeline, there have been more setbacks and failures than treatment successes.: The classes of drugs that have failed to date include the monoclonal antibodies, the gamma secretase inhibitors, dimebon, neurochem. enhancers, and one tau drug.  Data for these compds. were sought through a PubMed search and a clin. trials.gov search.: The obvious question to be posed is: Why are they failing.  Is the treatment of symptomatic dementia too late.  Are the therapeutic targets incorrect.  Are the clin. methodologies imprecise, misleading, or inaccurate.  This review summarizes the drugs that have failed during 2010-2015 and offers possible theories as to why they have failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphTh-OjoTzgbVg90H21EOLACvtfcHk0lh7hM_WG8eW0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot1Shu7Y%253D&md5=efa88fffd86b5674b1b3f19342947933</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F13543784.2017.1323868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543784.2017.1323868%26sid%3Dliteratum%253Aachs%26aulast%3DMehta%26aufirst%3DD.%26aulast%3DJackson%26aufirst%3DR.%26aulast%3DPaul%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DSabbagh%26aufirst%3DM.%26atitle%3DWhy%2520do%2520trials%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520drugs%2520keep%2520failing%253F%2520A%2520discontinued%2520drug%2520perspective%2520for%25202010%25E2%2580%25932015%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2017%26volume%3D26%26spage%3D735%26epage%3D739%26doi%3D10.1080%2F13543784.2017.1323868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mosconi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glodzik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pupi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Santi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon, M. J.</span></span> <span> </span><span class="NLM_article-title">Pre-clinical detection of Alzheimer’s disease using FDG-PET, with or without amyloid imaging</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">854</span>, <span class="refDoi"> DOI: 10.3233/JAD-2010-091504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.3233%2FJAD-2010-091504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20182025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BC3cvot1KhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=843-854&author=L.+Mosconiauthor=V.+Bertiauthor=L.+Glodzikauthor=A.+Pupiauthor=S.+De+Santiauthor=M.+J.+de+Leon&title=Pre-clinical+detection+of+Alzheimer%E2%80%99s+disease+using+FDG-PET%2C+with+or+without+amyloid+imaging&doi=10.3233%2FJAD-2010-091504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging</span></div><div class="casAuthors">Mosconi Lisa; Berti Valentina; Glodzik Lidia; Pupi Alberto; De Santi Susan; de Leon Mony J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">843-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The development of prevention therapies for Alzheimer's disease (AD) would greatly benefit from biomarkers that are sensitive to subtle brain changes occurring in the preclinical stage of the disease.  Early diagnostics is necessary to identify and treat at risk individuals before irreversible neuronal loss occurs.  In vivo imaging has long been used to evaluate brain structural and functional abnormalities as predictors of future AD in non-demented persons.  Prior to development of amyloid-beta (Abeta) tracers for positron emission tomography (PET), the most widely utilized PET tracer in AD was 2-[18F]fluoro-2-Deoxy-D-glucose (FDG) PET.  For over 20 years, FDG-PET has been used to measure cerebral metabolic rates of glucose (CMRglc), a proxy for neuronal activity, in AD.  Many studies have shown that CMRglc reductions occur early in AD, correlate with disease progression, and predict histopathological diagnosis.  This paper reviews reports of clinical and preclinical CMRglc reductions observed in association with genetic and non-genetic risk factors for AD.  We then briefly review brain Abeta PET imaging studies in AD and discuss the potential of combining symptoms-sensitive FDG-PET measures with pathology-specific Abeta-PET to improve the early detection of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRa4AJGgW2Fdz69zv1FsJFMfW6udTcc2eZZ6L4g0WSg67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cvot1KhtQ%253D%253D&md5=2355d20a2e0c79a8ac4b12e7306680e1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-091504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-091504%26sid%3Dliteratum%253Aachs%26aulast%3DMosconi%26aufirst%3DL.%26aulast%3DBerti%26aufirst%3DV.%26aulast%3DGlodzik%26aufirst%3DL.%26aulast%3DPupi%26aufirst%3DA.%26aulast%3DDe%2BSanti%26aufirst%3DS.%26aulast%3Dde%2BLeon%26aufirst%3DM.%2BJ.%26atitle%3DPre-clinical%2520detection%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520using%2520FDG-PET%252C%2520with%2520or%2520without%2520amyloid%2520imaging%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2010%26volume%3D20%26spage%3D843%26epage%3D854%26doi%3D10.3233%2FJAD-2010-091504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bender, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">488</span>– <span class="NLM_lpage">520</span>, <span class="refDoi"> DOI: 10.1124/pr.58.3.5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1124%2Fpr.58.3.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16968949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=488-520&author=A.+T.+Benderauthor=J.+A.+Beavo&title=Cyclic+nucleotide+phosphodiesterases%3A+molecular+regulation+to+clinical+use&doi=10.1124%2Fpr.58.3.5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use</span></div><div class="casAuthors">Bender, Andrew T.; Beavo, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">488-520</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that regulate the cellular levels of the second messengers, cAMP and cGMP, by controlling their rates of degrdn.  There are 11 different PDE families, with each family typically having several different isoforms and splice variants.  These unique PDEs differ in their three-dimensional structure, kinetic properties, modes of regulation, intracellular localization, cellular expression, and inhibitor sensitivities.  Current data suggest that individual isoenzymes modulate distinct regulatory pathways in the cell.  These properties therefore offer the opportunity for selectively targeting specific PDEs for treatment of specific disease states.  The feasibility of these enzymes as drug targets is exemplified by the com. and clin. successes of the erectile dysfunction drugs, sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra).  PDE inhibitors are also currently available or in development for treatment of a variety of other pathol. conditions.  In this review the basic biochem. properties, cellular regulation, expression patterns, and physiol. functions of the different PDE isoforms will be discussed.  How these properties relate to the current and future development of PDE inhibitors as pharmacol. agents is esp. considered.  PDEs hold great promise as drug targets and recent research advances make this an exciting time for the field of PDE research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJl4RDiZ0ugrVg90H21EOLACvtfcHk0lh7hM_WG8eW0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfI&md5=af31cf6952efe7adb428a951779f36bc</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.5%26sid%3Dliteratum%253Aachs%26aulast%3DBender%26aufirst%3DA.%2BT.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DCyclic%2520nucleotide%2520phosphodiesterases%253A%2520molecular%2520regulation%2520to%2520clinical%2520use%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D488%26epage%3D520%26doi%3D10.1124%2Fpr.58.3.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganiello, V. C.</span></span> <span> </span><span class="NLM_article-title">Advances in targeting cyclic nucleotide phosphodiesterases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1038/nrd4228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnrd4228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=24687066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFOiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=290-314&author=D.+H.+Mauriceauthor=H.+Keauthor=F.+Ahmadauthor=Y.+Wangauthor=J.+Chungauthor=V.+C.+Manganiello&title=Advances+in+targeting+cyclic+nucleotide+phosphodiesterases&doi=10.1038%2Fnrd4228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in targeting cyclic nucleotide phosphodiesterases</span></div><div class="casAuthors">Maurice, Donald H.; Ke, Hengming; Ahmad, Faiyaz; Wang, Yousheng; Chung, Jay; Manganiello, Vincent C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">290-314</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cyclic GMP, thereby regulating the intracellular concns. of these cyclic nucleotides, their signalling pathways and, consequently, myriad biol. responses in health and disease.  Currently, a small no. of PDE inhibitors are used clin. for treating the pathophysiol. dysregulation of cyclic nucleotide signalling in several disorders, including erectile dysfunction, pulmonary hypertension, acute refractory cardiac failure, intermittent claudication and chronic obstructive pulmonary disease.  However, pharmaceutical interest in PDEs has been reignited by the increasing understanding of the roles of individual PDEs in regulating the subcellular compartmentalization of specific cyclic nucleotide signalling pathways, by the structure-based design of novel specific inhibitors and by the development of more sophisticated strategies to target individual PDE variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwMRfUs-zUmLVg90H21EOLACvtfcHk0lgf_Z8hDckSRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFOiu7s%253D&md5=410c8d5bb5fbd7d2906e30dc1b5f2876</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd4228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4228%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DD.%2BH.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DJ.%26aulast%3DManganiello%26aufirst%3DV.%2BC.%26atitle%3DAdvances%2520in%2520targeting%2520cyclic%2520nucleotide%2520phosphodiesterases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D290%26epage%3D314%26doi%3D10.1038%2Fnrd4228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azevedo, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucz, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bimpaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Alexandre, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganiello, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratakis, C. A.</span></span> <span> </span><span class="NLM_article-title">Clinical and molecular genetics of the phosphodiesterases (PDEs)</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1210/er.2013-1053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1210%2Fer.2013-1053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=24311737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVahu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=195-233&author=M.+F.+Azevedoauthor=F.+R.+Fauczauthor=E.+Bimpakiauthor=A.+Horvathauthor=I.+Levyauthor=R.+B.+de+Alexandreauthor=F.+Ahmadauthor=V.+Manganielloauthor=C.+A.+Stratakis&title=Clinical+and+molecular+genetics+of+the+phosphodiesterases+%28PDEs%29&doi=10.1210%2Fer.2013-1053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and molecular genetics of the phosphodiesterases (PDEs)</span></div><div class="casAuthors">Azevedo, Monalisa F.; Faucz, Fabio R.; Bimpaki, Eirini; Horvath, Anelia; Levy, Isaac; de Alexandre, Rodrigo B.; Ahmad, Faiyaz; Manganiello, Vincent; Stratakis, Constantine A.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-233</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that have the unique function of terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP.  They are crit. regulators of the intracellular concns. of cAMP and cGMP as well as of their signaling pathways and downstream biol. effects.  PDEs have been exploited pharmacol. for more than half a century, and some of the most successful drugs worldwide today affect PDE function.  Recently, mutations in PDE genes have been identified as causative of certain human genetic diseases; even more recently, functional variants of PDE genes have been suggested to play a potential role in predisposition to tumors and/or cancer, esp. in cAMP-sensitive tissues.  Mouse models have been developed that point to wide developmental effects of PDEs from heart function to reprodn., to tumors, and beyond.  This review brings together knowledge from a variety of disciplines (biochem. and pharmacol., oncol., endocrinol., and reproductive sciences) with emphasis on recent research on PDEs, how PDEs affect cAMP and cGMP signaling in health and disease, and what pharmacol. exploitations of PDEs may be useful in modulating cyclic nucleotide signaling in a way that prevents or treats certain human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTE7qPz_LMLrVg90H21EOLACvtfcHk0lgf_Z8hDckSRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVahu7g%253D&md5=1f0b1cc883e0ad5d2d977ecd50edcfe2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1210%2Fer.2013-1053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2013-1053%26sid%3Dliteratum%253Aachs%26aulast%3DAzevedo%26aufirst%3DM.%2BF.%26aulast%3DFaucz%26aufirst%3DF.%2BR.%26aulast%3DBimpaki%26aufirst%3DE.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DLevy%26aufirst%3DI.%26aulast%3Dde%2BAlexandre%26aufirst%3DR.%2BB.%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DManganiello%26aufirst%3DV.%26aulast%3DStratakis%26aufirst%3DC.%2BA.%26atitle%3DClinical%2520and%2520molecular%2520genetics%2520of%2520the%2520phosphodiesterases%2520%2528PDEs%2529%26jtitle%3DEndocr.%2520Rev.%26date%3D2014%26volume%3D35%26spage%3D195%26epage%3D233%26doi%3D10.1210%2Fer.2013-1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. F.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase: an interface connecting cognitive deficits to neuropsychiatric and neurodegenerative diseases</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.2174/1381612820666140826115559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.2174%2F1381612820666140826115559" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=303-316&author=Z.+Wangauthor=Y.+Zhangauthor=H.+T.+Zhangauthor=Y.+F.+Li&title=Phosphodiesterase%3A+an+interface+connecting+cognitive+deficits+to+neuropsychiatric+and+neurodegenerative+diseases&doi=10.2174%2F1381612820666140826115559"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F1381612820666140826115559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666140826115559%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26aulast%3DLi%26aufirst%3DY.%2BF.%26atitle%3DPhosphodiesterase%253A%2520an%2520interface%2520connecting%2520cognitive%2520deficits%2520to%2520neuropsychiatric%2520and%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2015%26volume%3D21%26spage%3D303%26epage%3D316%26doi%3D10.2174%2F1381612820666140826115559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, R. D.</span></span> <span> </span><span class="NLM_article-title">Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus</span>. <i>J. Neurophysiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">1270</span>– <span class="NLM_lpage">1278</span>, <span class="refDoi"> DOI: 10.1152/jn.2002.88.3.1270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1152%2Fjn.2002.88.3.1270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=12205148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1Omtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2002&pages=1270-1278&author=Y.+F.+Luauthor=R.+D.+Hawkins&title=Ryanodine+receptors+contribute+to+cGMP-induced+late-phase+LTP+and+CREB+phosphorylation+in+the+hippocampus&doi=10.1152%2Fjn.2002.88.3.1270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Rynodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus</span></div><div class="casAuthors">Lu, Yun-Fei; Hawkins, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurophysiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1270-1278</span>CODEN:
                <span class="NLM_cas:coden">JONEA4</span>;
        ISSN:<span class="NLM_cas:issn">0022-3077</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">We previously found that the nitric oxide (NO)-cGMP-cGMP-dependent protein kinase (PKG) signaling pathway acts in parallel with the cAMP-cAMP-dependent protein kinase (PKA) pathway to produce protein and RNA synthesis-dependent late-phase long-term potentiation (L-LTP) and cAMP response element-binding protein (CREB) phosphorylation in the CA1 region of mouse hippocampus.  We have now investigated the possible involvement of a downstream target of PKG, ryanodine receptors.  L-LTP can be induced by either multiple-train tetanization, NO or 8-Br-cGMP paired with one-train tetanization, or the cAMP activator forskolin, and all three types of potentiation are accompanied by an increase in phospho-CREB immunofluorescence in the CA1 cell body area.  Both the potentiation and the increase in phospho-CREB immunofluorescence induced by multiple-train tetanization or 8-Br-cGMP paired with one-train tetanization are reduced by prolonged perfusion with ryanodine, which blocks Ca2+ release from ryanodine-sensitive Ca2+ stores.  By contrast, neither the potentiation nor the increase in immunofluorescence induced by forskolin are reduced by depletion of ryanodine and inositol-1,4,5-triphosphate (IP3)-sensitive Ca2+ stores.  These results suggest that NO, cGMP, and PKG cause release of Ca2+ from ryanodine-sensitive stores, which in turn causes phosphorylation of CREB in parallel with PKA during the induction of L-LTP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtfo8dwmELf7Vg90H21EOLACvtfcHk0lgf_Z8hDckSRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1Omtrk%253D&md5=685215b90ae99649c22b63e54b960439</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1152%2Fjn.2002.88.3.1270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.2002.88.3.1270%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%2BF.%26aulast%3DHawkins%26aufirst%3DR.%2BD.%26atitle%3DRyanodine%2520receptors%2520contribute%2520to%2520cGMP-induced%2520late-phase%2520LTP%2520and%2520CREB%2520phosphorylation%2520in%2520the%2520hippocampus%26jtitle%3DJ.%2520Neurophysiol.%26date%3D2002%26volume%3D88%26spage%3D1270%26epage%3D1278%26doi%3D10.1152%2Fjn.2002.88.3.1270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott Bitner, R.</span></span> <span> </span><span class="NLM_article-title">Cyclic AMP response element-binding protein (CREB) phosphorylation: a mechanistic marker in the development of memory enhancing Alzheimer’s disease therapeutics</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bcp.2011.11.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=705-714&author=R.+Scott+Bitner&title=Cyclic+AMP+response+element-binding+protein+%28CREB%29+phosphorylation%3A+a+mechanistic+marker+in+the+development+of+memory+enhancing+Alzheimer%E2%80%99s+disease+therapeutics&doi=10.1016%2Fj.bcp.2011.11.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DScott%2BBitner%26aufirst%3DR.%26atitle%3DCyclic%2520AMP%2520response%2520element-binding%2520protein%2520%2528CREB%2529%2520phosphorylation%253A%2520a%2520mechanistic%2520marker%2520in%2520the%2520development%2520of%2520memory%2520enhancing%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutics%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D705%26epage%3D714%26doi%3D10.1016%2Fj.bcp.2011.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domek-Lopacinska, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strosznajder, J. B.</span></span> <span> </span><span class="NLM_article-title">Cyclic GMP and nitric oxide synthase in aging and Alzheimer’s disease</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1007/s12035-010-8104-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1007%2Fs12035-010-8104-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20213343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFSqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2010&pages=129-137&author=K.+U.+Domek-Lopacinskaauthor=J.+B.+Strosznajder&title=Cyclic+GMP+and+nitric+oxide+synthase+in+aging+and+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs12035-010-8104-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic GMP and nitric oxide synthase in aging and Alzheimer's Disease</span></div><div class="casAuthors">Domek-Lopacinska, Katarzyna Urszula; Strosznajder, Joanna B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">129-137</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Cyclic guanosine monophosphate (cGMP) is an important secondary messenger synthesized by the guanylyl cyclases which are found in the sol. (sGC) and particular isoforms.  In the central nervous system, the nitric oxide (NO)-sensitive sGC isoform is the major enzyme responsible for cGMP synthesis.  Phosphodiesterases (PDEs) are enzymes for hydrolysis of cGMP in the brain, and they are mainly isoforms 2, 5, and 9.  The NO/cGMP signaling pathway has been shown to play an important role in the process underlying learning and memory.  Aging is assocd. with an increase in PDE expression and activity and a decrease in cGMP concn.  In addn., aging is also assocd. with an enhancement of neuronal NO synthase, a lowering of endothelial, and no alteration in inducible activity.  The obsd. changes in NMDA receptor d. along with the Ca2+/NO/cGMP pathway underscore the lower synaptic plasticity and cognitive performance during aging.  This notion is in agreement with last data indicating that inhibitors of PDE2 and PDE9 improve learning and memory in older rats.  In this review, we focus on recent studies supporting the role of Ca2+/NO/cGMP pathway in aging and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPy5cay399abVg90H21EOLACvtfcHk0lhq52vCrWTBGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFSqtr0%253D&md5=91f5bed7d285558234fb84a933d17973</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs12035-010-8104-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-010-8104-x%26sid%3Dliteratum%253Aachs%26aulast%3DDomek-Lopacinska%26aufirst%3DK.%2BU.%26aulast%3DStrosznajder%26aufirst%3DJ.%2BB.%26atitle%3DCyclic%2520GMP%2520and%2520nitric%2520oxide%2520synthase%2520in%2520aging%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Neurobiol.%26date%3D2010%26volume%3D41%26spage%3D129%26epage%3D137%26doi%3D10.1007%2Fs12035-010-8104-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ciani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartesaghi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contestabile, A.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">1282</span>– <span class="NLM_lpage">1289</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.01080.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1046%2Fj.1471-4159.2002.01080.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=12358775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvVerur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=1282-1289&author=E.+Cianiauthor=S.+Guidiauthor=R.+Bartesaghiauthor=A.+Contestabile&title=Nitric+oxide+regulates+cGMP-dependent+cAMP-responsive+element+binding+protein+phosphorylation+and+Bcl-2+expression+in+cerebellar+neurons%3A+implication+for+a+survival+role+of+nitric+oxide&doi=10.1046%2Fj.1471-4159.2002.01080.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: Implication for a survival role of nitric oxide</span></div><div class="casAuthors">Ciani, Elisabetta; Guidi, Sandra; Bartesaghi, Renata; Contestabile, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1282-1289</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">NO is a small, diffusible, highly reactive mol. with a dichotomous regulatory role in the brain as an intra- and intercellular messenger under physiol. conditions and a neurodegenerative agent under pathol. conditions.  The authors recently demonstrated that long-lasting exposure to an neuronal nitric oxide synthase (nNOS) inhibitor down-regulated the serine/threonine kinase Akt survival pathway and caused apoptosis in cerebellar granule cell cultures.  The present study further substantiated the role of NO in neuronal survival by demonstrating that blocking its prodn. down-regulated the activity of cAMP-responsive element binding protein (CREB), a transcription factor involved in cell survival and synaptic plasticity.  Pharmacol. dissection of the pathway linking NO to CREB showed that cGMP and its kinase were intermediate effectors.  The authors also identified Bcl-2 as one of the anti-apoptotic genes down-regulated by NO shortage and decreased CREB phosphorylation.  Thus, these results not only confirmed the role of CREB in neuronal survival but also provided circumstantial evidence for a novel link among NO, CREB activation, and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4EpdhJVzkrVg90H21EOLACvtfcHk0lhq52vCrWTBGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvVerur8%253D&md5=919d465c919f768d97c93a650efde1a9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01080.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01080.x%26sid%3Dliteratum%253Aachs%26aulast%3DCiani%26aufirst%3DE.%26aulast%3DGuidi%26aufirst%3DS.%26aulast%3DBartesaghi%26aufirst%3DR.%26aulast%3DContestabile%26aufirst%3DA.%26atitle%3DNitric%2520oxide%2520regulates%2520cGMP-dependent%2520cAMP-responsive%2520element%2520binding%2520protein%2520phosphorylation%2520and%2520Bcl-2%2520expression%2520in%2520cerebellar%2520neurons%253A%2520implication%2520for%2520a%2520survival%2520role%2520of%2520nitric%2520oxide%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26spage%3D1282%26epage%3D1289%26doi%3D10.1046%2Fj.1471-4159.2002.01080.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourtchouladze, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winder, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandel, E.</span></span> <span> </span><span class="NLM_article-title">Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting LTP and improves memory</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">15020</span>– <span class="NLM_lpage">15025</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.25.15020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1073%2Fpnas.95.25.15020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15020-15025&author=M.+Baradauthor=R.+Bourtchouladzeauthor=D.+G.+Winderauthor=H.+Golanauthor=E.+Kandel&title=Rolipram%2C+a+type+IV-specific+phosphodiesterase+inhibitor%2C+facilitates+the+establishment+of+long-lasting+LTP+and+improves+memory&doi=10.1073%2Fpnas.95.25.15020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.25.15020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.25.15020%26sid%3Dliteratum%253Aachs%26aulast%3DBarad%26aufirst%3DM.%26aulast%3DBourtchouladze%26aufirst%3DR.%26aulast%3DWinder%26aufirst%3DD.%2BG.%26aulast%3DGolan%26aufirst%3DH.%26aulast%3DKandel%26aufirst%3DE.%26atitle%3DRolipram%252C%2520a%2520type%2520IV-specific%2520phosphodiesterase%2520inhibitor%252C%2520facilitates%2520the%2520establishment%2520of%2520long-lasting%2520LTP%2520and%2520improves%2520memory%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D15020%26epage%3D15025%26doi%3D10.1073%2Fpnas.95.25.15020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmikuttyamma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrivastav, A.</span></span> <span> </span><span class="NLM_article-title">Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): Review</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.3892/ijmm.18.1.95</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.3892%2Fijmm.18.1.95" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16786160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1CnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=95-105&author=R.+K.+Sharmaauthor=S.+B.+Dasauthor=A.+Lakshmikuttyammaauthor=P.+Selvakumarauthor=A.+Shrivastav&title=Regulation+of+calmodulin-stimulated+cyclic+nucleotide+phosphodiesterase+%28PDE1%29%3A+Review&doi=10.3892%2Fijmm.18.1.95"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): review</span></div><div class="casAuthors">Sharma, Rajendra K.; Das, Shankar B.; Lakshmikuttyamma, Ashakumary; Selvakumar, Ponniah; Shrivastav, Anuraag</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">A review.  The response of living cells to change in cell environment depends on the action of second messenger mols.  The two second messenger mols. cAMP and Ca2+ regulate a large no. of eukaryotic cellular events.  Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1) is one of the key enzymes involved in the complex interaction between cAMP and Ca2+ second messenger systems.  Some PDE1 isoenzymes have similar kinetic and immunol. properties but are differentially regulated by Ca2+ and calmodulin.  Accumulating evidence suggests that the activity of PDE1 is selectively regulated by cross-talk between Ca2+ and cAMP signaling pathways.  These isoenzymes are also further distinguished by various pharmacol. agents.  We have demonstrated a potentially novel regulation of PDE1 by calpain.  This study suggests that limited proteolysis by calpain could be an alternative mechanism for the activation of PDE1.  We have also shown PDE1 activity, expression and effect of calpain in the rat model in vitro of cardiac ischemia-reperfusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZnr-AhNApDLVg90H21EOLACvtfcHk0lgK3YsHuufxew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1CnsLo%253D&md5=671b71e77c39fcf4782b9d3e2bceebcd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3892%2Fijmm.18.1.95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.18.1.95%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DDas%26aufirst%3DS.%2BB.%26aulast%3DLakshmikuttyamma%26aufirst%3DA.%26aulast%3DSelvakumar%26aufirst%3DP.%26aulast%3DShrivastav%26aufirst%3DA.%26atitle%3DRegulation%2520of%2520calmodulin-stimulated%2520cyclic%2520nucleotide%2520phosphodiesterase%2520%2528PDE1%2529%253A%2520Review%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2006%26volume%3D18%26spage%3D95%26epage%3D105%26doi%3D10.3892%2Fijmm.18.1.95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakics, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boess, F. G.</span></span> <span> </span><span class="NLM_article-title">Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2010.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20493887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1SqsLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2010&pages=367-374&author=V.+Lakicsauthor=E.+H.+Karranauthor=F.+G.+Boess&title=Quantitative+comparison+of+phosphodiesterase+mRNA+distribution+in+human+brain+and+peripheral+tissues&doi=10.1016%2Fj.neuropharm.2010.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues</span></div><div class="casAuthors">Lakics, Viktor; Karran, Eric H.; Boess, Frank G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">367-374</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyclic nucleotide-specific phosphodiesterases (PDEs) play a crit. role in signal transduction by regulating the level of adenosine 3',5'-cyclic monophosphate (cAMP) and guanosine 3',5'-cyclic monophosphate (cGMP) in cells.  The gene expression pattern of a PDE provides important information regarding its role in physiol. and pathol. processes.  In this study, we have established the mRNA expression profile all PDE isoenzymes (PDE1A/B/C, 2A, 3A/B, 4A/B/C/D, 5A, 6A/B/C, 7A/B, 8A/B, 9A, 10A, 11A) in a human cDNA collection consisting of 10 brain regions (parietal, frontal, temporal cortex, hippocampus, striatum, thalamus, hypothalamus, substantia nigra, nucleus accumbens, cerebellum), spinal cord, dorsal root ganglia and 12 peripheral tissues (skeletal muscle, heart, thyroid, adrenal gland, pancreas, bladder, kidney, liver, lung, small intestine, spleen, and stomach).  Using quant. real-time polymerase chain reaction and parallel anal. of a carefully selected group of ref. genes, we have detd. the relative expression of each PDE isoenzyme across the 24 selected tissues, and also compared the expression of selected PDEs to each other within a given tissue type.  Several PDEs show strikingly selective expression (e.g. PDE10A and PDE1B mRNA levels in the caudate nucleus are 20-fold higher than in most other tissues; PDE1C and PDE3A are highly expressed in the heart and PDE8B is expressed very strongly in the thyroid gland).  This comprehensive approach provides a coherent and quant. view of the mRNA expression of the PDE gene family and enables an integration of data obtained with other non-quant. methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGz6OEkRjbLVg90H21EOLACvtfcHk0lgK3YsHuufxew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1SqsLbJ&md5=ee55772f572818eaa7194a1ae3f52f45</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DLakics%26aufirst%3DV.%26aulast%3DKarran%26aufirst%3DE.%2BH.%26aulast%3DBoess%26aufirst%3DF.%2BG.%26atitle%3DQuantitative%2520comparison%2520of%2520phosphodiesterase%2520mRNA%2520distribution%2520in%2520human%2520brain%2520and%2520peripheral%2520tissues%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D59%26spage%3D367%26epage%3D374%26doi%3D10.1016%2Fj.neuropharm.2010.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 1: a unique therapeutic target with multiple potential indications</span>. <i>Chin. J. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=452&author=L.+Wennogle&title=Phosphodiesterase+1%3A+a+unique+therapeutic+target+with+multiple+potential+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWennogle%26aufirst%3DL.%26atitle%3DPhosphodiesterase%25201%253A%2520a%2520unique%2520therapeutic%2520target%2520with%2520multiple%2520potential%2520indications%26jtitle%3DChin.%2520J.%2520Pharmacol.%2520Toxicol.%26date%3D2017%26volume%3D31%26spage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonoczk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam-Vizi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpati, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szantay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koncz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelles, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vas, A.</span></span> <span> </span><span class="NLM_article-title">Role of sodium channel inhibition in neuroprotection: effect of vinpocetine</span>. <i>Brain Res. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/S0361-9230(00)00354-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2FS0361-9230%2800%2900354-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=11113577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslGgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2000&pages=245-254&author=P.+Bonoczkauthor=B.+Gulyasauthor=V.+Adam-Viziauthor=A.+Nemesauthor=E.+Karpatiauthor=B.+Kissauthor=M.+Kapasauthor=C.+Szantayauthor=I.+Konczauthor=T.+Zellesauthor=A.+Vas&title=Role+of+sodium+channel+inhibition+in+neuroprotection%3A+effect+of+vinpocetine&doi=10.1016%2FS0361-9230%2800%2900354-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Role of sodium channel inhibition in neuroprotection: effect of vinpocetine</span></div><div class="casAuthors">Bonoczk, P.; Gulyas, B.; Adam-Vizi, V.; Nemes, A.; Karpati, E.; Kiss, B.; Kapas, M.; Szantay, C.; Koncz, I.; Zelles, T.; Vas, A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-254</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 111 refs.  Vinpocetine (Et apovincaminate) discovered during the late 1960s has successfully been used in the treatment of central nervous system disorders of cerebrovascular origin for decades.  The increase in the regional cerebral blood flow in response to vinpocetine administration is well established and strengthened by new diagnostical techniques (transcranial Doppler, near IR spectroscopy, positron emission tomog.).  The latest in vitro studies have revealed the effect of the compd. on Ca2+/calmodulin dependent cGMP-phosphodiesterase 1, voltage-operated Ca2+ channels, glutamate receptors and voltage dependent Na+-channels; the latest being esp. relevant to the neuroprotective action of vinpocetine.  The good brain penetration profile and heterogeneous brain distribution pattern (mainly in the thalamus, basal ganglia and visual cortex) of labeled vinpocetine were demonstrated by positron emission tomog. in primates and man.  Multicentric, randomized, placebo-controlled clin. studies proved the efficacy of orally administered vinpocetine in patients with org. psychosyndrome.  Recently positron emission tomog. studies have proved that vinpocetine is able to redistribute regional cerebral blood flow and enhance glucose supply of brain tissue in ischemic post-stroke patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFVCMjshLcbVg90H21EOLACvtfcHk0lhIqV_CUZ4nkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslGgtrY%253D&md5=656c03dd9e9cd41a7638c6eb8674c5e4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0361-9230%2800%2900354-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0361-9230%252800%252900354-3%26sid%3Dliteratum%253Aachs%26aulast%3DBonoczk%26aufirst%3DP.%26aulast%3DGulyas%26aufirst%3DB.%26aulast%3DAdam-Vizi%26aufirst%3DV.%26aulast%3DNemes%26aufirst%3DA.%26aulast%3DKarpati%26aufirst%3DE.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DKapas%26aufirst%3DM.%26aulast%3DSzantay%26aufirst%3DC.%26aulast%3DKoncz%26aufirst%3DI.%26aulast%3DZelles%26aufirst%3DT.%26aulast%3DVas%26aufirst%3DA.%26atitle%3DRole%2520of%2520sodium%2520channel%2520inhibition%2520in%2520neuroprotection%253A%2520effect%2520of%2520vinpocetine%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2000%26volume%3D53%26spage%3D245%26epage%3D254%26doi%3D10.1016%2FS0361-9230%2800%2900354-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span> <span> </span><span class="NLM_article-title">Eburnamine derivatives and the brain</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">757</span>, <span class="refDoi"> DOI: 10.1002/med.20043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1002%2Fmed.20043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16158388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Sru7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=737-757&author=A.+Vasauthor=B.+Gulyas&title=Eburnamine+derivatives+and+the+brain&doi=10.1002%2Fmed.20043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Eburnamine derivatives and the brain</span></div><div class="casAuthors">Vas, Adam; Gulyas, Balazs</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">737-757</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Apocynaceae plant family contains a great no. of so called eburnamine-vincumine alkaloids.  Quite a few of these alkaloids exert varied pharmacol. activities on the cell multiplication, cardiovascular system, and brain functions.  Many derivs. were also synthesized to find pharmacol. active compds. better characterized and safer to be administered than the natural plant alkaloids themselves.  We conc. on the eburnamine structures with cerebral activities in this review.  Vincamine, vinburnine, vindeburnol, apovincaminate, and vinpocetine (cis-ethyl-apovincaminate) all share modulatory effects on brain circulation and neuronal homeostasis, bear antihypoxic and neuroprotective potencies to various degrees.  The most eminent compd. of this class of alkaloids is vinpocetine.  Since its introduction to the market as a neuroprotective agent many non clin. and clin. studies proved vinpocetine's effects on calmodulin dependent phosphodiesterase E1, on sodium, calcium channels, peripheral benzodiazepine receptor, and glutamate receptors as well as its clin. usefulness in the treatment of post-ischemic stroke disease states and various disorders of cerebrovascular origin.  Lately, positron emission tomog. studies proved that vinpocetine has a rapid uptake in the primate and human brain with a heterogenous distribution pattern (preference areas: thalamus, basal ganglia, and visual cortex) both after i.v. and oral administration.  Vinpocetine exerts beneficial effects in cerebral glucose metab. and regional cerebral blood flow in chronic post-stroke patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLyDJ8hXTg5rVg90H21EOLACvtfcHk0lhIqV_CUZ4nkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Sru7fL&md5=105e483bb41cebbb36c513785da4492a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fmed.20043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20043%26sid%3Dliteratum%253Aachs%26aulast%3DVas%26aufirst%3DA.%26aulast%3DGulyas%26aufirst%3DB.%26atitle%3DEburnamine%2520derivatives%2520and%2520the%2520brain%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2005%26volume%3D25%26spage%3D737%26epage%3D757%26doi%3D10.1002%2Fmed.20043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedi, K. L.</span></span> <span> </span><span class="NLM_article-title">Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>620</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2009.08.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejphar.2009.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=19699735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGlt73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=620&publication_year=2009&pages=49-56&author=R.+Deshmukhauthor=V.+Sharmaauthor=S.+Mehanauthor=N.+Sharmaauthor=K.+L.+Bedi&title=Amelioration+of+intracerebroventricular+streptozotocin+induced+cognitive+dysfunction+and+oxidative+stress+by+vinpocetine+-+a+PDE1+inhibitor&doi=10.1016%2Fj.ejphar.2009.08.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor</span></div><div class="casAuthors">Deshmukh, Rahul; Sharma, Vivek; Mehan, Sidharth; Sharma, Nidhi; Bedi, K. L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">620</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enhancing cyclic nucleotides signaling by inhibition of phosphodiesterases (PDEs) is known to be beneficial in disorders assocd. with cognitive decline.  The present study was designed to investigate the effect of vinpocetine (PDE1 inhibitor) on intracerebroventricular (i.c.v.) streptozotocin induced exptl. sporadic dementia of Alzheimer's type.  Infusion of streptozotocin impaired learning and memory, increased oxidative-nitritive stress and induced cholinergic hypofunction in rats.  Chronic treatment with vinpocetine (5, 10 and 20 mg/kg i.p.) for 21 days following first i.c.v. streptozotocin infusion significantly improved learning and memory in Morris water maze and passive avoidance paradigms.  Further, vinpocetine significantly reduced the oxidative-nitritive stress, as evidenced by decrease in malondialdehyde (MDA) and nitrite levels, and restored the reduced glutathione (GSH) levels.  Significant increase in acetylcholinesterase activity and lactate dehydrogenase levels was obsd. in the present model indicating cholinergic hypofunction and increase in neuronal cell damage.  Chronic treatment with vinpocetine also reduced significantly the increase in acetylcholinesterase activity and lactate dehydrogenase levels indicating restorative capacity of vinpocetine with respect to cholinergic functions and preventing the neuronal damage.  The obsd. beneficial effects of vinpocetine on spatial memory may be due to its ability to favorably modulate cholinergic functions, prevent neuronal cell damage and possibly through its antioxidant mechanism also.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokMQmZ9Cf3ybVg90H21EOLACvtfcHk0liSaImzQIdeHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGlt73L&md5=59b849a1799de087fe52b8eb62605be5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DDeshmukh%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DMehan%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DBedi%26aufirst%3DK.%2BL.%26atitle%3DAmelioration%2520of%2520intracerebroventricular%2520streptozotocin%2520induced%2520cognitive%2520dysfunction%2520and%2520oxidative%2520stress%2520by%2520vinpocetine%2520-%2520a%2520PDE1%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D620%26spage%3D49%26epage%3D56%26doi%3D10.1016%2Fj.ejphar.2009.08.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polgar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vereczkey, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyary, I.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of vinpocetine and its metabolite, apovincaminic acid, in plasma and cerebrospinal fluid after intravenous infusion</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/0731-7085(85)80016-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2F0731-7085%2885%2980016-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16867695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BD28vksVGnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1985&pages=131-139&author=M.+Polgarauthor=L.+Vereczkeyauthor=I.+Nyary&title=Pharmacokinetics+of+vinpocetine+and+its+metabolite%2C+apovincaminic+acid%2C+in+plasma+and+cerebrospinal+fluid+after+intravenous+infusion&doi=10.1016%2F0731-7085%2885%2980016-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of vinpocetine and its metabolite, apovincaminic acid, in plasma and cerebrospinal fluid after intravenous infusion</span></div><div class="casAuthors">Polgar M; Vereczkey L; Nyary I</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmaceutical and biomedical analysis</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-9</span>
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    </div><div class="casAbstract">The pharmacokinetics of vinpocetine (ethyl apovincaminate, Cavinton) and its metabolite, apovincaminic acid, was studied in patients with cerebrovascular disorders.  Vinpocetine (1 mg/kg) was infused intravenously over 25 min.  The elimination half-life of the parent drug in plasma was 4.7+/-2.13 h.  Total clearance of vinpocetine was 0.79+/-0.1 1 h(-1) kg(-1).  The presence of vinpocetine in cerebrospinal fluid shows that the drug is able to pass through the blood-brain barrier and reach the central nervous system which is a possible site of action.  The maximum increase of cerebral blood flow (25%) was measured at 32 min after the start of the infusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlCzlURmC27dbHMBt0mMIXfW6udTcc2eZCRP0UZC12prntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vksVGnsQ%253D%253D&md5=0c6b445421738cae19542472523a807f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0731-7085%2885%2980016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0731-7085%252885%252980016-9%26sid%3Dliteratum%253Aachs%26aulast%3DPolgar%26aufirst%3DM.%26aulast%3DVereczkey%26aufirst%3DL.%26aulast%3DNyary%26aufirst%3DI.%26atitle%3DPharmacokinetics%2520of%2520vinpocetine%2520and%2520its%2520metabolite%252C%2520apovincaminic%2520acid%252C%2520in%2520plasma%2520and%2520cerebrospinal%2520fluid%2520after%2520intravenous%2520infusion%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D1985%26volume%3D3%26spage%3D131%26epage%3D139%26doi%3D10.1016%2F0731-7085%2885%2980016-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hindmarch, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erzigkeit, H.</span></span> <span> </span><span class="NLM_article-title">Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes</span>. <i>Int. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1097/00004850-199100610-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1097%2F00004850-199100610-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=2071888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADyaK3Mzgt1Oktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=31-43&author=I.+Hindmarchauthor=H.+H.+Fuchsauthor=H.+Erzigkeit&title=Efficacy+and+tolerance+of+vinpocetine+in+ambulant+patients+suffering+from+mild+to+moderate+organic+psychosyndromes&doi=10.1097%2F00004850-199100610-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes</span></div><div class="casAuthors">Hindmarch I; Fuchs H H; Erzigkeit H</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-43</span>
        ISSN:<span class="NLM_cas:issn">0268-1315</span>.
    </div><div class="casAbstract">The efficacy and tolerance of orally administered vinpocetine was investigated in patients suffering from mild to moderate organic psychosyndromes including primary dementia.  Two hundred and three patients were included in a placebo-controlled, randomized double-blind, multicentre trial and received every day for 16 weeks either: 3 x 10 mg doses of vinpocetine, 3 x 20 mg doses of vinpocetine, or 3 x placebo.  Patients were assessed on ratings of clinical global impression, cognitive performance and on measures of the quality of life including depressive illness.  There were no clinically relevant side-effects reported and the frequencies of adverse events between patients treated with vinpocetine (30 mg or 60 mg) and placebo were comparable.  Statistically significant improvements were found in favour of both active treatment groups compared to placebo in both confirmatory evaluations of efficacy of treatment: the "Global Improvement" (on the CGI scale) and cognitive performance (SKT).  Vinpocetine was also superior to placebo in ratings of the "severity of illness".  This study demonstrates the usefulness and efficacy of vinpocetine in the management of patients with moderate organic psychosyndromes.  An apparently greater therapeutic efficacy of 3 x 10 mg vinpocetine compared with the higher vinpocetine dosage is statistically not significant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRImv0le3k4vOR_TJajKxJDfW6udTcc2eZCRP0UZC12prntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3Mzgt1Oktg%253D%253D&md5=73e08f92c644e8ae2bc16e96652ff720</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1097%2F00004850-199100610-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004850-199100610-00005%26sid%3Dliteratum%253Aachs%26aulast%3DHindmarch%26aufirst%3DI.%26aulast%3DFuchs%26aufirst%3DH.%2BH.%26aulast%3DErzigkeit%26aufirst%3DH.%26atitle%3DEfficacy%2520and%2520tolerance%2520of%2520vinpocetine%2520in%2520ambulant%2520patients%2520suffering%2520from%2520mild%2520to%2520moderate%2520organic%2520psychosyndromes%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D1991%26volume%3D6%26spage%3D31%26epage%3D43%26doi%3D10.1097%2F00004850-199100610-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyser, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1164</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1149-1164&author=P.+Liauthor=H.+Zhengauthor=J.+Zhaoauthor=L.+Zhangauthor=W.+Yaoauthor=H.+Zhuauthor=J.+D.+Beardauthor=K.+Idaauthor=W.+Laneauthor=G.+Snellauthor=S.+Sogabeauthor=C.+J.+Heyserauthor=G.+L.+Snyderauthor=J.+P.+Hendrickauthor=K.+E.+Vanoverauthor=R.+E.+Davisauthor=L.+P.+Wennogle&title=Discovery+of+potent+and+selective+inhibitors+of+phosphodiesterase+1+for+the+treatment+of+cognitive+impairment+associated+with+neurodegenerative+and+neuropsychiatric+diseases&doi=10.1021%2Facs.jmedchem.5b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases</span></div><div class="casAuthors">Li, Peng; Zheng, Hailin; Zhao, Jun; Zhang, Lei; Yao, Wei; Zhu, Hongwen; Beard, J. David; Ida, Koh; Lane, Weston; Snell, Gyorgy; Sogabe, Satoshi; Heyser, Charles J.; Snyder, Gretchen L.; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert E.; Wennogle, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1149-1164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A diverse set of 3-aminopyrazolo[3,4-d]pyrimidinones was designed and synthesized.  The structure-activity relationships of these polycyclic compds. as phosphodiesterase 1 (PDE1) inhibitors were studied along with their physicochem. and pharmacokinetic properties.  Systematic optimizations of this novel scaffold culminated in the identification of a clin. candidate I, which exhibited picomolar inhibitory potency for PDE1, demonstrated excellent selectivity against all other PDE families and showed good efficacy in vivo.  Currently, this investigational new drug is in Phase I clin. development and being considered for the treatment of several indications including cognitive deficits assocd. with schizophrenia and Alzheimer's disease, movement disorders, attention deficit and hyperactivity disorders, and other central nervous system (CNS) and non-CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiqQuMoLsXnbVg90H21EOLACvtfcHk0lhHJIK30AagAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D&md5=73741521722dc906869ffa3504ceaf2e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01751%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBeard%26aufirst%3DJ.%2BD.%26aulast%3DIda%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DHeyser%26aufirst%3DC.%2BJ.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520phosphodiesterase%25201%2520for%2520the%2520treatment%2520of%2520cognitive%2520impairment%2520associated%2520with%2520neurodegenerative%2520and%2520neuropsychiatric%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1149%26epage%3D1164%26doi%3D10.1021%2Facs.jmedchem.5b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadenberg, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkerman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mates, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L. P.</span></span> <span> </span><span class="NLM_article-title">Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>233</i></span>,  <span class="NLM_fpage">3113</span>– <span class="NLM_lpage">3124</span>, <span class="refDoi"> DOI: 10.1007/s00213-016-4346-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1007%2Fs00213-016-4346-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=27342643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=2016&pages=3113-3124&author=G.+L.+Snyderauthor=J.+Prickaertsauthor=M.+L.+Wadenbergauthor=L.+Zhangauthor=H.+Zhengauthor=W.+Yaoauthor=S.+Akkermanauthor=H.+Zhuauthor=J.+P.+Hendrickauthor=K.+E.+Vanoverauthor=R.+Davisauthor=P.+Liauthor=S.+Matesauthor=L.+P.+Wennogle&title=Preclinical+profile+of+ITI-214%2C+an+inhibitor+of+phosphodiesterase+1%2C+for+enhancement+of+memory+performance+in+rats&doi=10.1007%2Fs00213-016-4346-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats</span></div><div class="casAuthors">Snyder, Gretchen L.; Prickaerts, Jos; Wadenberg, Marie-Louise; Zhang, Lei; Zheng, Hailin; Yao, Wei; Akkerman, Sven; Zhu, Hongwen; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert; Li, Peng; Mates, Sharon; Wennogle, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3113-3124</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Therapeutic agents for memory enhancement in psychiatric disorders, such as schizophrenia, are urgently needed.  Objective: The aim of this study is to characterize the preclin. profile of ITI-214, a potent inhibitor of phosphodiesterase 1 (PDE1).  Methods: ITI-214 was assayed for inhibition of PDE1 vs. other PDE enzyme families using recombinant human PDE enzymes and for off-target binding to 70 substrates (General SEP II diversity panel; Caliper Life Sciences).  Effects of ITI-214 (0.1-10 mg/kg, po) on memory performance were assayed in rats using the novel object recognition (NOR) paradigm, with drug given at specified time points prior to or following exposure to objects in an open field.  ITI-214 was evaluated for potential drug-drug interaction with risperidone in rats using conditioned avoidance response (CAR) and pharmacokinetic assessments.  Results: ITI-214 inhibited PDE1A (Ki = 33 pmol) with >1000-fold selectivity for the nearest other PDE family (PDE4D) and displayed minimal off-target binding interactions in a 70-substrate selectivity profile.  By using specific timing of oral ITI-214 administration, it was demonstrated in the NOR that ITI-214 is able to enhance acquisition, consolidation, and retrieval memory processes.  All memory effects were in the absence of effects on exploratory behavior.  ITI-214 did not disrupt the risperidone pharmacokinetic profile or effects in CAR.  Conclusions: ITI-214 improved the memory processes of acquisition, consolidation, and retrieval across a broad dose range (0.1-10 mg/kg, po) without disrupting the antipsychotic-like activity of a clin. antipsychotic medication, specifically risperidone.  Clin. development of ITI-214 is currently in progress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7eUb8S0yISLVg90H21EOLACvtfcHk0li5D_EAWYdioA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnsLrF&md5=90f1653bd30aaf1ffe5a543f0181e4c1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00213-016-4346-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-016-4346-2%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DWadenberg%26aufirst%3DM.%2BL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DAkkerman%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DMates%26aufirst%3DS.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DPreclinical%2520profile%2520of%2520ITI-214%252C%2520an%2520inhibitor%2520of%2520phosphodiesterase%25201%252C%2520for%2520enhancement%2520of%2520memory%2520performance%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2016%26volume%3D233%26spage%3D3113%26epage%3D3124%26doi%3D10.1007%2Fs00213-016-4346-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span>Clinical trial study found in clinical trials for ITI-214:
NCT01900522. <a href="https://clinicaltrials.gov/ct2/show/NCT01900522?term=NCT01900522&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01900522?term=NCT01900522&rank=1</a> (accessed <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+ITI-214%3A%0ANCT01900522.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01900522%3Fterm%3DNCT01900522%26rank%3D1+%28accessed+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dyck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branstetter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharbaoui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitenbucher, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cedervall, E. P.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discovery of selective phosphodiesterase 1 inhibitors with memory enhancing properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3472</span>– <span class="NLM_lpage">3483</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvF2jsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3472-3483&author=B.+Dyckauthor=B.+Branstetterauthor=T.+Gharbaouiauthor=A.+R.+Hudsonauthor=J.+G.+Breitenbucherauthor=L.+Gomezauthor=E.+P.+Cedervall&title=Discovery+of+selective+phosphodiesterase+1+inhibitors+with+memory+enhancing+properties&doi=10.1021%2Facs.jmedchem.7b00302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties</span></div><div class="casAuthors">Dyck, Brian; Branstetter, Bryan; Gharbaoui, Tawfik; Hudson, Andrew R.; Breitenbucher, J. Guy; Gomez, Laurent; Botrous, Iriny; Marrone, Tami; Barido, Richard; Allerston, Charles K.; Cedervall, E. Peder; Xu, Rui; Sridhar, Vandana; Barker, Ryan; Aertgeerts, Kathleen; Schmelzer, Kara; Neul, David; Lee, Dong; Massari, Mark Eben; Andersen, Carsten B.; Sebring, Kristen; Zhou, Xianbo; Petroski, Robert; Limberis, James; Augustin, Martin; Chun, Lawrence E.; Edwards, Thomas E.; Peters, Marco; Tabatabaei, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3472-3483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of potent thienotriazolopyrimidinone-based PDE1 inhibitors was discovered.  X-ray crystal structures of example compds. from this series in complex with the catalytic domain of PDE1B and PDE10A were detd., allowing optimization of PDE1B potency and PDE selectivity.  Redn. of hERG affinity led to greater than a 3000-fold selectivity for PDE1B over hERG. 6-(4-Methoxybenzyl)-9-((tetrahydro-2H-pyran-4-yl)methyl)-8,9,10,11-tetrahydropyrido[4',3':4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one was identified as an orally bioavailable and brain penetrating PDE1B enzyme inhibitor with potent memory-enhancing effects in a rat model of object recognition memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX2wxwLW-OPLVg90H21EOLACvtfcHk0li5D_EAWYdioA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvF2jsLk%253D&md5=ff7c3c08432646621c8d2cc32693e75f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00302%26sid%3Dliteratum%253Aachs%26aulast%3DDyck%26aufirst%3DB.%26aulast%3DBranstetter%26aufirst%3DB.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DHudson%26aufirst%3DA.%2BR.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26aulast%3DGomez%26aufirst%3DL.%26aulast%3DCedervall%26aufirst%3DE.%2BP.%26atitle%3DDiscovery%2520of%2520selective%2520phosphodiesterase%25201%2520inhibitors%2520with%2520memory%2520enhancing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3472%26epage%3D3483%26doi%3D10.1021%2Facs.jmedchem.7b00302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stangherlin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesellchen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoccarato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surdo, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaccolo, M.</span></span> <span> </span><span class="NLM_article-title">cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.110.230698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1161%2FCIRCRESAHA.110.230698" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=929-939&author=A.+Stangherlinauthor=F.+Gesellchenauthor=A.+Zoccaratoauthor=A.+Terrinauthor=L.+A.+Fieldsauthor=M.+Berreraauthor=N.+C.+Surdoauthor=M.+A.+Craigauthor=G.+Smithauthor=G.+Hamiltonauthor=M.+Zaccolo&title=cGMP+signals+modulate+cAMP+levels+in+a+compartment-specific+manner+to+regulate+catecholamine-dependent+signaling+in+cardiac+myocytes&doi=10.1161%2FCIRCRESAHA.110.230698"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.110.230698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.110.230698%26sid%3Dliteratum%253Aachs%26aulast%3DStangherlin%26aufirst%3DA.%26aulast%3DGesellchen%26aufirst%3DF.%26aulast%3DZoccarato%26aufirst%3DA.%26aulast%3DTerrin%26aufirst%3DA.%26aulast%3DFields%26aufirst%3DL.%2BA.%26aulast%3DBerrera%26aufirst%3DM.%26aulast%3DSurdo%26aufirst%3DN.%2BC.%26aulast%3DCraig%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DG.%26aulast%3DHamilton%26aufirst%3DG.%26aulast%3DZaccolo%26aufirst%3DM.%26atitle%3DcGMP%2520signals%2520modulate%2520cAMP%2520levels%2520in%2520a%2520compartment-specific%2520manner%2520to%2520regulate%2520catecholamine-dependent%2520signaling%2520in%2520cardiac%2520myocytes%26jtitle%3DCirc.%2520Res.%26date%3D2011%26volume%3D108%26spage%3D929%26epage%3D939%26doi%3D10.1161%2FCIRCRESAHA.110.230698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boss, F. G.</span>; <span class="NLM_string-name">Hendrix, M.</span>; <span class="NLM_string-name">Konig, G.</span>; <span class="NLM_string-name">Niewohner, U.</span>; <span class="NLM_string-name">Schlemmer, K.-H.</span>; <span class="NLM_string-name">Schreiber, R.</span>; <span class="NLM_string-name">Van Der Staay, F. J.</span>; <span class="NLM_string-name">Schauss, D.</span></span> <span> </span><span class="NLM_article-title">Selective Phosphodiesterase 2 Inhibitors Used as Medicaments for Improving Cognition</span>. <span class="NLM_patent">WO2002009713 A2</span>, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=F.+G.+Boss&author=M.+Hendrix&author=G.+Konig&author=U.+Niewohner&author=K.-H.+Schlemmer&author=R.+Schreiber&author=F.+J.+Van+Der+Staay&author=D.+Schauss&title=Selective+Phosphodiesterase+2+Inhibitors+Used+as+Medicaments+for+Improving+Cognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoss%26aufirst%3DF.%2BG.%26atitle%3DSelective%2520Phosphodiesterase%25202%2520Inhibitors%2520Used%2520as%2520Medicaments%2520for%2520Improving%2520Cognition%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boess, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Staay, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Staveren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vente, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, G.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2004.07.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2004.07.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1081-1092&author=F.+G.+Boessauthor=M.+Hendrixauthor=F.+J.+van+der+Staayauthor=C.+Erbauthor=R.+Schreiberauthor=W.+van+Staverenauthor=J.+de+Venteauthor=J.+Prickaertsauthor=A.+Bloklandauthor=G.+Koenig&title=Inhibition+of+phosphodiesterase+2+increases+neuronal+cGMP%2C+synaptic+plasticity+and+memory+performance&doi=10.1016%2Fj.neuropharm.2004.07.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2004.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2004.07.040%26sid%3Dliteratum%253Aachs%26aulast%3DBoess%26aufirst%3DF.%2BG.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3Dvan%2BStaveren%26aufirst%3DW.%26aulast%3Dde%2BVente%26aufirst%3DJ.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520phosphodiesterase%25202%2520increases%2520neuronal%2520cGMP%252C%2520synaptic%2520plasticity%2520and%2520memory%2520performance%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D47%26spage%3D1081%26epage%3D1092%26doi%3D10.1016%2Fj.neuropharm.2004.07.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Staay, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span> <span> </span><span class="NLM_article-title">Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>558</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2006.11.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejphar.2006.11.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=17207788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVGgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=558&publication_year=2007&pages=107-112&author=K.+Ruttenauthor=J.+Prickaertsauthor=M.+Hendrixauthor=F.+J.+van+der+Staayauthor=A.+Sikauthor=A.+Blokland&title=Time-dependent+involvement+of+cAMP+and+cGMP+in+consolidation+of+object+memory%3A+studies+using+selective+phosphodiesterase+type+2%2C+4+and+5+inhibitors&doi=10.1016%2Fj.ejphar.2006.11.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Time-dependent involvement of cAMP and cGMP in consolidation of object memory: Studies using selective phosphodiesterase type 2, 4 and 5 inhibitors</span></div><div class="casAuthors">Rutten, Kris; Prickaerts, Jos; Hendrix, Martin; van der Staay, F. Josef; Sik, Ayhan; Blokland, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">558</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">107-112</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study investigated the time-dependent memory enhancing properties of three selective phosphodiesterase inhibitors (PDE-I) vardenafil (PDE5-I), rolipram (PDE4-I) and BAY 60-7550 (PDE2-I) in the object recognition task.  In particular, the time-dependent involvement of cAMP and cGMP in memory consolidation was assessed by altering the time points of drug administration.  Vardenafil (1 mg/kg, p.o.), rolipram (0.03 mg/kg, i.p.), and BAY 60-7550 (3 mg/kg, p.o.) were tested in rats with a 24 h delay between the learning and the test trial.  The PDE-Is were administered at different time points, i.e. directly after, 1 h, 3 h and 6 h after the first trial.  Using a 24 h interval, vardenafil only showed an effect on object memory when injected directly after trial 1, rolipram only showed an improvement when injected 3 h after trial 1 and BAY 60-7550 improved memory when injected either directly after or 3 h after trial 1.  No treatment effects were found when the compds. were administered 1 h or 6 h after the first trial.  Our results extend our previous data that different types of PDE-Is affect different stages of memory consolidation.  Moreover, the present study provides further support that selective PDE-Is can influence memory consolidation in a time-dependent manner, assumingly by elevating central cAMP and cGMP levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEtk2Ty9RwdbVg90H21EOLACvtfcHk0ligBSrZsTNCKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVGgtbs%253D&md5=cdfabbc2dc208ca9279d6804f626e0a3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.11.041%26sid%3Dliteratum%253Aachs%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DSik%26aufirst%3DA.%26aulast%3DBlokland%26aufirst%3DA.%26atitle%3DTime-dependent%2520involvement%2520of%2520cAMP%2520and%2520cGMP%2520in%2520consolidation%2520of%2520object%2520memory%253A%2520studies%2520using%2520selective%2520phosphodiesterase%2520type%25202%252C%25204%2520and%25205%2520inhibitors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D558%26spage%3D107%26epage%3D112%26doi%3D10.1016%2Fj.ejphar.2006.11.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domek-Lopacinska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strosznajder, J. B.</span></span> <span> </span><span class="NLM_article-title">The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1216</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2008.02.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.brainres.2008.02.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=18499090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVKku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1216&publication_year=2008&pages=68-77&author=K.+Domek-Lopacinskaauthor=J.+B.+Strosznajder&title=The+effect+of+selective+inhibition+of+cyclic+GMP+hydrolyzing+phosphodiesterases+2+and+5+on+learning+and+memory+processes+and+nitric+oxide+synthase+activity+in+brain+during+aging&doi=10.1016%2Fj.brainres.2008.02.108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging</span></div><div class="casAuthors">Domek-Lopacinska, K.; Strosznajder, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1216</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">68-77</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Our previous studies have shown that there is a lower cGMP concn. in the aged brain as well as an alteration in the activity of cGMP-hydrolyzing phosphodiesterases (PDEs) and nitric oxide synthase (NOS).  The aim of this study was to investigate the effect of specific inhibitors of selected PDEs on object recognition memory and locomotor activity during aging, and to correlate their action with NOS activity in the following brain regions: hippocampus, striatum, and cerebral cortex.  The study was carried out using 3, 12, and 24 mo-old rats.  Inhibitors of PDE2 and PDE5 (Bayer 60-7550 and zaprinast, resp.) were used.  Evaluation of memory and locomotor activity was carried out using an object recognition task and the open field test.  NOS activity was detd. using a radiochem. method after behavioral anal. in the cytosolic fraction from all brain areas investigated.  We have found that the inhibitor of PDE2, Bayer 60-7550, improves object recognition memory in all age groups investigated and increases basal constitutive NOS activity in the hippocampus and striatum.  Moreover, in 3 mo-old rats, addnl. inhibition of PDE5 by zaprinast improves object memory and elevates NOS activity in all brain regions studied.  Specific inhibition of nNOS eliminates the effect of Bayer 60-7550 on memory function and on NOS activity in 24 mo-old rats.  In summary, our results indicate that inhibition of PDE2 is able to improve cognition and memory function in 3, 12, and 24 mo-old rats through the enhancement of nNOS activity in the brain, whereas inhibition of PDE5 is effective only in 3 mo-old animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroSn1Uayy6qrVg90H21EOLACvtfcHk0liKZhsSwEYAtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVKku7c%253D&md5=bbc77008c158141527bb046db313f6bf</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2008.02.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2008.02.108%26sid%3Dliteratum%253Aachs%26aulast%3DDomek-Lopacinska%26aufirst%3DK.%26aulast%3DStrosznajder%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520effect%2520of%2520selective%2520inhibition%2520of%2520cyclic%2520GMP%2520hydrolyzing%2520phosphodiesterases%25202%2520and%25205%2520on%2520learning%2520and%2520memory%2520processes%2520and%2520nitric%2520oxide%2520synthase%2520activity%2520in%2520brain%2520during%2520aging%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1216%26spage%3D68%26epage%3D77%26doi%3D10.1016%2Fj.brainres.2008.02.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Donkelaar, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrington, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbusch, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J. H.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1914</span>– <span class="NLM_lpage">1925</span>, <span class="refDoi"> DOI: 10.1038/npp.2009.24</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnpp.2009.24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=19262466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFSju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=1914-1925&author=K.+Ruttenauthor=E.+L.+Van+Donkelaarauthor=L.+Ferringtonauthor=A.+Bloklandauthor=E.+Bollenauthor=H.+W.+Steinbuschauthor=P.+A.+Kellyauthor=J.+H.+Prickaerts&title=Phosphodiesterase+inhibitors+enhance+object+memory+independent+of+cerebral+blood+flow+and+glucose+utilization+in+rats&doi=10.1038%2Fnpp.2009.24"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats</span></div><div class="casAuthors">Rutten, Kris; Van Donkelaar, Eva L.; Ferrington, Linda; Blokland, Arjan; Bollen, Eva; Steinbusch, Harry W. M.; Kelly, Paul A. T.; Prickaerts, Jos H. H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1914-1925</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) inhibitors prevent the breakdown of the second messengers, cAMP (cAMP) and cyclic GMP (cGMP), and are currently studied as possible targets for cognitive enhancement.  Earlier studies indicated beneficial effects of PDE inhibitors in object recognition.  In this study we tested the effects of three PDE inhibitors on spatial memory as assessed in a place and object recognition task.  Furthermore, as both cAMP and cGMP are known vasodilators, the effects of PDE inhibition on cognitive functions could be explained by enhancement of cerebrovascular function.  We examd. this possibility by measuring the effects of PDE5 and PDE4 inhibitor treatment on local cerebral blood flow and glucose utilization in rats using [14C]-iodoantipyrine and [14C]-2-deoxyglucose quant. autoradiog., resp.  In the spatial location task, PDE5 inhibition (cGMP) with vardenafil enhanced only early phase consolidation, PDE4 inhibition (cAMP) with rolipram enhanced only late phase consolidation, and PDE2 inhibition (cAMP and cGMP) with Bay 60-7550 enhanced both consolidation processes.  Furthermore, PDE5 inhibition had no cerebrovascular effects in hippocampal or rhinal areas.  PDE4 inhibition increased rhinal, but not hippocampal blood flow, whereas it decreased glucose utilization in both areas.  In general, PDE5 inhibition decreased the ratio between blood flow and glucose utilization, indicative of general oligemia; whereas PDE4 inhibition increased this ratio, indicative of general hyperemia.  Both oligemic and hyperemic conditions are detrimental for brain function and do not explain memory enhancement.  These results underscore the specific effects of cAMP and cGMP on memory consolidation (object and spatial memory) and provide evidence that the underlying mechanisms of PDE inhibition on cognition are independent of cerebrovascular effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfAElwT0GL1rVg90H21EOLACvtfcHk0liKZhsSwEYAtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFSju7c%253D&md5=506d0fbcb1b4a7a0c25bf92ab08fc270</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2009.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2009.24%26sid%3Dliteratum%253Aachs%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DVan%2BDonkelaar%26aufirst%3DE.%2BL.%26aulast%3DFerrington%26aufirst%3DL.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DBollen%26aufirst%3DE.%26aulast%3DSteinbusch%26aufirst%3DH.%2BW.%26aulast%3DKelly%26aufirst%3DP.%2BA.%26aulast%3DPrickaerts%26aufirst%3DJ.%2BH.%26atitle%3DPhosphodiesterase%2520inhibitors%2520enhance%2520object%2520memory%2520independent%2520of%2520cerebral%2520blood%2520flow%2520and%2520glucose%2520utilization%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D1914%26epage%3D1925%26doi%3D10.1038%2Fnpp.2009.24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sierksma, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sydlik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostamian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbusch, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Hove, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer’s disease</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2012.06.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=124-136&author=A.+S.+Sierksmaauthor=K.+Ruttenauthor=S.+Sydlikauthor=S.+Rostamianauthor=H.+W.+Steinbuschauthor=D.+L.+van+den+Hoveauthor=J.+Prickaerts&title=Chronic+phosphodiesterase+type+2+inhibition+improves+memory+in+the+APPswe%2FPS1dE9+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuropharm.2012.06.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.048%26sid%3Dliteratum%253Aachs%26aulast%3DSierksma%26aufirst%3DA.%2BS.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DSydlik%26aufirst%3DS.%26aulast%3DRostamian%26aufirst%3DS.%26aulast%3DSteinbusch%26aufirst%3DH.%2BW.%26aulast%3Dvan%2Bden%2BHove%26aufirst%3DD.%2BL.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DChronic%2520phosphodiesterase%2520type%25202%2520inhibition%2520improves%2520memory%2520in%2520the%2520APPswe%252FPS1dE9%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D124%26epage%3D136%26doi%3D10.1016%2Fj.neuropharm.2012.06.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klabnik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">955</span>– <span class="NLM_lpage">970</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neurobiolaging.2014.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=25442113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsF2mu7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=955-970&author=Y.+Xuauthor=J.+Panauthor=J.+Sunauthor=L.+Dingauthor=L.+Ruanauthor=M.+Reedauthor=X.+Yuauthor=J.+Klabnikauthor=D.+Linauthor=J.+Liauthor=L.+Chenauthor=C.+Zhangauthor=H.+Zhangauthor=J.+M.+O%E2%80%99Donnell&title=Inhibition+of+phosphodiesterase+2+reverses+impaired+cognition+and+neuronal+remodeling+caused+by+chronic+stress&doi=10.1016%2Fj.neurobiolaging.2014.08.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress</span></div><div class="casAuthors">Xu, Ying; Pan, Jianchun; Sun, Jiao; Ding, Lianshu; Ruan, Lina; Reed, Miranda; Yu, Xuefeng; Klabni, Jonathan; Lin, Dan; Li, Jianxin; Chen, Ling; Zhang, Chong; Zhang, Hanting; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">955-970</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chronic stress and neuronal vulnerability have recently been recognized as factors contributing to cognitive disorders.  One way to modify neuronal vulnerability is through mediation of phosphodiesterase 2 (PDE2), an enzyme that exerts its action on cognitive processes via the control of intracellular second messengers, cGMP and, to a lesser extent, cAMP.  This study explored the effects of a PDE2 inhibitor, Bay 60-7550, on stress-induced learning and memory dysfunction in terms of its ramification on behavioral, morphol., and mol. changes.  Bay 60-7550 reversed stress-induced cognitive impairment in the Morris water maze, novel object recognition, and location tasks (object recognition test and/or object location test), effects prevented by treatment with 7-NI, a selective inhibitor of neuronal nitric oxide synthase; MK801, a glutamate receptor (NMDAR) inhibitor; myr-AIP, a CaMKII inhibitor; and KT5823, a protein kinase G inhibitor.  Bay 60-7550 also ameliorated stress-induced structural remodeling in the CA1 of the hippocampus, leading to increases in dendritic branching, length, and spine d.  However, the neuroplasticity initiated by Bay 60-7550 was not seen in the presence of 7-NI, MK801, myr-AIP, or KT5823.  PDE2 inhibition reduced stress-induced extracellular-regulated protein kinase activation and attenuated stress-induced decreases in transcription factors (e.g., Elk-1, TORC1, and CREB phosphorylation) and plasticity-related proteins (e.g., Egr-1 and brain-derived neurotrophic factor).  Pretreatment with inhibitors of NMDA, CaMKII, neuronal nitric oxide synthase, and protein kinase G (or protein kinase A) blocked the effects of Bay 60-7550 on cGMP or cAMP signaling.  These findings indicate that the effect of PDE2 inhibition on stress-induced memory impairment is potentially mediated via modulation of neuroplasticity-related NMDAR-CaMKII-cGMP/cAMP signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC4VvV9CfvU7Vg90H21EOLACvtfcHk0lgK46RP38jhOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsF2mu7rL&md5=bd201c08a67c20c036958d7ed02cd25f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DRuan%26aufirst%3DL.%26aulast%3DReed%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DKlabnik%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520phosphodiesterase%25202%2520reverses%2520impaired%2520cognition%2520and%2520neuronal%2520remodeling%2520caused%2520by%2520chronic%2520stress%26jtitle%3DNeurobiol.%2520Aging%26date%3D2015%26volume%3D36%26spage%3D955%26epage%3D970%26doi%3D10.1016%2Fj.neurobiolaging.2014.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reneerkens, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hage, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbusch, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>236</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2012.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bbr.2012.08.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2013&pages=16-22&author=O.+A.+Reneerkensauthor=K.+Ruttenauthor=E.+Bollenauthor=T.+Hageauthor=A.+Bloklandauthor=H.+W.+Steinbuschauthor=J.+Prickaerts&title=Inhibition+of+phoshodiesterase+type+2+or+type+10+reverses+object+memory+deficits+induced+by+scopolamine+or+MK-801&doi=10.1016%2Fj.bbr.2012.08.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2012.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2012.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DReneerkens%26aufirst%3DO.%2BA.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBollen%26aufirst%3DE.%26aulast%3DHage%26aufirst%3DT.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DSteinbusch%26aufirst%3DH.%2BW.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520phoshodiesterase%2520type%25202%2520or%2520type%252010%2520reverses%2520object%2520memory%2520deficits%2520induced%2520by%2520scopolamine%2520or%2520MK-801%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2013%26volume%3D236%26spage%3D16%26epage%3D22%26doi%3D10.1016%2Fj.bbr.2012.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abarghaz, M.</span>; <span class="NLM_string-name">Biondi, S.</span>; <span class="NLM_string-name">Duranton, J.</span>; <span class="NLM_string-name">Limanton, E.</span>; <span class="NLM_string-name">Mondadori, C.</span>; <span class="NLM_string-name">Wagner, P.</span></span> <span> </span><span class="NLM_article-title">Benzo-1,4-diazepin-2-one Derivatives as Phosphodiesterase 2 Inhibitors, Preparation and Therapeutic Use Thereof</span>. <span class="NLM_patent">WO2005063723</span>, <span class="NLM_year">2005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+Abarghaz&author=S.+Biondi&author=J.+Duranton&author=E.+Limanton&author=C.+Mondadori&author=P.+Wagner&title=Benzo-1%2C4-diazepin-2-one+Derivatives+as+Phosphodiesterase+2+Inhibitors%2C+Preparation+and+Therapeutic+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAbarghaz%26aufirst%3DM.%26atitle%3DBenzo-1%252C4-diazepin-2-one%2520Derivatives%2520as%2520Phosphodiesterase%25202%2520Inhibitors%252C%2520Preparation%2520and%2520Therapeutic%2520Use%2520Thereof%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitenbucher, J. G.</span></span> <span> </span><span class="NLM_article-title">PDE2 inhibition: potential for the treatment of cognitive disorders</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6522</span>– <span class="NLM_lpage">6527</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bmcl.2013.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=24189054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslartbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6522-6527&author=L.+Gomezauthor=J.+G.+Breitenbucher&title=PDE2+inhibition%3A+potential+for+the+treatment+of+cognitive+disorders&doi=10.1016%2Fj.bmcl.2013.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">PDE2 inhibition: Potential for the treatment of cognitive disorders</span></div><div class="casAuthors">Gomez, Laurent; Breitenbucher, J. Guy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6522-6527</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase inhibition has received much attention in the past 20 years for the potential treatment of CNS disorders.  A primary focus of this work is the enhancement of memory and/or cognitive functioning.  The role of PDEs in the augmentation of cyclic nucleotide signaling makes these enzymes attractive targets for enhancing the effects of neuronal communication.  This review focuses on recent findings with respect to the role of PDE2 inhibition in cognitive functioning.  Special attention is paid to recently disclosed, selective tool compds. and the use of these tool compds. to support the role of PDE2 inhibition in cognition.  Recently reported SAR and modeling work will be presented along with discussion of the entry of new PDE2 inhibitors into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGUUFzh2-kTrVg90H21EOLACvtfcHk0ljg7Csr6bvUjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslartbjL&md5=04ca2bdc35dc0b436a228ba62934b91e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%26aufirst%3DL.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DPDE2%2520inhibition%253A%2520potential%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6522%26epage%3D6527%26doi%3D10.1016%2Fj.bmcl.2013.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span>; <span class="NLM_string-name">Chappie, T. A.</span>; <span class="NLM_string-name">Humphrey, J. M.</span>; <span class="NLM_string-name">Verhoest, P. R.</span>; <span class="NLM_string-name">Yang, E.</span></span> <span> </span><span class="NLM_article-title">Imidazo[5,1-f][1,2,4]triazines for the Treatment of Neurological Disorders</span>. <span class="NLM_patent">US 20120214791</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+J.+Helal&author=T.+A.+Chappie&author=J.+M.+Humphrey&author=P.+R.+Verhoest&author=E.+Yang&title=Imidazo%5B5%2C1-f%5D%5B1%2C2%2C4%5Dtriazines+for+the+Treatment+of+Neurological+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26atitle%3DImidazo%255B5%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2520for%2520the%2520Treatment%2520of%2520Neurological%2520Disorders%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Fernandez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroker, K. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1002/syn.21840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1002%2Fsyn.21840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26178667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1elu7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=484-496&author=D.+Fernandez-Fernandezauthor=H.+Rosenbrockauthor=K.+S.+Kroker&title=Inhibition+of+PDE2A%2C+but+not+PDE9A%2C+modulates+presynaptic+short-term+plasticity+measured+by+paired-pulse+facilitation+in+the+CA1+region+of+the+hippocampus&doi=10.1002%2Fsyn.21840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus</span></div><div class="casAuthors">Fernandez-Fernandez, Diego; Rosenbrock, Holger; Kroker, Katja S.</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">484-496</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) inhibitors are currently considered promising therapeutic targets for treatment of cognitive impairment in diseases such as Schizophrenia and Alzheimer's disease.  Inhibitors of PDE2A and PDE9A have emerged as potential candidates shown to improve synaptic plasticity and memory function in animals.  However, the functional relevance of their putative different localization in the neuron is not understood.  Thus, this study aims at elucidating potential presynaptic effects of PDE2A inhibition in comparison to the inhibition of PDE9A.  For this purpose, we used paired-pulse facilitation (PPF), a model of short-term synaptic plasticity related to presynaptic function.  First, we performed a series of expts. to validate the model in acute rat hippocampal slices using several ref. substances including calcium channel blockers, glutamatergic receptor antagonists, and GPCR agonists.  Second, we analyzed the effect of PDE2A and PDE9A inhibition and their role regulating the influence that the second messengers cAMP and cGMP exert on basal transmission.  Our results show that the interplay between the adenylyl cyclase activator forskolin, the sol. guanylyl cyclase activator BAY 41-8543 and the PDE2A inhibitor PF-999 reveals a primarily presynaptic mechanism of action of PDE2A inhibition.  On the contrary, inhibition of PDE9A did not alter PPF under similar conditions.  In conclusion, these data provide new evidence supporting a role of PDE2A modulating short-term synaptic plasticity.  Moreover, this function of PDE2A is suggested to rely on an active modulation of the cAMP hydrolysis as a response to changes in cGMP levels at the presynaptic level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMx3KC2TNDKrVg90H21EOLACvtfcHk0ljg7Csr6bvUjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1elu7vI&md5=990c6e54c53f4d8a08ae91d2fbdcef83</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21840%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Fernandez%26aufirst%3DD.%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DKroker%26aufirst%3DK.%2BS.%26atitle%3DInhibition%2520of%2520PDE2A%252C%2520but%2520not%2520PDE9A%252C%2520modulates%2520presynaptic%2520short-term%2520plasticity%2520measured%2520by%2520paired-pulse%2520facilitation%2520in%2520the%2520CA1%2520region%2520of%2520the%2520hippocampus%26jtitle%3DSynapse%26date%3D2015%26volume%3D69%26spage%3D484%26epage%3D496%26doi%3D10.1002%2Fsyn.21840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span> <span> </span><span class="NLM_article-title">Identification of a brain penetrant, highly selective phosphodiesterase 2A inhibitor for the treatment of cognitive impairment associated with schizophrenia (CIAS)</span>.  <i>Abstracts of Papers</i>, 244th National Meeting & Exposition of the American Chemical Society, Philadelphia, PA, U.S., August 19–23, 2012; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+J.+Helal&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26atitle%3DIdentification%2520of%2520a%2520brain%2520penetrant%252C%2520highly%2520selective%2520phosphodiesterase%25202A%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cognitive%2520impairment%2520associated%2520with%2520schizophrenia%2520%2528CIAS%2529%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span>Clinical
trial study found in clinical trials for PF-05180999: NCT01429740. <a href="https://clinicaltrials.gov/ct2/show/NCT01429740?term=PF-05180999&amp;rank=2" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01429740?term=PF-05180999&rank=2</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+PF-05180999%3A+NCT01429740.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01429740%3Fterm%3DPF-05180999%26rank%3D2+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span>Clinical trial study
found in clinical trials for PF-05180999: NCT01530529. <a href="https://clinicaltrials.gov/ct2/show/NCT01530529?term=PF-05180999&amp;rank=3" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01530529?term=PF-05180999&rank=3</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+PF-05180999%3A+NCT01530529.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01530529%3Fterm%3DPF-05180999%26rank%3D3+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyden, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kormos, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maklad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piotrowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. X.</span></span> <span> </span><span class="NLM_article-title">Application of structure-based design and parallel chemistry to identify a potent, selective, and brain penetrant phosphodiesterase 2A inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5673</span>– <span class="NLM_lpage">5698</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00397</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00397" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1Sitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5673-5698&author=C.+J.+Helalauthor=E.+P.+Arnoldauthor=T.+L.+Boydenauthor=C.+Changauthor=T.+A.+Chappieauthor=K.+F.+Fennellauthor=M.+D.+Formanauthor=M.+Hajosauthor=J.+F.+Harmsauthor=W.+E.+Hoffmanauthor=J.+M.+Humphreyauthor=Z.+Kangauthor=R.+J.+Kleimanauthor=B.+L.+Kormosauthor=C.+W.+Leeauthor=J.+Luauthor=N.+Makladauthor=L.+McDowellauthor=S.+Menteauthor=R.+E.+O%E2%80%99Connorauthor=J.+Panditauthor=M.+Piotrowskiauthor=A.+W.+Schmidtauthor=C.+J.+Schmidtauthor=H.+Uenoauthor=P.+R.+Verhoestauthor=E.+X.+Yang&title=Application+of+structure-based+design+and+parallel+chemistry+to+identify+a+potent%2C+selective%2C+and+brain+penetrant+phosphodiesterase+2A+inhibitor&doi=10.1021%2Facs.jmedchem.7b00397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor</span></div><div class="casAuthors">Helal, Christopher J.; Arnold, Eric P.; Boyden, Tracey L.; Chang, Cheng; Chappie, Thomas A.; Fennell, Kimberly F.; Forman, Michael D.; Hajos, Mihaly; Harms, John F.; Hoffman, William E.; Humphrey, John M.; Kang, Zhijun; Kleiman, Robin J.; Kormos, Bethany L.; Lee, Che-Wah; Lu, Jiemin; Maklad, Noha; McDowell, Laura; Mente, Scot; O'Connor, Rebecca E.; Pandit, Jayvardhan; Piotrowski, Mary; Schmidt, Anne W.; Schmidt, Christopher J.; Ueno, Hirokazu; Verhoest, Patrick R.; Yang, Edward X.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5673-5698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 2A (PDE2A) inhibitors have been reported to demonstrate in vivo activity in preclin. models of cognition.  To more fully explore the biol. of PDE2A inhibition, we sought to identify potent PDE2A inhibitors with improved brain penetration as compared to current literature compds.  Applying estd. human dose calcns. while simultaneously leveraging synthetically enabled chem. and structure-based drug design has resulted in a highly potent, selective, brain penetrant compd. 71 (PF-05085727) that effects in vivo biochem. changes commensurate with PDE2A inhibition along with behavioral and electrophysiol. reversal of the effects of NMDA antagonists in rodents.  This data supports the ability of PDE2A inhibitors to potentiate NMDA signaling and their further development for clin. cognition indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpZdZgTF6GMLVg90H21EOLACvtfcHk0lh6XZ2hGiT45w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1Sitb4%253D&md5=e1c3c778fc622ac2f5917625a983323f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00397%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DArnold%26aufirst%3DE.%2BP.%26aulast%3DBoyden%26aufirst%3DT.%2BL.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DFennell%26aufirst%3DK.%2BF.%26aulast%3DForman%26aufirst%3DM.%2BD.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DKang%26aufirst%3DZ.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DMcDowell%26aufirst%3DL.%26aulast%3DMente%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BE.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DPiotrowski%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DYang%26aufirst%3DE.%2BX.%26atitle%3DApplication%2520of%2520structure-based%2520design%2520and%2520parallel%2520chemistry%2520to%2520identify%2520a%2520potent%252C%2520selective%252C%2520and%2520brain%2520penetrant%2520phosphodiesterase%25202A%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5673%26epage%3D5698%26doi%3D10.1021%2Facs.jmedchem.7b00397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span>Clinical trial study found in clinical trials for TAK-915: NCT02584569. <a href="https://clinicaltrials.gov/ct2/show/NCT02584569?term=TAK-915&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02584569?term=TAK-915&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+TAK-915%3A+NCT02584569.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02584569%3Fterm%3DTAK-915%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span>Clinical trial study
found in clinical trials for TAK-915: NCT02461160. <a href="https://clinicaltrials.gov/ct2/show/NCT02461160?term=NCT02461160&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02461160?term=NCT02461160&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+TAK-915%3A+NCT02461160.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02461160%3Fterm%3DNCT02461160%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Movsesian, M.</span></span> <span> </span><span class="NLM_article-title">Novel approaches to targeting PDE3 in cardiovascular disease</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.pharmthera.2016.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=27108947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVOms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2016&pages=74-81&author=M.+Movsesian&title=Novel+approaches+to+targeting+PDE3+in+cardiovascular+disease&doi=10.1016%2Fj.pharmthera.2016.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Novel approaches to targeting PDE3 in cardiovascular disease</span></div><div class="casAuthors">Movsesian, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-81</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Inhibitors of PDE3, a family of dual-specificity cyclic nucleotide phosphodiesterases, are used clin. to increase cardiac contractility by raising intracellular cAMP content in cardiac myocytes and to reduce vascular resistance by increasing intracellular cGMP content in vascular smooth muscle myocytes.  When used in the treatment of patients with heart failure, PDE3 inhibitors are effective in the acute setting but increase sudden cardiac death with long-term administration, possibly reflecting pro-apoptotic and pro-hypertrophic consequences of increased cAMP-mediated signaling in cardiac myocytes.  CAMP-mediated signaling in cardiac myocytes is highly compartmentalized, and different phosphodiesterases, by controlling cAMP content in functionally discrete intracellular microcompartments, regulate different cAMP-mediated pathways.  Four variants/isoforms of PDE3 (PDE3A1, PDE3A2, PDE3A3, and PDE3B) are expressed in cardiac myocytes, and new exptl. results have demonstrated that these isoforms, which are differentially localized intracellularly through unique protein-protein interactions, control different physiol. responses.  While the catalytic regions of these isoforms may be too similar to allow the catalytic activity of each isoform to be selectively inhibited, targeting their unique protein-protein interactions may allow desired responses to be elicited without the adverse consequences that limit the usefulness of existing PDE3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpySUN0pntSI7Vg90H21EOLACvtfcHk0lh6XZ2hGiT45w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVOms7g%253D&md5=6e933dbd53f91fb96ad1664b273d8d99</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DMovsesian%26aufirst%3DM.%26atitle%3DNovel%2520approaches%2520to%2520targeting%2520PDE3%2520in%2520cardiovascular%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D163%26spage%3D74%26epage%3D81%26doi%3D10.1016%2Fj.pharmthera.2016.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tokuchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hishikawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, K.</span></span> <span> </span><span class="NLM_article-title">Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer’s disease and reverting to normal cognition</span>. <i>J. Neurol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>346</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.jns.2014.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.jns.2014.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=25248955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BC2M7jvFKquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2014&pages=288-292&author=R.+Tokuchiauthor=N.+Hishikawaauthor=T.+Kurataauthor=K.+Satoauthor=S.+Konoauthor=T.+Yamashitaauthor=K.+Deguchiauthor=K.+Abe&title=Clinical+and+demographic+predictors+of+mild+cognitive+impairment+for+converting+to+Alzheimer%E2%80%99s+disease+and+reverting+to+normal+cognition&doi=10.1016%2Fj.jns.2014.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition</span></div><div class="casAuthors">Tokuchi Ryo; Hishikawa Nozomi; Sato Kota; Kono Syoichiro; Yamashita Toru; Deguchi Kentaro; Kurata Tomoko; Abe Koji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the neurological sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">288-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To identify clinical and demographic predictors for mild cognitive impairment (MCI) conversion to Alzheimer's disease (AD) or reversion to normal cognition, and sustained MCI.  METHODS:  In total, 74 baseline MCI subjects were retrospectively investigated and categorized into three subgroups: conversion to AD, sustained MCI, or reversion to normal cognition during one year.  The clinical and demographic characteristics assessed were age, gender, educational attainment, vascular risk factors, white matter lesions (WMLs), and parahippocampal gyrus atrophy (PGA), analyzed by magnetic resonance imaging (MRI) using the voxel-based specific regional analysis system for AD (VSRAD).  RESULTS:  Of the 74 MCI subjects, 29 (39.2%) were classified as "converters", 39 (52.7%) as "sustained MCI", and 6 (8.1%) as "reverters".  Among the three subgroups, there were significant differences in educational attainment (years) (*p = 0.03), baseline mini-mental state examination (MMSE) scores (***p<0.001), and periventricular and deep white matter hyperintensity grades (*p = 0.02 and *p = 0.03, respectively).  Baseline PGA showed a significant increasing trend among the three subgroups (reverters<sustained MCI<converters, (###)p<0.001).  MCI subjects with higher educational attainment and low VSRAD Z-scores without WMLs were associated with reversion to normal cognitive function.  CONCLUSIONS:  Risk factors for MCI conversion to AD were low educational attainment, low baseline MMSE scores, high grade WMLs, and high VSRAD Z-scores.  High educational attainment, low VSRAD Z-scores, and no WMLs characterized reversion to normal cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDOQFApSkp6lZoq0fPSOTvfW6udTcc2eZdi80QS6HXcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7jvFKquw%253D%253D&md5=71ce876e1635cd1b5ae8ffe4b3bc5c84</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.jns.2014.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jns.2014.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DTokuchi%26aufirst%3DR.%26aulast%3DHishikawa%26aufirst%3DN.%26aulast%3DKurata%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DKono%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DDeguchi%26aufirst%3DK.%26aulast%3DAbe%26aufirst%3DK.%26atitle%3DClinical%2520and%2520demographic%2520predictors%2520of%2520mild%2520cognitive%2520impairment%2520for%2520converting%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520reverting%2520to%2520normal%2520cognition%26jtitle%3DJ.%2520Neurol.%2520Sci.%26date%3D2014%26volume%3D346%26spage%3D288%26epage%3D292%26doi%3D10.1016%2Fj.jns.2014.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jellinger, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attems, J.</span></span> <span> </span><span class="NLM_article-title">Prevalence of dementia disorders in the oldest-old: an autopsy study</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1007/s00401-010-0654-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1007%2Fs00401-010-0654-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2010&pages=421-433&author=K.+A.+Jellingerauthor=J.+Attems&title=Prevalence+of+dementia+disorders+in+the+oldest-old%3A+an+autopsy+study&doi=10.1007%2Fs00401-010-0654-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs00401-010-0654-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-010-0654-5%26sid%3Dliteratum%253Aachs%26aulast%3DJellinger%26aufirst%3DK.%2BA.%26aulast%3DAttems%26aufirst%3DJ.%26atitle%3DPrevalence%2520of%2520dementia%2520disorders%2520in%2520the%2520oldest-old%253A%2520an%2520autopsy%2520study%26jtitle%3DActa%2520Neuropathol.%26date%3D2010%26volume%3D119%26spage%3D421%26epage%3D433%26doi%3D10.1007%2Fs00401-010-0654-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanzi, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moir, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S. L.</span></span> <span> </span><span class="NLM_article-title">Clearance of Alzheimer’s Abeta peptide: the many roads to perdition</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2004.08.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuron.2004.08.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=605-608&author=R.+E.+Tanziauthor=R.+D.+Moirauthor=S.+L.+Wagner&title=Clearance+of+Alzheimer%E2%80%99s+Abeta+peptide%3A+the+many+roads+to+perdition&doi=10.1016%2Fj.neuron.2004.08.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2004.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2004.08.024%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DMoir%26aufirst%3DR.%2BD.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DClearance%2520of%2520Alzheimer%25E2%2580%2599s%2520Abeta%2520peptide%253A%2520the%2520many%2520roads%2520to%2520perdition%26jtitle%3DNeuron%26date%3D2004%26volume%3D43%26spage%3D605%26epage%3D608%26doi%3D10.1016%2Fj.neuron.2004.08.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalaria, R. N.</span></span> <span> </span><span class="NLM_article-title">The role of cerebral ischemia in Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1016/S0197-4580(00)00125-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2FS0197-4580%2800%2900125-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10867217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BD3cvgs1eltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=321-330&author=R.+N.+Kalaria&title=The+role+of+cerebral+ischemia+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0197-4580%2800%2900125-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The role of cerebral ischemia in Alzheimer's disease</span></div><div class="casAuthors">Kalaria R N</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of aging</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-30</span>
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    </div><div class="casAbstract">The Alzheimer type of dementia and stroke are known to increase at comparable rates with age.  Recent advances suggest that vascular risk factors linked to cerebrovascular disease and stroke in the elderly significantly increase the risk of developing Alzheimer's disease (AD).  These include atherosclerosis, atrial fibrillation, coronary artery disease, hypertension, and diabetes mellitus.  Moreover, review of various autopsy series shows that 60-90% of AD cases exhibit variable cerebrovascular pathology.  Although some vascular lesions such as cerebral amyloid angiopathy, endothelial degeneration, and periventricular white matter lesions are evident in most cases of AD, a third will exhibit cerebral infarction.  Despite the interpretation of pathological evidence, longitudinal clinical studies suggest that the co-existence of stroke and AD occurs more than by chance alone.  Strokes known to occur in patients with Alzheimer syndrome and most frequently in the oldest old substantially worsen cognitive decline and outcome, implicating some interaction between the disorders.  Nevertheless, the nature of a true relationship between the two disorders seems little explored.  What predisposes to strokes in underlying cognitive decline or AD? Is it possible that cerebral ischemia is a causal factor for AD? I examined several vascular factors and the vascular pathophysiology implicated in stroke and AD, and propose that cerebral ischemia or oligemia may promote Alzheimer type of changes in the aging brain.  Irrespective of the ultimate pathogenetic mechanism, these approaches implicate that management of peripheral vascular disease is important in the treatment or prevention of Alzheimer's disease or mixed dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtwE-qlOsc2aqcneEtCi92fW6udTcc2eY0MEVFLPTCNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3cvgs1eltg%253D%253D&md5=8a852961b34f99767becbf60a8b74bdd</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2800%2900125-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252800%252900125-1%26sid%3Dliteratum%253Aachs%26aulast%3DKalaria%26aufirst%3DR.%2BN.%26atitle%3DThe%2520role%2520of%2520cerebral%2520ischemia%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2000%26volume%3D21%26spage%3D321%26epage%3D330%26doi%3D10.1016%2FS0197-4580%2800%2900125-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. S.</span></span> <span> </span><span class="NLM_article-title">Cilostazol: therapeutic potential against focal cerebral ischemic damage</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.2174/138161206775474323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.2174%2F138161206775474323" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=565-573&author=K.+W.+Hongauthor=J.+H.+Leeauthor=K.+Y.+Kimauthor=S.+Y.+Parkauthor=W.+S.+Lee&title=Cilostazol%3A+therapeutic+potential+against+focal+cerebral+ischemic+damage&doi=10.2174%2F138161206775474323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2174%2F138161206775474323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775474323%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DK.%2BY.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DW.%2BS.%26atitle%3DCilostazol%253A%2520therapeutic%2520potential%2520against%2520focal%2520cerebral%2520ischemic%2520damage%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D565%26epage%3D573%26doi%3D10.2174%2F138161206775474323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takiguchi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span> <span> </span><span class="NLM_article-title">Cilostazol prevents amyloid beta peptide(25-35)-induced memory impairment and oxidative stress in mice</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">1899</span>– <span class="NLM_lpage">1912</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.01014.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fj.1476-5381.2010.01014.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20825411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWhsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2010&pages=1899-1912&author=M.+Hiramatsuauthor=O.+Takiguchiauthor=A.+Nishiyamaauthor=H.+Mori&title=Cilostazol+prevents+amyloid+beta+peptide%2825-35%29-induced+memory+impairment+and+oxidative+stress+in+mice&doi=10.1111%2Fj.1476-5381.2010.01014.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol prevents amyloid β peptide25-35-induced memory impairment and oxidative stress in mice</span></div><div class="casAuthors">Hiramatsu, Masayuki; Takiguchi, Osanao; Nishiyama, Aki; Mori, Hiromasa</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1899-1912</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Cilostazol may be effective in dementia assocd. with a cerebral ischemia.  In this study, we examd. whether it exerts beneficial effects on learning and/or memory impairment induced by Aβ25-35 in mice, and compared its effects with those of aspirin.  Aβ25-35 (9 nmol) was administered to mice i.c.v.  Learning and memory behavior were evaluated by measuring spontaneous alternation in a Y-maze and a step-down type passive avoidance test, on the 5th and 8th days after injection resp.  Levels of lipid peroxidn. (malondialdehyde) and cytokines in the frontal cortex and hippocampus were measured 2, 3, 5 and 7 days after the Aβ25-35 injection.  The effects of repeated administration of cilostazol and aspirin (both at 30 and 100 mg/kg-1, p.o.) on any changes induced by Aβ25-35 were evaluated.  Repeated administration of cilostazol significantly attenuated the impairment of spontaneous alternation and the shortened step-down latency induced by Aβ25-35.  Aspirin did not show any beneficial effect.  A significant increase in the levels of malondialdehyde (MDA) and IL-1β (only measured in hippocampus) was obsd. 2, 3 and 5 days after the Aβ25-35 injection in the frontal cortex and hippocampus.  Repeated administration of cilostazol (100 mg/kg-1) completely prevented the increase in MDA levels but failed to antagonize the increase in the expression of IL-1β induced by Aβ25-35.  These results suggest that the protective effect of cilostazol on Aβ25-35-induced memory impairment may be related to oxidative stress in the frontal cortex and the hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo29phkvEihHLVg90H21EOLACvtfcHk0ljrnO6G_moV9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWhsb%252FK&md5=d3e02a6445fdea4e98b023cf78f4c2a0</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.01014.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.01014.x%26sid%3Dliteratum%253Aachs%26aulast%3DHiramatsu%26aufirst%3DM.%26aulast%3DTakiguchi%26aufirst%3DO.%26aulast%3DNishiyama%26aufirst%3DA.%26aulast%3DMori%26aufirst%3DH.%26atitle%3DCilostazol%2520prevents%2520amyloid%2520beta%2520peptide%252825-35%2529-induced%2520memory%2520impairment%2520and%2520oxidative%2520stress%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D161%26spage%3D1899%26epage%3D1912%26doi%3D10.1111%2Fj.1476-5381.2010.01014.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leem, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H. K.</span></span> <span> </span><span class="NLM_article-title">Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid beta-induced cognitive deficits associated with decreased amyloid beta accumulation</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2011.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bbrc.2011.04.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2011&pages=602-608&author=S.+H.+Parkauthor=J.+H.+Kimauthor=S.+S.+Baeauthor=K.+W.+Hongauthor=D.+S.+Leeauthor=J.+Y.+Leemauthor=B.+T.+Choiauthor=H.+K.+Shin&title=Protective+effect+of+the+phosphodiesterase+III+inhibitor+cilostazol+on+amyloid+beta-induced+cognitive+deficits+associated+with+decreased+amyloid+beta+accumulation&doi=10.1016%2Fj.bbrc.2011.04.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2011.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2011.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DBae%26aufirst%3DS.%2BS.%26aulast%3DHong%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DLeem%26aufirst%3DJ.%2BY.%26aulast%3DChoi%26aufirst%3DB.%2BT.%26aulast%3DShin%26aufirst%3DH.%2BK.%26atitle%3DProtective%2520effect%2520of%2520the%2520phosphodiesterase%2520III%2520inhibitor%2520cilostazol%2520on%2520amyloid%2520beta-induced%2520cognitive%2520deficits%2520associated%2520with%2520decreased%2520amyloid%2520beta%2520accumulation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D408%26spage%3D602%26epage%3D608%26doi%3D10.1016%2Fj.bbrc.2011.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span> <span> </span><span class="NLM_article-title">A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study</span>. <i>Am. J. Geriatr. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1097/JGP.0b013e31819431ea</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1097%2FJGP.0b013e31819431ea" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=19307864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ivVCgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=353-354&author=H.+Araiauthor=T.+Takahashi&title=A+combination+therapy+of+donepezil+and+cilostazol+for+patients+with+moderate+Alzheimer+disease%3A+pilot+follow-up+study&doi=10.1097%2FJGP.0b013e31819431ea"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study</span></div><div class="casAuthors">Arai Heii; Takahashi Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCx1PkgV5nGvEeosoOnpOLfW6udTcc2eYunnGQRONGU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ivVCgsw%253D%253D&md5=722b0e9a3896ed1fcc3161ff5ec31d93</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1097%2FJGP.0b013e31819431ea&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJGP.0b013e31819431ea%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DT.%26atitle%3DA%2520combination%2520therapy%2520of%2520donepezil%2520and%2520cilostazol%2520for%2520patients%2520with%2520moderate%2520Alzheimer%2520disease%253A%2520pilot%2520follow-up%2520study%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Psychiatry%26date%3D2009%26volume%3D17%26spage%3D353%26epage%3D354%26doi%3D10.1097%2FJGP.0b013e31819431ea" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, M.</span></span> <span> </span><span class="NLM_article-title">Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e89516</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0089516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1371%2Fjournal.pone.0089516" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e89516&author=M.+Iharaauthor=M.+Nishinoauthor=A.+Taguchiauthor=Y.+Yamamotoauthor=Y.+Hattoriauthor=S.+Saitoauthor=Y.+Takahashiauthor=M.+Tsujiauthor=Y.+Kasaharaauthor=Y.+Takataauthor=M.+Okada&title=Cilostazol+add-on+therapy+in+patients+with+mild+dementia+receiving+donepezil%3A+a+retrospective+study&doi=10.1371%2Fjournal.pone.0089516"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0089516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0089516%26sid%3Dliteratum%253Aachs%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DNishino%26aufirst%3DM.%26aulast%3DTaguchi%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DM.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DTakata%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DM.%26atitle%3DCilostazol%2520add-on%2520therapy%2520in%2520patients%2520with%2520mild%2520dementia%2520receiving%2520donepezil%253A%2520a%2520retrospective%2520study%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De89516%26doi%3D10.1371%2Fjournal.pone.0089516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, M.</span></span> <span> </span><span class="NLM_article-title">Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis</span>. <i>Psychogeriatrics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1111/psyg.12021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fpsyg.12021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=25707423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BC2Mrot1ajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=164-169&author=A.+Taguchiauthor=Y.+Takataauthor=M.+Iharaauthor=Y.+Kasaharaauthor=M.+Tsujiauthor=M.+Nishinoauthor=D.+Sternauthor=M.+Okada&title=Cilostazol+improves+cognitive+function+in+patients+with+mild+cognitive+impairment%3A+a+retrospective+analysis&doi=10.1111%2Fpsyg.12021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis</span></div><div class="casAuthors">Taguchi Akihiko; Takata Yu; Ihara Masafumi; Kasahara Yukiko; Tsuji Masahiro; Nishino Madoka; Stern David; Okada Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">164-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Cerebral ischemia and accumulation of amyloid β (Aβ) are major risk factors for the development of dementia, including vascular dementia and Alzheimer's disease.  Cilostazol, an antiplatelet drug, has been shown to improve cerebral circulation and reduce accumulation of Aβ.  In this study, the long-term effect of cilostazol on cognitive function was investigated retrospectively.  METHODS:  Medical records at Sumotoitsuki Hospital were surveyed to find all patients treated with cilostazol and evaluated by the Mini-Mental State Examination (MMSE) during at least two visits separated by an interval of more than 6 months.  Patients receiving anti-dementia drugs were excluded.  Temporal changes in MMSE scores were compared between patients treated with cilostazol (n = 70) and those who ceased administration of this drug (n = 22).  The mean follow-up period was 691 days.  RESULTS:  Decrease in MMSE score was significantly ameliorated by administration of cilostazol.  Subgroup analysis revealed that cilostazol significantly improved MMSE score in patients with mild cognitive impairment, though no significant effect was observed in patients with normal cognitive function or dementia.  CONCLUSIONS:  Although there are limitations to such a retrospective study, these results significantly encourage undertaking a prospective cohort study to determine the effect of cilostazol on mild cognitive impairment where no treatments currently exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkwhSfdrbgnCXXDYhVZBdlfW6udTcc2eYunnGQRONGU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mrot1ajsw%253D%253D&md5=96c6a6e5803056c9a9c96d4f28376871</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1111%2Fpsyg.12021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpsyg.12021%26sid%3Dliteratum%253Aachs%26aulast%3DTaguchi%26aufirst%3DA.%26aulast%3DTakata%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DM.%26aulast%3DNishino%26aufirst%3DM.%26aulast%3DStern%26aufirst%3DD.%26aulast%3DOkada%26aufirst%3DM.%26atitle%3DCilostazol%2520improves%2520cognitive%2520function%2520in%2520patients%2520with%2520mild%2520cognitive%2520impairment%253A%2520a%2520retrospective%2520analysis%26jtitle%3DPsychogeriatrics%26date%3D2013%26volume%3D13%26spage%3D164%26epage%3D169%26doi%3D10.1111%2Fpsyg.12021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hishikawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, K.</span></span> <span> </span><span class="NLM_article-title">Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer’s disease with asymptomatic lacunar infarction</span>. <i>Geriatr. Gerontol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1384</span>– <span class="NLM_lpage">1391</span>, <span class="refDoi"> DOI: 10.1111/ggi.12870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fggi.12870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=27578455" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=1384-1391&issue=10&author=N.+Hishikawaauthor=Y.+Fukuiauthor=K.+Satoauthor=Y.+Ohtaauthor=T.+Yamashitaauthor=K.+Abe&title=Comprehensive+effects+of+galantamine+and+cilostazol+combination+therapy+on+patients+with+Alzheimer%E2%80%99s+disease+with+asymptomatic+lacunar+infarction&doi=10.1111%2Fggi.12870"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1111%2Fggi.12870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fggi.12870%26sid%3Dliteratum%253Aachs%26aulast%3DHishikawa%26aufirst%3DN.%26aulast%3DFukui%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DAbe%26aufirst%3DK.%26atitle%3DComprehensive%2520effects%2520of%2520galantamine%2520and%2520cilostazol%2520combination%2520therapy%2520on%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520asymptomatic%2520lacunar%2520infarction%26jtitle%3DGeriatr.%2520Gerontol.%2520Int.%26date%3D2016%26volume%3D17%26issue%3D10%26spage%3D1384%26epage%3D1391%26doi%3D10.1111%2Fggi.12870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tai, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. H.</span></span> <span> </span><span class="NLM_article-title">Cilostazol use is associated with reduced risk of dementia: a nationwide cohort study</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">784</span>, <span class="refDoi"> DOI: 10.1007/s13311-017-0512-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1007%2Fs13311-017-0512-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=28194663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVaqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=784&author=S.+Y.+Taiauthor=C.+Y.+Chienauthor=Y.+H.+Changauthor=Y.+H.+Yang&title=Cilostazol+use+is+associated+with+reduced+risk+of+dementia%3A+a+nationwide+cohort+study&doi=10.1007%2Fs13311-017-0512-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study</span></div><div class="casAuthors">Tai, Shu-Yu; Chien, Chen-Yu; Chang, Yu-Han; Yang, Yuan-Han</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">784-791</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Whether antiplatelet agents have a preventive effect on cognitive function remains unknown.  We examd. the potential assocn. between the use of cilostazol, an antiplatelet agent and cyclic adenosine monophosphate phosphodiesterase 3 inhibitor, and the risk of dementia in an Asian population.  Patients initiating cilostazol therapy between 1 Jan. 2004 and 31 Dec. 2009 without a prior history of dementia were identified from Taiwan's National Health Insurance database.  Participants were stratified by age, sex, comorbidities, and comedication.  The outcome of interest was all-cause dementia (ICD-9-CM codes 290.0, 290.4, 294.1, 331.0).  Cox regression models were used to est. the hazard ratio (HR) of dementia.  The cumulative cilostazol dosage was stratified by quartile of defined daily doses using no cilostazol use as a ref.  A total of 9148 participants 40 years of age or older and free of dementia at baseline were analyzed.  Patients using cilostazol (n = 2287) had a significantly decreased risk of incident dementia compared with patients not using the drug [n = 6861; adjusted HR (aHR) 0.75; 95% confidence interval (CI) 0.61-0.92].  Notably, cilostazol use was found to have a dose-dependent assocn. with reduced rate of dementia emergence (p for trend = 0.001).  Subgroup anal. identified a decline of dementia in cilostazol users with diagnosed ischemic heart disease (aHR 0.44, 95% CI 0.24-0.83) and cerebral vascular disease (aHR 0.34, 95% CI 0.21-0.54).  These observations suggest that cilostazol use may reduce the risk to develop dementia, and a high cumulative dose further decreases the risk of dementia.  These findings should be examd. further in randomized clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ZP4x682GkLVg90H21EOLACvtfcHk0lilutLeN5wVHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVaqs78%253D&md5=d5867d3221d14af26c08fe9d65fc8cca</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1007%2Fs13311-017-0512-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-017-0512-4%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DS.%2BY.%26aulast%3DChien%26aufirst%3DC.%2BY.%26aulast%3DChang%26aufirst%3DY.%2BH.%26aulast%3DYang%26aufirst%3DY.%2BH.%26atitle%3DCilostazol%2520use%2520is%2520associated%2520with%2520reduced%2520risk%2520of%2520dementia%253A%2520a%2520nationwide%2520cohort%2520study%26jtitle%3DNeurotherapeutics%26date%3D2017%26volume%3D14%26spage%3D784%26doi%3D10.1007%2Fs13311-017-0512-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span>Clinical trial study found in clinical trials for Cilostazol:
NCT01409564. <a href="https://clinicaltrials.gov/ct2/show/NCT01409564?term=Cilostazol&amp;draw=3&amp;rank=12" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01409564?term=Cilostazol&draw=3&rank=12</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+Cilostazol%3A%0ANCT01409564.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01409564%3Fterm%3DCilostazol%26draw%3D3%26rank%3D12+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span>Clinical trial study
found in clinical trials for Cilostazol: NCT02491268. <a href="https://clinicaltrials.gov/ct2/show/NCT02491268?term=Cilostazol&amp;draw=3&amp;rank=37" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02491268?term=Cilostazol&draw=3&rank=37</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+Cilostazol%3A+NCT02491268.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02491268%3Fterm%3DCilostazol%26draw%3D3%26rank%3D37+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLachlan, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynex, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S. K.</span></span> <span> </span><span class="NLM_article-title">Changes in PDE4D isoforms in the hippocampus of a patient with advanced Alzheimer disease</span>. <i>Arch. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1001/archneur.64.3.456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1001%2Farchneur.64.3.456" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=17353396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ltlWhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=456-457&author=C.+S.+McLachlanauthor=M.+L.+Chenauthor=C.+N.+Lynexauthor=D.+L.+Gohauthor=S.+Brennerauthor=S.+K.+Tay&title=Changes+in+PDE4D+isoforms+in+the+hippocampus+of+a+patient+with+advanced+Alzheimer+disease&doi=10.1001%2Farchneur.64.3.456"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in PDE4D isoforms in the hippocampus of a patient with advanced Alzheimer disease</span></div><div class="casAuthors">McLachlan Craig S; Chen Melissa L; Lynex Clare N; Goh Denise L M; Brenner Sydney; Tay Stacey K H</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">456-7</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR80keTmBw1i4hLSh9fo81bfW6udTcc2easQvCchzYjybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ltlWhtw%253D%253D&md5=54ff9fefa37f74e59ae19d4c1c092795</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1001%2Farchneur.64.3.456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.64.3.456%26sid%3Dliteratum%253Aachs%26aulast%3DMcLachlan%26aufirst%3DC.%2BS.%26aulast%3DChen%26aufirst%3DM.%2BL.%26aulast%3DLynex%26aufirst%3DC.%2BN.%26aulast%3DGoh%26aufirst%3DD.%2BL.%26aulast%3DBrenner%26aufirst%3DS.%26aulast%3DTay%26aufirst%3DS.%2BK.%26atitle%3DChanges%2520in%2520PDE4D%2520isoforms%2520in%2520the%2520hippocampus%2520of%2520a%2520patient%2520with%2520advanced%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2007%26volume%3D64%26spage%3D456%26epage%3D457%26doi%3D10.1001%2Farchneur.64.3.456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spina, D.</span></span> <span> </span><span class="NLM_article-title">PDE4 inhibitors: current status</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1038/bjp.2008.307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fbjp.2008.307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=18660825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFKkurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2008&pages=308-315&author=D.+Spina&title=PDE4+inhibitors%3A+current+status&doi=10.1038%2Fbjp.2008.307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">PDE4 inhibitors: current status</span></div><div class="casAuthors">Spina, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-315</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 4 (PDE4) inhibitors are currently under development for the treatment of respiratory diseases including asthma and chronic obstructive pulmonary disease.  The rationale for the development of this drug class stems from our understanding of the role of PDE4 in suppressing the function of a range of inflammatory and resident cells thought to contribute toward the pathogenesis of these diseases.  Similarly, numerous preclin. in vivo studies have shown that PDE4 inhibitors suppress characteristic features of these diseases, namely, cell recruitment, activation of inflammatory cells and physiol. changes in lung function in response to a range of insults to the airways.  These potentially beneficial actions of PDE4 inhibitors have been successfully translated in phase II and III clin. trials with roflumilast and cilomilast.  However, dose limiting side effects of nausea, diarrhea and headache have tempered the enthusiasm of this drug class for the treatment of these respiratory diseases.  A no. of strategies are currently being pursued in attempts to improve clin. efficacy and reduce side effects, including delivery via the inhaled route, and/or development of non-emetic PDE4 inhibitors and mixed PDE inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWb9EsDIbiDbVg90H21EOLACvtfcHk0lilutLeN5wVHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFKkurbM&md5=6d540b4fc5da7ed20c5df9b73120a6c0</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.307%26sid%3Dliteratum%253Aachs%26aulast%3DSpina%26aufirst%3DD.%26atitle%3DPDE4%2520inhibitors%253A%2520current%2520status%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D155%26spage%3D308%26epage%3D315%26doi%3D10.1038%2Fbjp.2008.307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krause, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kühne, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.3109/00498258809041693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.3109%2F00498258809041693" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=561-571&author=W.+Krauseauthor=G.+K%C3%BChne&title=Pharmacokinetics+of+rolipram+in+the+rhesus+and+cynomolgus+monkeys%2C+the+rat+and+the+rabbit.+Studies+on+species+differences&doi=10.3109%2F00498258809041693"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.3109%2F00498258809041693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498258809041693%26sid%3Dliteratum%253Aachs%26aulast%3DKrause%26aufirst%3DW.%26aulast%3DK%25C3%25BChne%26aufirst%3DG.%26atitle%3DPharmacokinetics%2520of%2520rolipram%2520in%2520the%2520rhesus%2520and%2520cynomolgus%2520monkeys%252C%2520the%2520rat%2520and%2520the%2520rabbit.%2520Studies%2520on%2520species%2520differences%26jtitle%3DXenobiotica%26date%3D1998%26volume%3D18%26spage%3D561%26epage%3D571%26doi%3D10.3109%2F00498258809041693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitolo, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinchese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">1624</span>– <span class="NLM_lpage">1634</span>, <span class="refDoi"> DOI: 10.1172/JCI22831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1172%2FJCI22831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=15578094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2004&pages=1624-1634&author=B.+Gongauthor=O.+V.+Vitoloauthor=F.+Trincheseauthor=S.+Liuauthor=M.+Shelanskiauthor=O.+Arancio&title=Persistent+improvement+in+synaptic+and+cognitive+functions+in+an+Alzheimer+mouse+model+after+rolipram+treatment&doi=10.1172%2FJCI22831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment</span></div><div class="casAuthors">Gong, Bing; Vitolo, Ottavio V.; Trinchese, Fabrizio; Liu, Shumin; Shelanski, Michael; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1624-1634</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Evidence suggests that Alzheimer disease (AD) begins as a disorder of synaptic function, caused in part by increased levels of amyloid β-peptide 1-42 (Aβ42).  Both synaptic and cognitive deficits are reproduced in mice double transgenic for amyloid precursor protein (AA substitution K670N,M671L) and presenilin-1 (AA substitution M146V).  Here the authors demonstrate that brief treatment with the phosphodiesterase 4 inhibitor rolipram ameliorates deficits in both long-term potentiation (LTP) and contextual learning in the double-transgenic mice.  Most importantly, this beneficial effect can be extended beyond the duration of the administration.  One course of long-term systemic treatment with rolipram improves LTP and basal synaptic transmission as well as working, ref., and associative memory deficits for at least 2 mo after the end of the treatment.  This protective effect is possibly due to stabilization of synaptic circuitry via alterations in gene expression by activation of the cAMP-dependent protein kinase (PKA)/cAMP regulatory element-binding protein (CREB) signaling pathway that make the synapses more resistant to the insult inflicted by Aβ.  Thus, agents that enhance the cAMP/PKA/CREB pathway have potential for the treatment of AD and other diseases assocd. with elevated Aβ42 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI79h3DC1rU7Vg90H21EOLACvtfcHk0ljqZZ86qZNUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhur3I&md5=72e43d10754678b58a452160fe7142e2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1172%2FJCI22831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI22831%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DB.%26aulast%3DVitolo%26aufirst%3DO.%2BV.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DShelanski%26aufirst%3DM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPersistent%2520improvement%2520in%2520synaptic%2520and%2520cognitive%2520functions%2520in%2520an%2520Alzheimer%2520mouse%2520model%2520after%2520rolipram%2520treatment%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2004%26volume%3D114%26spage%3D1624%26epage%3D1634%26doi%3D10.1172%2FJCI22831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozueta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelanski, M.</span></span> <span> </span><span class="NLM_article-title">Reversal of long-term dendritic spine alterations in Alzheimer disease models</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">16877</span>– <span class="NLM_lpage">16882</span>, <span class="refDoi"> DOI: 10.1073/pnas.0908706106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1073%2Fpnas.0908706106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=16877-16882&author=D.+L.+Smithauthor=J.+Pozuetaauthor=B.+Gongauthor=O.+Arancioauthor=M.+Shelanski&title=Reversal+of+long-term+dendritic+spine+alterations+in+Alzheimer+disease+models&doi=10.1073%2Fpnas.0908706106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908706106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908706106%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DPozueta%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DB.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DShelanski%26aufirst%3DM.%26atitle%3DReversal%2520of%2520long-term%2520dendritic%2520spine%2520alterations%2520in%2520Alzheimer%2520disease%2520models%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D16877%26epage%3D16882%26doi%3D10.1073%2Fpnas.0908706106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ<sub>25–35</sub> or Aβ<sub>1–40</sub> peptide in rats</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>212</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1007/s00213-010-1943-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1007%2Fs00213-010-1943-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20640406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFCgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2010&pages=181-191&author=Y.+F.+Chengauthor=C.+Wangauthor=H.+B.+Linauthor=Y.+F.+Liauthor=Y.+Huangauthor=J.+P.+Xuauthor=H.+T.+Zhang&title=Inhibition+of+phosphodiesterase-4+reverses+memory+deficits+produced+by+A%CE%B225%E2%80%9335+or+A%CE%B21%E2%80%9340+peptide+in+rats&doi=10.1007%2Fs00213-010-1943-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats</span></div><div class="casAuthors">Cheng, Yu-Fang; Wang, Chuang; Lin, Huan-Bing; Li, Yun-Feng; Huang, Ying; Xu, Jiang-Ping; Zhang, Han-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-191</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">CAMP signaling plays an important role in memory loss assocd. with Alzheimer's disease (AD).  However, little is known about whether inhibition of phosphodiesterase-4 (PDE4), which increases intracellular cAMP, reverses β-amyloid peptide (Aβ)-induced memory deficits.  Expts. were performed to demonstrate the effect of the PDE4 inhibitor rolipram on memory impairment produced by Aβ1-40 (Aβ40) or its core fragment Aβ25-35.  We tested memory using Morris water-maze and passive avoidance tasks and examd. expression of phosphorylated cAMP response-element binding protein (pCREB) in the hippocampus in rats treated with Aβ25-35 or Aβ40 into bilateral CA1 subregions, with or without rolipram administration.  Aβ25-35 (10 μg/side) increased escape latency during acquisition training and decreased swimming time and distance in the target quadrant in the water-maze probe trial; it also decreased 24-h retention in the passive avoidance paradigm.  All these were reversed by chronic administration of rolipram (0.5 mg/kg).  Similarly, Aβ40 (4 μg/side) produced memory impairment, as demonstrated by decreased retention in passive avoidance; this was also reversed by repeated treatment with rolipram.  In addn., rolipram blocked extinction of memory during the 32-day testing period in the passive avoidance test.  Further, Aβ40 decreased pCREB expression in the hippocampus, which was also reversed by rolipram; the changes in pCREB were highly correlated with those in memory.  These results suggest that the PDE4 inhibitor rolipram reverses cognitive deficits assocd. with AD most likely via increased cAMP/CREB signaling in the hippocampus; PDE4 could be a target for drugs that improve cognition in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgj5q7VduLnrVg90H21EOLACvtfcHk0ljqZZ86qZNUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFCgu7g%253D&md5=47deb157f2d749f9d8801731b5a63cea</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1007%2Fs00213-010-1943-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-010-1943-3%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%2BF.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DH.%2BB.%26aulast%3DLi%26aufirst%3DY.%2BF.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26atitle%3DInhibition%2520of%2520phosphodiesterase-4%2520reverses%2520memory%2520deficits%2520produced%2520by%2520A%25CE%25B225%25E2%2580%259335%2520or%2520A%25CE%25B21%25E2%2580%259340%2520peptide%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2010%26volume%3D212%26spage%3D181%26epage%3D191%26doi%3D10.1007%2Fs00213-010-1943-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. T.</span></span> <span> </span><span class="NLM_article-title">The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats</span>. <i>Int. J. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1017/S1461145711000836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1017%2FS1461145711000836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=21733236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVWgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=749-766&author=C.+Wangauthor=X.+M.+Yangauthor=Y.+Y.+Zhuoauthor=H.+Zhouauthor=H.+B.+Linauthor=Y.+F.+Chengauthor=J.+P.+Xuauthor=H.+T.+Zhang&title=The+phosphodiesterase-4+inhibitor+rolipram+reverses+A%CE%B2-induced+cognitive+impairment+and+neuroinflammatory+and+apoptotic+responses+in+rats&doi=10.1017%2FS1461145711000836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats</span></div><div class="casAuthors">Wang, Chuang; Yang, Xue-Mei; Zhuo, Ye-Ye; Zhou, Heng; Lin, Huan-Bing; Cheng, Yu-Fang; Xu, Jiang-Ping; Zhang, Han-Ting</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">749-766</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">β-Amyloid (Aβ) peptides play an important role in cognition deficits, neuroinflammation, and apoptosis obsd. in Alzheimer's disease (AD).  Activation of cAMP signaling enhances memory and inhibits inflammatory and apoptotic responses.  However, it is not known whether inhibition of phosphodiesterase-4 (PDE4), a crit. controller of intracellular cAMP concns., affects AD-assocd. neuroinflammatory and apoptotic responses and whether these responses contribute to deficits of memory mediated by cAMP signaling.  We addressed these issues using memory tests and neurochem. measures.  Specifically, rats microinfused with aggregated Aβ25-35 (10 μg/side) into bilateral CA1 subregions displayed deficits in learning ability and memory, as evidenced by decreases in escape latency during acquisition trials and exploratory activities in the probe trial in the water-maze task and 24-h retention in the passive avoidance test.  These effects were reversed by rolipram (0.1, 0.25 and 0.5 mg/kg.d i.p.), a prototypic PDE4 inhibitor, in a dose-dependent manner.  Interestingly, Aβ25-35-treated rats also displayed decreases in expression of phosphorylated cAMP response-element binding protein (pCREB) and Bcl-2, but increases in expression of NF-κB p65 and Bax in the hippocampus; these effects were also reversed by rolipram in a dose-dependent manner.  Similar neurochem. results were obsd. by replacing Aβ25-35 with Aβ1-42, a full-length amyloid peptide that quickly forms toxic oligomers.  These results suggest that PDE4 inhibitors such as rolipram may reverse Aβ-induced memory deficits at least in part via the attenuation of neuronal inflammation and apoptosis mediated by cAMP/CREB signaling.  PDE4 could be a target for treatment of memory loss assocd. with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdUA81iV8V8bVg90H21EOLACvtfcHk0lgsQSVNcLTvYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVWgurk%253D&md5=aeddc1b317c45f05990b7f4dd564106e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1017%2FS1461145711000836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145711000836%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DX.%2BM.%26aulast%3DZhuo%26aufirst%3DY.%2BY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DH.%2BB.%26aulast%3DCheng%26aufirst%3DY.%2BF.%26aulast%3DXu%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26atitle%3DThe%2520phosphodiesterase-4%2520inhibitor%2520rolipram%2520reverses%2520A%25CE%25B2-induced%2520cognitive%2520impairment%2520and%2520neuroinflammatory%2520and%2520apoptotic%2520responses%2520in%2520rats%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2012%26volume%3D15%26spage%3D749%26epage%3D766%26doi%3D10.1017%2FS1461145711000836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span> <span> </span><span class="NLM_article-title">Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action</span>. <i>Neurobiol. Learn. Mem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1016/j.nlm.2005.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.nlm.2005.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16242977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsF2nt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2006&pages=132-138&author=K.+Ruttenauthor=J.+Prickaertsauthor=A.+Blokland&title=Rolipram+reverses+scopolamine-induced+and+time-dependent+memory+deficits+in+object+recognition+by+different+mechanisms+of+action&doi=10.1016%2Fj.nlm.2005.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action</span></div><div class="casAuthors">Rutten, K.; Prickaerts, J.; Blokland, A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Learning and Memory</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-138</span>CODEN:
                <span class="NLM_cas:coden">NLMEFR</span>;
        ISSN:<span class="NLM_cas:issn">1074-7427</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In this study, the effect of the selective phosphodiesterase type 4 (PDE4) inhibitor rolipram on memory performance was investigated using the object recognition task.  First, three doses of rolipram (0.01, 0.03 or 0.1 mg/kg) were tested with a 24 h delay between the learning (T1) and the test (T2) trial.  Doses of rolipram were injected at different time points (30 min before T1, immediately after T1 or 3 h after T1).  In a second expt., the effects of rolipram (0.03, 0.1 or 0.3 mg/kg) were tested in combination with scopolamine (0.1 mg/kg) applying a 1 h delay between trials.  Both substances were administered 30 min before T1.  Using a 24 h interval, rolipram showed an improvement in long-term memory performance when injected 3 h after T1 at a dose of 0.03 mg/kg.  Further, rolipram reversed the scopolamine-induced short-term memory deficit at a dose of 0.1 mg/kg.  Although the improved memory performance in both conditions is likely to be explained by elevated cAMP levels, two sep. working mechanisms might explain these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPmOMfSpMePLVg90H21EOLACvtfcHk0lgsQSVNcLTvYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsF2nt7o%253D&md5=1bbb751b6dcbb187d08cea3eaa1ad693</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.nlm.2005.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nlm.2005.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26atitle%3DRolipram%2520reverses%2520scopolamine-induced%2520and%2520time-dependent%2520memory%2520deficits%2520in%2520object%2520recognition%2520by%2520different%2520mechanisms%2520of%2520action%26jtitle%3DNeurobiol.%2520Learn.%2520Mem.%26date%3D2006%26volume%3D85%26spage%3D132%26epage%3D138%26doi%3D10.1016%2Fj.nlm.2005.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by Abeta<sub>25–35</sub> in rats</span>. <i>Metab. Brain Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1007/s11011-016-9814-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1007%2Fs11011-016-9814-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26920899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslCrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=779-791&author=Y.+Zhuoauthor=H.+Guoauthor=Y.+Chengauthor=C.+Wangauthor=C.+Wangauthor=J.+Wuauthor=Z.+Zouauthor=D.+Ganauthor=Y.+Liauthor=J.+Xu&title=Inhibition+of+phosphodiesterase-4+reverses+the+cognitive+dysfunction+and+oxidative+stress+induced+by+Abeta25%E2%80%9335+in+rats&doi=10.1007%2Fs11011-016-9814-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by Aβ25-35 in rats</span></div><div class="casAuthors">Zhuo, Yeye; Guo, Haibiao; Cheng, Yufang; Wang, Chuang; Wang, Canmao; Wu, Jingang; Zou, Zhengqiang; Gan, Danna; Li, Yiwen; Xu, Jiangping</div><div class="citationInfo"><span class="NLM_cas:title">Metabolic Brain Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">779-791</span>CODEN:
                <span class="NLM_cas:coden">MBDIEE</span>;
        ISSN:<span class="NLM_cas:issn">0885-7490</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Phosphodiesterase-4 (PDE4) inhibitors prevent the breakdown of the second messenger cAMP and have been demonstrated to improve learning in several animal models of cognition.  In this study, we explored the antioxidative effects of rolipram in Alzheimer's disease (AD) by using bilateral Aβ25-35 injection into the hippocampus of rats, which were used as an AD model.  Rats received 3 i.p. (i.p.) doses of rolipram (0.1, 0.5 and 1.25 mg/kg) daily after the injection of Aβ25-35 for 25 days.  Chronic administration of rolipram prevented the memory impairments induced by Aβ25-35, as assessed using the passive avoidance test and the Morris water maze test.  Furthermore, rolipram significantly reduced the oxidative stress induced by Aβ25-35, as evidenced by the decrease in the levels of reactive oxygen species (ROS) and malondialdehyde (MDA), and restored the reduced GSH levels and superoxide dismutase (SOD) activity.  Moreover, western blotting and real-time reverse transcription polymerase chain reaction (RT-PCR) anal. showed that rolipram remarkably upregulated thioredoxin (Trx) and inhibited the inducible nitric oxide synthase/nitric oxide (iNOS/NO) pathway in the hippocampus.  These results demonstrated that rolipram improved the learning and memory abilities in an Aβ25-35-induced AD rat model.  The mechanism underlying these effects may be due to the noticeable antioxidative effects of rolipram.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXJjU2lmgtrLVg90H21EOLACvtfcHk0lgsQSVNcLTvYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslCrt7o%253D&md5=ce1b7dcb4a859d07fb5c4e6bd2c6f1e5</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1007%2Fs11011-016-9814-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11011-016-9814-1%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DZ.%26aulast%3DGan%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520phosphodiesterase-4%2520reverses%2520the%2520cognitive%2520dysfunction%2520and%2520oxidative%2520stress%2520induced%2520by%2520Abeta25%25E2%2580%259335%2520in%2520rats%26jtitle%3DMetab.%2520Brain%2520Dis.%26date%3D2016%26volume%3D31%26spage%3D779%26epage%3D791%26doi%3D10.1007%2Fs11011-016-9814-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer’s Type</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2017.01.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.biopha.2017.01.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=28152479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVSlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2017&pages=698-707&author=A.+Kumarauthor=N.+Singh&title=Inhibitor+of+phosphodiestearse-4+improves+memory+deficits%2C+oxidative+stress%2C+neuroinflammation+and+neuropathological+alterations+in+mouse+models+of+dementia+of+Alzheimer%E2%80%99s+Type&doi=10.1016%2Fj.biopha.2017.01.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's Type</span></div><div class="casAuthors">Kumar, Amit; Singh, Nirmal</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">698-707</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The study investigates the potential of Rolipram a phosphodiesterase-4 inhibitor in cognitive deficits induced by streptozotocin (STZ, 3 mg/kg intracerebroventricularly) and natural ageing in mice.  Morris water maze (MWM) test was employed to evaluate learning and memory of the animals.  Extent of oxidative stress was measured by estg. the levels of brain glutathione (GSH) and thiobarbituric acid reactive species (TBARS).  Brain acetylcholinestrase (AChE) activity was also estd.  The brain activity of myeloperoxidase (MPO) was measured as a marker of inflammation.  STZ and ageing results in marked decline in MWM performance of the animals, reflecting impairment of learning and memory.  STZ treated mice and aged mice exhibited a marked accentuation of AChE activity, TBARS and MPO activity along with fall in GSH level.  Further the stained micrographs of STZ treated mice and aged mice indicate pathol. changes, severe neutrophilic infiltration and amyloid deposition.  Rolipram treatment significantly attenuated STZ induced and age related memory deficits, biochem. and histopathol. alterations.  The findings demonstrate the potential of Rolipram in memory dysfunctions which may probably be attributed to its anti-cholinesterase, anti-amyloid, anti-oxidative and anti-inflammatory effects.  The study concludes that PDE-4 can be explored as a potential therapeutic target in dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolyQDD1R3sxrVg90H21EOLACvtfcHk0lgsQSVNcLTvYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVSlt7w%253D&md5=283d145e47d12940a38df6cfe8ae5b00</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.01.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.01.059%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DInhibitor%2520of%2520phosphodiestearse-4%2520improves%2520memory%2520deficits%252C%2520oxidative%2520stress%252C%2520neuroinflammation%2520and%2520neuropathological%2520alterations%2520in%2520mouse%2520models%2520of%2520dementia%2520of%2520Alzheimer%25E2%2580%2599s%2520Type%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D88%26spage%3D698%26epage%3D707%26doi%3D10.1016%2Fj.biopha.2017.01.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Lima, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Presti-Torres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimaraes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalco, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, N.</span></span> <span> </span><span class="NLM_article-title">Amelioration of recognition memory impairment associated with iron loading or aging by the type 4-specific phosphodiesterase inhibitor rolipram in rats</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2008.06.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=788-792&author=M.+N.+de+Limaauthor=J.+Presti-Torresauthor=V.+A.+Garciaauthor=M.+R.+Guimaraesauthor=F.+S.+Scalcoauthor=R.+Roeslerauthor=N.+Schroder&title=Amelioration+of+recognition+memory+impairment+associated+with+iron+loading+or+aging+by+the+type+4-specific+phosphodiesterase+inhibitor+rolipram+in+rats&doi=10.1016%2Fj.neuropharm.2008.06.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.06.025%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLima%26aufirst%3DM.%2BN.%26aulast%3DPresti-Torres%26aufirst%3DJ.%26aulast%3DGarcia%26aufirst%3DV.%2BA.%26aulast%3DGuimaraes%26aufirst%3DM.%2BR.%26aulast%3DScalco%26aufirst%3DF.%2BS.%26aulast%3DRoesler%26aufirst%3DR.%26aulast%3DSchroder%26aufirst%3DN.%26atitle%3DAmelioration%2520of%2520recognition%2520memory%2520impairment%2520associated%2520with%2520iron%2520loading%2520or%2520aging%2520by%2520the%2520type%25204-specific%2520phosphodiesterase%2520inhibitor%2520rolipram%2520in%2520rats%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D788%26epage%3D792%26doi%3D10.1016%2Fj.neuropharm.2008.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabe, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bredenbröker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethke, T. D.</span></span> <span> </span><span class="NLM_article-title">Roflumilast-an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(05)67100-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2FS0140-6736%2805%2967100-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2005&pages=563-571&author=K.+F.+Rabeauthor=E.+D.+Batemanauthor=D.+O%E2%80%99Donnellauthor=S.+Witteauthor=D.+Bredenbr%C3%B6kerauthor=T.+D.+Bethke&title=Roflumilast-an+oral+anti-inflammatory+treatment+for+chronic+obstructive+pulmonary+disease%3A+a+randomised+controlled+trial&doi=10.1016%2FS0140-6736%2805%2967100-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2967100-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252967100-0%26sid%3Dliteratum%253Aachs%26aulast%3DRabe%26aufirst%3DK.%2BF.%26aulast%3DBateman%26aufirst%3DE.%2BD.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DD.%26aulast%3DWitte%26aufirst%3DS.%26aulast%3DBredenbr%25C3%25B6ker%26aufirst%3DD.%26aulast%3DBethke%26aufirst%3DT.%2BD.%26atitle%3DRoflumilast-an%2520oral%2520anti-inflammatory%2520treatment%2520for%2520chronic%2520obstructive%2520pulmonary%2520disease%253A%2520a%2520randomised%2520controlled%2520trial%26jtitle%3DLancet%26date%3D2005%26volume%3D366%26spage%3D563%26epage%3D571%26doi%3D10.1016%2FS0140-6736%2805%2967100-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanmierlo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creemers, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkerman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Duinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambeth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2016.01.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bbr.2016.01.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2016&pages=26-33&author=T.+Vanmierloauthor=P.+Creemersauthor=S.+Akkermanauthor=M.+van+Duinenauthor=A.+Sambethauthor=J.+De+Vryauthor=T.+Uzauthor=A.+Bloklandauthor=J.+Prickaerts&title=The+PDE4+inhibitor+roflumilast+improves+memory+in+rodents+at+non-emetic+doses&doi=10.1016%2Fj.bbr.2016.01.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2016.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2016.01.031%26sid%3Dliteratum%253Aachs%26aulast%3DVanmierlo%26aufirst%3DT.%26aulast%3DCreemers%26aufirst%3DP.%26aulast%3DAkkerman%26aufirst%3DS.%26aulast%3Dvan%2BDuinen%26aufirst%3DM.%26aulast%3DSambeth%26aufirst%3DA.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26aulast%3DUz%26aufirst%3DT.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DThe%2520PDE4%2520inhibitor%2520roflumilast%2520improves%2520memory%2520in%2520rodents%2520at%2520non-emetic%2520doses%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D303%26spage%3D26%26epage%3D33%26doi%3D10.1016%2Fj.bbr.2016.01.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span>Clinical trial study
found in clinical trials for roflumilast, NCT01433666. <a href="https://clinicaltrials.gov/ct2/show/NCT01433666?term=NCT01433666&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01433666?term=NCT01433666&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+roflumilast%2C+NCT01433666.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01433666%3Fterm%3DNCT01433666%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span>Clinical trial study
found in clinical trials for roflumilast, NCT02051335. <a href="https://clinicaltrials.gov/ct2/show/NCT02051335?term=NCT02051335&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02051335?term=NCT02051335&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+roflumilast%2C+NCT02051335.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02051335%3Fterm%3DNCT02051335%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span>Clinical trial study
found in clinical trials for roflumilast, NCT02835716. <a href="https://clinicaltrials.gov/ct2/show/NCT02835716?term=NCT02835716&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02835716?term=NCT02835716&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+roflumilast%2C+NCT02835716.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02835716%3Fterm%3DNCT02835716%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jabaris, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumathy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girish, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugumar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saravana Babu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanikachalam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanikachalam, M.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/ CREB signaling system</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1622</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2015.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.brainres.2015.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26168894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOktrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1622&publication_year=2015&pages=279-291&author=S.+S.+Jabarisauthor=H.+Sumathyauthor=R.+Girishauthor=S.+Narayananauthor=M.+Sugumarauthor=C.+Saravana+Babuauthor=S.+Thanikachalamauthor=M.+Thanikachalam&title=Phosphodiesterase-4+inhibitors+ameliorates+cognitive+deficits+in+deoxycorticosterone+acetate+induced+hypertensive+rats+via+cAMP%2F+CREB+signaling+system&doi=10.1016%2Fj.brainres.2015.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/CREB signaling system</span></div><div class="casAuthors">Jabaris, S. Sugin Lal; Sumathy, Haridass; Girish, Ramesh; Narayanan, Shridhar; Sugumar, Mani; Saravana Babu, Chidambaram; Thanikachalam, Sadagopan; Thanikachalam, Mohan</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1622</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">279-291</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphodiesterase-4 (PDE-4) inhibitors promote memory by blocking the degrdn. of cAMP.  Existing evidence also shows that neuronal survival and plasticity are dependent on the phosphorylation of cAMP-response element-binding protein.  In this regard, PDE-4 inhibitors have also been shown to reverse pharmacol. and genetically induced memory impairment in animal models.  In the present study, the authors examd. the effect of both rolipram and roflumilast (PDE-4 inhibitors) on the impairment of learning and memory obsd. in hypertensive rats.  Deoxycorticosterone acetate (DOCA) salt hypertensive model was used to induce learning and memory deficits.  The mRNA expression of different PDE-4 subtypes along with the protein levels of pCREB and BDNF in the hippocampus was quantified.  Systolic blood pressure was significantly increased in DOCA salt hypertensive rats when compared to sham operated rats.  This effect was reversed by clonidine, an α2 receptor agonist, while PDE-4 inhibitors did not.  PDE-4 inhibitors significantly improved the time-induced memory deficits in object recognition task (ORT).  In DOCA salt hypertensive rats, the gene expression of PDE-4B and PDE-4D was significantly increased.  Furthermore, both pCREB and BDNF showed decreased levels of expression in hypertensive rats in comparison to sham operated rats.  Repeated administration of PDE-4 inhibitors significantly decreased both PDE-4B and PDE-4D with an increase in the expression of pCREB and BDNF in hypersensitive rats.  Also, rolipram, roflumilast and roflumilast N-oxide showed a linear increase in the plasma and brain concns. after ORT.  Our present findings suggested that PDE-4 inhibitors ameliorate hypertension-induced learning impairment via cAMP/CREB signaling that regulates BDNF expression downstream in the rat hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor2T-qJ90KbrVg90H21EOLACvtfcHk0ljABNKPaHJXKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOktrjP&md5=de346d07555e0ae055e5c27d3d85cb4b</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2015.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2015.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DJabaris%26aufirst%3DS.%2BS.%26aulast%3DSumathy%26aufirst%3DH.%26aulast%3DGirish%26aufirst%3DR.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DSugumar%26aufirst%3DM.%26aulast%3DSaravana%2BBabu%26aufirst%3DC.%26aulast%3DThanikachalam%26aufirst%3DS.%26aulast%3DThanikachalam%26aufirst%3DM.%26atitle%3DPhosphodiesterase-4%2520inhibitors%2520ameliorates%2520cognitive%2520deficits%2520in%2520deoxycorticosterone%2520acetate%2520induced%2520hypertensive%2520rats%2520via%2520cAMP%252F%2520CREB%2520signaling%2520system%26jtitle%3DBrain%2520Res.%26date%3D2015%26volume%3D1622%26spage%3D279%26epage%3D291%26doi%3D10.1016%2Fj.brainres.2015.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jabaris, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumathy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanikachalam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, C. S.</span></span> <span> </span><span class="NLM_article-title">Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>746</i></span>,  <span class="NLM_fpage">138</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2014.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejphar.2014.10.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=25446433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSmsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=746&publication_year=2015&pages=138-147&author=S.+G.+Jabarisauthor=H.+Sumathyauthor=R.+S.+Kumarauthor=S.+Narayananauthor=S.+Thanikachalamauthor=C.+S.+Babu&title=Effects+of+rolipram+and+roflumilast%2C+phosphodiesterase-4+inhibitors%2C+on+hypertension-induced+defects+in+memory+function+in+rats&doi=10.1016%2Fj.ejphar.2014.10.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats</span></div><div class="casAuthors">Jabaris, Sobhana George Sugin Lal; Sumathy, Haridass; Kumar, Ramadass Satiesh; Narayanan, Shridhar; Thanikachalam, Sadagopan; Babu, Chidambaram Saravana</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">746</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138-147</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypertension (HT) is a prevailing risk factor for cognitive impairment, the most common cause of vascular dementia; yet, no possible mechanism underlying the cognitive impairment induced by hypertension has been identified so far.  Inhibition of PDE-4 has been shown to increase phosphorylation of cAMP-response element binding protein in the hippocampus and enhance the memory performance.  Here, we examd. the effects of PDE-4 inhibitors, rolipram and roflumilast, on the impairment of learning and memory obsd. in hypertensive rats.  We used 2k-1c hypertensive model to induce learning and memory defects.  In addn., mRNA expression of PDE-4 sub-types A-D was also assessed in the hippocampus tissue.  Systolic blood pressure (SBP) was measured by tail-cuff method was significantly increased in 2k-1c rats when compared to sham operated rats; this effect was reversed by clonidine, whereas, PDE-4 inhibitors did not.  PDE-4 inhibitors significantly reversed time induced memory deficit in novel object recognition task (NORT).  Further, the retention latency on the second day in the elevated plus maze model was significantly shortened after repeated administration of rolipram and roflumilast.  Plasma and brain concns. of rolipram, roflumilast and roflumilast N-oxide were also measured after the NORT and showed linear increase in plasma and brain concns.  The PDE4B and PDE4D gene expression was significantly enhanced in hypertensive rats compared with sham operated however PDE4A and PDE4C remained unaltered.  Repeated treatment with PDE-4 inhibitors caused down regulation of PDE4B and PDE4D in hypertensive rats.  These results suggest that inhibition of PDE-4 ameliorates HT-induced impairment of learning and memory functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKT6L29U_H4bVg90H21EOLACvtfcHk0li9K-s8bzB1Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSmsLnO&md5=7a461c0debc0b3e2c32ec304846aed55</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2014.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2014.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DJabaris%26aufirst%3DS.%2BG.%26aulast%3DSumathy%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DR.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DThanikachalam%26aufirst%3DS.%26aulast%3DBabu%26aufirst%3DC.%2BS.%26atitle%3DEffects%2520of%2520rolipram%2520and%2520roflumilast%252C%2520phosphodiesterase-4%2520inhibitors%252C%2520on%2520hypertension-induced%2520defects%2520in%2520memory%2520function%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D746%26spage%3D138%26epage%3D147%26doi%3D10.1016%2Fj.ejphar.2014.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bourtchouladze, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lidge, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catapano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gossweiler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romashko, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, T.</span></span> <span> </span><span class="NLM_article-title">A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">10518</span>– <span class="NLM_lpage">10522</span>, <span class="refDoi"> DOI: 10.1073/pnas.1834280100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1073%2Fpnas.1834280100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=10518-10522&author=R.+Bourtchouladzeauthor=R.+Lidgeauthor=R.+Catapanoauthor=J.+Stanleyauthor=S.+Gossweilerauthor=D.+Romashkoauthor=R.+Scottauthor=T.+Tully&title=A+mouse+model+of+Rubinstein-Taybi+syndrome%3A+defective+long-term+memory+is+ameliorated+by+inhibitors+of+phosphodiesterase+4&doi=10.1073%2Fpnas.1834280100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1834280100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1834280100%26sid%3Dliteratum%253Aachs%26aulast%3DBourtchouladze%26aufirst%3DR.%26aulast%3DLidge%26aufirst%3DR.%26aulast%3DCatapano%26aufirst%3DR.%26aulast%3DStanley%26aufirst%3DJ.%26aulast%3DGossweiler%26aufirst%3DS.%26aulast%3DRomashko%26aufirst%3DD.%26aulast%3DScott%26aufirst%3DR.%26aulast%3DTully%26aufirst%3DT.%26atitle%3DA%2520mouse%2520model%2520of%2520Rubinstein-Taybi%2520syndrome%253A%2520defective%2520long-term%2520memory%2520is%2520ameliorated%2520by%2520inhibitors%2520of%2520phosphodiesterase%25204%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D10518%26epage%3D10522%26doi%3D10.1073%2Fpnas.1834280100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bletsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, T.</span></span> <span> </span><span class="NLM_article-title">The PDE4 inhibitor HT-0712 improves hippocampus-dependent memory in aged mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2938</span>– <span class="NLM_lpage">2948</span>, <span class="refDoi"> DOI: 10.1038/npp.2014.154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnpp.2014.154" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=2938-2948&author=M.+Petersauthor=M.+Bletschauthor=J.+Stanleyauthor=D.+Wheelerauthor=R.+Scottauthor=T.+Tully&title=The+PDE4+inhibitor+HT-0712+improves+hippocampus-dependent+memory+in+aged+mice&doi=10.1038%2Fnpp.2014.154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.154%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DM.%26aulast%3DBletsch%26aufirst%3DM.%26aulast%3DStanley%26aufirst%3DJ.%26aulast%3DWheeler%26aufirst%3DD.%26aulast%3DScott%26aufirst%3DR.%26aulast%3DTully%26aufirst%3DT.%26atitle%3DThe%2520PDE4%2520inhibitor%2520HT-0712%2520improves%2520hippocampus-dependent%2520memory%2520in%2520aged%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D2938%26epage%3D2948%26doi%3D10.1038%2Fnpp.2014.154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span>Clinical trial study found in clinical trials for HT-0712,
NCT02013310. <a href="https://clinicaltrials.gov/ct2/show/NCT02013310?term=NCT02013310&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02013310?term=NCT02013310&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+HT-0712%2C%0ANCT02013310.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02013310%3Fterm%3DNCT02013310%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aspiotis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesen, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacombe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laliberte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Styhler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairment</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6387</span>– <span class="NLM_lpage">6393</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bmcl.2010.09.087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6387-6393&author=M.+Gallantauthor=R.+Aspiotisauthor=S.+Dayauthor=R.+Diasauthor=D.+Dubeauthor=L.+Dubeauthor=R.+W.+Friesenauthor=M.+Girardauthor=D.+Guayauthor=P.+Hamelauthor=Z.+Huangauthor=P.+Lacombeauthor=S.+Laliberteauthor=J.+F.+Levesqueauthor=S.+Liuauthor=D.+Macdonaldauthor=J.+Manciniauthor=D.+W.+Nicholsonauthor=A.+Styhlerauthor=K.+Townsonauthor=K.+Watersauthor=R.+N.+Youngauthor=Y.+Girard&title=Discovery+of+MK-0952%2C+a+selective+PDE4+inhibitor+for+the+treatment+of+long-term+memory+loss+and+mild+cognitive+impairment&doi=10.1016%2Fj.bmcl.2010.09.087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.087%26sid%3Dliteratum%253Aachs%26aulast%3DGallant%26aufirst%3DM.%26aulast%3DAspiotis%26aufirst%3DR.%26aulast%3DDay%26aufirst%3DS.%26aulast%3DDias%26aufirst%3DR.%26aulast%3DDube%26aufirst%3DD.%26aulast%3DDube%26aufirst%3DL.%26aulast%3DFriesen%26aufirst%3DR.%2BW.%26aulast%3DGirard%26aufirst%3DM.%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DHamel%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLacombe%26aufirst%3DP.%26aulast%3DLaliberte%26aufirst%3DS.%26aulast%3DLevesque%26aufirst%3DJ.%2BF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMacdonald%26aufirst%3DD.%26aulast%3DMancini%26aufirst%3DJ.%26aulast%3DNicholson%26aufirst%3DD.%2BW.%26aulast%3DStyhler%26aufirst%3DA.%26aulast%3DTownson%26aufirst%3DK.%26aulast%3DWaters%26aufirst%3DK.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DGirard%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520MK-0952%252C%2520a%2520selective%2520PDE4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520long-term%2520memory%2520loss%2520and%2520mild%2520cognitive%2520impairment%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6387%26epage%3D6393%26doi%3D10.1016%2Fj.bmcl.2010.09.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span>Clinical trial study
found in clinical trials for MK-0952, NCT00362024. <a href="https://clinicaltrials.gov/ct2/show/NCT00362024?term=MK-0952&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT00362024?term=MK-0952&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+MK-0952%2C+NCT00362024.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00362024%3Fterm%3DMK-0952%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drouin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pando, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haun, F.</span></span> <span> </span><span class="NLM_article-title">Etazolate improves performance in a foraging and homing task in aged rats</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>634</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2010.02.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejphar.2010.02.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20223232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1WmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=634&publication_year=2010&pages=95-100&author=J.+Drottauthor=L.+Desireauthor=D.+Drouinauthor=M.+Pandoauthor=F.+Haun&title=Etazolate+improves+performance+in+a+foraging+and+homing+task+in+aged+rats&doi=10.1016%2Fj.ejphar.2010.02.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Etazolate improves performance in a foraging and homing task in aged rats</span></div><div class="casAuthors">Drott, Jason; Desire, L.; Drouin, D.; Pando, M.; Haun, Forrest</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">634</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">95-100</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Etazolate is a phosphodiesterase 4 (PDE4) inhibitor and GABAA receptor modulator that also stimulates alpha-secretase activity and neurotrophic sol. amyloid precursor protein (sAPPα) prodn., currently developed as a possible Alzheimer's disease therapeutic.  In this study two doses of etazolate were tested for cognitive effects in normally aged rats, using a complex spatial learning and memory task that emphasized two naturally occurring behaviors in rodents, foraging for food and returning large pieces of found food to a safe home location.  Both etazolate doses completely prevented both (1) a foraging deficit that developed in untreated aged rats over the course of the test, as well as (2) a trial-specific deficit in memory for previously visited food locations that also developed over the course of the test in untreated aged rats.  Both doses also significantly reduced a sep. memory deficit for changing locations of the animals' home box, plus completely prevented a significant tendency for untreated aged animals to attempt entry into similar-appearing but incorrect home boxes.  The combined behavioral data demonstrate pos. effects of etazolate on sep. age-related cognitive deficits, using a complex task based on naturally occurring rodent behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBSaIGIW7gI7Vg90H21EOLACvtfcHk0lheuZfTlbtdvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1WmtL0%253D&md5=b7ad137dde90330fa736bebe0104787f</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2010.02.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2010.02.036%26sid%3Dliteratum%253Aachs%26aulast%3DDrott%26aufirst%3DJ.%26aulast%3DDesire%26aufirst%3DL.%26aulast%3DDrouin%26aufirst%3DD.%26aulast%3DPando%26aufirst%3DM.%26aulast%3DHaun%26aufirst%3DF.%26atitle%3DEtazolate%2520improves%2520performance%2520in%2520a%2520foraging%2520and%2520homing%2520task%2520in%2520aged%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D634%26spage%3D95%26epage%3D100%26doi%3D10.1016%2Fj.ejphar.2010.02.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span> <span> </span><span class="NLM_article-title">Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons</span>. <i>J. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1002/neu.480250409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1002%2Fneu.480250409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=7915758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADyaK2cXktVWmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=439-450&author=M.+P.+Mattson&title=Secreted+forms+of+%CE%B2-amyloid+precursor+protein+modulate+dendrite+outgrowth+and+calcium+responses+to+glutamate+in+cultured+embryonic+hippocampal+neurons&doi=10.1002%2Fneu.480250409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons</span></div><div class="casAuthors">Mattson, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurobiology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">439-50</span>CODEN:
                <span class="NLM_cas:coden">JNEUBZ</span>;
        ISSN:<span class="NLM_cas:issn">0022-3034</span>.
    </div><div class="casAbstract">In addn. to being the major excitatory neurotransmitter in the mammalian brain, glutamate is believed to play a key role in the regulation of neurite outgrowth and synaptogenesis during development.  In cultured embryonic hippocampal pyramidal neurons, glutamate inhibits dendrite outgrowth by a mechanism involving elevation of intracellular-free calcium levels ([Ca2+]i).  In the present study, secreted forms of the β-amyloid precursor protein (APPss) counteracted the inhibitory effect of glutamate on dendrite outgrowth in cultured embryonic hippocampal neurons.  The prolonged elevation of [Ca2+]i normally induced by glutamate was significantly attenuated in neurons that had been pretreated with 2-10 nM of APPs695 or APPs751.  Immunocytochem. with β-amyloid precursor protein antibodies showed that immunoreactivity was concd. in axons and, particularly, in their growth cones.  Because β-amyloid precursor proteins are axonally transported, and APPss can be released from axon terminals/growth cones in response to elec. activity, the present findings suggest that APPss may play a role in developmental and synaptic plasticity by modulating dendritic responses to glutamate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVPyu96qthDLVg90H21EOLACvtfcHk0lheuZfTlbtdvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktVWmu7w%253D&md5=49392b043f8f14f9d8dd2318fd5e59cc</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2Fneu.480250409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fneu.480250409%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26atitle%3DSecreted%2520forms%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein%2520modulate%2520dendrite%2520outgrowth%2520and%2520calcium%2520responses%2520to%2520glutamate%2520in%2520cultured%2520embryonic%2520hippocampal%2520neurons%26jtitle%3DJ.%2520Neurobiol.%26date%3D1994%26volume%3D25%26spage%3D439%26epage%3D450%26doi%3D10.1002%2Fneu.480250409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span>Clinical trial study found in clinical trials for Etazolate,
NCT00880412. <a href="https://clinicaltrials.gov/ct2/results?cond=&amp;term=NCT00880412&amp;cntry1=&amp;state1=&amp;Search=Search" class="extLink">https://clinicaltrials.gov/ct2/results?cond=&term=NCT00880412&cntry1=&state1=&Search=Search</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+Etazolate%2C%0ANCT00880412.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fresults%3Fcond%3D%26term%3DNCT00880412%26cntry1%3D%26state1%3D%26Search%3DSearch+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ousset, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemarie, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">P. Pando, M.</span></span> <span> </span><span class="NLM_article-title">EHT0202 in Alzheimer’s disease: a 3-month, randomized, placebo-controlled, double-blind study</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.2174/156720511795256053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.2174%2F156720511795256053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=21222604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslOisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=203-212&author=B.+Vellasauthor=O.+Solauthor=P.+J.+Snyderauthor=P.+J.+Oussetauthor=R.+Haddadauthor=M.+Maurinauthor=J.+C.+Lemarieauthor=L.+Desireauthor=M.+P.+Pando&title=EHT0202+in+Alzheimer%E2%80%99s+disease%3A+a+3-month%2C+randomized%2C+placebo-controlled%2C+double-blind+study&doi=10.2174%2F156720511795256053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">EHT0202 in Alzheimer's disease: a 3-month, randomized, placebo-controlled, double-blind study</span></div><div class="casAuthors">Vellas, B.; Sol, O.; Snyder, P. J.; Ousset, P.-J.; Haddad, R.; Maurin, M.; Lemarie, J.-C.; Desire, L.; Pando, M. P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-212</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: EHT0202 (etazolate hydrochloride) is a new compd. exhibiting both potential diseasemodifying and symptomatic treatment properties in Alzheimer's Disease increasing alpha-secretase activity and sAPP alpha secretion, as well as acting as a GABA-A receptor modulator and as a PDE-4 inhibitor.  Methods: This pilot, randomized, double-blind, placebo-controlled, parallel group, multicentre, Phase IIA study was conducted in 159 randomized patients suffering from mild to moderate Alzheimer's Disease.  EHT0202 (40 or 80mg bid) or placebo was administered as adjunctive therapy to one acetylcholinesterase inhibitor over a 3-mo period.  This study was designed to assess the clin. safety and tolerability of EHT0202 as a primary objective, with secondary endpoints (cognitive function, daily living activities, behavior, caregiver burden and global functioning) included to explore clin. efficacy of EHT0202 vs. placebo.  Results: EHT0202 was shown to be safe and generally well tolerated.  Dose-dependent nos. of early withdrawal and central nervous system related adverse events were obsd.  As expected, since the study was not powered and not designed to show drug efficacy, and except for ratings on the ADCS-ADL scale, no significant differences were seen between treatment groups.  Conclusions: These first encouraging safety results do support further development of EHT0202 in order to assess its clin. efficacy and to confirm its tolerability in a larger cohort of Alzheimer patients and for a longer period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGT7btT8TzVrVg90H21EOLACvtfcHk0lheuZfTlbtdvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslOisLk%253D&md5=b48e7cc084616eb4d81bd4d7c25763de</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.2174%2F156720511795256053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720511795256053%26sid%3Dliteratum%253Aachs%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DSol%26aufirst%3DO.%26aulast%3DSnyder%26aufirst%3DP.%2BJ.%26aulast%3DOusset%26aufirst%3DP.%2BJ.%26aulast%3DHaddad%26aufirst%3DR.%26aulast%3DMaurin%26aufirst%3DM.%26aulast%3DLemarie%26aufirst%3DJ.%2BC.%26aulast%3DDesire%26aufirst%3DL.%26aulast%3DP.%2BPando%26aufirst%3DM.%26atitle%3DEHT0202%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%25203-month%252C%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%2520study%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2011%26volume%3D8%26spage%3D203%26epage%3D212%26doi%3D10.2174%2F156720511795256053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macnaughtan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prestegard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and structure-activity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7673</span>– <span class="NLM_lpage">7688</span>, <span class="refDoi"> DOI: 10.1021/jm701635j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701635j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKlu7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7673-7688&author=S.+Zhengauthor=G.+Kaurauthor=H.+Wangauthor=M.+Liauthor=M.+Macnaughtanauthor=X.+Yangauthor=S.+Reidauthor=J.+Prestegardauthor=B.+Wangauthor=H.+Ke&title=Design%2C+synthesis%2C+and+structure-activity+relationship%2C+molecular+modeling%2C+and+NMR+studies+of+a+series+of+phenyl+alkyl+ketones+as+highly+potent+and+selective+phosphodiesterase-4+inhibitors&doi=10.1021%2Fjm701635j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and structure-activity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors</span></div><div class="casAuthors">Zheng, Shilong; Kaur, Gurpreet; Wang, Huanchen; Li, Minyong; Macnaughtan, Megan; Yang, Xiaochuan; Reid, Suazette; Prestegard, James; Wang, Binghe; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7673-7688</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 4 catalyzes the hydrolysis of cAMP and is a target for the development of anti-inflammatory agents.  We have designed and synthesized a series of Ph alkyl ketones as PDE4 inhibitors.  Among them, 13 compds. were identified as having submicromolar IC50 values.  The most potent compds. have IC50 values of in the mid- to low-nanomolar range.  Compd. I (R = i-Pr, X = O)also showed preference for PDE4 with selectivity of >2000-fold over PDE7, PDE9, PDE2, and PDE5.  Docking of I, II (R = i-Pr, X = CH2), and III (R = n-Pr, X = O) into the binding pocket of the PDE4 catalytic domain revealed a similar binding profile to PDE4 with rolipram except that the fluorine atoms of the difluoromethyl groups of I, II, and III are within a reasonable range for hydrogen bond formation with the amide hydrogen of Thr 333 and the long alkyl chain bears addnl. van der Waals interactions with His 160, Asp 318, and Tyr 159.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkyBtbusd487Vg90H21EOLACvtfcHk0lg6gcHPueS7fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKlu7vN&md5=cc9e4b0a1e090e8bead52686da67d047</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm701635j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701635j%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DMacnaughtan%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DReid%26aufirst%3DS.%26aulast%3DPrestegard%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationship%252C%2520molecular%2520modeling%252C%2520and%2520NMR%2520studies%2520of%2520a%2520series%2520of%2520phenyl%2520alkyl%2520ketones%2520as%2520highly%2520potent%2520and%2520selective%2520phosphodiesterase-4%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7673%26epage%3D7688%26doi%3D10.1021%2Fjm701635j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2017.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=28065587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFakt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=260-269&author=H.+Guoauthor=Y.+Chengauthor=C.+Wangauthor=J.+Wuauthor=Z.+Zouauthor=B.+Niuauthor=H.+Yuauthor=H.+Wangauthor=J.+Xu&title=FFPM%2C+a+PDE4+inhibitor%2C+reverses+learning+and+memory+deficits+in+APP%2FPS1+transgenic+mice+via+cAMP%2FPKA%2FCREB+signaling+and+anti-inflammatory+effects&doi=10.1016%2Fj.neuropharm.2017.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects</span></div><div class="casAuthors">Guo, Haibiao; Cheng, Yufang; Wang, Canmao; Wu, Jingang; Zou, Zhengqiang; Niu, Bo; Yu, Hui; Wang, Haitao; Xu, Jiangping</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">260-269</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Thus far, phosphodiesterase-4 (PDE4) inhibitors have not been approved for application in Alzheimer's disease (AD) in a clin. setting due to severe side effects, such as nausea and vomiting.  In this study, we investigated the effect of FFPM, a novel PDE4 inhibitor, on learning and memory abilities, as well as the underlying mechanism in the APP/PS1 mouse model of AD.  Pharmacokinetic studies have revealed that FFPM efficiently permeates into the brain, and reached peak values in plasma 2 h after orally dosing.  A 3-wk treatment with FFPM, at doses of 0.25 mg/kg and 0.5 mg/kg, significantly improved the learning and memory abilities of APP/PS1 transgenic mice in the Morris water maze and the Step-down passive avoidance task.  Interestingly, we found that while rolipram (0.5 mg/kg) reduced the duration of the α2 adrenergic receptor-mediated anesthesia induced by xylazine/ketamine, FFPM (0.5 mg/kg) or the vehicle did not have an evident effect.  FFPM increased the cAMP, PKA and CREB phosphorylation and BDNF levels, and reduced the NF-κB p65, iNOS, TNF-α and IL-1β levels in the hippocampi of APP/PS1 trangenic mice, as obsd. by ELISA and Western blot anal.  Taken together, our data demonstrated that the reversal effect of FFPM on cognitive deficits in APP/PS1 transgenic mice might be related to stimulation of the cAMP/PKA/CREB/BDNF pathway and anti-inflammatory effects.  Moreover, FFPM appears to have potential as an effective PDE4 inhibitor in AD treatment with little emetic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqueQvekWB9CbVg90H21EOLACvtfcHk0lgNuW1-4fntOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFakt70%253D&md5=024f56897208ce4c5c36e3a89d90c407</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DZ.%26aulast%3DNiu%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DFFPM%252C%2520a%2520PDE4%2520inhibitor%252C%2520reverses%2520learning%2520and%2520memory%2520deficits%2520in%2520APP%252FPS1%2520transgenic%2520mice%2520via%2520cAMP%252FPKA%252FCREB%2520signaling%2520and%2520anti-inflammatory%2520effects%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D116%26spage%3D260%26epage%3D269%26doi%3D10.1016%2Fj.neuropharm.2017.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. T.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">172</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.5236-10.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1523%2FJNEUROSCI.5236-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=21209202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1ygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=172-183&author=Y.+F.+Liauthor=Y.+F.+Chengauthor=Y.+Huangauthor=M.+Contiauthor=S.+P.+Wilsonauthor=J.+M.+O%E2%80%99Donnellauthor=H.+T.+Zhang&title=Phosphodiesterase-4D+knock-out+and+RNA+interference-mediated+knock-down+enhance+memory+and+increase+hippocampal+neurogenesis+via+increased+cAMP+signaling&doi=10.1523%2FJNEUROSCI.5236-10.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling</span></div><div class="casAuthors">Li, Yun-Feng; Cheng, Yu-Fang; Huang, Ying; Conti, Marco; Wilson, Steven P.; O'Donnell, James M.; Zhang, Han-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-183</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Phosphodiesterase-4 (PDE4) plays an important role in mediating memory via the control of intracellular cAMP signaling; inhibition of PDE4 enhances memory.  However, development of PDE4 inhibitors as memory enhancers has been hampered by their major side effect of emesis.  PDE4 has four subtypes (PDE4A-D) consisting of 25 splice variants.  Mice deficient in PDE4D displayed memory enhancement in radial arm maze, water maze, and object recognition tests.  These effects were mimicked by repeated treatment with rolipram in wild-type mice.  In addn., similarly as rolipram-treated wild-type mice, PDE4D-deficient mice also displayed increased hippocampal neurogenesis and phosphorylated cAMP response element-binding protein (pCREB).  Furthermore, microinfusion of lentiviral vectors that contained microRNAs (miRNAs) targeting long-form PDE4D isoforms into bilateral dentate gyri of the mouse hippocampus down-regulated PDE4D4 and PDE4D5, enhanced memory, and increased hippocampal neurogenesis and pCREB.  Finally, while rolipram and PDE4D deficiency shortened α2 adrenergic receptor-mediated anesthesia, a surrogate measure of emesis, miRNA-mediated PDE4D knock-down in the hippocampus did not.  The present results suggest that PDE4D, in particular long-form PDE4D, plays a crit. role in the mediation of memory and hippocampal neurogenesis, which are mediated by cAMP/CREB signaling; reduced expression of PDE4D, or at least PDE4D4 and PDE4D5, in the hippocampus enhances memory but appears not to cause emesis.  These novel findings will aid in the development of PDE4 subtype- or variant-selective inhibitors for treatment of disorders involving impaired cognition, including Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonKG03_qqdl7Vg90H21EOLACvtfcHk0lgNuW1-4fntOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1ygsg%253D%253D&md5=928836c09ff122681fdf11db58885b79</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5236-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5236-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BF.%26aulast%3DCheng%26aufirst%3DY.%2BF.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DConti%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DS.%2BP.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26atitle%3DPhosphodiesterase-4D%2520knock-out%2520and%2520RNA%2520interference-mediated%2520knock-down%2520enhance%2520memory%2520and%2520increase%2520hippocampal%2520neurogenesis%2520via%2520increased%2520cAMP%2520signaling%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D172%26epage%3D183%26doi%3D10.1523%2FJNEUROSCI.5236-10.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamatiou, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S. L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachance, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laliberté, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.-C.</span></span> <span> </span><span class="NLM_article-title">Deletion of phosphodiesterase 4D in mice shortens α2-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1045</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1172/JCI0215506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1172%2FJCI0215506" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2002&pages=1045-1052&author=A.+Robichaudauthor=P.+B.+Stamatiouauthor=S.+L.+C.+Jinauthor=N.+Lachanceauthor=D.+MacDonaldauthor=F.+Lalibert%C3%A9author=S.+Liuauthor=Z.+Huangauthor=M.+Contiauthor=C.-C.+Chan&title=Deletion+of+phosphodiesterase+4D+in+mice+shortens+%CE%B12-adrenoceptor-mediated+anesthesia%2C+a+behavioral+correlate+of+emesis&doi=10.1172%2FJCI0215506"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1172%2FJCI0215506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI0215506%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DA.%26aulast%3DStamatiou%26aufirst%3DP.%2BB.%26aulast%3DJin%26aufirst%3DS.%2BL.%2BC.%26aulast%3DLachance%26aufirst%3DN.%26aulast%3DMacDonald%26aufirst%3DD.%26aulast%3DLalibert%25C3%25A9%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DConti%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DC.-C.%26atitle%3DDeletion%2520of%2520phosphodiesterase%25204D%2520in%2520mice%2520shortens%2520%25CE%25B12-adrenoceptor-mediated%2520anesthesia%252C%2520a%2520behavioral%2520correlate%2520of%2520emesis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D110%26spage%3D1045%26epage%3D1052%26doi%3D10.1172%2FJCI0215506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savoie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamatiou, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachance, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolicoeur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.-C.</span></span> <span> </span><span class="NLM_article-title">Assessing the emetic potential of PDE4 inhibitors in rats</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0704457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fsj.bjp.0704457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=11786486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVegug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2002&pages=113-118&author=A.+Robichaudauthor=C.+Savoieauthor=P.+B.+Stamatiouauthor=N.+Lachanceauthor=P.+Jolicoeurauthor=R.+Rasoriauthor=C.-C.+Chan&title=Assessing+the+emetic+potential+of+PDE4+inhibitors+in+rats&doi=10.1038%2Fsj.bjp.0704457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the emetic potential of PDE4 inhibitors in rats</span></div><div class="casAuthors">Robichaud, A.; Savoie, C.; Stamatiou, P. B.; Lachance, N.; Jolicoeur, P.; Rasori, R.; Chan, C. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-118</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Type 4 phosphodiesterase (PDE4) inhibitors mimic the pharmacol. actions of alpha2-adrenoceptor antagonists.  This has been postulated as the mechanism by which PDE4 inhibitors induce emesis and was also demonstrated by their ability to reverse xylazine/ketamine-induced anesthesia.  We further characterized this latter effect since it appears to reflect the emetic potential of PDE4 inhibitors.  Selective inhibitors of PDE 1, 2, 3, 4 and 5 were studied in rats, on the duration of anesthesia induced by the combination of xylazine (10 mg kg-1, i.m.) and ketamine (10 mg kg-1, i.m.).  PMNPQ ((i.e. 6-(4-pyridylmethyl)-8-(3-nitrophenyl)quinoline) - PDE4 inhibitor 0.01-3 mg kg-1), like MK-912 (alpha2-adrenoceptor antagonist: 0.01-3 mg kg-1), dose-dependently reduced the duration of anesthesia.  In contrast, vinpocetine (PDE1 inhibitor), EHNA (PDE2 inhibitor), milrinone (PDE3 inhibitor) and zaprinast (PDE5 inhibitor) had no significant effect at the doses tested (1-10 mg kg-1).  Anal. of plasma and cerebrospinal fluid (CSF) of treated animals confirmed the absorption and distribution to the brain of the inactive inhibitors.  Neither MK-912 (3 mg kg-1) nor PMNPQ (0.1-1 mg kg-1) altered the duration of anesthesia induced via a non-alpha2-adrenoceptor pathway (sodium pentobarbitone 50 mg kg-1, i.p.).  Central NK1 receptors are involved in PDE4 inhibitor-induced emesis.  Consistently, [sar9, Met(O2)11]-substance P (NK1 receptor agonist, 6 μg i.c.v.) reduced the duration of anesthesia induced by xylazine/ketamine.  In summary, this model is functionally coupled to PDE4, specific to alpha2-adrenoceptors and relevant to PDE4 inhibitor-induced emesis.  It therefore provides a novel way of evaluating the emetic potential of PDE4 inhibitors in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhFBpxwaft4bVg90H21EOLACvtfcHk0lgNuW1-4fntOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVegug%253D%253D&md5=ce6141bb9867f3b9e469bc72393d33e7</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704457%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DA.%26aulast%3DSavoie%26aufirst%3DC.%26aulast%3DStamatiou%26aufirst%3DP.%2BB.%26aulast%3DLachance%26aufirst%3DN.%26aulast%3DJolicoeur%26aufirst%3DP.%26aulast%3DRasori%26aufirst%3DR.%26aulast%3DChan%26aufirst%3DC.-C.%26atitle%3DAssessing%2520the%2520emetic%2520potential%2520of%2520PDE4%2520inhibitors%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D135%26spage%3D113%26epage%3D118%26doi%3D10.1038%2Fsj.bjp.0704457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romussi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spallarossa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brullo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondavalli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanthuyne, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roussel, C.</span></span> <span> </span><span class="NLM_article-title">New selective phosphodiesterase 4D inhibitors differently acting on long, short, and supershort isoforms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6546</span>– <span class="NLM_lpage">6557</span>, <span class="refDoi"> DOI: 10.1021/jm900977c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900977c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6546-6557&author=O.+Brunoauthor=A.+Romussiauthor=A.+Spallarossaauthor=C.+Brulloauthor=S.+Schenoneauthor=F.+Bondavalliauthor=N.+Vanthuyneauthor=C.+Roussel&title=New+selective+phosphodiesterase+4D+inhibitors+differently+acting+on+long%2C+short%2C+and+supershort+isoforms&doi=10.1021%2Fjm900977c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">New Selective Phosphodiesterase 4D Inhibitors Differently Acting on Long, Short, and Supershort Isoforms</span></div><div class="casAuthors">Bruno, Olga; Romussi, Alessia; Spallarossa, Andrea; Brullo, Chiara; Schenone, Silvia; Bondavalli, Francesco; Vanthuyne, Nicolas; Roussel, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6546-6557</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lack of selective inhibitors toward the long, short, or supershort phosphodiesterases (PDE4s) prevented researchers from carefully defining the connection between different enzyme isoforms, their brain localization, and their role in neurodegenerative diseases such as Alzheimer's disease (AD).  In the search for new therapeutic agents for treating memory and learning disorders, we synthesized new rolipram related PDE4 inhibitors, which had some selectivity toward the long form PDE4D3.  The first series was synthesized as racemate and then resolved by semipreparative HPLC on chiral supports.  Herein we report the synthetic pathways to obtain rolipram related compds. and their biol. activities and some SAR considerations that provide some insights and hints for the structural requirements for PDE4D subtype selectivity and enzyme inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrp9k6gslEYrVg90H21EOLACvtfcHk0lgrdWSrh16tNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtL3M&md5=db19da5da1e6781c62dd6b6415ca68c3</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjm900977c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900977c%26sid%3Dliteratum%253Aachs%26aulast%3DBruno%26aufirst%3DO.%26aulast%3DRomussi%26aufirst%3DA.%26aulast%3DSpallarossa%26aufirst%3DA.%26aulast%3DBrullo%26aufirst%3DC.%26aulast%3DSchenone%26aufirst%3DS.%26aulast%3DBondavalli%26aufirst%3DF.%26aulast%3DVanthuyne%26aufirst%3DN.%26aulast%3DRoussel%26aufirst%3DC.%26atitle%3DNew%2520selective%2520phosphodiesterase%25204D%2520inhibitors%2520differently%2520acting%2520on%2520long%252C%2520short%252C%2520and%2520supershort%2520isoforms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6546%26epage%3D6557%26doi%3D10.1021%2Fjm900977c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canepa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brullo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardella, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domenicotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijselaers, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanmierlo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limebeer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argellati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinari, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pronzato, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricciarelli, R.</span></span> <span> </span><span class="NLM_article-title">GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">2054</span>– <span class="NLM_lpage">2063</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01524.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fj.1476-5381.2011.01524.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=21649644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2011&pages=2054-2063&author=O.+Brunoauthor=E.+Fedeleauthor=J.+Prickaertsauthor=L.+A.+Parkerauthor=E.+Canepaauthor=C.+Brulloauthor=A.+Cavalleroauthor=E.+Gardellaauthor=A.+Balbiauthor=C.+Domenicottiauthor=E.+Bollenauthor=H.+J.+Gijselaersauthor=T.+Vanmierloauthor=K.+Erbauthor=C.+L.+Limebeerauthor=F.+Argellatiauthor=U.+M.+Marinariauthor=M.+A.+Pronzatoauthor=R.+Ricciarelli&title=GEBR-7b%2C+a+novel+PDE4D+selective+inhibitor+that+improves+memory+in+rodents+at+non-emetic+doses&doi=10.1111%2Fj.1476-5381.2011.01524.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses</span></div><div class="casAuthors">Bruno, O.; Fedele, E.; Prickaerts, J.; Parker, L. A.; Canepa, E.; Brullo, C.; Cavallero, A.; Gardella, E.; Balbi, A.; Domenicotti, C.; Bollen, E.; Gijselaers, H. J. M.; Vanmierlo, T.; Erb, K.; Limebeer, C. L.; Argellati, F.; Marinari, U. M.; Pronzato, M. A.; Ricciarelli, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2054-2063</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: Strategies designed to enhance cerebral cAMP have been proposed as symptomatic treatments to counteract cognitive deficits.  However, pharmacol. therapies aimed at reducing PDE4, the main class of cAMP catabolizing enzymes in the brain, produce severe emetic side effects.  We have recently synthesized a 3-cyclopentyloxy-4-methoxybenzaldehyde deriv., structurally related to rolipram, and endowed with selective PDE4D inhibitory activity.  The aim of the present study was to investigate the effect of the new drug, namely GEBR-7b, on memory performance, nausea, hippocampal cAMP and amyloid-β (Aβ) levels.  Exptl. Approach: To measure memory performance, we performed object recognition tests on rats and mice treated with GEBR-7b or rolipram.  The emetic potential of the drug, again compared with rolipram, was evaluated in rats using the taste reactivity test and in mice using the xylazine/ketamine anesthesia test.  Extracellular hippocampal cAMP was evaluated by intracerebral microdialysis in freely moving rats.  Levels of sol. Aβ peptides were measured in hippocampal tissues and cultured N2a cells by ELISA.  Key Results: GEBR-7b increased hippocampal cAMP, did not influence Aβ levels and improved spatial, as well as object memory performance in the object recognition tests.  The effect of GEBR-7b on memory was 3 to 10 times more potent than that of rolipram, and its EDs had no effect on surrogate measures of emesis in rodents.  Conclusion and Implications: Our results demonstrate that GEBR-7b enhances memory functions at doses that do not cause emesis-like behavior in rodents, thus offering a promising pharmacol. perspective for the treatment of memory impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpATGYg_M20rVg90H21EOLACvtfcHk0lgrdWSrh16tNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsLrN&md5=3cb12b993944a55d6052b10bd07c9c09</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01524.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01524.x%26sid%3Dliteratum%253Aachs%26aulast%3DBruno%26aufirst%3DO.%26aulast%3DFedele%26aufirst%3DE.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DParker%26aufirst%3DL.%2BA.%26aulast%3DCanepa%26aufirst%3DE.%26aulast%3DBrullo%26aufirst%3DC.%26aulast%3DCavallero%26aufirst%3DA.%26aulast%3DGardella%26aufirst%3DE.%26aulast%3DBalbi%26aufirst%3DA.%26aulast%3DDomenicotti%26aufirst%3DC.%26aulast%3DBollen%26aufirst%3DE.%26aulast%3DGijselaers%26aufirst%3DH.%2BJ.%26aulast%3DVanmierlo%26aufirst%3DT.%26aulast%3DErb%26aufirst%3DK.%26aulast%3DLimebeer%26aufirst%3DC.%2BL.%26aulast%3DArgellati%26aufirst%3DF.%26aulast%3DMarinari%26aufirst%3DU.%2BM.%26aulast%3DPronzato%26aufirst%3DM.%2BA.%26aulast%3DRicciarelli%26aufirst%3DR.%26atitle%3DGEBR-7b%252C%2520a%2520novel%2520PDE4D%2520selective%2520inhibitor%2520that%2520improves%2520memory%2520in%2520rodents%2520at%2520non-emetic%2520doses%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D164%26spage%3D2054%26epage%3D2063%26doi%3D10.1111%2Fj.1476-5381.2011.01524.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brullo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricciarelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotolo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Hagen, B. T.</span></span> <span> </span><span class="NLM_article-title">New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2, 6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejmech.2016.08.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=82-102&author=C.+Brulloauthor=R.+Ricciarelliauthor=J.+Prickaertsauthor=O.+Arancioauthor=M.+Massaauthor=C.+Rotoloauthor=B.+T.+van+Hagen&title=New+insights+into+selective+PDE4D+inhibitors%3A+3-%28Cyclopentyloxy%29-4-methoxybenzaldehyde+O-%282-%282%2C+6-dimethylmorpholino%29-2-oxoethyl%29+oxime+%28GEBR-7b%29+structural+development+and+promising+activities+to+restore+memory+impairment&doi=10.1016%2Fj.ejmech.2016.08.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DBrullo%26aufirst%3DC.%26aulast%3DRicciarelli%26aufirst%3DR.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DMassa%26aufirst%3DM.%26aulast%3DRotolo%26aufirst%3DC.%26aulast%3Dvan%2BHagen%26aufirst%3DB.%2BT.%26atitle%3DNew%2520insights%2520into%2520selective%2520PDE4D%2520inhibitors%253A%25203-%2528Cyclopentyloxy%2529-4-methoxybenzaldehyde%2520O-%25282-%25282%252C%25206-dimethylmorpholino%2529-2-oxoethyl%2529%2520oxime%2520%2528GEBR-7b%2529%2520structural%2520development%2520and%2520promising%2520activities%2520to%2520restore%2520memory%2520impairment%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D82%26epage%3D102%26doi%3D10.1016%2Fj.ejmech.2016.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staker, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsteinsdottir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrafnsdottir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselyov, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span> <span> </span><span class="NLM_article-title">Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1038/nbt.1598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnbt.1598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20037581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SktbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=63-70&author=A.+B.+Burginauthor=O.+T.+Magnussonauthor=J.+Singhauthor=P.+Witteauthor=B.+L.+Stakerauthor=J.+M.+Bjornssonauthor=M.+Thorsteinsdottirauthor=S.+Hrafnsdottirauthor=T.+Hagenauthor=A.+S.+Kiselyovauthor=L.+J.+Stewartauthor=M.+E.+Gurney&title=Design+of+phosphodiesterase+4D+%28PDE4D%29+allosteric+modulators+for+enhancing+cognition+with+improved+safety&doi=10.1038%2Fnbt.1598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety</span></div><div class="casAuthors">Burgin, Alex B.; Magnusson, Olafur T.; Singh, Jasbir; Witte, Pam; Staker, Bart L.; Bjornsson, Jon M.; Thorsteinsdottir, Margret; Hrafnsdottir, Sigrun; Hagen, Timothy; Kiselyov, Alex S.; Stewart, Lance J.; Gurney, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-70</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphodiesterase 4 (PDE4), the primary cAMP-hydrolyzing enzyme in cells, is a promising drug target for a wide range of conditions.  Here we present seven co-crystal structures of PDE4 and bound inhibitors that show the regulatory domain closed across the active site, thereby revealing the structural basis of PDE4 regulation.  This structural insight, together with supporting mutagenesis and kinetic studies, allowed us to design small-mol. allosteric modulators of PDE4D that do not completely inhibit enzymic activity (Imax ∼ 80-90%).  These allosteric modulators have reduced potential to cause emesis, a dose-limiting side effect of existing active site-directed PDE4 inhibitors, while maintaining biol. activity in cellular and in vivo models.  Our results may facilitate the design of CNS therapeutics modulating cAMP signaling for the treatment of Alzheimer's disease, Huntington's disease, schizophrenia and depression, where brain distribution is desired for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr18KdQE2oVsbVg90H21EOLACvtfcHk0liiolTB7kvxzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SktbzJ&md5=1e8651a7116206eefddb9fa6b79d5112</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1598%26sid%3Dliteratum%253Aachs%26aulast%3DBurgin%26aufirst%3DA.%2BB.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DWitte%26aufirst%3DP.%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DBjornsson%26aufirst%3DJ.%2BM.%26aulast%3DThorsteinsdottir%26aufirst%3DM.%26aulast%3DHrafnsdottir%26aufirst%3DS.%26aulast%3DHagen%26aufirst%3DT.%26aulast%3DKiselyov%26aufirst%3DA.%2BS.%26aulast%3DStewart%26aufirst%3DL.%2BJ.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DDesign%2520of%2520phosphodiesterase%25204D%2520%2528PDE4D%2529%2520allosteric%2520modulators%2520for%2520enhancing%2520cognition%2520with%2520improved%2520safety%26jtitle%3DNat.%2520Biotechnol.%26date%3D2010%26volume%3D28%26spage%3D63%26epage%3D70%26doi%3D10.1038%2Fnbt.1598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J.</span></span> <span> </span><span class="NLM_article-title">Role of phosphodiesterase 4D in memory and cognition</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">662.4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=662.4&author=C.+Zhangauthor=Y.+Xuauthor=M.+Gurneyauthor=J.+O%E2%80%99Donnell&title=Role+of+phosphodiesterase+4D+in+memory+and+cognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DGurney%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%26atitle%3DRole%2520of%2520phosphodiesterase%25204D%2520in%2520memory%2520and%2520cognition%26jtitle%3DFASEB%2520J.%26date%3D2017%26volume%3D31%26spage%3D662.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span>Clinical
trial study found in clinical trials for BPN14770, NCT02648672. <a href="https://clinicaltrials.gov/ct2/show/NCT02648672?term=BPN14770&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02648672?term=BPN14770&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+BPN14770%2C+NCT02648672.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02648672%3Fterm%3DBPN14770%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span>Clinical
trial study found in clinical trials for BPN14770, NCT02840279. <a href="https://clinicaltrials.gov/ct2/show/NCT02840279?term=BPN14770&amp;rank=2" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02840279?term=BPN14770&rank=2</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+BPN14770%2C+NCT02840279.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02840279%3Fterm%3DBPN14770%26rank%3D2+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span>Clinical
trial study found in clinical trials for BPN14770, NCT03030105. <a href="https://clinicaltrials.gov/ct2/show/NCT03030105?term=BPN14770&amp;rank=3" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03030105?term=BPN14770&rank=3</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+BPN14770%2C+NCT03030105.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03030105%3Fterm%3DBPN14770%26rank%3D3+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, P. J.</span></span> <span> </span><span class="NLM_article-title"><i>Comparison</i> of phosphodiesterase type 5 (PDE5) inhibitors</span>. <i>Int. J. Clin. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.1111/j.1742-1241.2006.01049.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fj.1742-1241.2006.01049.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16780568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVemsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2006&pages=967-975&author=P.+J.+Wright&title=Comparison+of+phosphodiesterase+type+5+%28PDE5%29+inhibitors&doi=10.1111%2Fj.1742-1241.2006.01049.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of phosphodiesterase type 5 (PDE5) inhibitors</span></div><div class="casAuthors">Wright, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">967-975</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Of the current options available to treat erectile dysfunction, oral phosphodiesterase type 5 (PDE5) inhibitors are the recommended first-line treatment.  This review compares the three currently licensed PDE5 inhibitors: sildenafil citrate (sildenafil), vardenafil HCl (vardenafil) and tadalafil.  All three drugs have similar efficacy and toxicity profiles.  Sildenafil and vardenafil have similar mol. structures, but tadalafil is structurally different, which is reflected in its pharmacokinetic profile.  With regard to the onset of action, achievement of an erection that leads to successful intercourse has been reported for 35% of patients treated with sildenafil within 14 min, 21% of patients treated with vardenafil within 10 min and 16% of patients treated with tadalafil within 16 min.  Sildenafil and vardenafil both have half-lives of approx. 4 h but the half-life of tadalafil is 17.5 h.  Another difference between the PDE5 inhibitors is that food, esp. fatty food, affects the pharmacokinetic profiles of sildenafil and vardenafil, but not that of tadalafil.  These pharmacokinetic differences among the PDE5 inhibitors may underlie patient preference, an important and emerging aspect of ED therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq23EQj8sircbVg90H21EOLACvtfcHk0liiolTB7kvxzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVemsb0%253D&md5=7a1da0d485aee821949c1e373032b590</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2006.01049.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2006.01049.x%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DP.%2BJ.%26atitle%3DComparison%2520of%2520phosphodiesterase%2520type%25205%2520%2528PDE5%2529%2520inhibitors%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2006%26volume%3D60%26spage%3D967%26epage%3D975%26doi%3D10.1111%2Fj.1742-1241.2006.01049.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoraghi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Multiple conformations of phosphodiesterase-5: implications for enzyme function and drug development</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">21469</span>– <span class="NLM_lpage">21479</span>, <span class="refDoi"> DOI: 10.1074/jbc.M512527200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1074%2Fjbc.M512527200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16735511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1KjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=21469-21479&author=H.+Wangauthor=Y.+Liuauthor=Q.+Huaiauthor=J.+Caiauthor=R.+Zoraghiauthor=S.+H.+Francisauthor=J.+D.+Corbinauthor=H.+Robinsonauthor=Z.+Xinauthor=G.+Linauthor=H.+Ke&title=Multiple+conformations+of+phosphodiesterase-5%3A+implications+for+enzyme+function+and+drug+development&doi=10.1074%2Fjbc.M512527200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Conformations of Phosphodiesterase-5: implications for enzyme function and drug development</span></div><div class="casAuthors">Wang, Huanchen; Liu, Yudong; Huai, Qing; Cai, Jiwen; Zoraghi, Roya; Francis, Sharron H.; Corbin, Jackie D.; Robinson, Howard; Xin, Zhongcheng; Lin, Guiting; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">21469-21479</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Phosphodiesterase-5 (PDE5) is the target for sildenafil, vardenafil, and tadalafil, which are drugs for treatment of erectile dysfunction and pulmonary hypertension.  We report here the crystal structures of a fully active catalytic domain of unliganded PDE5A1 and its complexes with sildenafil or icarisid II.  These structures together with the PDE5A1-isobutyl-1-methylxanthine complex show that the H-loop (residues 660-683) at the active site of PDE5A1 has four different conformations and migrates 7-35 Å upon inhibitor binding.  In addn., the conformation of sildenafil reported herein differs significantly from those in the previous structures of chimerically hybridized or almost inactive PDE5.  Mutagenesis and kinetic analyses confirm that the H-loop is particularly important for substrate recognition and that invariant Gly659, which immediately precedes the H-loop, is crit. for optimal substrate affinity and catalytic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplF9ohkT9ogLVg90H21EOLACvtfcHk0liiolTB7kvxzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1KjsLs%253D&md5=3a5ac86273a74da4a559bc6efc647181</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M512527200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M512527200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHuai%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DZoraghi%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DS.%2BH.%26aulast%3DCorbin%26aufirst%3DJ.%2BD.%26aulast%3DRobinson%26aufirst%3DH.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DMultiple%2520conformations%2520of%2520phosphodiesterase-5%253A%2520implications%2520for%2520enzyme%2520function%2520and%2520drug%2520development%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D21469%26epage%3D21479%26doi%3D10.1074%2Fjbc.M512527200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniszewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privitera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leznik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer’s disease mouse model</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">8075</span>– <span class="NLM_lpage">8086</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0864-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1523%2FJNEUROSCI.0864-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=19553447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=8075-8086&author=D.+Puzzoauthor=A.+Staniszewskiauthor=S.+X.+Dengauthor=L.+Priviteraauthor=E.+Leznikauthor=S.+Liuauthor=H.+Zhangauthor=Y.+Fengauthor=A.+Palmeriauthor=D.+W.+Landryauthor=O.+Arancio&title=Phosphodiesterase+5+inhibition+improves+synaptic+function%2C+memory%2C+and+amyloid-%CE%B2+load+in+an+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1523%2FJNEUROSCI.0864-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer's disease mouse model</span></div><div class="casAuthors">Puzzo, Daniela; Staniszewski, Agnieszka; Deng, Shi Xian; Privitera, Lucia; Leznik, Elena; Liu, Shumin; Zhang, Hong; Feng, Yan; Palmeri, Agostino; Landry, Donald W.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8075-8086</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Memory loss, synaptic dysfunction, and accumulation of amyloid β-peptides (Aβ) are major hallmarks of Alzheimer's disease (AD).  Downregulation of the nitric oxide/cGMP/cGMP-dependent protein kinase/c-AMP responsive element-binding protein (CREB) cascade has been linked to the synaptic deficits after Aβ elevation.  Here, we report that the phosphodiesterase 5 inhibitor (PDE5) sildenafil (Viagra), a mol. that enhances phosphorylation of CREB, a mol. involved in memory, through elevation of cGMP levels, is beneficial against the AD phenotype in a mouse model of amyloid deposition.  We demonstrate that the inhibitor produces an immediate and long-lasting amelioration of synaptic function, CREB phosphorylation, and memory.  This effect is also assocd. with a long-lasting redn. of Aβ levels.  Given that side effects of PDE5 inhibitors are widely known and do not preclude their administration to a senile population, these drugs have potential for the treatment of AD and other diseases assocd. with elevated Aβ levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69pOrzfjxY7Vg90H21EOLACvtfcHk0lgifK6Om3aEtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D&md5=5aead1f7c92b6166b8591c3e7951f78d</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0864-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0864-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DPrivitera%26aufirst%3DL.%26aulast%3DLeznik%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPhosphodiesterase%25205%2520inhibition%2520improves%2520synaptic%2520function%252C%2520memory%252C%2520and%2520amyloid-%25CE%25B2%2520load%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D8075%26epage%3D8086%26doi%3D10.1523%2FJNEUROSCI.0864-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>250</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2013.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bbr.2013.05.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=2013&pages=230-237&author=J.+Zhangauthor=J.+Guoauthor=X.+Zhaoauthor=Z.+Chenauthor=G.+Wangauthor=A.+Liuauthor=Q.+Wangauthor=W.+Zhouauthor=Y.+Xueauthor=C.+Wang&title=Phosphodiesterase-5+inhibitor+sildenafil+prevents+neuroinflammation%2C+lowers+beta-amyloid+levels+and+improves+cognitive+performance+in+APP%2FPS1+transgenic+mice&doi=10.1016%2Fj.bbr.2013.05.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2013.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2013.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DPhosphodiesterase-5%2520inhibitor%2520sildenafil%2520prevents%2520neuroinflammation%252C%2520lowers%2520beta-amyloid%2520levels%2520and%2520improves%2520cognitive%2520performance%2520in%2520APP%252FPS1%2520transgenic%2520mice%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2013%26volume%3D250%26spage%3D230%26epage%3D237%26doi%3D10.1016%2Fj.bbr.2013.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervias, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricobaraza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puerta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Roldán, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Osta, A.</span></span> <span> </span><span class="NLM_article-title">sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer’s disease</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">2029</span>– <span class="NLM_lpage">2041</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01517.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fj.1476-5381.2011.01517.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=21627640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2011&pages=2029-2041&author=M.+Cuadrado-Tejedorauthor=I.+Herviasauthor=A.+Ricobarazaauthor=E.+Puertaauthor=J.+M.+P%C3%A9rez-Rold%C3%A1nauthor=C.+Garc%C3%ADa-Barrosoauthor=R.+Francoauthor=N.+Aguirreauthor=A.+Garc%C3%ADa-Osta&title=sildenafil+restores+cognitive+function+without+affecting+%CE%B2-amyloid+burden+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1476-5381.2011.01517.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Cuadrado-Tejedor, M.; Hervias, I.; Ricobaraza, A.; Puerta, E.; Perez-Roldan, J. M.; Garcia-Barroso, C.; Franco, R.; Aguirre, N.; Garcia-Osta, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2029-2041</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Inhibitors of phosphodiesterase 5 (PDE5) affect signalling pathways by elevating cGMP, which is a second messenger involved in processes of neuroplasticity.  In the present study, the effects of the PDE5 inhibitor, sildenafil, on the pathol. features of Alzheimer's disease and on memory-related behavior were investigated.  Exptl. Approach Sildenafil was administered to the Tg2576 transgenic mouse model of Alzheimer's disease and to age-matched neg. littermates (controls).  Memory function was analyzed using the Morris water maze test and fear conditioning tasks.  Biochem. analyses were performed in brain lysates from animals treated with saline or with sildenafil.  Key Results Treatment of aged Tg2576 animals with sildenafil completely reversed their cognitive impairment.  Such changes were accompanied in the hippocampus by a redn. of tau hyperphosphorylation and a decrease in the activity of glycogen synthase kinase 3β (GSK3β) and of cyclin-dependent kinase 5 (CDK5) (p25/p35 ratio).  Moreover, sildenafil also increased levels of brain-derived neurotrophic factor (BDNF) and the activity-regulated cytoskeletal-assocd. protein (Arc) in the hippocampus without any detectable modification of brain amyloid burden.  Conclusions and Implications Sildenafil improved cognitive functions in Tg2576 mice and the effect was not related to changes in the amyloid burden.  These data further strengthen the potential of sildenafil as a therapeutic agent for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSIHZg2HFLZbVg90H21EOLACvtfcHk0lgifK6Om3aEtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsL3F&md5=5bda5d02186b430428a2d7ce8c354696</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01517.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01517.x%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DHervias%26aufirst%3DI.%26aulast%3DRicobaraza%26aufirst%3DA.%26aulast%3DPuerta%26aufirst%3DE.%26aulast%3DP%25C3%25A9rez-Rold%25C3%25A1n%26aufirst%3DJ.%2BM.%26aulast%3DGarc%25C3%25ADa-Barroso%26aufirst%3DC.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DAguirre%26aufirst%3DN.%26aulast%3DGarc%25C3%25ADa-Osta%26aufirst%3DA.%26atitle%3Dsildenafil%2520restores%2520cognitive%2520function%2520without%2520affecting%2520%25CE%25B2-amyloid%2520burden%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D164%26spage%3D2029%26epage%3D2041%26doi%3D10.1111%2Fj.1476-5381.2011.01517.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orejana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros-Minones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puerta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, N.</span></span> <span> </span><span class="NLM_article-title">Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">625.e11</span>– <span class="NLM_lpage">625.e20</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2011.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neurobiolaging.2011.03.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=625.e11-625.e20&author=L.+Orejanaauthor=L.+Barros-Minonesauthor=J.+Jordanauthor=E.+Puertaauthor=N.+Aguirre&title=Sildenafil+ameliorates+cognitive+deficits+and+tau+pathology+in+a+senescence-accelerated+mouse+model&doi=10.1016%2Fj.neurobiolaging.2011.03.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2011.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2011.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DOrejana%26aufirst%3DL.%26aulast%3DBarros-Minones%26aufirst%3DL.%26aulast%3DJordan%26aufirst%3DJ.%26aulast%3DPuerta%26aufirst%3DE.%26aulast%3DAguirre%26aufirst%3DN.%26atitle%3DSildenafil%2520ameliorates%2520cognitive%2520deficits%2520and%2520tau%2520pathology%2520in%2520a%2520senescence-accelerated%2520mouse%2520model%26jtitle%3DNeurobiol.%2520Aging%26date%3D2012%26volume%3D33%26spage%3D625.e11%26epage%3D625.e20%26doi%3D10.1016%2Fj.neurobiolaging.2011.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orejana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros-Minones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cedazo-Minguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tordera, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puerta, E.</span></span> <span> </span><span class="NLM_article-title">Sildenafil decreases BACE1 and cathepsin B levels and reduces APP Amyloidogenic processing in the SAMP8 Mouse</span>. <i>J. Gerontol., Ser. A</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1093/gerona/glu106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1093%2Fgerona%2Fglu106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=25063079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvFCqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=675-685&author=L.+Orejanaauthor=L.+Barros-Minonesauthor=J.+Jordanauthor=A.+Cedazo-Minguezauthor=R.+M.+Torderaauthor=N.+Aguirreauthor=E.+Puerta&title=Sildenafil+decreases+BACE1+and+cathepsin+B+levels+and+reduces+APP+Amyloidogenic+processing+in+the+SAMP8+Mouse&doi=10.1093%2Fgerona%2Fglu106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Sildenafil decreases BACE1 and cathepsin B levels and reduces app amyloidogenic processing in the SAMP8 mouse</span></div><div class="casAuthors">Orejana, Lourdes; Barros-Minones, Lucia; Cedazo-Minguez, Joaquin Jordan Angel; Tordera, Rosa M.; Aguirre, Norberto; Puerta, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Journals of Gerontology, Series A: Biological Sciences and Medical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">675-685</span>CODEN:
                <span class="NLM_cas:coden">JGASFW</span>;
        ISSN:<span class="NLM_cas:issn">1079-5006</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The senescence-accelerated mouse-prone 8 (SAMP8), used as a model of aging, displays many established pathol. features of Alzheimer's disease.  Cognitive impairments and increased levels of hyperphosphorylated tau are found in the hippocampus of SAMP8 mice along with an increased β-secretase activity and amyloid-β (Aβ) depositions that increase in no. and extent with age.  Based on a previous study from our lab. showing an amelioration of cognitive impairments and tau pathol. by sildenafil, in this study we tested whether this drug could also modulate the amyloid precursor protein amyloidogenic processing in this mouse model.  Our results show that the protein levels of the β-secretases β-site amyloid precursor protein cleaving enzyme 1 and cathepsin B are higher in the hippocampus of 9-mo-old SAMP8 mice than those of age-matched senescence-resistant-1.  Sildenafil (7.5mg/kg for 4 wk) attenuated learning and memory impairments shown by SAMP8 mice in the passive avoidance test.  The increased expression of β-site amyloid precursor protein cleaving enzyme 1 was also reduced by sildenafil, an effect paralleled to decreases in the activities of two β-site amyloid precursor protein cleaving enzyme 1 modulators, calpain and cyclin-dependent kinase 5 protein.  Interestingly, sildenafil enhanced both Akt and glycogen synthase kinase-3β (ser9) phosphorylation, which could be mediating the redn. in cathepsin B levels found in the hippocampus of sildenafil-treated SAMP8 mice.  Sildenafil-induced redn. in β-site amyloid precursor protein cleaving enzyme 1 and cathepsin B expression in SAMP8 mice was assocd. with a decrease in hippocampal Aβ42 levels which, in turn, could mediate the parallel decline in glial fibrillary acidic protein expression obsd. in these animals.  These findings highlight the therapeutic potential of sildenafil in Alzheimer's disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgbd3y0L5j67Vg90H21EOLACvtfcHk0lhVEnsq5nBOkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvFCqs7w%253D&md5=3df8df3da69c8e04d5e4ceecb2e0a98f</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1093%2Fgerona%2Fglu106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fgerona%252Fglu106%26sid%3Dliteratum%253Aachs%26aulast%3DOrejana%26aufirst%3DL.%26aulast%3DBarros-Minones%26aufirst%3DL.%26aulast%3DJordan%26aufirst%3DJ.%26aulast%3DCedazo-Minguez%26aufirst%3DA.%26aulast%3DTordera%26aufirst%3DR.%2BM.%26aulast%3DAguirre%26aufirst%3DN.%26aulast%3DPuerta%26aufirst%3DE.%26atitle%3DSildenafil%2520decreases%2520BACE1%2520and%2520cathepsin%2520B%2520levels%2520and%2520reduces%2520APP%2520Amyloidogenic%2520processing%2520in%2520the%2520SAMP8%2520Mouse%26jtitle%3DJ.%2520Gerontol.%252C%2520Ser.%2520A%26date%3D2015%26volume%3D70%26spage%3D675%26epage%3D685%26doi%3D10.1093%2Fgerona%2Fglu106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span>Clinical
trial study found in clinical trials for sildenafil, NCT00455715. <a href="https://clinicaltrials.gov/ct2/show/NCT00455715?term=sildenafil&amp;draw=3&amp;rank=12" class="extLink">https://clinicaltrials.gov/ct2/show/NCT00455715?term=sildenafil&draw=3&rank=12</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+sildenafil%2C+NCT00455715.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00455715%3Fterm%3Dsildenafil%26draw%3D3%26rank%3D12+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span>Clinical
trial study found in clinical trials for sildenafil, NCT01941732. <a href="https://clinicaltrials.gov/ct2/show/NCT01941732?term=sildenafil&amp;draw=3&amp;rank=28" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01941732?term=sildenafil&draw=3&rank=28</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+sildenafil%2C+NCT01941732.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01941732%3Fterm%3Dsildenafil%26draw%3D3%26rank%3D28+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Arrastia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devous, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womack, K. B.</span></span> <span> </span><span class="NLM_article-title">Sildenafil improves vascular and metabolic function in patients with Alzheimer’s Disease</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1351</span>– <span class="NLM_lpage">1364</span>, <span class="refDoi"> DOI: 10.3233/JAD-161006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.3233%2FJAD-161006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=29036811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2gtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1351-1364&author=M.+Shengauthor=H.+Luauthor=P.+Liuauthor=Y.+Liauthor=H.+Raviauthor=S.+L.+Pengauthor=R.+Diaz-Arrastiaauthor=M.+D.+Devousauthor=K.+B.+Womack&title=Sildenafil+improves+vascular+and+metabolic+function+in+patients+with+Alzheimer%E2%80%99s+Disease&doi=10.3233%2FJAD-161006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease</span></div><div class="casAuthors">Sheng, Min; Lu, Hanzhang; Liu, Peiying; Li, Yang; Ravi, Harshan; Peng, Shin-Lei; Diaz-Arrastia, Ramon; Devous, Michael D.; Womack, Kyle B.; Claassen, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1351-1364</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Background: : Alzheimer's disease (AD) is the leading cause of degenerative dementia in the aging population.  Patients with AD have alterations in cerebral hemodynamic function including reduced cerebral blood flow (CBF) and cerebral metabolic rate.  Therefore, improved cerebrovascular function may be an attractive goal for pharmaceutical intervention in AD.  Objective: : We wished to observe the acute effects of sildenafil on cerebrovascular function and brain metab. in patients with AD.  Methods: : We used several novel non-invasive MRI techniques to investigate the alterations of CBF, cerebral metabolic rate of oxygen (CMRO2), and cerebrovascular reactivity (CVR) after a single dose of sildenafil administration in order to assess its physiol. effects in patients with AD.  CBF, CMRO2, and CVR measurements using MRI were performed before and one hour after the oral administration of 50mg sildenafil.  Baseline Montreal Cognitive Assessment score was also obtained.  Results: : Complete CBF and CMRO2 data were obtained in twelve patients.  Complete CVR data were obtained in eight patients.  Global CBF and CMRO2 significantly increased (p=0.03, p=0.05, resp.) following sildenafil administration.  Voxel-wise analyses of CBF maps showed that increased CBF was most pronounced in the bilateral medial temporal lobes.  CVR significantly decreased after administration of sildenafil.  Conclusion: : Our data suggest that a single dose of sildenafil improves cerebral hemodynamic function and increases cerebral oxygen metab. in patients with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQe1EPHEsy_LVg90H21EOLACvtfcHk0lhVEnsq5nBOkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2gtLnE&md5=3ce96e3a5346d3e536a22bc9a7fdcdcb</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.3233%2FJAD-161006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-161006%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DRavi%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DS.%2BL.%26aulast%3DDiaz-Arrastia%26aufirst%3DR.%26aulast%3DDevous%26aufirst%3DM.%2BD.%26aulast%3DWomack%26aufirst%3DK.%2BB.%26atitle%3DSildenafil%2520improves%2520vascular%2520and%2520metabolic%2520function%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2017%26volume%3D60%26spage%3D1351%26epage%3D1364%26doi%3D10.3233%2FJAD-161006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forgue, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedding, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrishko, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M. I.</span></span> <span> </span><span class="NLM_article-title">Tadalafil pharmacokinetics in healthy subjects</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">280</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.2005.02553.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fj.1365-2125.2005.02553.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16487221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28XislKhsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2006&pages=280-288&author=S.+T.+Forgueauthor=B.+E.+Pattersonauthor=A.+W.+Beddingauthor=C.+D.+Payneauthor=D.+L.+Phillipsauthor=R.+E.+Wrishkoauthor=M.+I.+Mitchell&title=Tadalafil+pharmacokinetics+in+healthy+subjects&doi=10.1111%2Fj.1365-2125.2005.02553.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Tadalafil pharmacokinetics in healthy subjects</span></div><div class="casAuthors">Forgue, S. Thomas; Patterson, Beverley E.; Bedding, Alun W.; Payne, Christopher D.; Phillips, Diane L.; Wrishko, Rebecca E.; Mitchell, Malcolm I.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">280-288</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aims To characterize tadalafil plasma pharmacokinetics in healthy subjects following single and multiple doses.  Methods Noncompartmental parameters were calcd. for healthy subjects receiving a single 2.5-20-mg tadalafil does in 13 clin. pharmacol. studies.  An integrated statistical anal. of results in 237 subjects provided global avs. and an assessment of effects of body mass index (BMI), age, gender and smoking status.  Diurnal variation, food effects and proportionality of exposure to dose were analyzed in three studies.  Multiple-dose pharmacokinetics were evaluated in a sep. study in which parallel groups of 15 subjects received 10 or 20 mg tadalafil once daily for 10 days.  Results Tadalafil was absorbed rapidly with mean Cmax (378 μg l-1 for 20 mg) obsd. at 2 h; thereafter, concns. declined nearly monoexponentially with a mean (5th, 95th percentiles) t1/2 of 17.5 (11.5, 29.6) hours.  Mean oral clearance (CL/F) was 2.48 (1.35, 4.35) l h-1 and apparent vol. of distribution (Vz/F) was 62.6 (39.5, 92.1) l.  No clin. meaningful effect of BMI, age, gender or smoking was identified.  Exposure was not substantially affected by time of dosing.  Food had negligible effects on bioavailability as assessed by 90% confidence intervals for Cmax and AUC mean ratios.  Parameters were proportional to dose, indicating that doubling the dose doubled exposure.  Steady state was attained by day 5 following once-daily administration, and accumulation (1.6-fold) was consistent with the t1/2.  Conclusions Tadalafil pharmacokinetics are linear with respect to dose and time, and are not affected by food.  Systemic clearance is low relative to other phosphodiesterase 5 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw0ePo3xDnD7Vg90H21EOLACvtfcHk0lhVEnsq5nBOkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislKhsLc%253D&md5=a9dfc7d0d0d3aa07619a42c5c79b7495</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2005.02553.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2005.02553.x%26sid%3Dliteratum%253Aachs%26aulast%3DForgue%26aufirst%3DS.%2BT.%26aulast%3DPatterson%26aufirst%3DB.%2BE.%26aulast%3DBedding%26aufirst%3DA.%2BW.%26aulast%3DPayne%26aufirst%3DC.%2BD.%26aulast%3DPhillips%26aufirst%3DD.%2BL.%26aulast%3DWrishko%26aufirst%3DR.%2BE.%26aulast%3DMitchell%26aufirst%3DM.%2BI.%26atitle%3DTadalafil%2520pharmacokinetics%2520in%2520healthy%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D61%26spage%3D280%26epage%3D288%26doi%3D10.1111%2Fj.1365-2125.2005.02553.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricobaraza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual-Lucas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unceta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rico, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goicolea, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanciego, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2012.06.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=114-123&author=C.+Garcia-Barrosoauthor=A.+Ricobarazaauthor=M.+Pascual-Lucasauthor=N.+Uncetaauthor=A.+J.+Ricoauthor=M.+A.+Goicoleaauthor=J.+Sallesauthor=J.+L.+Lanciegoauthor=J.+Oyarzabalauthor=R.+Francoauthor=M.+Cuadrado-Tejedorauthor=A.+Garcia-Osta&title=Tadalafil+crosses+the+blood-brain+barrier+and+reverses+cognitive+dysfunction+in+a+mouse+model+of+AD&doi=10.1016%2Fj.neuropharm.2012.06.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.052%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DRicobaraza%26aufirst%3DA.%26aulast%3DPascual-Lucas%26aufirst%3DM.%26aulast%3DUnceta%26aufirst%3DN.%26aulast%3DRico%26aufirst%3DA.%2BJ.%26aulast%3DGoicolea%26aufirst%3DM.%2BA.%26aulast%3DSalles%26aufirst%3DJ.%26aulast%3DLanciego%26aufirst%3DJ.%2BL.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DTadalafil%2520crosses%2520the%2520blood-brain%2520barrier%2520and%2520reverses%2520cognitive%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520AD%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D114%26epage%3D123%26doi%3D10.1016%2Fj.neuropharm.2012.06.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span>Clinical trial study found in clinical  <i>trials</i> for sildenafil, NCT02450253. <a href="https://clinicaltrials.gov/ct2/show/NCT02450253?term=tadalafil&amp;cond=vascular+dementia&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02450253?term=tadalafil&cond=vascular+dementia&rank=1</a> (accessed Dec. 18, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+sildenafil%2C+NCT02450253.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02450253%3Fterm%3Dtadalafil%26cond%3Dvascular%2Bdementia%26rank%3D1+%28accessed+Dec.+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3Dtrials%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniszewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, Y. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakkar, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejmech.2012.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=23313637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVemsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=285-294&author=J.+Fioritoauthor=F.+Saeedauthor=H.+Zhangauthor=A.+Staniszewskiauthor=Y.+Fengauthor=Y.+I.+Francisauthor=S.+Raoauthor=D.+M.+Thakkarauthor=S.+X.+Dengauthor=D.+W.+Landryauthor=O.+Arancio&title=Synthesis+of+quinoline+derivatives%3A+discovery+of+a+potent+and+selective+phosphodiesterase+5+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2012.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Fiorito, Jole; Saeed, Faisal; Zhang, Hong; Staniszewski, Agnieszka; Feng, Yan; Francis, Yitshak I.; Rao, Sudha; Thakkar, Devarshi M.; Deng, Shi-Xian; Landry, Donald W.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">285-294</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Phosphodiesterase type 5 (PDE5) mediates the degrdn. of cGMP in a variety of tissues including brain.  Recent studies have demonstrated the importance of the nitric oxide/cGMP/cAMP-responsive element-binding protein (CREB) pathway to the process of learning and memory.  Thus, PDE5 inhibitors (PDE5Is) are thought to be promising new therapeutic agents for the treatment of Alzheimer's disease (AD), a neurodegenerative disorder characterized by memory loss.  To explore this possibility, a series of quinoline derivs. were synthesized and evaluated.  We found that compd. I selectively inhibits PDE5 with an IC50 of 0.27 nM and readily crosses the blood brain barrier.  In an in vivo mouse model of AD, compd. I rescues synaptic and memory defects.  Quinoline-based, CNS-permeant PDE5Is have potential for AD therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6B39cj4LBh7Vg90H21EOLACvtfcHk0lhWrcvqCHtcYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVemsrg%253D&md5=335f11f0576ec3fe8dc1bcf5df2cebdc</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DSaeed%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFrancis%26aufirst%3DY.%2BI.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DThakkar%26aufirst%3DD.%2BM.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DSynthesis%2520of%2520quinoline%2520derivatives%253A%2520discovery%2520of%2520a%2520potent%2520and%2520selective%2520phosphodiesterase%25205%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D60%26spage%3D285%26epage%3D294%26doi%3D10.1016%2Fj.ejmech.2012.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanzhez-Arias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mederos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual-Lucas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perea, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer’s disease</span>. <i>Clin. Epigenet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">108</span>, <span class="refDoi"> DOI: 10.1186/s13148-015-0142-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1186%2Fs13148-015-0142-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26457123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVOksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=108&author=M.+Cuadrado-Tejedorauthor=C.+Garcia-Barrosoauthor=J.+Sanzhez-Ariasauthor=S.+Mederosauthor=O.+Rabalauthor=A.+Ugarteauthor=R.+Francoauthor=M.+Pascual-Lucasauthor=V.+Seguraauthor=G.+Pereaauthor=J.+Oyarzabalauthor=A.+Garcia-Osta&title=Concomitant+histone+deacetylase+and+phosphodiesterase+5+inhibition+synergistically+prevents+the+disruption+in+synaptic+plasticity+and+it+reverses+cognitive+impairment+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs13148-015-0142-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Cuadrado-Tejedor, M.; Garcia-Barroso, C.; Sanzhez-Arias, J.; Mederos, S.; Rabal, O.; Ugarte, A.; Franco, R.; Pascual-Lucas, M.; Segura, V.; Perea, G.; Oyarzabal, J.; Garcia-Osta, A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Epigenetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108/1-108/11</span>CODEN:
                <span class="NLM_cas:coden">CELPCI</span>;
        ISSN:<span class="NLM_cas:issn">1868-7083</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Given the implication of histone acetylation in memory processes, histone deacetylase inhibitors (HDACIs) have been postulated as potential modulators of cognitive impairment in Alzheimer's disease (AD).  However, dose-dependent side effects have been described in patients with the currently available broad-spectrum HDACIs, explaining why their therapeutic potential has not been realized for chronic diseases.  Here, by simultaneously targeting two independent enzyme activities, histone deacetylase (HDAC) and phosphodiesterase-5 (PDE5), we propose a novel mode of inhibitory action that might increase the therapeutic specificity of HDACIs.  Results: The combination of vorinostat, a pan-HDACI, and tadalafil, a PDE5 inhibitor, rescued the long-term potentiation impaired in slices from APP/PS1 mice.  When administered in vivo, the combination of these drugs alleviated the cognitive deficits in AD mice, as well as the amyloid and tau pathol., and it reversed the reduced dendritic spine d. on hippocampal neurons.  Significantly, the combination of vorinostat and tadalafil was more effective than each drug alone, both against the symptoms and in terms of disease modification, and importantly, these effects persisted after a 4-wk washout period.  Conclusions: The results highlight the pharmacol. potential of a combination of mols. that inhibit HDAC and PDE5 as a therapeutic approach for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMSYuXPnR9SLVg90H21EOLACvtfcHk0lhWrcvqCHtcYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVOksbw%253D&md5=bb0f0702afbc1ac3fe7867bd037ca09e</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1186%2Fs13148-015-0142-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13148-015-0142-9%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DSanzhez-Arias%26aufirst%3DJ.%26aulast%3DMederos%26aufirst%3DS.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DPascual-Lucas%26aufirst%3DM.%26aulast%3DSegura%26aufirst%3DV.%26aulast%3DPerea%26aufirst%3DG.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DConcomitant%2520histone%2520deacetylase%2520and%2520phosphodiesterase%25205%2520inhibition%2520synergistically%2520prevents%2520the%2520disruption%2520in%2520synaptic%2520plasticity%2520and%2520it%2520reverses%2520cognitive%2520impairment%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DClin.%2520Epigenet.%26date%3D2015%26volume%3D7%26spage%3D108%26doi%3D10.1186%2Fs13148-015-0142-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Miguel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estella-Hermoso de Mendoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sáez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espelosin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haizhong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of first-in-class dual acting histone deacetylases (HDACs) and phosphodiesterase 5 (PDE5) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8967</span>– <span class="NLM_lpage">9004</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00908</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00908" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyqtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8967-9004&author=O.+Rabalauthor=J.+A.+S%C3%A1nchez-Ariasauthor=M.+Cuadrado-Tejedorauthor=I.+De+Miguelauthor=M.+P%C3%A9rez-Gonz%C3%A1lezauthor=C.+Garcia-Barrosoauthor=A.+Ugarteauthor=A.+Estella-Hermoso+de+Mendozaauthor=E.+S%C3%A1ezauthor=M.+Espelosinauthor=S.+Ursuaauthor=T.+Haizhongauthor=W.+Weiauthor=X.+Mushengauthor=A.+Garcia-Ostaauthor=J.+Oyarzabal&title=Design%2C+synthesis%2C+and+biological+evaluation+of+first-in-class+dual+acting+histone+deacetylases+%28HDACs%29+and+phosphodiesterase+5+%28PDE5%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Rabal, Obdulia; Sanchez-Arias, Juan A.; Cuadrado-Tejedor, Mar; de Miguel, Irene; Perez-Gonzalez, Marta; Garcia-Barroso, Carolina; Ugarte, Ana; Estella-Hermoso de Mendoza, Ander; Saez, Elena; Espelosin, Maria; Ursua, Susana; Haizhong, Tan; Wei, Wu; Musheng, Xu; Garcia-Osta, Ana; Oyarzabal, Julen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8967-9004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Simultaneous inhibition of phosphodiesterase 5 (PDE5) and histone deacetylases (HDAC) has recently been validated as a potentially novel therapeutic approach for Alzheimer's Disease (AD).  To further extend this concept, the authors designed and synthesized the first chem. series of dual acting PDE5 and HDAC inhibitors, and the authors validated this systems therapeutics approach.  Following the implementation of structure- and knowledge-based approaches, initial hits were designed and were shown to validate the hypothesis of dual in vitro inhibition.  Then, an optimization strategy was pursued to obtain a proper tool compd. for in vivo testing in AD models.  Initial hits were translated into mols. with adequate cellular functional responses (histone acetylation and cAMP/cGMP response element-binding (CREB) phosphorylation in the nanomolar range), an acceptable therapeutic window (>1 log unit) and the ability to cross the blood-brain barrier, leading to the identification of 7 as a candidate for in vivo proof-of-concept testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbHBoJlefNEbVg90H21EOLACvtfcHk0lh7e_kEuxQXCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyqtL7O&md5=756a252809f05f5d7fc59e828736cfba</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00908%26sid%3Dliteratum%253Aachs%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DS%25C3%25A1nchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DDe%2BMiguel%26aufirst%3DI.%26aulast%3DP%25C3%25A9rez-Gonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DEstella-Hermoso%2Bde%2BMendoza%26aufirst%3DA.%26aulast%3DS%25C3%25A1ez%26aufirst%3DE.%26aulast%3DEspelosin%26aufirst%3DM.%26aulast%3DUrsua%26aufirst%3DS.%26aulast%3DHaizhong%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DMusheng%26aufirst%3DX.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DOyarzabal%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520first-in-class%2520dual%2520acting%2520histone%2520deacetylases%2520%2528HDACs%2529%2520and%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8967%26epage%3D9004%26doi%3D10.1021%2Facs.jmedchem.6b00908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mederos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perea, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">A first-in-class small-molecule that acts as a dual inhibitor of HDAC and PDE5 and that rescues hippocampal synaptic impairment in Alzheimer’s Disease mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1038/npp.2016.163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnpp.2016.163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=27550730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOntLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=524-539&author=M.+Cuadrado-Tejedorauthor=C.+Garcia-Barrosoauthor=J.+A.+Sanchez-Ariasauthor=O.+Rabalauthor=M.+Perez-Gonzalezauthor=S.+Mederosauthor=A.+Ugarteauthor=R.+Francoauthor=V.+Seguraauthor=G.+Pereaauthor=J.+Oyarzabalauthor=A.+Garcia-Osta&title=A+first-in-class+small-molecule+that+acts+as+a+dual+inhibitor+of+HDAC+and+PDE5+and+that+rescues+hippocampal+synaptic+impairment+in+Alzheimer%E2%80%99s+Disease+mice&doi=10.1038%2Fnpp.2016.163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice</span></div><div class="casAuthors">Cuadrado-Tejedor, Mar; Garcia-Barroso, Carolina; Sanchez-Arias, Juan A.; Rabal, Obdulia; Perez-Gonzalez, Marta; Mederos, Sara; Ugarte, Ana; Franco, Rafael; Segura, Victor; Perea, Gertrudis; Oyarzabal, Julen; Garcia-Osta, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">524-539</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The targeting of two independent but synergistic enzymic activities, histone deacetylases (HDACs, class I and HDAC6) and phosphodiesterase 5 (PDE5), has recently been validated as a potentially novel therapeutic approach for Alzheimer's disease (AD).  Here we report the discovery of a new first-in-class small-mol. (CM-414) that acts as a dual inhibitor of PDE5 and HDACs.  We have used this compd. as a chem. probe to validate this systems therapeutics strategy, where an increase in the activation of cAMP/cGMP-responsive element-binding protein (CREB) induced by PDE5 inhibition, combined with moderate HDAC class I inhibition, leads to efficient histone acetylation.  This mol. rescued the impaired long-term potentiation evident in hippocampal slices from APP/PS1 mice.  Chronic treatment of Tg2576 mice with CM-414 diminished brain Aβ and tau phosphorylation (pTau) levels, increased the inactive form of GSK3β, reverted the decrease in dendritic spine d. on hippocampal neurons, and reversed their cognitive deficits, at least in part by inducing the expression of genes related to synaptic transmission.  Thus, CM-414 may serve as the starting point to discover balanced dual inhibitors with an optimal efficacy and safety profile for clin. testing on AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrel_KiPL5177Vg90H21EOLACvtfcHk0lh7e_kEuxQXCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOntLfP&md5=26482df7c58696a362ca1e73bab12264</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.163%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DSanchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DPerez-Gonzalez%26aufirst%3DM.%26aulast%3DMederos%26aufirst%3DS.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DSegura%26aufirst%3DV.%26aulast%3DPerea%26aufirst%3DG.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DA%2520first-in-class%2520small-molecule%2520that%2520acts%2520as%2520a%2520dual%2520inhibitor%2520of%2520HDAC%2520and%2520PDE5%2520and%2520that%2520rescues%2520hippocampal%2520synaptic%2520impairment%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2017%26volume%3D42%26spage%3D524%26epage%3D539%26doi%3D10.1038%2Fnpp.2016.163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Torres, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolnay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Probst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengod, G.</span></span> <span> </span><span class="NLM_article-title">Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer’s disease brains examined by in situ hybridization</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1016/S0014-4886(03)00042-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2FS0014-4886%2803%2900042-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=12895443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVCrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2003&pages=322-334&author=S.+Perez-Torresauthor=R.+Cortesauthor=M.+Tolnayauthor=A.+Probstauthor=J.+M.+Palaciosauthor=G.+Mengod&title=Alterations+on+phosphodiesterase+type+7+and+8+isozyme+mRNA+expression+in+Alzheimer%E2%80%99s+disease+brains+examined+by+in+situ+hybridization&doi=10.1016%2FS0014-4886%2803%2900042-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization</span></div><div class="casAuthors">Perez-Torres, S.; Cortes, R.; Tolnay, M.; Probst, A.; Palacios, J. M.; Mengod, G.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">322-334</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) play a central role in signal transduction by regulating intracellular levels of cAMP and cGMP.  It has been suggested that cAMP pathways could be upregulated in Alzheimer's disease.  By in situ hybridization histochem. we have detd. the expression pattern of two newly described cAMP-specific phosphodiesterases families, PDE7 and PDE8, in several brain areas in control subjects.  The hybridization levels of PDE8A mRNA were very low in all brain areas examd.  High PDE7B and PDE8B mRNA signal intensities were found in the hippocampal formation.  PDE7A was found to be present in both neuronal and non-neuronal cell populations.  When the expression of these isoenzymes in control brains was compared with that in Alzheimer's disease brains staged according to Braak and Braak we found that PDE8B was the only isoenzyme showing a significant increase, in cortical areas and parts of the hippocampal formation, at Braak stages III-VI.  Our results show that the expression of specific cAMP PDE isoforms is selectively regulated in Alzheimer's disease and assocd. with the stages of the disease.  The availability of animal models of Alzheimer's disease and of new pharmacol. tools such as selective PDE inhibitors will allow study of the therapeutic potential of the control of cAMP levels in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM6l4bt6haRbVg90H21EOLACvtfcHk0lh5ve_5gidYmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVCrtbw%253D&md5=3ce70d806673af55de7c0d8f32411320</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2FS0014-4886%2803%2900042-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-4886%252803%252900042-6%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Torres%26aufirst%3DS.%26aulast%3DCortes%26aufirst%3DR.%26aulast%3DTolnay%26aufirst%3DM.%26aulast%3DProbst%26aufirst%3DA.%26aulast%3DPalacios%26aufirst%3DJ.%2BM.%26aulast%3DMengod%26aufirst%3DG.%26atitle%3DAlterations%2520on%2520phosphodiesterase%2520type%25207%2520and%25208%2520isozyme%2520mRNA%2520expression%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brains%2520examined%2520by%2520in%2520situ%2520hybridization%26jtitle%3DExp.%2520Neurol.%26date%3D2003%26volume%3D182%26spage%3D322%26epage%3D334%26doi%3D10.1016%2FS0014-4886%2803%2900042-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span> <span> </span><span class="NLM_article-title">PDE7 inhibitors as new drugs for neurological and inflammatory disorders</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1127</span>– <span class="NLM_lpage">1139</span>, <span class="refDoi"> DOI: 10.1517/13543776.18.10.1127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1517%2F13543776.18.10.1127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1127-1139&author=C.+Gilauthor=N.+E.+Campilloauthor=D.+I.+Perezauthor=A.+Martinez&title=PDE7+inhibitors+as+new+drugs+for+neurological+and+inflammatory+disorders&doi=10.1517%2F13543776.18.10.1127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">PDE7 inhibitors as new drugs for neurological and inflammatory disorders</span></div><div class="casAuthors">Gil, Carmen; Campillo, Nuria E.; Perez, Daniel I.; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1127-1139</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 7 (PDE7) is a high affinity cAMP-specific PDE whose functional role in T cells has been the subject of some controversy.  Recent findings on tissue distribution, however, support the hypothesis that PDE7 could be a good target for the treatment of airway diseases, T-cell related diseases or even CNS disorders.  This review discloses recent discoveries of selective PDE7 and PDE4/PDE7 dual inhibitors with special emphasis on their potential for neurol. and inflammatory diseases.  PDE7 inhibitors constitute a new approach to be explored for the treatment of neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDb9sjzbO67Vg90H21EOLACvtfcHk0lh5ve_5gidYmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nO&md5=e1a3797094e7f79bc798198c110007ca</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.10.1127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.10.1127%26sid%3Dliteratum%253Aachs%26aulast%3DGil%26aufirst%3DC.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DPDE7%2520inhibitors%2520as%2520new%2520drugs%2520for%2520neurological%2520and%2520inflammatory%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D1127%26epage%3D1139%26doi%3D10.1517%2F13543776.18.10.1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domenech, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nueda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span> <span> </span><span class="NLM_article-title">CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application example</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1349</span>– <span class="NLM_lpage">1359</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2007.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejmech.2007.10.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1349-1359&author=A.+Castroauthor=M.+J.+Jerezauthor=C.+Gilauthor=F.+Calderonauthor=T.+Domenechauthor=A.+Nuedaauthor=A.+Martinez&title=CODES%2C+a+novel+procedure+for+ligand-based+virtual+screening%3A+PDE7+inhibitors+as+an+application+example&doi=10.1016%2Fj.ejmech.2007.10.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DJerez%26aufirst%3DM.%2BJ.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DCalderon%26aufirst%3DF.%26aulast%3DDomenech%26aufirst%3DT.%26aulast%3DNueda%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DCODES%252C%2520a%2520novel%2520procedure%2520for%2520ligand-based%2520virtual%2520screening%253A%2520PDE7%2520inhibitors%2520as%2520an%2520application%2520example%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1349%26epage%3D1359%26doi%3D10.1016%2Fj.ejmech.2007.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paterniti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Impellizzeri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span> <span> </span><span class="NLM_article-title">PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e15937</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0015937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1371%2Fjournal.pone.0015937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=21297958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFaitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e15937&author=I.+Paternitiauthor=E.+Mazzonauthor=C.+Gilauthor=D.+Impellizzeriauthor=V.+Palomoauthor=M.+Redondoauthor=D.+I.+Perezauthor=E.+Espositoauthor=A.+Martinezauthor=S.+Cuzzocrea&title=PDE+7+inhibitors%3A+new+potential+drugs+for+the+therapy+of+spinal+cord+injury&doi=10.1371%2Fjournal.pone.0015937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury</span></div><div class="casAuthors">Paterniti, Irene; Mazzon, Emanuela; Gil, Carmen; Impellizzeri, Daniela; Palomo, Valle; Redondo, Myriam; Perez, Daniel I.; Esposito, Emanuela; Martinez, Ana; Cuzzocrea, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e15937</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Primary traumatic mech. injury to the spinal cord (SCI) causes the death of a no. of neurons that to date can neither be recovered nor regenerated.  During the last years our group has been involved in the design, synthesis and evaluation of PDE7 inhibitors as new innovative drugs for several neurol. disorders.  Our working hypothesis is based on two different facts.  Firstly, neuroinflammation is modulated by cAMP levels, thus the key role for phosphodiesterases (PDEs), which hydrolyze cAMP, is undoubtedly demonstrated.  On the other hand, PDE7 is expressed simultaneously on leukocytes and on the brain, highlighting the potential crucial role of PDE7 as drug target for neuroinflammation.  Methodol./Principal Findings: Here we present two chem. diverse families of PDE7 inhibitors, designed using computational techniques such as virtual screening and neuronal networks.  We report their biol. profile and their efficacy in an exptl. SCI model induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy.  We have selected two candidates, namely S14 and VP1.15, as PDE7 inhibitors.  These compds. increase cAMP prodn. both in macrophage and neuronal cell lines.  Regarding drug-like properties, compds. were able to cross the blood brain barrier using parallel artificial membranes (PAMPA) methodol.  SCI in mice resulted in severe trauma characterized by edema, neutrophil infiltration, and prodn. of a range of inflammatory mediators, tissue damage, and apoptosis.  Treatment of the mice with S14 and VP1.15, two PDE7 inhibitors, significantly reduced the degree of spinal cord inflammation, tissue injury (histol. score), and TNF-α, IL-6, COX-2 and iNOS expression.  Conclusions/Significance: All these data together led us to propose PDE7 inhibitors, and specifically S14 and VP1.15, as potential drug candidates to be further studied for the treatment of SCI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvbyBbaYiCy7Vg90H21EOLACvtfcHk0lh5ve_5gidYmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFaitb0%253D&md5=57658a377f69fd7040dee1d4492946ee</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0015937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0015937%26sid%3Dliteratum%253Aachs%26aulast%3DPaterniti%26aufirst%3DI.%26aulast%3DMazzon%26aufirst%3DE.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DImpellizzeri%26aufirst%3DD.%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DRedondo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCuzzocrea%26aufirst%3DS.%26atitle%3DPDE%25207%2520inhibitors%253A%2520new%2520potential%2520drugs%2520for%2520the%2520therapy%2520of%2520spinal%2520cord%2520injury%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De15937%26doi%3D10.1371%2Fjournal.pone.0015937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Gonzalez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antequera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Grijalba, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krzyzanowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarasa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carro, E.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2133</span>– <span class="NLM_lpage">2145</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2013.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neurobiolaging.2013.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=23582662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlslWmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=2133-2145&author=R.+Perez-Gonzalezauthor=C.+Pascualauthor=D.+Antequeraauthor=M.+Bolosauthor=M.+Redondoauthor=D.+I.+Perezauthor=V.+Perez-Grijalbaauthor=A.+Krzyzanowskaauthor=M.+Sarasaauthor=C.+Gilauthor=I.+Ferrerauthor=A.+Martinezauthor=E.+Carro&title=Phosphodiesterase+7+inhibitor+reduced+cognitive+impairment+and+pathological+hallmarks+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2013.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Perez-Gonzalez, Rocio; Pascual, Consuelo; Antequera, Desiree; Bolos, Marta; Redondo, Miriam; Perez, Daniel I.; Perez-Grijalba, Virginia; Krzyzanowska, Agnieszka; Sarasa, Manuel; Gil, Carmen; Ferrer, Isidro; Martinez, Ana; Carro, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2133-2145</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Elevated levels of amyloid beta (Aβ) peptide, hyperphosphorylation of tau protein, and inflammation are pathol. hallmarks in Alzheimer's disease (AD).  Phosphodiesterase 7 (PDE7) regulates the inflammatory response through the cyclic adenosine monophosphate signaling cascade, and thus plays a central role in AD.  The aim of this study was to evaluate the efficacy of an inhibitor of PDE7, named S14, in a mouse model of AD.  We report that APP/Ps1 mice treated daily for 4 wk with S14 show: (1) significant attenuation in behavioral impairment; (2) decreased brain Aβ deposition; (3) enhanced astrocyte-mediated Aβ degrdn.; and (4) decreased tau phosphorylation.  These effects are mediated via the cyclic adenosine monophosphate/cyclic adenosine monophosphate response element-binding protein signaling pathway, and inactivation of glycogen synthase kinase (GSK)3.  Our data support the use of PDE7 inhibitors, and specifically S14, as effective therapeutic agents for the prevention and treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJq9wIJNY9n7Vg90H21EOLACvtfcHk0ljzsROsIKH7Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslWmt74%253D&md5=5d7deb7766409e1f27dd671b67bb5fbc</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2013.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2013.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Gonzalez%26aufirst%3DR.%26aulast%3DPascual%26aufirst%3DC.%26aulast%3DAntequera%26aufirst%3DD.%26aulast%3DBolos%26aufirst%3DM.%26aulast%3DRedondo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DPerez-Grijalba%26aufirst%3DV.%26aulast%3DKrzyzanowska%26aufirst%3DA.%26aulast%3DSarasa%26aufirst%3DM.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DFerrer%26aufirst%3DI.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCarro%26aufirst%3DE.%26atitle%3DPhosphodiesterase%25207%2520inhibitor%2520reduced%2520cognitive%2520impairment%2520and%2520pathological%2520hallmarks%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D2133%26epage%3D2145%26doi%3D10.1016%2Fj.neurobiolaging.2013.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soderling, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayuga, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">15553</span>– <span class="NLM_lpage">15558</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.25.15553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1074%2Fjbc.273.25.15553" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=15553-15558&author=S.+H.+Soderlingauthor=S.+J.+Bayugaauthor=J.+A.+Beavo&title=Identification+and+characterization+of+a+novel+family+of+cyclic+nucleotide+phosphodiesterases&doi=10.1074%2Fjbc.273.25.15553"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.25.15553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.25.15553%26sid%3Dliteratum%253Aachs%26aulast%3DSoderling%26aufirst%3DS.%2BH.%26aulast%3DBayuga%26aufirst%3DS.%2BJ.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520novel%2520family%2520of%2520cyclic%2520nucleotide%2520phosphodiesterases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D15553%26epage%3D15558%26doi%3D10.1074%2Fjbc.273.25.15553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wunder, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tersteegen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahrig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, M.</span></span> <span> </span><span class="NLM_article-title">Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1775</span>– <span class="NLM_lpage">1781</span>, <span class="refDoi"> DOI: 10.1124/mol.105.017608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1124%2Fmol.105.017608" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=1775-1781&author=F.+Wunderauthor=A.+Tersteegenauthor=A.+Rebmannauthor=C.+Erbauthor=T.+Fahrigauthor=M.+Hendrix&title=Characterization+of+the+first+potent+and+selective+PDE9+inhibitor+using+a+cGMP+reporter+cell+line&doi=10.1124%2Fmol.105.017608"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.017608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.017608%26sid%3Dliteratum%253Aachs%26aulast%3DWunder%26aufirst%3DF.%26aulast%3DTersteegen%26aufirst%3DA.%26aulast%3DRebmann%26aufirst%3DA.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DFahrig%26aufirst%3DT.%26aulast%3DHendrix%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520the%2520first%2520potent%2520and%2520selective%2520PDE9%2520inhibitor%2520using%2520a%2520cGMP%2520reporter%2520cell%2520line%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D1775%26epage%3D1781%26doi%3D10.1124%2Fmol.105.017608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van der Staay, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barfacker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckroth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karthaus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tersteegen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kampen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, M.</span></span> <span> </span><span class="NLM_article-title">The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2008.07.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=908-918&author=F.+J.+van+der+Staayauthor=K.+Ruttenauthor=L.+Barfackerauthor=J.+Devryauthor=C.+Erbauthor=H.+Heckrothauthor=D.+Karthausauthor=A.+Tersteegenauthor=M.+van+Kampenauthor=A.+Bloklandauthor=J.+Prickaertsauthor=K.+G.+Reymannauthor=U.+H.+Schroderauthor=M.+Hendrix&title=The+novel+selective+PDE9+inhibitor+BAY+73-6691+improves+learning+and+memory+in+rodents&doi=10.1016%2Fj.neuropharm.2008.07.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.07.005%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBarfacker%26aufirst%3DL.%26aulast%3DDevry%26aufirst%3DJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DHeckroth%26aufirst%3DH.%26aulast%3DKarthaus%26aufirst%3DD.%26aulast%3DTersteegen%26aufirst%3DA.%26aulast%3Dvan%2BKampen%26aufirst%3DM.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DReymann%26aufirst%3DK.%2BG.%26aulast%3DSchroder%26aufirst%3DU.%2BH.%26aulast%3DHendrix%26aufirst%3DM.%26atitle%3DThe%2520novel%2520selective%2520PDE9%2520inhibitor%2520BAY%252073-6691%2520improves%2520learning%2520and%2520memory%2520in%2520rodents%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D908%26epage%3D918%26doi%3D10.1016%2Fj.neuropharm.2008.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroker, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rast, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorner-Ciossek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1964</span>– <span class="NLM_lpage">1974</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2011.12.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=1964-1974&author=K.+S.+Krokerauthor=G.+Rastauthor=R.+Giovanniniauthor=A.+Martiauthor=C.+Dorner-Ciossekauthor=H.+Rosenbrock&title=Inhibition+of+acetylcholinesterase+and+phosphodiesterase-9A+has+differential+effects+on+hippocampal+early+and+late+LTP&doi=10.1016%2Fj.neuropharm.2011.12.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DKroker%26aufirst%3DK.%2BS.%26aulast%3DRast%26aufirst%3DG.%26aulast%3DGiovannini%26aufirst%3DR.%26aulast%3DMarti%26aufirst%3DA.%26aulast%3DDorner-Ciossek%26aufirst%3DC.%26aulast%3DRosenbrock%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520acetylcholinesterase%2520and%2520phosphodiesterase-9A%2520has%2520differential%2520effects%2520on%2520hippocampal%2520early%2520and%2520late%2520LTP%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D1964%26epage%3D1974%26doi%3D10.1016%2Fj.neuropharm.2011.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroker, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorner-Ciossek, C.</span></span> <span> </span><span class="NLM_article-title">PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2072</span>– <span class="NLM_lpage">2078</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neurobiolaging.2014.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=24746365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlCgtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=2072-2078&author=K.+S.+Krokerauthor=C.+Mathisauthor=A.+Martiauthor=J.+C.+Casselauthor=H.+Rosenbrockauthor=C.+Dorner-Ciossek&title=PDE9A+inhibition+rescues+amyloid+beta-induced+deficits+in+synaptic+plasticity+and+cognition&doi=10.1016%2Fj.neurobiolaging.2014.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition</span></div><div class="casAuthors">Kroker, Katja S.; Mathis, Chantal; Marti, Anelise; Cassel, Jean-Christophe; Rosenbrock, Holger; Dorner-Ciossek, Cornelia</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2072-2078</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The cyclic nucleotide cGMP is an important intracellular messenger for synaptic plasticity and memory function in rodents.  Therefore, inhibition of cGMP degrading phosphodiesterases, like PDE9A, has gained interest as potential target for treatment of cognition deficits in indications like Alzheimer's disease (AD).  In fact, PDE9A inhibition results in increased hippocampal long-term potentiation and exhibits procognitive effects in rodents.  To date, however, no evidence has been published linking PDE9A inhibition to the pathol. hallmarks of AD such as amyloid beta (Aβ) deposition.  Therefore, we investigated the role of PDE9A inhibition in an AD relevant context by testing its effects on Aβ-related deficits in synaptic plasticity and cognition.  The PDE9A inhibitor BAY 73-6691 was found to restore long-term potentiation impaired by Aβ42 oligomers.  Furthermore, we demonstrated that BAY 73-6691 enhanced cGMP levels in the hippocampus of APP transgenic tg2576 mice and improved memory performance of these mice.  Altogether, our results support the hypothesis that inhibition of PDE9A could be a beneficial approach for the treatment of memory impairment in AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraWP3yArit6LVg90H21EOLACvtfcHk0lj5l_ycGaqP7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlCgtrk%253D&md5=d5942494c3143f65ff6c8e19141cfbce</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DKroker%26aufirst%3DK.%2BS.%26aulast%3DMathis%26aufirst%3DC.%26aulast%3DMarti%26aufirst%3DA.%26aulast%3DCassel%26aufirst%3DJ.%2BC.%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DDorner-Ciossek%26aufirst%3DC.%26atitle%3DPDE9A%2520inhibition%2520rescues%2520amyloid%2520beta-induced%2520deficits%2520in%2520synaptic%2520plasticity%2520and%2520cognition%26jtitle%3DNeurobiol.%2520Aging%26date%3D2014%26volume%3D35%26spage%3D2072%26epage%3D2078%26doi%3D10.1016%2Fj.neurobiolaging.2014.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y. J.</span></span> <span> </span><span class="NLM_article-title">Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-beta peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer’s disease</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1642</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2016.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.brainres.2016.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=27071547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtFCltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1642&publication_year=2016&pages=327-335&author=J.+Liauthor=C.+N.+Liuauthor=N.+Weiauthor=X.+D.+Liauthor=Y.+Y.+Liuauthor=R.+Yangauthor=Y.+J.+Jia&title=Protective+effects+of+BAY+73-6691%2C+a+selective+inhibitor+of+phosphodiesterase+9%2C+on+amyloid-beta+peptides-induced+oxidative+stress+in+in-vivo+and+in-vitro+models+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.brainres.2016.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-β peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease</span></div><div class="casAuthors">Li, Jian; Liu, Chun-Na; Wei, Ning; Li, Xi-Dong; Liu, Yuan-Yuan; Yang, Rui; Jia, Yu-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1642</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">327-335</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is accompanied by enhanced oxidative stress and excess free radicals.  Phosphodiesterase 9 inhibitors (PDE-9Is) showed memory improving effects in many pharmacol. deficit models.  However, whether BAY 73-6691 (a selective PDE-9I) may attenuate the oxidative stress during the development of AD is still unclear.  For this purpose, primary cultures of SH-SY5Y cells were incubated with 20 μM beta-amyloid25-35 (Aβ25-35), followed by exposure to different concns. (50, 100, 150 and 200 μg/mL) of BAY 73-6691.  Furthermore, the antioxidant effect of BAY 73-6691 was evaluated in mice subjected to intracerebroventricular injection of Aβ25-35 (day 0) and treatment with BAY 73-6691 by i.p. injection once daily (days 1-10).  Our results elucidated that treatment with BAY 73-6691 attenuated the Aβ25-35-induced cytotoxicity and oxidative stress in SH-SY5Y cells.  In vivo, BAY 73-6691 protected Aβ25-35-induced oxidative damage in hippocampus, assocd. with the attenuation of impairments in hippocampal neurons.  Administration of BAY 73-6691 improved learning and memory in the Morris water maze test, and restored several hippocampal memory-assocd. proteins.  Our study identified a neuroprotective role for BAY 73-6691 against Aβ25-35-induced oxidative stress in vivo and in vitro, harboring therapeutic potential for the treatment of AD by alleviating the impairments in spatial memory and hippocampal neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg-SItR1ICPrVg90H21EOLACvtfcHk0lj5l_ycGaqP7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtFCltb8%253D&md5=e4a386b4336a0be7ca6d55a536655b41</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2016.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2016.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%2BN.%26aulast%3DWei%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DX.%2BD.%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DJia%26aufirst%3DY.%2BJ.%26atitle%3DProtective%2520effects%2520of%2520BAY%252073-6691%252C%2520a%2520selective%2520inhibitor%2520of%2520phosphodiesterase%25209%252C%2520on%2520amyloid-beta%2520peptides-induced%2520oxidative%2520stress%2520in%2520in-vivo%2520and%2520in-vitro%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Res.%26date%3D2016%26volume%3D1642%26spage%3D327%26epage%3D335%26doi%3D10.1016%2Fj.brainres.2016.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proulx-Lafrance, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943), a selective brain penetrant PDE9A inhibitor for the treatment of cognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9045</span>– <span class="NLM_lpage">9054</span>, <span class="refDoi"> DOI: 10.1021/jm3007799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9045-9054&author=P.+R.+Verhoestauthor=K.+R.+Fonsecaauthor=X.+Houauthor=C.+Proulx-Lafranceauthor=M.+Cormanauthor=C.+J.+Helalauthor=M.+M.+Claffeyauthor=J.+B.+Tuttleauthor=K.+J.+Coffmanauthor=S.+Liuauthor=F.+Nelsonauthor=R.+J.+Kleimanauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+Vanase-Frawleyauthor=S.+Liras&title=Design+and+discovery+of+6-%5B%283S%2C4S%29-4-methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one+%28PF-04447943%29%2C+a+selective+brain+penetrant+PDE9A+inhibitor+for+the+treatment+of+cognitive+disorders&doi=10.1021%2Fjm3007799"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm3007799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007799%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DProulx-Lafrance%26aufirst%3DC.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDesign%2520and%2520discovery%2520of%25206-%255B%25283S%252C4S%2529-4-methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2520%2528PF-04447943%2529%252C%2520a%2520selective%2520brain%2520penetrant%2520PDE9A%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9045%26epage%3D9054%26doi%3D10.1021%2Fjm3007799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vardigan, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Converso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uslaner, J. M.</span></span> <span> </span><span class="NLM_article-title">The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task</span>. <i>J. Neurogenet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.3109/01677063.2011.630494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.3109%2F01677063.2011.630494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=22070409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=120-126&author=J.+D.+Vardiganauthor=A.+Conversoauthor=P.+H.+Hutsonauthor=J.+M.+Uslaner&title=The+selective+phosphodiesterase+9+%28PDE9%29+inhibitor+PF-04447943+attenuates+a+scopolamine-induced+deficit+in+a+novel+rodent+attention+task&doi=10.3109%2F01677063.2011.630494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task</span></div><div class="casAuthors">Vardigan, Joshua D.; Converso, Antonella; Hutson, Pete H.; Uslaner, Jason M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">120-126</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Numerous changes occur during aging and Alzheimer's disease (AD) progression, including a decline in cholinergic functioning and cognition, as well as alterations in gene expression and activity in the nitric oxide/cyclic guanosine monophosphate (NO/cGMP) pathway.  Donepezil, the current std. of care for Alzheimer's disease, improves cholinergic functioning and has demonstrated effects on multiple domains of cognition, including memory and attention in both preclin. species and patients.  We previously found that increasing activation of the NO/cGMP pathway via phosphodiesterase 9 (PDE9) inhibition also improves memory in rodents and suggested that PDE9 might be a promising target for novel treatments for AD.  Here we investigated whether PDE9 inhibition also enhances attention using a novel attention task in rats.  We validated this task using several pharmacol. manipulations and showed that the selective PDE9 inhibitor PF-04447943 produced effects similar to those of donepezil.  These data confirm and extend the hypothesis that PDE9 inhibition might serve as a novel treatment for AD and age-related cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJa-1clww9LrVg90H21EOLACvtfcHk0li8UskDv2KZgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF&md5=1d03e024134e690d1765bd4ee8576aad</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.630494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.630494%26sid%3Dliteratum%253Aachs%26aulast%3DVardigan%26aufirst%3DJ.%2BD.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520selective%2520phosphodiesterase%25209%2520%2528PDE9%2529%2520inhibitor%2520PF-04447943%2520attenuates%2520a%2520scopolamine-induced%2520deficit%2520in%2520a%2520novel%2520rodent%2520attention%2520task%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D120%26epage%3D126%26doi%3D10.3109%2F01677063.2011.630494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magliaro, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Converso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eschle, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rindgen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivian, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eddins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uslaner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le-Mair, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachs, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier-Batteur, S.</span></span> <span> </span><span class="NLM_article-title">The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1 -(pyrimidin-2 -ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2011.05.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=665-676&author=P.+H.+Hutsonauthor=E.+N.+Fingerauthor=B.+C.+Magliaroauthor=S.+M.+Smithauthor=A.+Conversoauthor=P.+E.+Sandersonauthor=D.+Mullinsauthor=L.+A.+Hydeauthor=B.+K.+Eschleauthor=Z.+Turnbullauthor=H.+Sloanauthor=M.+Guzziauthor=X.+Zhangauthor=A.+Wangauthor=D.+Rindgenauthor=R.+Mazzolaauthor=J.+A.+Vivianauthor=D.+Eddinsauthor=J.+M.+Uslanerauthor=R.+Bednarauthor=C.+Gamboneauthor=W.+Le-Mairauthor=M.+J.+Marinoauthor=N.+Sachsauthor=G.+Xuauthor=S.+Parmentier-Batteur&title=The+selective+phosphodiesterase+9+%28PDE9%29+inhibitor+PF-04447943+%286-%5B%283S%2C4S%29-4-methyl-1+-%28pyrimidin-2+-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one%29+enhances+synaptic+plasticity+and+cognitive+function+in+rodents&doi=10.1016%2Fj.neuropharm.2011.05.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26aulast%3DMullins%26aufirst%3DD.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DEschle%26aufirst%3DB.%2BK.%26aulast%3DTurnbull%26aufirst%3DZ.%26aulast%3DSloan%26aufirst%3DH.%26aulast%3DGuzzi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRindgen%26aufirst%3DD.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26aulast%3DEddins%26aufirst%3DD.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DBednar%26aufirst%3DR.%26aulast%3DGambone%26aufirst%3DC.%26aulast%3DLe-Mair%26aufirst%3DW.%26aulast%3DMarino%26aufirst%3DM.%2BJ.%26aulast%3DSachs%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DParmentier-Batteur%26aufirst%3DS.%26atitle%3DThe%2520selective%2520phosphodiesterase%25209%2520%2528PDE9%2529%2520inhibitor%2520PF-04447943%2520%25286-%255B%25283S%252C4S%2529-4-methyl-1%2520-%2528pyrimidin-2%2520-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2529%2520enhances%2520synaptic%2520plasticity%2520and%2520cognitive%2520function%2520in%2520rodents%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D665%26epage%3D676%26doi%3D10.1016%2Fj.neuropharm.2011.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanz, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bove, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majchrzak, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal-Gonzales, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, D. T.</span></span> <span> </span><span class="NLM_article-title">Dendritic spine density deficits in the hippocampal CA1 region of young Tg2576 mice are ameliorated with the PDE9A inhibitor PF-04447943</span>. <i>Alzheimer's Dementia</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">S563</span>– <span class="NLM_lpage">S564</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2010.05.1922</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.jalz.2010.05.1922" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S563-S564&author=R.+J.+Kleimanauthor=T.+A.+Lanzauthor=J.+E.+Finleyauthor=S.+E.+Boveauthor=M.+J.+Majchrzakauthor=S.+L.+Beckerauthor=S.+Carvajal-Gonzalesauthor=A.+M.+Kuhnauthor=K.+M.+Woodauthor=A.+Marigaauthor=F.+R.+Nelsonauthor=P.+R.+Verhoestauthor=P.+A.+Seymourauthor=D.+T.+Stephenson&title=Dendritic+spine+density+deficits+in+the+hippocampal+CA1+region+of+young+Tg2576+mice+are+ameliorated+with+the+PDE9A+inhibitor+PF-04447943&doi=10.1016%2Fj.jalz.2010.05.1922"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.05.1922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.05.1922%26sid%3Dliteratum%253Aachs%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DLanz%26aufirst%3DT.%2BA.%26aulast%3DFinley%26aufirst%3DJ.%2BE.%26aulast%3DBove%26aufirst%3DS.%2BE.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DCarvajal-Gonzales%26aufirst%3DS.%26aulast%3DKuhn%26aufirst%3DA.%2BM.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DMariga%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26atitle%3DDendritic%2520spine%2520density%2520deficits%2520in%2520the%2520hippocampal%2520CA1%2520region%2520of%2520young%2520Tg2576%2520mice%2520are%2520ameliorated%2520with%2520the%2520PDE9A%2520inhibitor%2520PF-04447943%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS563%26epage%3DS564%26doi%3D10.1016%2Fj.jalz.2010.05.1922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span>Clinical trial study found in clinical trials for PF-04447943,
NCT00988598. <a href="https://clinicaltrials.gov/ct2/show/NCT00988598?term=PF-04447943&amp;rank=6" class="extLink">https://clinicaltrials.gov/ct2/show/NCT00988598?term=PF-04447943&rank=6</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+PF-04447943%2C%0ANCT00988598.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00988598%3Fterm%3DPF-04447943%26rank%3D6+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span>Clinical
trial study found in clinical trials for PF-04447943, NCT00930059. <a href="https://clinicaltrials.gov/ct2/show/NCT00930059?term=PF-04447943&amp;rank=3" class="extLink">https://clinicaltrials.gov/ct2/show/NCT00930059?term=PF-04447943&rank=3</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+PF-04447943%2C+NCT00930059.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00930059%3Fterm%3DPF-04447943%26rank%3D3+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span>Clinical
trial study found in clinical trials for BI-409306, NCT02337907. <a href="https://clinicaltrials.gov/ct2/show/NCT02337907?term=BI-409306&amp;draw=3&amp;rank=12" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02337907?term=BI-409306&draw=3&rank=12</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+BI-409306%2C+NCT02337907.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02337907%3Fterm%3DBI-409306%26draw%3D3%26rank%3D12+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span>Clinical
trial study found in clinical trials for BI-409306, NCT02240693. <a href="https://clinicaltrials.gov/ct2/show/NCT02240693?term=BI-409306&amp;draw=3&amp;rank=13" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02240693?term=BI-409306&draw=3&rank=13</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+BI-409306%2C+NCT02240693.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02240693%3Fterm%3DBI-409306%26draw%3D3%26rank%3D13+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of highly selective phosphodiesterase-9A inhibitors and implications for inhibitor design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8549</span>– <span class="NLM_lpage">8558</span>, <span class="refDoi"> DOI: 10.1021/jm301189c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301189c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8549-8558&author=F.+Mengauthor=J.+Houauthor=Y.-X.+Shaoauthor=P.-Y.+Wuauthor=M.+Huangauthor=X.+Zhuauthor=Y.+Caiauthor=Z.+Liauthor=J.+Xuauthor=P.+Liuauthor=H.-B.+Luoauthor=Y.+Wanauthor=H.+Ke&title=Structure-based+discovery+of+highly+selective+phosphodiesterase-9A+inhibitors+and+implications+for+inhibitor+design&doi=10.1021%2Fjm301189c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design</span></div><div class="casAuthors">Meng, Fei; Hou, Jing; Shao, Yong-Xian; Wu, Pei-Ying; Huang, Manna; Zhu, Xinhai; Cai, Yonghong; Li, Zhe; Xu, Jie; Liu, Peiqing; Luo, Hai-Bin; Wan, Yiqian; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8549-8558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of phosphodiesterase-9 (PDE9) inhibitors that contain a scaffold of 6-amino-pyrazolopyrimidinone have been discovered by a combination of structure-based design and computational docking.  This procedure significantly saved the load of chem. synthesis and is an effective method for the discovery of inhibitors.  The best compd. 28 (I) has an IC50 of 21 nM and 3.3 μM, resp., for PDE9 and PDE5 and about 3 orders of magnitude of selectivity against other PDE families.  The crystal structure of the PDE9 catalytic domain in complex with 28 has been detd. and shows a hydrogen bond between 28 and Tyr424.  This hydrogen bond may account for the 860-fold selectivity of 28 against PDE1B, in comparison with about 30-fold selectivity of BAY73-6691.  Thus, our studies suggest that Tyr424, a unique residue of PDE8 and PDE9, is a potential target for improvement of selectivity of PDE9 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXPtJ-cQVCabVg90H21EOLACvtfcHk0liPwvyMZvKMNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ&md5=ed8c37d784c80b040c51c9e2b40e2d99</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Fjm301189c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301189c%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DY.-X.%26aulast%3DWu%26aufirst%3DP.-Y.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DH.-B.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DStructure-based%2520discovery%2520of%2520highly%2520selective%2520phosphodiesterase-9A%2520inhibitors%2520and%2520implications%2520for%2520inhibitor%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8549%26epage%3D8558%26doi%3D10.1021%2Fjm301189c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery of a phosphodiesterase 9A inhibitor as a potential hypoglycemic agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10304</span>– <span class="NLM_lpage">10313</span>, <span class="refDoi"> DOI: 10.1021/jm500836h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500836h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSju73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10304-10313&author=Y.+X.+Shaoauthor=M.+Huangauthor=W.+Cuiauthor=L.+J.+Fengauthor=Y.+Wuauthor=Y.+Caiauthor=Z.+Liauthor=X.+Zhuauthor=P.+Liuauthor=Y.+Wanauthor=H.+Keauthor=H.-B.+Luo&title=Discovery+of+a+phosphodiesterase+9A+inhibitor+as+a+potential+hypoglycemic+agent&doi=10.1021%2Fjm500836h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent</span></div><div class="casAuthors">Shao, Yong-xian; Huang, Manna; Cui, Wenjun; Feng, Ling-Jun; Wu, Yinuo; Cai, Yinghong; Li, Zhe; Zhu, Xinhai; Liu, Peiqing; Wan, Yiqian; Ke, Hengming; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10304-10313</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 9 (PDE9) inhibitors have been studied as potential therapeutics for treatment of diabetes and Alzheimer's disease.  Here we report a potent PDE9 inhibitor 3r that has an IC50 of 0.6 nM and >150-fold selectivity over other PDEs.  The HepG2 cell-based assay shows that 3r inhibits the mRNA expression of phosphoenolpyruvate carboxykinase and glucose 6-phosphatase.  These activities of 3r, together with the reasonable pharmacokinetic properties and no acute toxicity at 1200 mg/kg dosage, suggest its potential as a hypoglycemic agent.  The crystal structure of PDE9-3r reveals significantly different conformation and hydrogen bonding pattern of 3r from those of previously published 28s.  Both 3r and 28s form a hydrogen bond with Tyr424, a unique PDE9 residue (except for PDE8), but 3r shows an addnl. hydrogen bond with Ala452.  This structure information might be useful for design of PDE9 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo41BAQ4bJwqbVg90H21EOLACvtfcHk0liPwvyMZvKMNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSju73E&md5=71b59f683cfbd1b6620d507e654e231f</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjm500836h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500836h%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DY.%2BX.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DL.%2BJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DDiscovery%2520of%2520a%2520phosphodiesterase%25209A%2520inhibitor%2520as%2520a%2520potential%2520hypoglycemic%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10304%26epage%3D10313%26doi%3D10.1021%2Fjm500836h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Structural asymmetry of phosphodiesterase-9A and a unique pocket for selective binding of a potent enantiomeric inhibitor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">836</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.1124/mol.115.099747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1124%2Fmol.115.099747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26316540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=836-845&author=M.+Huangauthor=Y.+Shaoauthor=J.+Houauthor=W.+Cuiauthor=B.+Liangauthor=Y.+Huangauthor=Z.+Liauthor=Y.+Wuauthor=X.+Zhuauthor=P.+Liuauthor=Y.+Wanauthor=H.+Keauthor=H.-B.+Luo&title=Structural+asymmetry+of+phosphodiesterase-9A+and+a+unique+pocket+for+selective+binding+of+a+potent+enantiomeric+inhibitor&doi=10.1124%2Fmol.115.099747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Structural asymmetry of phosphodiesterase-9A and a unique pocket for selective binding of a potent enantiomeric inhibitor</span></div><div class="casAuthors">Huang, Manna; Shao, Yongxian; Hou, Jianying; Cui, Wenjun; Liang, Beibei; Huang, Yingchun; Li, Zhe; Wu, Yinuo; Zhu, Xinhai; Liu, Peiqing; Wan, Yiqian; Ke, Hengming; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">836-845</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphodiesterase-9 (PDE9) inhibitors have been studied as potential therapeutics for treatment of central nervous system diseases and diabetes.  Here, we report the discovery of a new category of PDE9 inhibitors by rational design on the basis of the crystal structures.  The best compd., (S)-6-((1-(4-chlorophenyl)ethyl)amino)-1-cyclopentyl-1,5,6,7-tetrahydro-4H-pyrazolo[3,4-day]pyrimidin-4-one [(S)-C33], has an IC50 value of 11 nM against PDE9 and the racemic C33 has bioavailability of 56.5% in the rat pharmacokinetic model.  The crystal structures of PDE9 in the complex with racemic C33, (R)-C33, and (S)-C33 reveal subtle conformational asymmetry of two M-loops in the PDE9 dimer and different conformations of two C33 enantiomers.  The structures also identified a small hydrophobic pocket that interacts with the tyrosyl tail of (S)-C33 but not with (R)-C33, and is thus possibly useful for improvement of selectivity of PDE9 inhibitors.  The asymmetry of the M-loop and the different interactions of the C33 enantiomers imply the necessity to consider the whole PDE9 dimer in the design of inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsftx1vMJFUbVg90H21EOLACvtfcHk0liPwvyMZvKMNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSnur8%253D&md5=2e6884812e3b703a74cf1495b5a5a9a3</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.099747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.099747%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DStructural%2520asymmetry%2520of%2520phosphodiesterase-9A%2520and%2520a%2520unique%2520pocket%2520for%2520selective%2520binding%2520of%2520a%2520potent%2520enantiomeric%2520inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D836%26epage%3D845%26doi%3D10.1124%2Fmol.115.099747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1039/C4MB00389F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1039%2FC4MB00389F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=25328054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslert73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=115-125&author=Z.+Liauthor=X.+Luauthor=L.-J.+Fengauthor=Y.+Guauthor=X.+Liauthor=Y.+Wuauthor=H.-B.+Luo&title=Molecular+dynamics-based+discovery+of+novel+phosphodiesterase-9A+inhibitors+with+non-pyrazolopyrimidinone+scaffolds&doi=10.1039%2FC4MB00389F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds</span></div><div class="casAuthors">Li, Zhe; Lu, Xiao; Feng, Ling-Jun; Gu, Ying; Li, Xingshu; Wu, Yinuo; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-125</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Phosphodiesterase-9A (PDE9A) is a promising therapeutic target for the treatment of diabetes and Alzheimer's disease (AD).  The Pfizer PDE9A inhibitor PF-04447943 has completed Phase II clin. trials in subjects with mild to moderate AD in 2013.  However, most of the reported PDE9A inhibitors share the same scaffold as pyrazolopyrimidinone, which lacks structural diversity and is unfavorable for the development of novel PDE9A inhibitors.  In the present study, a combinatorial method including pharmacophores, mol. docking, mol. dynamics simulations, binding free energy calcns., and bioassay was used to discover novel PDE9A inhibitors with new scaffolds rather than pyrazolopyrimidinones from the SPECS database contg. about 200,000 compds.  As a result, 15 hits out of 29 mols. (a hit rate of 52%) with five novel scaffolds were identified to be PDE9A inhibitors with inhibitory affinities no more than 50 μM to enrich the structural diversity, different from the pyrazolopyrimidinone-derived family.  The high hit ratio of 52% for this virtual screening method indicated that the combinatorial method is a good compromise between computational cost and accuracy.  Binding pattern analyses indicate that those hits with non-pyrazolopyrimidinone scaffolds can bind the same active site pocket of PDE9A as classical PDE9A inhibitors.  In addn., structural modification of compd. AG-690/40135604 (IC50 = 8.0 μM) led to a new one, 16, with an improved inhibitory affinity of 2.1 μM as expected.  The five novel scaffolds discovered in the present study can be used for the rational design of PDE9A inhibitors with higher affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6UunPMCOV57Vg90H21EOLACvtfcHk0lhwEPoOlVPV1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslert73L&md5=761bc5740f8a65cf23c2bd0e1bf7eccc</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1039%2FC4MB00389F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MB00389F%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DL.-J.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DMolecular%2520dynamics-based%2520discovery%2520of%2520novel%2520phosphodiesterase-9A%2520inhibitors%2520with%2520non-pyrazolopyrimidinone%2520scaffolds%26jtitle%3DMol.%2520BioSyst.%26date%3D2015%26volume%3D11%26spage%3D115%26epage%3D125%26doi%3D10.1039%2FC4MB00389F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soderling, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayuga, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span> <span> </span><span class="NLM_article-title">Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">7071</span>– <span class="NLM_lpage">7076</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.12.7071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1073%2Fpnas.96.12.7071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=7071-7076&author=S.+H.+Soderlingauthor=S.+J.+Bayugaauthor=J.+A.+Beavo&title=Isolation+and+characterization+of+a+dual-substrate+phosphodiesterase+gene+family%3A+PDE10A&doi=10.1073%2Fpnas.96.12.7071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.12.7071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.12.7071%26sid%3Dliteratum%253Aachs%26aulast%3DSoderling%26aufirst%3DS.%2BH.%26aulast%3DBayuga%26aufirst%3DS.%2BJ.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DIsolation%2520and%2520characterization%2520of%2520a%2520dual-substrate%2520phosphodiesterase%2520gene%2520family%253A%2520PDE10A%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D7071%26epage%3D7076%26doi%3D10.1073%2Fpnas.96.12.7071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hebb, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denovan-Wright, E. M.</span></span> <span> </span><span class="NLM_article-title">Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington’s disease transgenic mice prior to the onset of motor symptoms</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2003.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuroscience.2003.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=14751289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFKgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2004&pages=967-981&author=A.+L.+Hebbauthor=H.+A.+Robertsonauthor=E.+M.+Denovan-Wright&title=Striatal+phosphodiesterase+mRNA+and+protein+levels+are+reduced+in+Huntington%E2%80%99s+disease+transgenic+mice+prior+to+the+onset+of+motor+symptoms&doi=10.1016%2Fj.neuroscience.2003.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms</span></div><div class="casAuthors">Hebb, A. L. O.; Robertson, H. A.; Denovan-Wright, E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">967-981</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Inheritance of a single copy of the gene encoding huntingtin (HD) with an expanded polyglutamine-encoding CAG repeat leads to neuronal dysfunction, neurodegeneration and the development of the symptoms of Huntington's disease (HD).  The authors have found that the steady-state mRNA levels of two members of the phosphodiesterase (PDE) multi-gene family decrease over time in the striatum of R6 transgenic HD mice relative to age-matched wild-type littermates.  Phosphodiesterase 10A (PDE10A) mRNA and protein levels decline in the striatum of R6/1 and R6/2 HD mice prior to motor symptom development.  The rate of redn. in PDE10A protein correlates with the rate of decline of the message and the decrease in PDE10A mRNA and protein is more rapid in R6/2 compared with R6/1 mice.  Both PDE10A protein and mRNA, therefore, decline to min. levels prior to the onset of overt phys. symptoms in both strains of transgenic mice.  Moreover, protein levels of PDE10A are decreased in the caudate-putamen of grade 3 HD patients compared with age-matched neuropathol. normal controls.  Striatal PDE1B mRNA levels also decline in R6/1 and R6/2 HD mice; however, the decrease in striatal PDE10A levels (>60%) was greater than that obsd. for PDE1B and immediately preceded the onset of motor symptoms.  In contrast, PDE4A mRNA levels are relatively low in the striatum and do not differ between age-matched wild-type and transgenic HD mice.  This suggests that the regulation of PDE10A and PDE1B, but not PDE4A, mRNA levels is dependent on the relative expression of or no. of CAG repeats within the human HD transgene.  The loss of phosphodiesterase activity may lead to dysregulation of cAMP and cGMP levels in the striatum, a region of the brain that contributes to the control of movement and cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq097hFgJMexbVg90H21EOLACvtfcHk0lhwEPoOlVPV1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFKgsg%253D%253D&md5=f274758b2f39ce57fae14cb76d61ff50</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2003.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2003.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DHebb%26aufirst%3DA.%2BL.%26aulast%3DRobertson%26aufirst%3DH.%2BA.%26aulast%3DDenovan-Wright%26aufirst%3DE.%2BM.%26atitle%3DStriatal%2520phosphodiesterase%2520mRNA%2520and%2520protein%2520levels%2520are%2520reduced%2520in%2520Huntington%25E2%2580%2599s%2520disease%2520transgenic%2520mice%2520prior%2520to%2520the%2520onset%2520of%2520motor%2520symptoms%26jtitle%3DNeuroscience%26date%3D2004%26volume%3D123%26spage%3D967%26epage%3D981%26doi%3D10.1016%2Fj.neuroscience.2003.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapin, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marr, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proulx-LaFrance, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suiciak, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1<i>H</i>-pyrazol-3- yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of Schizophrenia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5188</span>– <span class="NLM_lpage">5196</span>, <span class="refDoi"> DOI: 10.1021/jm900521k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900521k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5188-5196&author=P.+R.+Verhoestauthor=D.+S.+Chapinauthor=M.+Cormanauthor=K.+Fonsecaauthor=J.+F.+Harmsauthor=X.+Houauthor=E.+S.+Marrauthor=F.+S.+Mennitiauthor=F.+Nelsonauthor=R.+O%E2%80%99Connorauthor=J.+Panditauthor=C.+Proulx-LaFranceauthor=A.+W.+Schmidtauthor=C.+J.+Schmidtauthor=J.+A.+Suiciakauthor=S.+Liras&title=Discovery+of+a+novel+class+of+phosphodiesterase+10A+inhibitors+and+identification+of+clinical+candidate+2-%5B4-%281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-+yl%29-phenoxymethyl%5D-quinoline+%28PF-2545920%29+for+the+treatment+of+Schizophrenia&doi=10.1021%2Fjm900521k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fjm900521k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900521k%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DProulx-LaFrance%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSuiciak%26aufirst%3DJ.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520phosphodiesterase%252010A%2520inhibitors%2520and%2520identification%2520of%2520clinical%2520candidate%25202-%255B4-%25281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-%2520yl%2529-phenoxymethyl%255D-quinoline%2520%2528PF-2545920%2529%2520for%2520the%2520treatment%2520of%2520Schizophrenia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5188%26epage%3D5196%26doi%3D10.1021%2Fjm900521k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span>Clinical trial study found in clinical trials for PF-02545920,
NCT02197130. <a href="https://clinicaltrials.gov/ct2/show/NCT02197130?term=PF-02545920&amp;draw=1&amp;rank=6" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02197130?term=PF-02545920&draw=1&rank=6</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+PF-02545920%2C%0ANCT02197130.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02197130%3Fterm%3DPF-02545920%26draw%3D1%26rank%3D6+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span>Clinical
trial study found in clinical trials for PF-02545920, NCT02342548. <a href="https://clinicaltrials.gov/ct2/show/NCT02342548?term=PF-02545920&amp;draw=1&amp;rank=4" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02342548?term=PF-02545920&draw=1&rank=4</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+PF-02545920%2C+NCT02342548.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02342548%3Fterm%3DPF-02545920%26draw%3D1%26rank%3D4+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kunitomo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fushimi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokubo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin- 4(1H)-one (TAK-063), a highly potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9627</span>– <span class="NLM_lpage">9643</span>, <span class="refDoi"> DOI: 10.1021/jm5013648</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5013648" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9627-9643&author=J.+Kunitomoauthor=M.+Yoshikawaauthor=M.+Fushimiauthor=A.+Kawadaauthor=J.+F.+Quinnauthor=H.+Okiauthor=H.+Kokuboauthor=M.+Kondoauthor=K.+Nakashimaauthor=N.+Kamiguchiauthor=K.+Suzukiauthor=H.+Kimuraauthor=T.+Taniguchi&title=Discovery+of+1-%5B2-fluoro-4-%281H-pyrazol-1-yl%29phenyl%5D-5-methoxy-3-%281-phenyl-1H-pyrazol-5-yl%29pyridazin-+4%281H%29-one+%28TAK-063%29%2C+a+highly+potent%2C+selective%2C+and+orally+active+phosphodiesterase+10A+%28PDE10A%29+inhibitor&doi=10.1021%2Fjm5013648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm5013648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5013648%26sid%3Dliteratum%253Aachs%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DYoshikawa%26aufirst%3DM.%26aulast%3DFushimi%26aufirst%3DM.%26aulast%3DKawada%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DKokubo%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DM.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520of%25201-%255B2-fluoro-4-%25281H-pyrazol-1-yl%2529phenyl%255D-5-methoxy-3-%25281-phenyl-1H-pyrazol-5-yl%2529pyridazin-%25204%25281H%2529-one%2520%2528TAK-063%2529%252C%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9627%26epage%3D9643%26doi%3D10.1021%2Fjm5013648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span> <span> </span><span class="NLM_article-title">TAK-063, a PDE10A inhibitor with balanced activation of direct and indirect pathways, provides potent antipsychotic-like effects in multiple paradigms</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2252</span>– <span class="NLM_lpage">2262</span>, <span class="refDoi"> DOI: 10.1038/npp.2016.20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnpp.2016.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26849714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFGktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=2252-2262&author=K.+Suzukiauthor=A.+Haradaauthor=H.+Suzukiauthor=M.+Miyamotoauthor=H.+Kimura&title=TAK-063%2C+a+PDE10A+inhibitor+with+balanced+activation+of+direct+and+indirect+pathways%2C+provides+potent+antipsychotic-like+effects+in+multiple+paradigms&doi=10.1038%2Fnpp.2016.20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms</span></div><div class="casAuthors">Suzuki, Kazunori; Harada, Akina; Suzuki, Hirobumi; Miyamoto, Maki; Kimura, Haruhide</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2252-2262</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) inhibitors are expected to be novel drugs for schizophrenia through activation of both direct and indirect pathway medium spiny neurons.  However, excess activation of the direct pathway by a dopamine D1 receptor agonist SKF82958 canceled antipsychotic-like effects of a dopamine D2 receptor antagonist haloperidol in methamphetamine (METH)-induced hyperactivity in rats.  Thus, balanced activation of these pathways may be crit. for PDE10A inhibitors.  Current antipsychotics and the novel PDE10A inhibitor TAK-063, but not the selective PDE10A inhibitor MP-10, produced dose-dependent antipsychotic-like effects in METH-induced hyperactivity and prepulse inhibition in rodents.  TAK-063 and MP-10 activated the indirect pathway to a similar extent; however, MP-10 caused greater activation of the direct pathway than did TAK-063.  Interestingly, the off-rate of TAK-063 from PDE10A in rat brain sections was faster than that of MP-10, and a slower off-rate PDE10A inhibitor with TAK-063-like chem. structure showed an MP-10-like pharmacol. profile.  In general, faster off-rate enzyme inhibitors are more sensitive than slower off-rate inhibitors to binding inhibition by enzyme substrates.  As expected, TAK-063 was more sensitive than MP-10 to binding inhibition by cyclic nucleotides.  Moreover, an immunohistochem. study suggested that cyclic adenosine monophosphate levels in the direct pathway were higher than those in the indirect pathway.  These data can explain why TAK-063 showed partial activation of the direct pathway compared with MP-10.  The findings presented here suggest that TAK-063's antipsychotic-like efficacy may be attributable to its unique pharmacol. properties, resulting in balanced activation of the direct and indirect striatal pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI0rSbqykBcbVg90H21EOLACvtfcHk0ljprs5RXUWv6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFGktbo%253D&md5=794c9b5aa0a0040f749d50db79c25446</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.20%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DH.%26atitle%3DTAK-063%252C%2520a%2520PDE10A%2520inhibitor%2520with%2520balanced%2520activation%2520of%2520direct%2520and%2520indirect%2520pathways%252C%2520provides%2520potent%2520antipsychotic-like%2520effects%2520in%2520multiple%2520paradigms%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26volume%3D41%26spage%3D2252%26epage%3D2262%26doi%3D10.1038%2Fnpp.2016.20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiraishi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span> <span> </span><span class="NLM_article-title">The phosphodiesterase 10A selective inhibitor TAK-063 improves cognitive functions associated with Schizophrenia in rodent models</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">587</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.230482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1124%2Fjpet.115.230482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26675680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtF2ksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=587-595&author=E.+Shiraishiauthor=K.+Suzukiauthor=A.+Haradaauthor=N.+Suzukiauthor=H.+Kimura&title=The+phosphodiesterase+10A+selective+inhibitor+TAK-063+improves+cognitive+functions+associated+with+Schizophrenia+in+rodent+models&doi=10.1124%2Fjpet.115.230482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">The Phosphodiesterase 10A Selective Inhibitor TAK-063 Improves Cognitive Functions Associated with Schizophrenia in Rodent Models</span></div><div class="casAuthors">Shiraishi Eri; Suzuki Kazunori; Harada Akina; Suzuki Noriko; Kimura Haruhide</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">587-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cognitive deficits in various domains, including recognition memory, attention, impulsivity, working memory, and executive function, substantially affect functional outcomes in patients with schizophrenia.  TAK-063 [1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one] is a potent and selective phosphodiesterase 10A inhibitor that produces antipsychotic-like effects in rodent models of schizophrenia.  We evaluated the effects of TAK-063 on multiple cognitive functions associated with schizophrenia using naive and drug-perturbed rodents.  TAK-063 at 0.1 and 0.3 mg/kg p.o. improved time-dependent memory decay in object recognition in naive rats.  TAK-063 at 0.1 and 0.3 mg/kg p.o. increased accuracy rate, and TAK-063 at 0.3 mg/kg p.o. reduced impulsivity in a five-choice serial reaction time task in naive rats.  N-methyl-d-aspartate receptor antagonists, such as phencyclidine and MK-801 [(5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine], were used to induce working memory deficits relevant to schizophrenia in animals.  TAK-063 at 0.3 mg/kg p.o. attenuated both phencyclidine-induced working memory deficits in a Y-maze test in mice and MK-801-induced working memory deficits in an eight-arm radial maze task in rats.  An attentional set-shifting task using subchronic phencyclidine-treated rats was used to assess the executive function.  TAK-063 at 0.3 mg/kg p.o. reversed cognitive deficits in extradimensional shifts.  These findings suggest that TAK-063 has a potential to ameliorate deficits in multiple cognitive domains impaired in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZGT27-BUcZ0H3Rlp_k91zfW6udTcc2eYuFJFsZt14Q7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtF2ksg%253D%253D&md5=a66911d6a23b448aafe7b9277ffebc2e</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230482%26sid%3Dliteratum%253Aachs%26aulast%3DShiraishi%26aufirst%3DE.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DKimura%26aufirst%3DH.%26atitle%3DThe%2520phosphodiesterase%252010A%2520selective%2520inhibitor%2520TAK-063%2520improves%2520cognitive%2520functions%2520associated%2520with%2520Schizophrenia%2520in%2520rodent%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D587%26epage%3D595%26doi%3D10.1124%2Fjpet.115.230482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span>Clinical trial study found in clinical trials for TAK-063,
NCT02477020. <a href="https://clinicaltrials.gov/ct2/show/NCT02477020?term=NCT02477020&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02477020?term=NCT02477020&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+TAK-063%2C%0ANCT02477020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02477020%3Fterm%3DNCT02477020%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span>; <span class="NLM_string-name">Donello, J. E.</span>; <span class="NLM_string-name">Chauvignac, C.</span>; <span class="NLM_string-name">Taverne, T.</span>; <span class="NLM_string-name">Beausoleil, E.</span>; <span class="NLM_string-name">Casagrande, A. S.</span>; <span class="NLM_string-name">Yang, R.</span></span> <span> </span><span class="NLM_article-title">PDE10 Inhibitors and Related Compositions and Methods</span>. <span class="NLM_patent">WO2011112828 A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=B.+Leblond&author=J.+E.+Donello&author=C.+Chauvignac&author=T.+Taverne&author=E.+Beausoleil&author=A.+S.+Casagrande&author=R.+Yang&title=PDE10+Inhibitors+and+Related+Compositions+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLeblond%26aufirst%3DB.%26atitle%3DPDE10%2520Inhibitors%2520and%2520Related%2520Compositions%2520and%2520Methods%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span>Clinical trial study found in
clinical trials for OMS643762, NCT01952132. <a href="https://clinicaltrials.gov/ct2/show/NCT01952132?term=NCT01952132&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01952132?term=NCT01952132&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in%0Aclinical+trials+for+OMS643762%2C+NCT01952132.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01952132%3Fterm%3DNCT01952132%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span>Clinical
trial study found in clinical trials for EVP-6308, NCT02037074. <a href="https://clinicaltrials.gov/ct2/show/NCT02037074?term=NCT02037074&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02037074?term=NCT02037074&rank=1</a>(accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+EVP-6308%2C+NCT02037074.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02037074%3Fterm%3DNCT02037074%26rank%3D1%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cote, R. H.</span></span> <span> </span><span class="NLM_article-title">Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5</span>. <i>Int. J. Impotence Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">S28</span>– <span class="NLM_lpage">S33</span>, <span class="refDoi"> DOI: 10.1038/sj.ijir.3901212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fsj.ijir.3901212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=15224133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=S28-S33&author=R.+H.+Cote&title=Characteristics+of+photoreceptor+PDE+%28PDE6%29%3A+similarities+and+differences+to+PDE5&doi=10.1038%2Fsj.ijir.3901212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5</span></div><div class="casAuthors">Cote, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Impotence Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S28-S33</span>CODEN:
                <span class="NLM_cas:coden">IJIRFB</span>;
        ISSN:<span class="NLM_cas:issn">0955-9930</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 6 (PDE6) is highly concd. in the retina.  It is most abundant in the internal membranes of retinal photoreceptors, where it reduces cytoplasmic levels of cGMP in rod and cone outer segments in response to light.  The rod PDE6 holoenzyme comprises α and β catalytic subunits and two identical inhibitory γ subunits.  Each catalytic subunit contains three distinct globular domains corresponding to the catalytic domain and two GAF domains (responsible for allosteric cGMP binding).  The PDE6 catalytic subunits resemble PDE5 in amino-acid sequence as well as in three-dimensional structure of the catalytic dimer; preference for cGMP over cAMP (cAMP) as a substrate; and the ability to bind cGMP at the regulatory GAF domains.  Most PDE5 inhibitors inhibit PDE6 with similar potency, and electroretinogram studies show modest effects of PDE5 inhibitors on visual function-an observation potentially important in designing PDE5-specific therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwrGvfie0U1bVg90H21EOLACvtfcHk0lgvAtncXiaOCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsbs%253D&md5=7700b18905668782047be0bbdd461726</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1038%2Fsj.ijir.3901212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ijir.3901212%26sid%3Dliteratum%253Aachs%26aulast%3DCote%26aufirst%3DR.%2BH.%26atitle%3DCharacteristics%2520of%2520photoreceptor%2520PDE%2520%2528PDE6%2529%253A%2520similarities%2520and%2520differences%2520to%2520PDE5%26jtitle%3DInt.%2520J.%2520Impotence%2520Res.%26date%3D2004%26volume%3D16%26spage%3DS28%26epage%3DS33%26doi%3D10.1038%2Fsj.ijir.3901212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boolell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, S. A.</span></span> <span> </span><span class="NLM_article-title">Sildenafil, an inhibitor of phosphodiesterase type 5, enhances nitric oxide mediated relaxation of human corpus cavernosum</span>. <i>Int. J. Impotence Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=103&author=M.+Boolellauthor=M.+J.+Allenauthor=S.+A.+Ballard&title=Sildenafil%2C+an+inhibitor+of+phosphodiesterase+type+5%2C+enhances+nitric+oxide+mediated+relaxation+of+human+corpus+cavernosum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoolell%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DBallard%26aufirst%3DS.%2BA.%26atitle%3DSildenafil%252C%2520an%2520inhibitor%2520of%2520phosphodiesterase%2520type%25205%252C%2520enhances%2520nitric%2520oxide%2520mediated%2520relaxation%2520of%2520human%2520corpus%2520cavernosum%26jtitle%3DInt.%2520J.%2520Impotence%2520Res.%26date%3D1996%26volume%3D8%26spage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gamanuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuasa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, K.</span></span> <span> </span><span class="NLM_article-title">Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1016/S0898-6568(02)00146-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2FS0898-6568%2802%2900146-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=12681444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislemsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=565-574&author=M.+Gamanumaauthor=K.+Yuasaauthor=T.+Sasakiauthor=N.+Sakuraiauthor=J.+Koteraauthor=K.+Omori&title=Comparison+of+enzymatic+characterization+and+gene+organization+of+cyclic+nucleotide+phosphodiesterase+8+family+in+humans&doi=10.1016%2FS0898-6568%2802%2900146-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans</span></div><div class="casAuthors">Gamanuma, Michiko; Yuasa, Keizo; Sasaki, Takashi; Sakurai, Naoki; Kotera, Jun; Omori, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-574</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Full-length cDNAs of human cyclic nucleotide phosphodiesterase 8B (PDE8B) were isolated.  Enzymic characteristics of a dominant variant encoding a protein of 885 residues (PDE8B1) were compared with those of PDE8A1.  The recombinant PDE8A1 and PDE8B1 proteins of an entire form were produced in both cytosolic and membrane fractions of the transfected COS cells.  The human PDE8B1 was a high-affinity cAMP-PDE with Km value of 101±12 nM for cAMP, which is greater than that of PDE8A1 (40±1 nM).  Relative Vmax value of PDE8A1 was 57±8% compared with that of PDE8B1 (100±12%).  Although PDE8A1 was moderately inhibited by dipyridamole with IC50 value of 8±2 μM, the compd. antagonized the PDE8B1 activity at three-fold higher concn. (IC50=23±2 μM).  The human PDE8B gene was composed of 22 exons, spanning over 217 kb.  Although overall sequence identity between PDE8A1 and PDE8B1 was 68%, positions of junctions of each exon between the PDE8A1 and PDE8B1 sequences were well matched, indicating evolutionary relatedness of both genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp35CEEyORktrVg90H21EOLACvtfcHk0lgvAtncXiaOCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislemsbs%253D&md5=c47dd94b28601e42b6b9353401b92fe4</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2FS0898-6568%2802%2900146-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0898-6568%252802%252900146-8%26sid%3Dliteratum%253Aachs%26aulast%3DGamanuma%26aufirst%3DM.%26aulast%3DYuasa%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DN.%26aulast%3DKotera%26aufirst%3DJ.%26aulast%3DOmori%26aufirst%3DK.%26atitle%3DComparison%2520of%2520enzymatic%2520characterization%2520and%2520gene%2520organization%2520of%2520cyclic%2520nucleotide%2520phosphodiesterase%25208%2520family%2520in%2520humans%26jtitle%3DCell.%2520Signalling%26date%3D2003%26volume%3D15%26spage%3D565%26epage%3D574%26doi%3D10.1016%2FS0898-6568%2802%2900146-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu-Albergine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span> <span> </span><span class="NLM_article-title">The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">639</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1124/mol.110.069104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1124%2Fmol.110.069104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=639-648&author=L.+C.+Tsaiauthor=M.+Shimizu-Albergineauthor=J.+A.+Beavo&title=The+high-affinity+cAMP-specific+phosphodiesterase+8B+controls+steroidogenesis+in+the+mouse+adrenal+gland&doi=10.1124%2Fmol.110.069104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.069104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.069104%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DL.%2BC.%26aulast%3DShimizu-Albergine%26aufirst%3DM.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520high-affinity%2520cAMP-specific%2520phosphodiesterase%25208B%2520controls%2520steroidogenesis%2520in%2520the%2520mouse%2520adrenal%2520gland%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D639%26epage%3D648%26doi%3D10.1124%2Fmol.110.069104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu-Albergine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrucco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span> <span> </span><span class="NLM_article-title">cAMP-specific phosphodiesterases 8A and 8B, essential regulators of Leydig cell steroidogenesis</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">556</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1124/mol.111.076125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1124%2Fmol.111.076125" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=556-566&author=M.+Shimizu-Albergineauthor=L.+C.+Tsaiauthor=E.+Patruccoauthor=J.+A.+Beavo&title=cAMP-specific+phosphodiesterases+8A+and+8B%2C+essential+regulators+of+Leydig+cell+steroidogenesis&doi=10.1124%2Fmol.111.076125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1124%2Fmol.111.076125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.111.076125%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu-Albergine%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DL.%2BC.%26aulast%3DPatrucco%26aufirst%3DE.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DcAMP-specific%2520phosphodiesterases%25208A%2520and%25208B%252C%2520essential%2520regulators%2520of%2520Leydig%2520cell%2520steroidogenesis%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D81%26spage%3D556%26epage%3D566%26doi%3D10.1124%2Fmol.111.076125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vang, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Sasson, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kream, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNinno, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Housley, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brocke, S.</span></span> <span> </span><span class="NLM_article-title">PDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e12011</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0012011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1371%2Fjournal.pone.0012011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e12011&author=A.+G.+Vangauthor=S.+Z.+Ben-Sassonauthor=H.+Dongauthor=B.+Kreamauthor=M.+P.+DeNinnoauthor=M.+M.+Claffeyauthor=W.+Housleyauthor=R.+B.+Clarkauthor=P.+M.+Epsteinauthor=S.+Brocke&title=PDE8+regulates+rapid+Teff+cell+adhesion+and+proliferation+independent+of+ICER&doi=10.1371%2Fjournal.pone.0012011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0012011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0012011%26sid%3Dliteratum%253Aachs%26aulast%3DVang%26aufirst%3DA.%2BG.%26aulast%3DBen-Sasson%26aufirst%3DS.%2BZ.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DKream%26aufirst%3DB.%26aulast%3DDeNinno%26aufirst%3DM.%2BP.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DHousley%26aufirst%3DW.%26aulast%3DClark%26aufirst%3DR.%2BB.%26aulast%3DEpstein%26aufirst%3DP.%2BM.%26aulast%3DBrocke%26aufirst%3DS.%26atitle%3DPDE8%2520regulates%2520rapid%2520Teff%2520cell%2520adhesion%2520and%2520proliferation%2520independent%2520of%2520ICER%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De12011%26doi%3D10.1371%2Fjournal.pone.0012011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 47 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jiyun Sun, Zhiwei Xiao, Ahmed Haider, Catherine Gebhard, Hao Xu, Hai-Bin Luo, Han-Ting Zhang, Lee Josephson, Lu Wang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7083-7109. <a href="https://doi.org/10.1021/acs.jmedchem.1c00115" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00115%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Bin%252BCyclic%252BNucleotide%252BPhosphodiesterase-Targeted%252BPET%252BImaging%252Band%252BDrug%252BDiscovery%26aulast%3DSun%26aufirst%3DJiyun%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21012021%26date%3D27052021%26volume%3D64%26issue%3D11%26spage%3D7083%26epage%3D7109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yu Zhou, Yan Fu, Wanchao Yin, Jian Li, Wei Wang, Fang Bai, Shengtao Xu, Qi Gong, Tao Peng, Yu Hong, Dong Zhang, Dan Zhang, Qiufeng Liu, Yechun Xu, H. Eric Xu, Haiyan Zhang, Hualiang Jiang, <span class="NLM_string-name hlFld-ContribAuthor">Hong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 1844-1855. <a href="https://doi.org/10.1021/acs.jmedchem.0c01863" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01863%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinetics-Driven%252BDrug%252BDesign%252BStrategy%252Bfor%252BNext-Generation%252BAcetylcholinesterase%252BInhibitors%252Bto%252BClinical%252BCandidate%26aulast%3DZhou%26aufirst%3DYu%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D27102020%26date%3D11022021%26volume%3D64%26issue%3D4%26spage%3D1844%26epage%3D1855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gary Tresadern, Ingrid Velter, Andrés A. Trabanco, Frans Van den Keybus, Gregor J. Macdonald, Marijke V. F. Somers, Greet Vanhoof, Philip M. Leonard, Marieke B. A. C. Lamers, Yves E. M. Van Roosbroeck, <span class="NLM_string-name hlFld-ContribAuthor">Peter J. J. A. Buijnsters</span>. </span><span class="cited-content_cbyCitation_article-title">[1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2A Inhibitors: Structure and Free-Energy Perturbation-Guided Exploration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12887-12910. <a href="https://doi.org/10.1021/acs.jmedchem.0c01272" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01272%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%25255B1%25252C2%25252C4%25255DTriazolo%25255B1%25252C5-a%25255Dpyrimidine%252BPhosphodiesterase%252B2A%252BInhibitors%25253A%252BStructure%252Band%252BFree-Energy%252BPerturbation-Guided%252BExploration%26aulast%3DTresadern%26aufirst%3DGary%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21072020%26date%3D27102020%26volume%3D63%26issue%3D21%26spage%3D12887%26epage%3D12910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anish K. Vadukoot, Swagat Sharma, Christopher D. Aretz, Sushil Kumar, Nagsen Gautam, Yazen Alnouti, Amy L. Aldrich, Cortney E. Heim, Tammy Kielian, <span class="NLM_string-name hlFld-ContribAuthor">Corey R. Hopkins</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR Studies of 1H-Pyrrolo[2,3-b]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1848-1854. <a href="https://doi.org/10.1021/acsmedchemlett.9b00369" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00369%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252BStudies%252Bof%252B1H-Pyrrolo%25255B2%25252C3-b%25255Dpyridine-2-carboxamides%252Bas%252BPhosphodiesterase%252B4B%252B%252528PDE4B%252529%252BInhibitors%26aulast%3DVadukoot%26aufirst%3DAnish%2BK.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D08082019%26date%3D24012020%26date%3D03022020%26date%3D24012020%26volume%3D11%26issue%3D10%26spage%3D1848%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Giovanni Ribaudo, Alberto Ongaro, Giuseppe Zagotto, Maurizio Memo, <span class="NLM_string-name hlFld-ContribAuthor">Alessandra Gianoncelli</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 1726-1739. <a href="https://doi.org/10.1021/acschemneuro.0c00244" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00244%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DTherapeutic%252BPotential%252Bof%252BPhosphodiesterase%252BInhibitors%252Bagainst%252BNeurodegeneration%25253A%252BThe%252BPerspective%252Bof%252Bthe%252BMedicinal%252BChemist%26aulast%3DRibaudo%26aufirst%3DGiovanni%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24042020%26date%3D13052020%26date%3D28052020%26date%3D13052020%26volume%3D11%26issue%3D12%26spage%3D1726%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinhao Liang, Yi-You Huang, Qian Zhou, Yuqi Gao, Zhe Li, Deyan Wu, Si Yu, Lei Guo, Zhen Chen, Ling Huang, Steven H. Liang, Xixin He, Ruibo Wu, <span class="NLM_string-name hlFld-ContribAuthor">Hai-Bin Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of α-Mangostin Derivatives as Novel PDE4 Inhibitors for the Treatment of Vascular Dementia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 3370-3380. <a href="https://doi.org/10.1021/acs.jmedchem.0c00060" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00060%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252B%2525CE%2525B1-Mangostin%252BDerivatives%252Bas%252BNovel%252BPDE4%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BVascular%252BDementia%26aulast%3DLiang%26aufirst%3DJinhao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D13012020%26date%3D12032020%26date%3D02032020%26volume%3D63%26issue%3D6%26spage%3D3370%26epage%3D3380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiren Wang, Mengru Cao, Hongling Xiang, Wei Wang, Xing Feng, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoping Yang</span>. </span><span class="cited-content_cbyCitation_article-title">WBQ5187, a Multitarget Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease and Modulates Cerebral β-Amyloid, Gliosis, cAMP Levels, and Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (12)
                                     , 4787-4799. <a href="https://doi.org/10.1021/acschemneuro.9b00409" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00409%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DWBQ5187%25252C%252Ba%252BMultitarget%252BDirected%252BAgent%25252C%252BAmeliorates%252BCognitive%252BImpairment%252Bin%252Ba%252BTransgenic%252BMouse%252BModel%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BModulates%252BCerebral%252B%2525CE%2525B2-Amyloid%25252C%252BGliosis%25252C%252BcAMP%252BLevels%25252C%252Band%252BNeurodegeneration%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20072019%26date%3D07112019%26date%3D20112019%26date%3D07112019%26volume%3D10%26issue%3D12%26spage%3D4787%26epage%3D4799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Obdulia Rabal, Juan A. Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García-Barroso, Ana Ugarte, Ander Estella-Hermoso de Mendoza, Elena Sáez, Maria Espelosin, Susana Ursua, Haizhong Tan, Wei Wu, Musheng Xu, Antonio Pineda-Lucena, Ana Garcia-Osta, <span class="NLM_string-name hlFld-ContribAuthor">Julen Oyarzabal</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Approach for the Treatment of Alzheimer’s Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 4076-4101. <a href="https://doi.org/10.1021/acschemneuro.9b00303" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00303%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DMultitarget%252BApproach%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BInhibition%252Bof%252BPhosphodiesterase%252B9%252B%252528PDE9%252529%252Band%252BHistone%252BDeacetylases%252B%252528HDACs%252529%252BCovering%252BDiverse%252BSelectivity%252BProfiles%26aulast%3DRabal%26aufirst%3DObdulia%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24052019%26date%3D23082019%26date%3D04092019%26date%3D23082019%26volume%3D10%26issue%3D9%26spage%3D4076%26epage%3D4101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yinuo Wu, Qian Zhou, Tianhua Zhang, Zhe Li, Yi-Ping Chen, Pei Zhang, Yan-Fa Yu, Haiju Geng, Yi-Jing Tian, Chen Zhang, Yu Wang, Jian-Wen Chen, Yan Chen, <span class="NLM_string-name hlFld-ContribAuthor">Hai-Bin Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 4218-4224. <a href="https://doi.org/10.1021/acs.jmedchem.8b01041" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01041%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BInhibitors%252Bagainst%252BPhosphodiesterase-9%25252C%252Ba%252BNovel%252BTarget%252Bfor%252Bthe%252BTreatment%252Bof%252BVascular%252BDementia%26aulast%3DWu%26aufirst%3DYinuo%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D30062018%26date%3D03042019%26date%3D27032019%26volume%3D62%26issue%3D8%26spage%3D4218%26epage%3D4224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shawn J. Stachel, Richard Berger, Ashley B. Nomland, Anthony T. Ginnetti, Daniel V. Paone, Deping Wang, Vanita Puri, Henry Lange, Jason Drott, Jun Lu, Jacob Marcus, Michael P. Dwyer, Sokreine Suon, Jason M. Uslaner, <span class="NLM_string-name hlFld-ContribAuthor">Sean M. Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Design and Procognitive Assessment of a Potent and Selective Phosphodiesterase 2A Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (8)
                                     , 815-820. <a href="https://doi.org/10.1021/acsmedchemlett.8b00214" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00214%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-Guided%252BDesign%252Band%252BProcognitive%252BAssessment%252Bof%252Ba%252BPotent%252Band%252BSelective%252BPhosphodiesterase%252B2A%252BInhibitor%26aulast%3DStachel%26aufirst%3DShawn%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09052018%26date%3D26072018%26date%3D30072018%26date%3D26072018%26volume%3D9%26issue%3D8%26spage%3D815%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei-Yan  Jiang</span>, <span class="hlFld-ContribAuthor ">Chuan  Han</span>, <span class="hlFld-ContribAuthor ">Chen  Zhang</span>, <span class="hlFld-ContribAuthor ">Qian  Zhou</span>, <span class="hlFld-ContribAuthor ">Bei  Zhang</span>, <span class="hlFld-ContribAuthor ">Mei-Ling  Le</span>, <span class="hlFld-ContribAuthor ">Meng-Xing  Huang</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of effective phosphodiesterase 2 inhibitors with antioxidant activities for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>41 </em>, 128016. <a href="https://doi.org/10.1016/j.bmcl.2021.128016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Beffective%252Bphosphodiesterase%252B2%252Binhibitors%252Bwith%252Bantioxidant%252Bactivities%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DJiang%26aufirst%3DMei-Yan%26date%3D2021%26volume%3D41%26spage%3D128016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helmi  Helmi</span>, <span class="hlFld-ContribAuthor ">Nanang  Fakhrudin</span>, <span class="hlFld-ContribAuthor ">Arief  Nurrochmad</span>, <span class="hlFld-ContribAuthor ">Zullies  Ikawati</span>. </span><span class="cited-content_cbyCitation_article-title">Caesalpinia sappan L. Ameliorates Scopolamine-Induced Memory Deficits in Mice via the cAMP/PKA/CREB/BDNF Pathway. </span><span class="cited-content_cbyCitation_journal-name">Scientia Pharmaceutica</span><span> <strong>2021,</strong> <em>89 </em>
                                    (2)
                                     , 29. <a href="https://doi.org/10.3390/scipharm89020029" title="DOI URL">https://doi.org/10.3390/scipharm89020029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/scipharm89020029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fscipharm89020029%26sid%3Dliteratum%253Aachs%26jtitle%3DScientia%2520Pharmaceutica%26atitle%3DCaesalpinia%252Bsappan%252BL.%252BAmeliorates%252BScopolamine-Induced%252BMemory%252BDeficits%252Bin%252BMice%252Bvia%252Bthe%252BcAMP%25252FPKA%25252FCREB%25252FBDNF%252BPathway%26aulast%3DHelmi%26aufirst%3DHelmi%26date%3D2021%26date%3D2021%26volume%3D89%26issue%3D2%26spage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uzma  Saleem</span>, <span class="hlFld-ContribAuthor ">Sundas  Hira</span>, <span class="hlFld-ContribAuthor ">Fareeha  Anwar</span>, <span class="hlFld-ContribAuthor ">Muhammad Ajmal  Shah</span>, <span class="hlFld-ContribAuthor ">Samia  Bashir</span>, <span class="hlFld-ContribAuthor ">Roua S.  Baty</span>, <span class="hlFld-ContribAuthor ">Reem H.  Badr</span>, <span class="hlFld-ContribAuthor ">Renald  Blundell</span>, <span class="hlFld-ContribAuthor ">Gaber El-Saber  Batiha</span>, <span class="hlFld-ContribAuthor ">Bashir  Ahmad</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Screening of Viola odorata L. for Memory-Enhancing Effect via Modulation of Oxidative Stress and Inflammatory Biomarkers. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphar.2021.664832" title="DOI URL">https://doi.org/10.3389/fphar.2021.664832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2021.664832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2021.664832%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DPharmacological%252BScreening%252Bof%252BViola%252Bodorata%252BL.%252Bfor%252BMemory-Enhancing%252BEffect%252Bvia%252BModulation%252Bof%252BOxidative%252BStress%252Band%252BInflammatory%252BBiomarkers%26aulast%3DSaleem%26aufirst%3DUzma%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhou</span>, <span class="hlFld-ContribAuthor ">Jinjian  Li</span>, <span class="hlFld-ContribAuthor ">Han  Yuan</span>, <span class="hlFld-ContribAuthor ">Rui  Su</span>, <span class="hlFld-ContribAuthor ">Yue  Huang</span>, <span class="hlFld-ContribAuthor ">Yiyou  Huang</span>, <span class="hlFld-ContribAuthor ">Zhe  Li</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Haibin  Luo</span>, <span class="hlFld-ContribAuthor ">Chen  Zhang</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Dihydropyranopyrazole Derivatives as Novel PDE2 Inhibitors for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (10)
                                     , 3034. <a href="https://doi.org/10.3390/molecules26103034" title="DOI URL">https://doi.org/10.3390/molecules26103034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26103034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26103034%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BDihydropyranopyrazole%252BDerivatives%252Bas%252BNovel%252BPDE2%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DZhou%26aufirst%3DYan%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D10%26spage%3D3034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Hayes</span>, <span class="hlFld-ContribAuthor ">Bettina  Laursen</span>, <span class="hlFld-ContribAuthor ">Elin  Eneberg</span>, <span class="hlFld-ContribAuthor ">Jan  Kehler</span>, <span class="hlFld-ContribAuthor ">Lars Kyhn  Rasmussen</span>, <span class="hlFld-ContribAuthor ">Morten  Langgard</span>, <span class="hlFld-ContribAuthor ">Jesper F.  Bastlund</span>, <span class="hlFld-ContribAuthor ">Todor V.  Gerdjikov</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase type 1 inhibition alters medial prefrontal cortical activity during goal-driven behaviour and partially reverses neurophysiological deficits in the rat phencyclidine model of schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2021,</strong> <em>186 </em>, 108454. <a href="https://doi.org/10.1016/j.neuropharm.2021.108454" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2021.108454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2021.108454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2021.108454%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DPhosphodiesterase%252Btype%252B1%252Binhibition%252Balters%252Bmedial%252Bprefrontal%252Bcortical%252Bactivity%252Bduring%252Bgoal-driven%252Bbehaviour%252Band%252Bpartially%252Breverses%252Bneurophysiological%252Bdeficits%252Bin%252Bthe%252Brat%252Bphencyclidine%252Bmodel%252Bof%252Bschizophrenia%26aulast%3DHayes%26aufirst%3DJessica%26date%3D2021%26volume%3D186%26spage%3D108454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronika  Furlan</span>, <span class="hlFld-ContribAuthor ">Urban  Bren</span>. </span><span class="cited-content_cbyCitation_article-title">Insight into Inhibitory Mechanism of PDE4D by Dietary Polyphenols Using Molecular Dynamics Simulations and Free Energy Calculations. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 479. <a href="https://doi.org/10.3390/biom11030479" title="DOI URL">https://doi.org/10.3390/biom11030479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11030479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11030479%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DInsight%252Binto%252BInhibitory%252BMechanism%252Bof%252BPDE4D%252Bby%252BDietary%252BPolyphenols%252BUsing%252BMolecular%252BDynamics%252BSimulations%252Band%252BFree%252BEnergy%252BCalculations%26aulast%3DFurlan%26aufirst%3DVeronika%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Licheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Ximeng  Shi</span>, <span class="hlFld-ContribAuthor ">Huanhuan  Yin</span>, <span class="hlFld-ContribAuthor ">Yi  Huang</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Nobiletin Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (4)
                                     , 569-575. <a href="https://doi.org/10.1002/slct.202004239" title="DOI URL">https://doi.org/10.1002/slct.202004239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202004239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202004239%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNobiletin%252BDerivatives%252Bas%252BMultifunctional%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%252527s%252BDisease%26aulast%3DZhou%26aufirst%3DLicheng%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D4%26spage%3D569%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seungyoon  Kang</span>, <span class="hlFld-ContribAuthor ">Byoung Yong  Park</span>, <span class="hlFld-ContribAuthor ">Suji  Lee</span>, <span class="hlFld-ContribAuthor ">Namgeol  Lee</span>, <span class="hlFld-ContribAuthor ">Min Su  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Colorimetric discrimination of nucleoside phosphates based on catalytic signal amplification strategy and its application to related enzyme assays. </span><span class="cited-content_cbyCitation_journal-name">The Analyst</span><span> <strong>2021,</strong> <em>146 </em>
                                    (2)
                                     , 463-470. <a href="https://doi.org/10.1039/D0AN01918F" title="DOI URL">https://doi.org/10.1039/D0AN01918F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0AN01918F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0AN01918F%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Analyst%26atitle%3DColorimetric%252Bdiscrimination%252Bof%252Bnucleoside%252Bphosphates%252Bbased%252Bon%252Bcatalytic%252Bsignal%252Bamplification%252Bstrategy%252Band%252Bits%252Bapplication%252Bto%252Brelated%252Benzyme%252Bassays%26aulast%3DKang%26aufirst%3DSeungyoon%26date%3D2021%26date%3D2021%26volume%3D146%26issue%3D2%26spage%3D463%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maarten  Ooms</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>. </span><span class="cited-content_cbyCitation_article-title">PET Imaging of Phosphodiesterases in Brain. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 851-877. <a href="https://doi.org/10.1007/978-3-030-53176-8_23" title="DOI URL">https://doi.org/10.1007/978-3-030-53176-8_23</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53176-8_23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53176-8_23%26sid%3Dliteratum%253Aachs%26atitle%3DPET%252BImaging%252Bof%252BPhosphodiesterases%252Bin%252BBrain%26aulast%3DOoms%26aufirst%3DMaarten%26date%3D2021%26date%3D2020%26spage%3D851%26epage%3D877%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%252Band%252BSPECT%252Bof%252BNeurobiological%252BSystems%26aulast%3DDierckx%26aufirst%3DRudi%2BA.J.O.%26date%3D2021%26volume%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Fang-fang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Hua-rong  Fu</span>, <span class="hlFld-ContribAuthor ">Xiao-dan  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao-yan  Xu</span>, <span class="hlFld-ContribAuthor ">Yong-feng  Gao</span>, <span class="hlFld-ContribAuthor ">Ji-guo  Zhang</span>, <span class="hlFld-ContribAuthor ">Han-Ting  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer’s Disease: A Preclinical Study in APP/PS1 Transgenic Mice. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Neuropsychopharmacology</span><span> <strong>2020,</strong> <em>23 </em>
                                    (10)
                                     , 700-711. <a href="https://doi.org/10.1093/ijnp/pyaa048" title="DOI URL">https://doi.org/10.1093/ijnp/pyaa048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/ijnp/pyaa048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fijnp%2Fpyaa048%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Neuropsychopharmacology%26atitle%3DThe%252BPhosphodiesterase-4%252BInhibitor%252BRoflumilast%25252C%252Ba%252BPotential%252BTreatment%252Bfor%252Bthe%252BComorbidity%252Bof%252BMemory%252BLoss%252Band%252BDepression%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BA%252BPreclinical%252BStudy%252Bin%252BAPP%25252FPS1%252BTransgenic%252BMice%26aulast%3DWang%26aufirst%3DHao%26date%3D2020%26date%3D2020%26volume%3D23%26issue%3D10%26spage%3D700%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mayasah Y.  Al-Nema</span>, <span class="hlFld-ContribAuthor ">Anand  Gaurav</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase as a Target for Cognition Enhancement in Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (26)
                                     , 2404-2421. <a href="https://doi.org/10.2174/1568026620666200613202641" title="DOI URL">https://doi.org/10.2174/1568026620666200613202641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200613202641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200613202641%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DPhosphodiesterase%252Bas%252Ba%252BTarget%252Bfor%252BCognition%252BEnhancement%252Bin%252BSchizophrenia%26aulast%3DAl-Nema%26aufirst%3DMayasah%2BY.%26date%3D2020%26volume%3D20%26issue%3D26%26spage%3D2404%26epage%3D2421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiansong  Fang</span>, <span class="hlFld-ContribAuthor ">Andrew A.  Pieper</span>, <span class="hlFld-ContribAuthor ">Ruth  Nussinov</span>, <span class="hlFld-ContribAuthor ">Garam  Lee</span>, <span class="hlFld-ContribAuthor ">Lynn  Bekris</span>, <span class="hlFld-ContribAuthor ">James B.  Leverenz</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Cummings</span>, <span class="hlFld-ContribAuthor ">Feixiong  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (6)
                                     , 2386-2426. <a href="https://doi.org/10.1002/med.21709" title="DOI URL">https://doi.org/10.1002/med.21709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21709%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DHarnessing%252Bendophenotypes%252Band%252Bnetwork%252Bmedicine%252Bfor%252BAlzheimer%252527s%252Bdrug%252Brepurposing%26aulast%3DFang%26aufirst%3DJiansong%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D6%26spage%3D2386%26epage%3D2426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek K.  Sharma</span>, <span class="hlFld-ContribAuthor ">Thakur G.  Singh</span>, <span class="hlFld-ContribAuthor ">Shareen  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclic Nucleotides Signaling and Phosphodiesterase Inhibition: Defying Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Targets</span><span> <strong>2020,</strong> <em>21 </em>
                                    (13)
                                     , 1371-1384. <a href="https://doi.org/10.2174/1389450121666200727104728" title="DOI URL">https://doi.org/10.2174/1389450121666200727104728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389450121666200727104728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389450121666200727104728%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Targets%26atitle%3DCyclic%252BNucleotides%252BSignaling%252Band%252BPhosphodiesterase%252BInhibition%25253A%252BDefying%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DSharma%26aufirst%3DVivek%2BK.%26date%3D2020%26volume%3D21%26issue%3D13%26spage%3D1371%26epage%3D1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pankaj  Bhatia</span>, <span class="hlFld-ContribAuthor ">Nirmal  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Tadalafil ameliorates memory deficits, oxidative stress, endothelial dysfunction and neuropathological changes in rat model of hyperhomocysteinemia induced vascular dementia. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Neuroscience</span><span> <strong>2020,</strong> <em>9 </em>, 1-13. <a href="https://doi.org/10.1080/00207454.2020.1817009" title="DOI URL">https://doi.org/10.1080/00207454.2020.1817009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00207454.2020.1817009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00207454.2020.1817009%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Neuroscience%26atitle%3DTadalafil%252Bameliorates%252Bmemory%252Bdeficits%25252C%252Boxidative%252Bstress%25252C%252Bendothelial%252Bdysfunction%252Band%252Bneuropathological%252Bchanges%252Bin%252Brat%252Bmodel%252Bof%252Bhyperhomocysteinemia%252Binduced%252Bvascular%252Bdementia%26aulast%3DBhatia%26aufirst%3DPankaj%26date%3D2020%26date%3D2020%26volume%3D9%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Graeme B.  Bolger</span>, <span class="hlFld-ContribAuthor ">Lisa High Mitchell  Smoot</span>, <span class="hlFld-ContribAuthor ">Thomas  van Groen</span>. </span><span class="cited-content_cbyCitation_article-title">Dominant-Negative Attenuation of cAMP-Selective Phosphodiesterase PDE4D Action Affects Learning and Behavior. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (16)
                                     , 5704. <a href="https://doi.org/10.3390/ijms21165704" title="DOI URL">https://doi.org/10.3390/ijms21165704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21165704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21165704%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDominant-Negative%252BAttenuation%252Bof%252BcAMP-Selective%252BPhosphodiesterase%252BPDE4D%252BAction%252BAffects%252BLearning%252Band%252BBehavior%26aulast%3DBolger%26aufirst%3DGraeme%2BB.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D16%26spage%3D5704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Zagórska</span>, <span class="hlFld-ContribAuthor ">Anna  Jaromin</span>. </span><span class="cited-content_cbyCitation_article-title">Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (15)
                                     , 3337. <a href="https://doi.org/10.3390/molecules25153337" title="DOI URL">https://doi.org/10.3390/molecules25153337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25153337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25153337%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPerspectives%252Bfor%252BNew%252Band%252BMore%252BEfficient%252BMultifunctional%252BLigands%252Bfor%252BAlzheimer%2525E2%252580%2525B2s%252BDisease%252BTherapy%26aulast%3DZag%25C3%25B3rska%26aufirst%3DAgnieszka%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D15%26spage%3D3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei  Zhang</span>, <span class="hlFld-ContribAuthor ">Mei-Yan  Jiang</span>, <span class="hlFld-ContribAuthor ">Mei-Ling  Le</span>, <span class="hlFld-ContribAuthor ">Bei  Zhang</span>, <span class="hlFld-ContribAuthor ">Qian  Zhou</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Chen  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of pyrazolopyrimidinone derivatives as novel PDE9A inhibitors for treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (14)
                                     , 127254. <a href="https://doi.org/10.1016/j.bmcl.2020.127254" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127254%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bpyrazolopyrimidinone%252Bderivatives%252Bas%252Bnovel%252BPDE9A%252Binhibitors%252Bfor%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhang%26aufirst%3DPei%26date%3D2020%26volume%3D30%26issue%3D14%26spage%3D127254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nurul  Husna Ibrahim</span>, <span class="hlFld-ContribAuthor ">Mohamad Fairuz  Yahaya</span>, <span class="hlFld-ContribAuthor ">Wael  Mohamed</span>, <span class="hlFld-ContribAuthor ">Seong Lin  Teoh</span>, <span class="hlFld-ContribAuthor ">Chua Kien  Hui</span>, <span class="hlFld-ContribAuthor ">Jaya  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00261" title="DOI URL">https://doi.org/10.3389/fphar.2020.00261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00261%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DPharmacotherapy%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BSeeking%252BClarity%252Bin%252Ba%252BTime%252Bof%252BUncertainty%26aulast%3DHusna%2BIbrahim%26aufirst%3DNurul%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cai-Hong  Li</span>, <span class="hlFld-ContribAuthor ">Jun-Li  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Wolfberry extracts inhibit Aβ1-42 aggregation and rescue memory loss of AD drosophila. </span><span class="cited-content_cbyCitation_journal-name">Food Science and Human Wellness</span><span> <strong>2020,</strong> <em>9 </em>
                                    (1)
                                     , 64-70. <a href="https://doi.org/10.1016/j.fshw.2019.12.007" title="DOI URL">https://doi.org/10.1016/j.fshw.2019.12.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fshw.2019.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fshw.2019.12.007%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Science%2520and%2520Human%2520Wellness%26atitle%3DWolfberry%252Bextracts%252Binhibit%252BA%2525CE%2525B21-42%252Baggregation%252Band%252Brescue%252Bmemory%252Bloss%252Bof%252BAD%252Bdrosophila%26aulast%3DLi%26aufirst%3DCai-Hong%26date%3D2020%26volume%3D9%26issue%3D1%26spage%3D64%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gui-Xiang  Yang</span>, <span class="hlFld-ContribAuthor ">Yan  Huang</span>, <span class="hlFld-ContribAuthor ">Lu-Lu  Zheng</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Lin  Su</span>, <span class="hlFld-ContribAuthor ">Yu-Hang  Wu</span>, <span class="hlFld-ContribAuthor ">Jie  Li</span>, <span class="hlFld-ContribAuthor ">Li-Cheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Jin  Huang</span>, <span class="hlFld-ContribAuthor ">Yun  Tang</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of diosgenin carbamate derivatives as multitarget anti-Alzheimer’s disease agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111913. <a href="https://doi.org/10.1016/j.ejmech.2019.111913" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111913%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bdiosgenin%252Bcarbamate%252Bderivatives%252Bas%252Bmultitarget%252Banti-Alzheimer%2525E2%252580%252599s%252Bdisease%252Bagents%26aulast%3DYang%26aufirst%3DGui-Xiang%26date%3D2020%26volume%3D187%26spage%3D111913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Bibliography. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 137-248. <a href="https://doi.org/10.1016/B978-0-12-812212-9.16001-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-812212-9.16001-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-812212-9.16001-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-812212-9.16001-4%26sid%3Dliteratum%253Aachs%26atitle%3DBibliography%26date%3D2020%26spage%3D137%26epage%3D248%26pub%3DElsevier%26atitle%3DBiological%252BChirality%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Li</span>, <span class="hlFld-ContribAuthor ">Shuaishuai  Xing</span>, <span class="hlFld-ContribAuthor ">Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Qinghong  Liao</span>, <span class="hlFld-ContribAuthor ">Qihang  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Siyu  He</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Qinglong  Guo</span>, <span class="hlFld-ContribAuthor ">Yuan  Sun</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111862. <a href="https://doi.org/10.1016/j.ejmech.2019.111862" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111862%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DReasonably%252Bactivating%252BNrf2%25253A%252BA%252Blong-term%25252C%252Beffective%252Band%252Bcontrollable%252Bstrategy%252Bfor%252Bneurodegenerative%252Bdiseases%26aulast%3DLi%26aufirst%3DQi%26date%3D2020%26volume%3D185%26spage%3D111862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriela Dumitrita  Stanciu</span>, <span class="hlFld-ContribAuthor ">Andrei  Luca</span>, <span class="hlFld-ContribAuthor ">Razvan Nicolae  Rusu</span>, <span class="hlFld-ContribAuthor ">Veronica  Bild</span>, <span class="hlFld-ContribAuthor ">Sorin Ioan  Beschea Chiriac</span>, <span class="hlFld-ContribAuthor ">Carmen  Solcan</span>, <span class="hlFld-ContribAuthor ">Walther  Bild</span>, <span class="hlFld-ContribAuthor ">Daniela Carmen  Ababei</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     , 40. <a href="https://doi.org/10.3390/biom10010040" title="DOI URL">https://doi.org/10.3390/biom10010040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10010040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10010040%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%252BPharmacotherapy%252Bin%252BRelation%252Bto%252BCholinergic%252BSystem%252BInvolvement%26aulast%3DStanciu%26aufirst%3DGabriela%2BDumitrita%26date%3D2020%26date%3D2019%26volume%3D10%26issue%3D1%26spage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bessi  Qorri</span>, <span class="hlFld-ContribAuthor ">Mike  Tsay</span>, <span class="hlFld-ContribAuthor ">Abhishek  Agrawal</span>, <span class="hlFld-ContribAuthor ">Rhoda  Au</span>, <span class="hlFld-ContribAuthor ">Joseph  Gracie</span>. </span><span class="cited-content_cbyCitation_article-title">Using machine intelligence to uncover Alzheimer’s disease progression heterogeneity. </span><span class="cited-content_cbyCitation_journal-name">Exploration of Medicine</span><span> <strong>2020,</strong> <em>1 </em>
                                    (6)
                                     <a href="https://doi.org/10.37349/emed.2020.00026" title="DOI URL">https://doi.org/10.37349/emed.2020.00026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.37349/emed.2020.00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.37349%2Femed.2020.00026%26sid%3Dliteratum%253Aachs%26jtitle%3DExploration%2520of%2520Medicine%26atitle%3DUsing%252Bmachine%252Bintelligence%252Bto%252Buncover%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bprogression%252Bheterogeneity%26aulast%3DQorri%26aufirst%3DBessi%26date%3D2020%26date%3D2020%26volume%3D1%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seyed Mohammad  Nabavi</span>, <span class="hlFld-ContribAuthor ">Sylwia  Talarek</span>, <span class="hlFld-ContribAuthor ">Joanna  Listos</span>, <span class="hlFld-ContribAuthor ">Seyed Fazel  Nabavi</span>, <span class="hlFld-ContribAuthor ">Kasi Pandima  Devi</span>, <span class="hlFld-ContribAuthor ">Marcos  Roberto de Oliveira</span>, <span class="hlFld-ContribAuthor ">Devesh  Tewari</span>, <span class="hlFld-ContribAuthor ">Sandro  Argüelles</span>, <span class="hlFld-ContribAuthor ">Saeed  Mehrzadi</span>, <span class="hlFld-ContribAuthor ">Azam  Hosseinzadeh</span>, <span class="hlFld-ContribAuthor ">Grazia  D'onofrio</span>, <span class="hlFld-ContribAuthor ">Ilkay Erdogan  Orhan</span>, <span class="hlFld-ContribAuthor ">Antoni  Sureda</span>, <span class="hlFld-ContribAuthor ">Suowen  Xu</span>, <span class="hlFld-ContribAuthor ">Saeedeh  Momtaz</span>, <span class="hlFld-ContribAuthor ">Mohammad Hosein  Farzaei</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase inhibitors say NO to Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Food and Chemical Toxicology</span><span> <strong>2019,</strong> <em>134 </em>, 110822. <a href="https://doi.org/10.1016/j.fct.2019.110822" title="DOI URL">https://doi.org/10.1016/j.fct.2019.110822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fct.2019.110822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fct.2019.110822%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520and%2520Chemical%2520Toxicology%26atitle%3DPhosphodiesterase%252Binhibitors%252Bsay%252BNO%252Bto%252BAlzheimer%252527s%252Bdisease%26aulast%3DNabavi%26aufirst%3DSeyed%2BMohammad%26date%3D2019%26volume%3D134%26spage%3D110822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhou</span>, <span class="hlFld-ContribAuthor ">Lu</span>, <span class="hlFld-ContribAuthor ">Yang</span>, <span class="hlFld-ContribAuthor ">Chen</span>, <span class="hlFld-ContribAuthor ">Wang</span>, <span class="hlFld-ContribAuthor ">Li</span>, <span class="hlFld-ContribAuthor ">Tang</span>, <span class="hlFld-ContribAuthor ">Cheng</span>, <span class="hlFld-ContribAuthor ">Yang</span>, <span class="hlFld-ContribAuthor ">Xu</span>, <span class="hlFld-ContribAuthor ">Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (23)
                                     , 4217. <a href="https://doi.org/10.3390/molecules24234217" title="DOI URL">https://doi.org/10.3390/molecules24234217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24234217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24234217%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252BSelective%252BButyrylcholinesterase%252B%252528BChE%252529%252BInhibitors%252Bthrough%252Ba%252BCombination%252Bof%252BComputational%252BStudies%252Band%252BBiological%252BEvaluations%26aulast%3DZhou%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D23%26spage%3D4217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ritawidya</span>, <span class="hlFld-ContribAuthor ">Wenzel</span>, <span class="hlFld-ContribAuthor ">Teodoro</span>, <span class="hlFld-ContribAuthor ">Toussaint</span>, <span class="hlFld-ContribAuthor ">Kranz</span>, <span class="hlFld-ContribAuthor ">Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Dukic-Stefanovic</span>, <span class="hlFld-ContribAuthor ">Ludwig</span>, <span class="hlFld-ContribAuthor ">Scheunemann</span>, <span class="hlFld-ContribAuthor ">Brust</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (22)
                                     , 4149. <a href="https://doi.org/10.3390/molecules24224149" title="DOI URL">https://doi.org/10.3390/molecules24224149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24224149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24224149%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRadiosynthesis%252Band%252BBiological%252BInvestigation%252Bof%252Ba%252BNovel%252BFluorine-18%252BLabeled%252BBenzoimidazotriazine-%252BBased%252BRadioligand%252Bfor%252Bthe%252BImaging%252Bof%252BPhosphodiesterase%252B2A%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DRitawidya%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D22%26spage%3D4149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cai-Hong  Li</span>, <span class="hlFld-ContribAuthor ">Xian-Hua  Meng</span>, <span class="hlFld-ContribAuthor ">Dang  Lan Huong</span>, <span class="hlFld-ContribAuthor ">Won Keun  Oh</span>, <span class="hlFld-ContribAuthor ">Wei-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Jun-Li  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative visualization and detection of acetylcholinesterase activity and its inhibitor based on the oxidation character of ultrathin MnO
              2
              nanosheets. </span><span class="cited-content_cbyCitation_journal-name">Analytical Methods</span><span> <strong>2019,</strong> <em>11 </em>
                                    (38)
                                     , 4931-4938. <a href="https://doi.org/10.1039/C9AY01721F" title="DOI URL">https://doi.org/10.1039/C9AY01721F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9AY01721F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9AY01721F%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Methods%26atitle%3DQuantitative%252Bvisualization%252Band%252Bdetection%252Bof%252Bacetylcholinesterase%252Bactivity%252Band%252Bits%252Binhibitor%252Bbased%252Bon%252Bthe%252Boxidation%252Bcharacter%252Bof%252Bultrathin%252BMnO%252B2%252Bnanosheets%26aulast%3DLi%26aufirst%3DCai-Hong%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D38%26spage%3D4931%26epage%3D4938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingfei  Wu</span>, <span class="hlFld-ContribAuthor ">Jie  Ma</span>, <span class="hlFld-ContribAuthor ">Lijun  Ji</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Jianfei  Han</span>, <span class="hlFld-ContribAuthor ">Zeng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>177 </em>, 198-211. <a href="https://doi.org/10.1016/j.ejmech.2019.05.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Brutacecarpine%252Bderivatives%252Bas%252Bmultitarget-directed%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DWu%26aufirst%3DMingfei%26date%3D2019%26volume%3D177%26spage%3D198%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bahare  Salehi</span>, <span class="hlFld-ContribAuthor ">Yakup  Berkay Yılmaz</span>, <span class="hlFld-ContribAuthor ">Gizem  Antika</span>, <span class="hlFld-ContribAuthor ">Tugba  Boyunegmez Tumer</span>, <span class="hlFld-ContribAuthor ">Mohamad  Fawzi Mahomoodally</span>, <span class="hlFld-ContribAuthor ">Devina  Lobine</span>, <span class="hlFld-ContribAuthor ">Muhammad  Akram</span>, <span class="hlFld-ContribAuthor ">Muhammad  Riaz</span>, <span class="hlFld-ContribAuthor ">Esra  Capanoglu</span>, <span class="hlFld-ContribAuthor ">Farukh  Sharopov</span>, <span class="hlFld-ContribAuthor ">Natália  Martins</span>, <span class="hlFld-ContribAuthor ">William  C. Cho</span>, <span class="hlFld-ContribAuthor ">Javad  Sharifi-Rad</span>. </span><span class="cited-content_cbyCitation_article-title">Insights on the Use of α-Lipoic Acid for Therapeutic Purposes. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (8)
                                     , 356. <a href="https://doi.org/10.3390/biom9080356" title="DOI URL">https://doi.org/10.3390/biom9080356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9080356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9080356%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DInsights%252Bon%252Bthe%252BUse%252Bof%252B%2525CE%2525B1-Lipoic%252BAcid%252Bfor%252BTherapeutic%252BPurposes%26aulast%3DSalehi%26aufirst%3DBahare%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D8%26spage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lv  Tang</span>, <span class="hlFld-ContribAuthor ">Chang  Huang</span>, <span class="hlFld-ContribAuthor ">Jiahong  Zhong</span>, <span class="hlFld-ContribAuthor ">JiaPeng  He</span>, <span class="hlFld-ContribAuthor ">Jiayin  Guo</span>, <span class="hlFld-ContribAuthor ">Menghua  Liu</span>, <span class="hlFld-ContribAuthor ">Jiang-Ping  Xu</span>, <span class="hlFld-ContribAuthor ">Hai-Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhen  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of arylbenzylamines as PDE4 inhibitors with potential neuroprotective effect. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>168 </em>, 221-231. <a href="https://doi.org/10.1016/j.ejmech.2019.02.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Barylbenzylamines%252Bas%252BPDE4%252Binhibitors%252Bwith%252Bpotential%252Bneuroprotective%252Beffect%26aulast%3DTang%26aufirst%3DLv%26date%3D2019%26volume%3D168%26spage%3D221%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  An</span>, <span class="hlFld-ContribAuthor ">YingLi  Li</span>, <span class="hlFld-ContribAuthor ">ShuangNing  Song</span>, <span class="hlFld-ContribAuthor ">Shi  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Electroacupuncture promotes the gastrointestinal motility of diabetic mice by CNP/NPR‐B‐cGMP and PDE3A‐cGMP signaling. </span><span class="cited-content_cbyCitation_journal-name">Neurogastroenterology & Motility</span><span> <strong>2019,</strong> <em>31 </em>
                                    (4)
                                     , e13539. <a href="https://doi.org/10.1111/nmo.13539" title="DOI URL">https://doi.org/10.1111/nmo.13539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/nmo.13539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fnmo.13539%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurogastroenterology%2520%2526%2520Motility%26atitle%3DElectroacupuncture%252Bpromotes%252Bthe%252Bgastrointestinal%252Bmotility%252Bof%252Bdiabetic%252Bmice%252Bby%252BCNP%25252FNPR%2525E2%252580%252590B%2525E2%252580%252590cGMP%252Band%252BPDE3A%2525E2%252580%252590cGMP%252Bsignaling%26aulast%3DAn%26aufirst%3DJing%26date%3D2019%26date%3D2019%26volume%3D31%26issue%3D4%26spage%3De13539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E.  Gurney</span>. </span><span class="cited-content_cbyCitation_article-title">Genetic Association of Phosphodiesterases With Human Cognitive Performance. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Neuroscience</span><span> <strong>2019,</strong> <em>12 </em><a href="https://doi.org/10.3389/fnmol.2019.00022" title="DOI URL">https://doi.org/10.3389/fnmol.2019.00022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnmol.2019.00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnmol.2019.00022%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Neuroscience%26atitle%3DGenetic%252BAssociation%252Bof%252BPhosphodiesterases%252BWith%252BHuman%252BCognitive%252BPerformance%26aulast%3DGurney%26aufirst%3DMark%2BE.%26date%3D2019%26date%3D2019%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susoma  Jannat</span>, <span class="hlFld-ContribAuthor ">Anand  Balupuri</span>, <span class="hlFld-ContribAuthor ">Md Yousof  Ali</span>, <span class="hlFld-ContribAuthor ">Seong Su  Hong</span>, <span class="hlFld-ContribAuthor ">Chun Whan  Choi</span>, <span class="hlFld-ContribAuthor ">Yun-Hyeok  Choi</span>, <span class="hlFld-ContribAuthor ">Jin-Mo  Ku</span>, <span class="hlFld-ContribAuthor ">Woo Jung  Kim</span>, <span class="hlFld-ContribAuthor ">Jae Yoon  Leem</span>, <span class="hlFld-ContribAuthor ">Ju Eun  Kim</span>, <span class="hlFld-ContribAuthor ">Abinash Chandra  Shrestha</span>, <span class="hlFld-ContribAuthor ">Ha Neul  Ham</span>, <span class="hlFld-ContribAuthor ">Kee-Ho  Lee</span>, <span class="hlFld-ContribAuthor ">Dong Min  Kim</span>, <span class="hlFld-ContribAuthor ">Nam Sook  Kang</span>, <span class="hlFld-ContribAuthor ">Gil Hong  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure−activity relationship with a strong BBB permeability. </span><span class="cited-content_cbyCitation_journal-name">Experimental & Molecular Medicine</span><span> <strong>2019,</strong> <em>51 </em>
                                    (2)
                                     , 1-18. <a href="https://doi.org/10.1038/s12276-019-0205-7" title="DOI URL">https://doi.org/10.1038/s12276-019-0205-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s12276-019-0205-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs12276-019-0205-7%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520%2526%2520Molecular%2520Medicine%26atitle%3DInhibition%252Bof%252B%2525CE%2525B2-site%252Bamyloid%252Bprecursor%252Bprotein%252Bcleaving%252Benzyme%252B1%252Band%252Bcholinesterases%252Bby%252Bpterosins%252Bvia%252Ba%252Bspecific%252Bstructure%2525E2%252588%252592activity%252Brelationship%252Bwith%252Ba%252Bstrong%252BBBB%252Bpermeability%26aulast%3DJannat%26aufirst%3DSusoma%26date%3D2019%26date%3D2019%26volume%3D51%26issue%3D2%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarana  Umar</span>, <span class="hlFld-ContribAuthor ">Shruti  Shalini</span>, <span class="hlFld-ContribAuthor ">Md Kausar  Raza</span>, <span class="hlFld-ContribAuthor ">Siddharth  Gusain</span>, <span class="hlFld-ContribAuthor ">Jitendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Waqar  Ahmed</span>, <span class="hlFld-ContribAuthor ">Manisha  Tiwari</span>, <span class="hlFld-ContribAuthor ">Nasimul  Hoda</span>. </span><span class="cited-content_cbyCitation_article-title">New amyloid beta-disaggregating agents: synthesis, pharmacological evaluation, crystal structure and molecular docking of
              N
              -(4-((7-chloroquinolin-4-yl)oxy)-3-ethoxybenzyl)amines. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (11)
                                     , 1891-1904. <a href="https://doi.org/10.1039/C8MD00312B" title="DOI URL">https://doi.org/10.1039/C8MD00312B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00312B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00312B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DNew%252Bamyloid%252Bbeta-disaggregating%252Bagents%25253A%252Bsynthesis%25252C%252Bpharmacological%252Bevaluation%25252C%252Bcrystal%252Bstructure%252Band%252Bmolecular%252Bdocking%252Bof%252BN%252B-%2525284-%252528%2525287-chloroquinolin-4-yl%252529oxy%252529-3-ethoxybenzyl%252529amines%26aulast%3DUmar%26aufirst%3DTarana%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D11%26spage%3D1891%26epage%3D1904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongbo  Zheng</span>, <span class="hlFld-ContribAuthor ">Yifeng  Wu</span>, <span class="hlFld-ContribAuthor ">Bin  Sun</span>, <span class="hlFld-ContribAuthor ">Chuanle  Cheng</span>, <span class="hlFld-ContribAuthor ">Yanan  Qiao</span>, <span class="hlFld-ContribAuthor ">Yuehua  Jiang</span>, <span class="hlFld-ContribAuthor ">Shengtian  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Xie</span>, <span class="hlFld-ContribAuthor ">Jing  Tan</span>, <span class="hlFld-ContribAuthor ">Hongxiang  Lou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of furyl/thienyl β-carboline derivatives as potent and selective PDE5 inhibitors with excellent vasorelaxant effect. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 767-780. <a href="https://doi.org/10.1016/j.ejmech.2018.09.028" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.028%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bfuryl%25252Fthienyl%252B%2525CE%2525B2-carboline%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252BPDE5%252Binhibitors%252Bwith%252Bexcellent%252Bvasorelaxant%252Beffect%26aulast%3DZheng%26aufirst%3DHongbo%26date%3D2018%26volume%3D158%26spage%3D767%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Li</span>, <span class="hlFld-ContribAuthor ">Siyu  He</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 463-477. <a href="https://doi.org/10.1016/j.ejmech.2018.09.031" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDonepezil-based%252Bmulti-functional%252Bcholinesterase%252Binhibitors%252Bfor%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLi%26aufirst%3DQi%26date%3D2018%26volume%3D158%26spage%3D463%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Relation of PDE inhibition and the cAMP or cGMP signaling pathway in the brain: PDE, phosphodiesterase; AC, adenyl cyclase; GC, guanylyl cyclase; ATP, adenosine triphosphate; GTP, guanosine triphosphate; PKA, protein kinase A; PKG, protein kinase G; P, phosphorylated; CREB, cAMP response element binding protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Current PDE1 inhibitors for the treatment of AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Current PDE2 inhibitors for the treatment of AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Selective PDE3 inhibitor, cilostazol, may be used to treat cerebrovascular diseases and AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Current PDE4 inhibitors for the treatment of AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Current PDE5 inhibitors for the treatment of AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Current PDE7 inhibitor for the treatment of AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Current PDE9 inhibitors for the treatment of AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/medium/jm-2017-01370g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Current PDE10 inhibitors for the treatment of AD and other diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b01370/20180706/images/large/jm-2017-01370g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01370&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 160 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stopschinski, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, M. I.</span></span> <span> </span><span class="NLM_article-title">The prion model for progression and diversity of neurodegenerative diseases</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">332</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(17)30037-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2FS1474-4422%2817%2930037-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=28238712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=323-332&author=B.+E.+Stopschinskiauthor=M.+I.+Diamond&title=The+prion+model+for+progression+and+diversity+of+neurodegenerative+diseases&doi=10.1016%2FS1474-4422%2817%2930037-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The prion model for progression and diversity of neurodegenerative diseases</span></div><div class="casAuthors">Stopschinski, Barbara E.; Diamond, Marc I.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">323-332</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The neuropathol. of different neurodegenerative diseases begins in different brain regions, and involves distinct brain networks.  Evidence indicates that transcellular propagation of protein aggregation, which is the basis of prion disease, might underlie the progression of pathol. in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.  The prion model predicts specific patterns of neuronal vulnerability and network involvement on the basis of the conformation of pathol. proteins.  Indeed, evidence indicates that self-propagating aggregate conformers, or so-called strains, are assocd. with distinct neuropathol. syndromes.  The extension of this hypothesis to our understanding of common neurodegenerative disorders can suggest new therapeutic approaches, such as immunotherapy and small mols., to block transcellular propagation, and new diagnostic tools to detect early evidence of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnR2DhaWpjBbVg90H21EOLACvtfcHk0ljKJYdTT-4Xyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGkt7w%253D&md5=e42b6241cba73884d43777c0bfc85b50</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2817%2930037-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252817%252930037-6%26sid%3Dliteratum%253Aachs%26aulast%3DStopschinski%26aufirst%3DB.%2BE.%26aulast%3DDiamond%26aufirst%3DM.%2BI.%26atitle%3DThe%2520prion%2520model%2520for%2520progression%2520and%2520diversity%2520of%2520neurodegenerative%2520diseases%26jtitle%3DLancet%2520Neurol.%26date%3D2017%26volume%3D16%26spage%3D323%26epage%3D332%26doi%3D10.1016%2FS1474-4422%2817%2930037-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span>Alzheimer’s
Disease International. World Alzheimer Report 2015. <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf" class="extLink">ps://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s%0ADisease+International.+World+Alzheimer+Report+2015.+ps%3A%2F%2Fwww.alz.co.uk%2Fresearch%2FWorldAlzheimerReport2015.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goedert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spillantini, M. G.</span></span> <span> </span><span class="NLM_article-title">A century of Alzheimer’s disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>314</i></span>,  <span class="NLM_fpage">777</span>– <span class="NLM_lpage">781</span>, <span class="refDoi"> DOI: 10.1126/science.1132814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1126%2Fscience.1132814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=17082447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKit73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=777-781&author=M.+Goedertauthor=M.+G.+Spillantini&title=A+century+of+Alzheimer%E2%80%99s+disease&doi=10.1126%2Fscience.1132814"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A Century of Alzheimer's Disease</span></div><div class="casAuthors">Goedert, Michel; Spillantini, Maria Grazia</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">5800</span>),
    <span class="NLM_cas:pages">777-781</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  One hundred years ago a small group of psychiatrists described the abnormal protein deposits in the brain that define the most common neurodegenerative diseases.  Over the past 25 years, it has become clear that the proteins forming the deposits are central to the disease process.  Amyloid-β and tau make up the plaques and tangles of Alzheimer's disease, where these normally sol. proteins assemble into amyloid-like filaments.  Tau inclusions are also found in a no. of related disorders.  Genetic studies have shown that dysfunction of amyloid-β or tau is sufficient to cause dementia.  The ongoing mol. dissection of the neurodegenerative pathways is expected to lead to a true understanding of disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlvQWrY5FMmrVg90H21EOLACvtfcHk0lg--bJQ6a3fvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKit73K&md5=6e152685c65d4a08e0b23c0807a35149</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1132814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1132814%26sid%3Dliteratum%253Aachs%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26atitle%3DA%2520century%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D777%26epage%3D781%26doi%3D10.1126%2Fscience.1132814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucke, L.</span></span> <span> </span><span class="NLM_article-title">Alzheimer mechanisms and therapeutic strategies</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1222</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.02.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.cell.2012.02.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=22424230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1CqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=1204-1222&author=Y.+Huangauthor=L.+Mucke&title=Alzheimer+mechanisms+and+therapeutic+strategies&doi=10.1016%2Fj.cell.2012.02.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer Mechanisms and Therapeutic Strategies</span></div><div class="casAuthors">Huang, Yadong; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1204-1222</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  There are still no effective treatments to prevent, halt, or reverse Alzheimer's disease, but research advances over the past three decades could change this gloomy picture.  Genetic studies demonstrate that the disease has multiple causes.  Interdisciplinary approaches combining biochem., mol. and cell biol., and transgenic modeling have revealed some of its mol. mechanisms.  Progress in chem., radiol., and systems biol. is beginning to provide useful biomarkers, and the emergence of personalized medicine is poised to transform pharmaceutical development and clin. trials.  However, investigative and drug development efforts should be diversified to fully address the multifactoriality of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx4Jw1D9na57Vg90H21EOLACvtfcHk0lg--bJQ6a3fvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1CqurY%253D&md5=4f44f2d5019321a668029282777946d1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.040%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DAlzheimer%2520mechanisms%2520and%2520therapeutic%2520strategies%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D1204%26epage%3D1222%26doi%3D10.1016%2Fj.cell.2012.02.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolgin, E.</span></span> <span> </span><span class="NLM_article-title">Failed Alzheimer’s trial does not kill leading theory of disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>540</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1038/nature.2016.21045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnature.2016.21045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=27905452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFylsLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=540&publication_year=2016&pages=15-16&author=A.+Abbottauthor=E.+Dolgin&title=Failed+Alzheimer%E2%80%99s+trial+does+not+kill+leading+theory+of+disease&doi=10.1038%2Fnature.2016.21045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Failed Alzheimer's trial does not kill leading theory of disease</span></div><div class="casAuthors">Abbott, Alison; Dolgin, Elie</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">540</span>
        (<span class="NLM_cas:issue">7631</span>),
    <span class="NLM_cas:pages">15-16</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Solanezumab flopped in a large clin. trial, but the drug or others like it could yet succeed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg8_Ct6Pm-f7Vg90H21EOLACvtfcHk0lg--bJQ6a3fvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFylsLjI&md5=32717907cf9871c72a44d373c5b45aa7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature.2016.21045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature.2016.21045%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DA.%26aulast%3DDolgin%26aufirst%3DE.%26atitle%3DFailed%2520Alzheimer%25E2%2580%2599s%2520trial%2520does%2520not%2520kill%2520leading%2520theory%2520of%2520disease%26jtitle%3DNature%26date%3D2016%26volume%3D540%26spage%3D15%26epage%3D16%26doi%3D10.1038%2Fnature.2016.21045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, M.</span></span> <span> </span><span class="NLM_article-title">Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010–2015</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1080/13543784.2017.1323868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1080%2F13543784.2017.1323868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=28460541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot1Shu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=735-739&author=D.+Mehtaauthor=R.+Jacksonauthor=G.+Paulauthor=J.+Shiauthor=M.+Sabbagh&title=Why+do+trials+for+Alzheimer%E2%80%99s+disease+drugs+keep+failing%3F+A+discontinued+drug+perspective+for+2010%E2%80%932015&doi=10.1080%2F13543784.2017.1323868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015</span></div><div class="casAuthors">Mehta, Dev; Jackson, Robert; Paul, Gaurav; Shi, Jiong; Sabbagh, Marwan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">735-739</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: There are dozens of drugs in development for AD with billions of dollars invested.  Despite the massive investment in AD drugs and a burgeoning pipeline, there have been more setbacks and failures than treatment successes.: The classes of drugs that have failed to date include the monoclonal antibodies, the gamma secretase inhibitors, dimebon, neurochem. enhancers, and one tau drug.  Data for these compds. were sought through a PubMed search and a clin. trials.gov search.: The obvious question to be posed is: Why are they failing.  Is the treatment of symptomatic dementia too late.  Are the therapeutic targets incorrect.  Are the clin. methodologies imprecise, misleading, or inaccurate.  This review summarizes the drugs that have failed during 2010-2015 and offers possible theories as to why they have failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphTh-OjoTzgbVg90H21EOLACvtfcHk0lhTX2Cr9hGuPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot1Shu7Y%253D&md5=efa88fffd86b5674b1b3f19342947933</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F13543784.2017.1323868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543784.2017.1323868%26sid%3Dliteratum%253Aachs%26aulast%3DMehta%26aufirst%3DD.%26aulast%3DJackson%26aufirst%3DR.%26aulast%3DPaul%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DSabbagh%26aufirst%3DM.%26atitle%3DWhy%2520do%2520trials%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520drugs%2520keep%2520failing%253F%2520A%2520discontinued%2520drug%2520perspective%2520for%25202010%25E2%2580%25932015%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2017%26volume%3D26%26spage%3D735%26epage%3D739%26doi%3D10.1080%2F13543784.2017.1323868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mosconi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glodzik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pupi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Santi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon, M. J.</span></span> <span> </span><span class="NLM_article-title">Pre-clinical detection of Alzheimer’s disease using FDG-PET, with or without amyloid imaging</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">854</span>, <span class="refDoi"> DOI: 10.3233/JAD-2010-091504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.3233%2FJAD-2010-091504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20182025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BC3cvot1KhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=843-854&author=L.+Mosconiauthor=V.+Bertiauthor=L.+Glodzikauthor=A.+Pupiauthor=S.+De+Santiauthor=M.+J.+de+Leon&title=Pre-clinical+detection+of+Alzheimer%E2%80%99s+disease+using+FDG-PET%2C+with+or+without+amyloid+imaging&doi=10.3233%2FJAD-2010-091504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging</span></div><div class="casAuthors">Mosconi Lisa; Berti Valentina; Glodzik Lidia; Pupi Alberto; De Santi Susan; de Leon Mony J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">843-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The development of prevention therapies for Alzheimer's disease (AD) would greatly benefit from biomarkers that are sensitive to subtle brain changes occurring in the preclinical stage of the disease.  Early diagnostics is necessary to identify and treat at risk individuals before irreversible neuronal loss occurs.  In vivo imaging has long been used to evaluate brain structural and functional abnormalities as predictors of future AD in non-demented persons.  Prior to development of amyloid-beta (Abeta) tracers for positron emission tomography (PET), the most widely utilized PET tracer in AD was 2-[18F]fluoro-2-Deoxy-D-glucose (FDG) PET.  For over 20 years, FDG-PET has been used to measure cerebral metabolic rates of glucose (CMRglc), a proxy for neuronal activity, in AD.  Many studies have shown that CMRglc reductions occur early in AD, correlate with disease progression, and predict histopathological diagnosis.  This paper reviews reports of clinical and preclinical CMRglc reductions observed in association with genetic and non-genetic risk factors for AD.  We then briefly review brain Abeta PET imaging studies in AD and discuss the potential of combining symptoms-sensitive FDG-PET measures with pathology-specific Abeta-PET to improve the early detection of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRa4AJGgW2Fdz69zv1FsJFMfW6udTcc2eb0u-gzLAo3Nrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cvot1KhtQ%253D%253D&md5=2355d20a2e0c79a8ac4b12e7306680e1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-091504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-091504%26sid%3Dliteratum%253Aachs%26aulast%3DMosconi%26aufirst%3DL.%26aulast%3DBerti%26aufirst%3DV.%26aulast%3DGlodzik%26aufirst%3DL.%26aulast%3DPupi%26aufirst%3DA.%26aulast%3DDe%2BSanti%26aufirst%3DS.%26aulast%3Dde%2BLeon%26aufirst%3DM.%2BJ.%26atitle%3DPre-clinical%2520detection%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520using%2520FDG-PET%252C%2520with%2520or%2520without%2520amyloid%2520imaging%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2010%26volume%3D20%26spage%3D843%26epage%3D854%26doi%3D10.3233%2FJAD-2010-091504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bender, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">488</span>– <span class="NLM_lpage">520</span>, <span class="refDoi"> DOI: 10.1124/pr.58.3.5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1124%2Fpr.58.3.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16968949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=488-520&author=A.+T.+Benderauthor=J.+A.+Beavo&title=Cyclic+nucleotide+phosphodiesterases%3A+molecular+regulation+to+clinical+use&doi=10.1124%2Fpr.58.3.5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use</span></div><div class="casAuthors">Bender, Andrew T.; Beavo, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">488-520</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that regulate the cellular levels of the second messengers, cAMP and cGMP, by controlling their rates of degrdn.  There are 11 different PDE families, with each family typically having several different isoforms and splice variants.  These unique PDEs differ in their three-dimensional structure, kinetic properties, modes of regulation, intracellular localization, cellular expression, and inhibitor sensitivities.  Current data suggest that individual isoenzymes modulate distinct regulatory pathways in the cell.  These properties therefore offer the opportunity for selectively targeting specific PDEs for treatment of specific disease states.  The feasibility of these enzymes as drug targets is exemplified by the com. and clin. successes of the erectile dysfunction drugs, sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra).  PDE inhibitors are also currently available or in development for treatment of a variety of other pathol. conditions.  In this review the basic biochem. properties, cellular regulation, expression patterns, and physiol. functions of the different PDE isoforms will be discussed.  How these properties relate to the current and future development of PDE inhibitors as pharmacol. agents is esp. considered.  PDEs hold great promise as drug targets and recent research advances make this an exciting time for the field of PDE research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJl4RDiZ0ugrVg90H21EOLACvtfcHk0lhTX2Cr9hGuPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfI&md5=af31cf6952efe7adb428a951779f36bc</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.5%26sid%3Dliteratum%253Aachs%26aulast%3DBender%26aufirst%3DA.%2BT.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DCyclic%2520nucleotide%2520phosphodiesterases%253A%2520molecular%2520regulation%2520to%2520clinical%2520use%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D488%26epage%3D520%26doi%3D10.1124%2Fpr.58.3.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganiello, V. C.</span></span> <span> </span><span class="NLM_article-title">Advances in targeting cyclic nucleotide phosphodiesterases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1038/nrd4228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnrd4228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=24687066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFOiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=290-314&author=D.+H.+Mauriceauthor=H.+Keauthor=F.+Ahmadauthor=Y.+Wangauthor=J.+Chungauthor=V.+C.+Manganiello&title=Advances+in+targeting+cyclic+nucleotide+phosphodiesterases&doi=10.1038%2Fnrd4228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in targeting cyclic nucleotide phosphodiesterases</span></div><div class="casAuthors">Maurice, Donald H.; Ke, Hengming; Ahmad, Faiyaz; Wang, Yousheng; Chung, Jay; Manganiello, Vincent C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">290-314</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cyclic GMP, thereby regulating the intracellular concns. of these cyclic nucleotides, their signalling pathways and, consequently, myriad biol. responses in health and disease.  Currently, a small no. of PDE inhibitors are used clin. for treating the pathophysiol. dysregulation of cyclic nucleotide signalling in several disorders, including erectile dysfunction, pulmonary hypertension, acute refractory cardiac failure, intermittent claudication and chronic obstructive pulmonary disease.  However, pharmaceutical interest in PDEs has been reignited by the increasing understanding of the roles of individual PDEs in regulating the subcellular compartmentalization of specific cyclic nucleotide signalling pathways, by the structure-based design of novel specific inhibitors and by the development of more sophisticated strategies to target individual PDE variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwMRfUs-zUmLVg90H21EOLACvtfcHk0ljwWC_rh_rgjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFOiu7s%253D&md5=410c8d5bb5fbd7d2906e30dc1b5f2876</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd4228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4228%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DD.%2BH.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DJ.%26aulast%3DManganiello%26aufirst%3DV.%2BC.%26atitle%3DAdvances%2520in%2520targeting%2520cyclic%2520nucleotide%2520phosphodiesterases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D290%26epage%3D314%26doi%3D10.1038%2Fnrd4228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azevedo, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucz, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bimpaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Alexandre, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganiello, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratakis, C. A.</span></span> <span> </span><span class="NLM_article-title">Clinical and molecular genetics of the phosphodiesterases (PDEs)</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1210/er.2013-1053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1210%2Fer.2013-1053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=24311737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVahu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=195-233&author=M.+F.+Azevedoauthor=F.+R.+Fauczauthor=E.+Bimpakiauthor=A.+Horvathauthor=I.+Levyauthor=R.+B.+de+Alexandreauthor=F.+Ahmadauthor=V.+Manganielloauthor=C.+A.+Stratakis&title=Clinical+and+molecular+genetics+of+the+phosphodiesterases+%28PDEs%29&doi=10.1210%2Fer.2013-1053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and molecular genetics of the phosphodiesterases (PDEs)</span></div><div class="casAuthors">Azevedo, Monalisa F.; Faucz, Fabio R.; Bimpaki, Eirini; Horvath, Anelia; Levy, Isaac; de Alexandre, Rodrigo B.; Ahmad, Faiyaz; Manganiello, Vincent; Stratakis, Constantine A.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-233</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that have the unique function of terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP.  They are crit. regulators of the intracellular concns. of cAMP and cGMP as well as of their signaling pathways and downstream biol. effects.  PDEs have been exploited pharmacol. for more than half a century, and some of the most successful drugs worldwide today affect PDE function.  Recently, mutations in PDE genes have been identified as causative of certain human genetic diseases; even more recently, functional variants of PDE genes have been suggested to play a potential role in predisposition to tumors and/or cancer, esp. in cAMP-sensitive tissues.  Mouse models have been developed that point to wide developmental effects of PDEs from heart function to reprodn., to tumors, and beyond.  This review brings together knowledge from a variety of disciplines (biochem. and pharmacol., oncol., endocrinol., and reproductive sciences) with emphasis on recent research on PDEs, how PDEs affect cAMP and cGMP signaling in health and disease, and what pharmacol. exploitations of PDEs may be useful in modulating cyclic nucleotide signaling in a way that prevents or treats certain human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTE7qPz_LMLrVg90H21EOLACvtfcHk0ljwWC_rh_rgjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVahu7g%253D&md5=1f0b1cc883e0ad5d2d977ecd50edcfe2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1210%2Fer.2013-1053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2013-1053%26sid%3Dliteratum%253Aachs%26aulast%3DAzevedo%26aufirst%3DM.%2BF.%26aulast%3DFaucz%26aufirst%3DF.%2BR.%26aulast%3DBimpaki%26aufirst%3DE.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DLevy%26aufirst%3DI.%26aulast%3Dde%2BAlexandre%26aufirst%3DR.%2BB.%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DManganiello%26aufirst%3DV.%26aulast%3DStratakis%26aufirst%3DC.%2BA.%26atitle%3DClinical%2520and%2520molecular%2520genetics%2520of%2520the%2520phosphodiesterases%2520%2528PDEs%2529%26jtitle%3DEndocr.%2520Rev.%26date%3D2014%26volume%3D35%26spage%3D195%26epage%3D233%26doi%3D10.1210%2Fer.2013-1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. F.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase: an interface connecting cognitive deficits to neuropsychiatric and neurodegenerative diseases</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.2174/1381612820666140826115559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.2174%2F1381612820666140826115559" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=303-316&author=Z.+Wangauthor=Y.+Zhangauthor=H.+T.+Zhangauthor=Y.+F.+Li&title=Phosphodiesterase%3A+an+interface+connecting+cognitive+deficits+to+neuropsychiatric+and+neurodegenerative+diseases&doi=10.2174%2F1381612820666140826115559"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F1381612820666140826115559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666140826115559%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26aulast%3DLi%26aufirst%3DY.%2BF.%26atitle%3DPhosphodiesterase%253A%2520an%2520interface%2520connecting%2520cognitive%2520deficits%2520to%2520neuropsychiatric%2520and%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2015%26volume%3D21%26spage%3D303%26epage%3D316%26doi%3D10.2174%2F1381612820666140826115559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, R. D.</span></span> <span> </span><span class="NLM_article-title">Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus</span>. <i>J. Neurophysiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">1270</span>– <span class="NLM_lpage">1278</span>, <span class="refDoi"> DOI: 10.1152/jn.2002.88.3.1270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1152%2Fjn.2002.88.3.1270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=12205148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1Omtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2002&pages=1270-1278&author=Y.+F.+Luauthor=R.+D.+Hawkins&title=Ryanodine+receptors+contribute+to+cGMP-induced+late-phase+LTP+and+CREB+phosphorylation+in+the+hippocampus&doi=10.1152%2Fjn.2002.88.3.1270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Rynodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus</span></div><div class="casAuthors">Lu, Yun-Fei; Hawkins, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurophysiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1270-1278</span>CODEN:
                <span class="NLM_cas:coden">JONEA4</span>;
        ISSN:<span class="NLM_cas:issn">0022-3077</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">We previously found that the nitric oxide (NO)-cGMP-cGMP-dependent protein kinase (PKG) signaling pathway acts in parallel with the cAMP-cAMP-dependent protein kinase (PKA) pathway to produce protein and RNA synthesis-dependent late-phase long-term potentiation (L-LTP) and cAMP response element-binding protein (CREB) phosphorylation in the CA1 region of mouse hippocampus.  We have now investigated the possible involvement of a downstream target of PKG, ryanodine receptors.  L-LTP can be induced by either multiple-train tetanization, NO or 8-Br-cGMP paired with one-train tetanization, or the cAMP activator forskolin, and all three types of potentiation are accompanied by an increase in phospho-CREB immunofluorescence in the CA1 cell body area.  Both the potentiation and the increase in phospho-CREB immunofluorescence induced by multiple-train tetanization or 8-Br-cGMP paired with one-train tetanization are reduced by prolonged perfusion with ryanodine, which blocks Ca2+ release from ryanodine-sensitive Ca2+ stores.  By contrast, neither the potentiation nor the increase in immunofluorescence induced by forskolin are reduced by depletion of ryanodine and inositol-1,4,5-triphosphate (IP3)-sensitive Ca2+ stores.  These results suggest that NO, cGMP, and PKG cause release of Ca2+ from ryanodine-sensitive stores, which in turn causes phosphorylation of CREB in parallel with PKA during the induction of L-LTP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtfo8dwmELf7Vg90H21EOLACvtfcHk0lhfx0TID_u8ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1Omtrk%253D&md5=685215b90ae99649c22b63e54b960439</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1152%2Fjn.2002.88.3.1270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.2002.88.3.1270%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%2BF.%26aulast%3DHawkins%26aufirst%3DR.%2BD.%26atitle%3DRyanodine%2520receptors%2520contribute%2520to%2520cGMP-induced%2520late-phase%2520LTP%2520and%2520CREB%2520phosphorylation%2520in%2520the%2520hippocampus%26jtitle%3DJ.%2520Neurophysiol.%26date%3D2002%26volume%3D88%26spage%3D1270%26epage%3D1278%26doi%3D10.1152%2Fjn.2002.88.3.1270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott Bitner, R.</span></span> <span> </span><span class="NLM_article-title">Cyclic AMP response element-binding protein (CREB) phosphorylation: a mechanistic marker in the development of memory enhancing Alzheimer’s disease therapeutics</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bcp.2011.11.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=705-714&author=R.+Scott+Bitner&title=Cyclic+AMP+response+element-binding+protein+%28CREB%29+phosphorylation%3A+a+mechanistic+marker+in+the+development+of+memory+enhancing+Alzheimer%E2%80%99s+disease+therapeutics&doi=10.1016%2Fj.bcp.2011.11.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DScott%2BBitner%26aufirst%3DR.%26atitle%3DCyclic%2520AMP%2520response%2520element-binding%2520protein%2520%2528CREB%2529%2520phosphorylation%253A%2520a%2520mechanistic%2520marker%2520in%2520the%2520development%2520of%2520memory%2520enhancing%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutics%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D705%26epage%3D714%26doi%3D10.1016%2Fj.bcp.2011.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domek-Lopacinska, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strosznajder, J. B.</span></span> <span> </span><span class="NLM_article-title">Cyclic GMP and nitric oxide synthase in aging and Alzheimer’s disease</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1007/s12035-010-8104-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1007%2Fs12035-010-8104-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20213343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFSqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2010&pages=129-137&author=K.+U.+Domek-Lopacinskaauthor=J.+B.+Strosznajder&title=Cyclic+GMP+and+nitric+oxide+synthase+in+aging+and+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs12035-010-8104-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic GMP and nitric oxide synthase in aging and Alzheimer's Disease</span></div><div class="casAuthors">Domek-Lopacinska, Katarzyna Urszula; Strosznajder, Joanna B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">129-137</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Cyclic guanosine monophosphate (cGMP) is an important secondary messenger synthesized by the guanylyl cyclases which are found in the sol. (sGC) and particular isoforms.  In the central nervous system, the nitric oxide (NO)-sensitive sGC isoform is the major enzyme responsible for cGMP synthesis.  Phosphodiesterases (PDEs) are enzymes for hydrolysis of cGMP in the brain, and they are mainly isoforms 2, 5, and 9.  The NO/cGMP signaling pathway has been shown to play an important role in the process underlying learning and memory.  Aging is assocd. with an increase in PDE expression and activity and a decrease in cGMP concn.  In addn., aging is also assocd. with an enhancement of neuronal NO synthase, a lowering of endothelial, and no alteration in inducible activity.  The obsd. changes in NMDA receptor d. along with the Ca2+/NO/cGMP pathway underscore the lower synaptic plasticity and cognitive performance during aging.  This notion is in agreement with last data indicating that inhibitors of PDE2 and PDE9 improve learning and memory in older rats.  In this review, we focus on recent studies supporting the role of Ca2+/NO/cGMP pathway in aging and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPy5cay399abVg90H21EOLACvtfcHk0lhfx0TID_u8ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFSqtr0%253D&md5=91f5bed7d285558234fb84a933d17973</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs12035-010-8104-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-010-8104-x%26sid%3Dliteratum%253Aachs%26aulast%3DDomek-Lopacinska%26aufirst%3DK.%2BU.%26aulast%3DStrosznajder%26aufirst%3DJ.%2BB.%26atitle%3DCyclic%2520GMP%2520and%2520nitric%2520oxide%2520synthase%2520in%2520aging%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Neurobiol.%26date%3D2010%26volume%3D41%26spage%3D129%26epage%3D137%26doi%3D10.1007%2Fs12035-010-8104-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ciani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartesaghi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contestabile, A.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">1282</span>– <span class="NLM_lpage">1289</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.01080.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1046%2Fj.1471-4159.2002.01080.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=12358775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvVerur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=1282-1289&author=E.+Cianiauthor=S.+Guidiauthor=R.+Bartesaghiauthor=A.+Contestabile&title=Nitric+oxide+regulates+cGMP-dependent+cAMP-responsive+element+binding+protein+phosphorylation+and+Bcl-2+expression+in+cerebellar+neurons%3A+implication+for+a+survival+role+of+nitric+oxide&doi=10.1046%2Fj.1471-4159.2002.01080.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: Implication for a survival role of nitric oxide</span></div><div class="casAuthors">Ciani, Elisabetta; Guidi, Sandra; Bartesaghi, Renata; Contestabile, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1282-1289</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">NO is a small, diffusible, highly reactive mol. with a dichotomous regulatory role in the brain as an intra- and intercellular messenger under physiol. conditions and a neurodegenerative agent under pathol. conditions.  The authors recently demonstrated that long-lasting exposure to an neuronal nitric oxide synthase (nNOS) inhibitor down-regulated the serine/threonine kinase Akt survival pathway and caused apoptosis in cerebellar granule cell cultures.  The present study further substantiated the role of NO in neuronal survival by demonstrating that blocking its prodn. down-regulated the activity of cAMP-responsive element binding protein (CREB), a transcription factor involved in cell survival and synaptic plasticity.  Pharmacol. dissection of the pathway linking NO to CREB showed that cGMP and its kinase were intermediate effectors.  The authors also identified Bcl-2 as one of the anti-apoptotic genes down-regulated by NO shortage and decreased CREB phosphorylation.  Thus, these results not only confirmed the role of CREB in neuronal survival but also provided circumstantial evidence for a novel link among NO, CREB activation, and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4EpdhJVzkrVg90H21EOLACvtfcHk0limNn0u3u-Jzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvVerur8%253D&md5=919d465c919f768d97c93a650efde1a9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01080.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01080.x%26sid%3Dliteratum%253Aachs%26aulast%3DCiani%26aufirst%3DE.%26aulast%3DGuidi%26aufirst%3DS.%26aulast%3DBartesaghi%26aufirst%3DR.%26aulast%3DContestabile%26aufirst%3DA.%26atitle%3DNitric%2520oxide%2520regulates%2520cGMP-dependent%2520cAMP-responsive%2520element%2520binding%2520protein%2520phosphorylation%2520and%2520Bcl-2%2520expression%2520in%2520cerebellar%2520neurons%253A%2520implication%2520for%2520a%2520survival%2520role%2520of%2520nitric%2520oxide%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26spage%3D1282%26epage%3D1289%26doi%3D10.1046%2Fj.1471-4159.2002.01080.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourtchouladze, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winder, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandel, E.</span></span> <span> </span><span class="NLM_article-title">Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting LTP and improves memory</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">15020</span>– <span class="NLM_lpage">15025</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.25.15020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1073%2Fpnas.95.25.15020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15020-15025&author=M.+Baradauthor=R.+Bourtchouladzeauthor=D.+G.+Winderauthor=H.+Golanauthor=E.+Kandel&title=Rolipram%2C+a+type+IV-specific+phosphodiesterase+inhibitor%2C+facilitates+the+establishment+of+long-lasting+LTP+and+improves+memory&doi=10.1073%2Fpnas.95.25.15020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.25.15020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.25.15020%26sid%3Dliteratum%253Aachs%26aulast%3DBarad%26aufirst%3DM.%26aulast%3DBourtchouladze%26aufirst%3DR.%26aulast%3DWinder%26aufirst%3DD.%2BG.%26aulast%3DGolan%26aufirst%3DH.%26aulast%3DKandel%26aufirst%3DE.%26atitle%3DRolipram%252C%2520a%2520type%2520IV-specific%2520phosphodiesterase%2520inhibitor%252C%2520facilitates%2520the%2520establishment%2520of%2520long-lasting%2520LTP%2520and%2520improves%2520memory%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D15020%26epage%3D15025%26doi%3D10.1073%2Fpnas.95.25.15020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmikuttyamma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrivastav, A.</span></span> <span> </span><span class="NLM_article-title">Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): Review</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.3892/ijmm.18.1.95</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.3892%2Fijmm.18.1.95" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16786160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1CnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=95-105&author=R.+K.+Sharmaauthor=S.+B.+Dasauthor=A.+Lakshmikuttyammaauthor=P.+Selvakumarauthor=A.+Shrivastav&title=Regulation+of+calmodulin-stimulated+cyclic+nucleotide+phosphodiesterase+%28PDE1%29%3A+Review&doi=10.3892%2Fijmm.18.1.95"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): review</span></div><div class="casAuthors">Sharma, Rajendra K.; Das, Shankar B.; Lakshmikuttyamma, Ashakumary; Selvakumar, Ponniah; Shrivastav, Anuraag</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">A review.  The response of living cells to change in cell environment depends on the action of second messenger mols.  The two second messenger mols. cAMP and Ca2+ regulate a large no. of eukaryotic cellular events.  Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1) is one of the key enzymes involved in the complex interaction between cAMP and Ca2+ second messenger systems.  Some PDE1 isoenzymes have similar kinetic and immunol. properties but are differentially regulated by Ca2+ and calmodulin.  Accumulating evidence suggests that the activity of PDE1 is selectively regulated by cross-talk between Ca2+ and cAMP signaling pathways.  These isoenzymes are also further distinguished by various pharmacol. agents.  We have demonstrated a potentially novel regulation of PDE1 by calpain.  This study suggests that limited proteolysis by calpain could be an alternative mechanism for the activation of PDE1.  We have also shown PDE1 activity, expression and effect of calpain in the rat model in vitro of cardiac ischemia-reperfusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZnr-AhNApDLVg90H21EOLACvtfcHk0limNn0u3u-Jzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1CnsLo%253D&md5=671b71e77c39fcf4782b9d3e2bceebcd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3892%2Fijmm.18.1.95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.18.1.95%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DDas%26aufirst%3DS.%2BB.%26aulast%3DLakshmikuttyamma%26aufirst%3DA.%26aulast%3DSelvakumar%26aufirst%3DP.%26aulast%3DShrivastav%26aufirst%3DA.%26atitle%3DRegulation%2520of%2520calmodulin-stimulated%2520cyclic%2520nucleotide%2520phosphodiesterase%2520%2528PDE1%2529%253A%2520Review%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2006%26volume%3D18%26spage%3D95%26epage%3D105%26doi%3D10.3892%2Fijmm.18.1.95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakics, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boess, F. G.</span></span> <span> </span><span class="NLM_article-title">Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2010.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20493887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1SqsLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2010&pages=367-374&author=V.+Lakicsauthor=E.+H.+Karranauthor=F.+G.+Boess&title=Quantitative+comparison+of+phosphodiesterase+mRNA+distribution+in+human+brain+and+peripheral+tissues&doi=10.1016%2Fj.neuropharm.2010.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues</span></div><div class="casAuthors">Lakics, Viktor; Karran, Eric H.; Boess, Frank G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">367-374</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyclic nucleotide-specific phosphodiesterases (PDEs) play a crit. role in signal transduction by regulating the level of adenosine 3',5'-cyclic monophosphate (cAMP) and guanosine 3',5'-cyclic monophosphate (cGMP) in cells.  The gene expression pattern of a PDE provides important information regarding its role in physiol. and pathol. processes.  In this study, we have established the mRNA expression profile all PDE isoenzymes (PDE1A/B/C, 2A, 3A/B, 4A/B/C/D, 5A, 6A/B/C, 7A/B, 8A/B, 9A, 10A, 11A) in a human cDNA collection consisting of 10 brain regions (parietal, frontal, temporal cortex, hippocampus, striatum, thalamus, hypothalamus, substantia nigra, nucleus accumbens, cerebellum), spinal cord, dorsal root ganglia and 12 peripheral tissues (skeletal muscle, heart, thyroid, adrenal gland, pancreas, bladder, kidney, liver, lung, small intestine, spleen, and stomach).  Using quant. real-time polymerase chain reaction and parallel anal. of a carefully selected group of ref. genes, we have detd. the relative expression of each PDE isoenzyme across the 24 selected tissues, and also compared the expression of selected PDEs to each other within a given tissue type.  Several PDEs show strikingly selective expression (e.g. PDE10A and PDE1B mRNA levels in the caudate nucleus are 20-fold higher than in most other tissues; PDE1C and PDE3A are highly expressed in the heart and PDE8B is expressed very strongly in the thyroid gland).  This comprehensive approach provides a coherent and quant. view of the mRNA expression of the PDE gene family and enables an integration of data obtained with other non-quant. methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGz6OEkRjbLVg90H21EOLACvtfcHk0lhknr3KlJZ7og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1SqsLbJ&md5=ee55772f572818eaa7194a1ae3f52f45</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DLakics%26aufirst%3DV.%26aulast%3DKarran%26aufirst%3DE.%2BH.%26aulast%3DBoess%26aufirst%3DF.%2BG.%26atitle%3DQuantitative%2520comparison%2520of%2520phosphodiesterase%2520mRNA%2520distribution%2520in%2520human%2520brain%2520and%2520peripheral%2520tissues%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D59%26spage%3D367%26epage%3D374%26doi%3D10.1016%2Fj.neuropharm.2010.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 1: a unique therapeutic target with multiple potential indications</span>. <i>Chin. J. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=452&author=L.+Wennogle&title=Phosphodiesterase+1%3A+a+unique+therapeutic+target+with+multiple+potential+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWennogle%26aufirst%3DL.%26atitle%3DPhosphodiesterase%25201%253A%2520a%2520unique%2520therapeutic%2520target%2520with%2520multiple%2520potential%2520indications%26jtitle%3DChin.%2520J.%2520Pharmacol.%2520Toxicol.%26date%3D2017%26volume%3D31%26spage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonoczk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam-Vizi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpati, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szantay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koncz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelles, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vas, A.</span></span> <span> </span><span class="NLM_article-title">Role of sodium channel inhibition in neuroprotection: effect of vinpocetine</span>. <i>Brain Res. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/S0361-9230(00)00354-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2FS0361-9230%2800%2900354-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=11113577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslGgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2000&pages=245-254&author=P.+Bonoczkauthor=B.+Gulyasauthor=V.+Adam-Viziauthor=A.+Nemesauthor=E.+Karpatiauthor=B.+Kissauthor=M.+Kapasauthor=C.+Szantayauthor=I.+Konczauthor=T.+Zellesauthor=A.+Vas&title=Role+of+sodium+channel+inhibition+in+neuroprotection%3A+effect+of+vinpocetine&doi=10.1016%2FS0361-9230%2800%2900354-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Role of sodium channel inhibition in neuroprotection: effect of vinpocetine</span></div><div class="casAuthors">Bonoczk, P.; Gulyas, B.; Adam-Vizi, V.; Nemes, A.; Karpati, E.; Kiss, B.; Kapas, M.; Szantay, C.; Koncz, I.; Zelles, T.; Vas, A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-254</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 111 refs.  Vinpocetine (Et apovincaminate) discovered during the late 1960s has successfully been used in the treatment of central nervous system disorders of cerebrovascular origin for decades.  The increase in the regional cerebral blood flow in response to vinpocetine administration is well established and strengthened by new diagnostical techniques (transcranial Doppler, near IR spectroscopy, positron emission tomog.).  The latest in vitro studies have revealed the effect of the compd. on Ca2+/calmodulin dependent cGMP-phosphodiesterase 1, voltage-operated Ca2+ channels, glutamate receptors and voltage dependent Na+-channels; the latest being esp. relevant to the neuroprotective action of vinpocetine.  The good brain penetration profile and heterogeneous brain distribution pattern (mainly in the thalamus, basal ganglia and visual cortex) of labeled vinpocetine were demonstrated by positron emission tomog. in primates and man.  Multicentric, randomized, placebo-controlled clin. studies proved the efficacy of orally administered vinpocetine in patients with org. psychosyndrome.  Recently positron emission tomog. studies have proved that vinpocetine is able to redistribute regional cerebral blood flow and enhance glucose supply of brain tissue in ischemic post-stroke patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFVCMjshLcbVg90H21EOLACvtfcHk0lhknr3KlJZ7og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslGgtrY%253D&md5=656c03dd9e9cd41a7638c6eb8674c5e4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0361-9230%2800%2900354-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0361-9230%252800%252900354-3%26sid%3Dliteratum%253Aachs%26aulast%3DBonoczk%26aufirst%3DP.%26aulast%3DGulyas%26aufirst%3DB.%26aulast%3DAdam-Vizi%26aufirst%3DV.%26aulast%3DNemes%26aufirst%3DA.%26aulast%3DKarpati%26aufirst%3DE.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DKapas%26aufirst%3DM.%26aulast%3DSzantay%26aufirst%3DC.%26aulast%3DKoncz%26aufirst%3DI.%26aulast%3DZelles%26aufirst%3DT.%26aulast%3DVas%26aufirst%3DA.%26atitle%3DRole%2520of%2520sodium%2520channel%2520inhibition%2520in%2520neuroprotection%253A%2520effect%2520of%2520vinpocetine%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2000%26volume%3D53%26spage%3D245%26epage%3D254%26doi%3D10.1016%2FS0361-9230%2800%2900354-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span> <span> </span><span class="NLM_article-title">Eburnamine derivatives and the brain</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">757</span>, <span class="refDoi"> DOI: 10.1002/med.20043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1002%2Fmed.20043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16158388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Sru7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=737-757&author=A.+Vasauthor=B.+Gulyas&title=Eburnamine+derivatives+and+the+brain&doi=10.1002%2Fmed.20043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Eburnamine derivatives and the brain</span></div><div class="casAuthors">Vas, Adam; Gulyas, Balazs</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">737-757</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Apocynaceae plant family contains a great no. of so called eburnamine-vincumine alkaloids.  Quite a few of these alkaloids exert varied pharmacol. activities on the cell multiplication, cardiovascular system, and brain functions.  Many derivs. were also synthesized to find pharmacol. active compds. better characterized and safer to be administered than the natural plant alkaloids themselves.  We conc. on the eburnamine structures with cerebral activities in this review.  Vincamine, vinburnine, vindeburnol, apovincaminate, and vinpocetine (cis-ethyl-apovincaminate) all share modulatory effects on brain circulation and neuronal homeostasis, bear antihypoxic and neuroprotective potencies to various degrees.  The most eminent compd. of this class of alkaloids is vinpocetine.  Since its introduction to the market as a neuroprotective agent many non clin. and clin. studies proved vinpocetine's effects on calmodulin dependent phosphodiesterase E1, on sodium, calcium channels, peripheral benzodiazepine receptor, and glutamate receptors as well as its clin. usefulness in the treatment of post-ischemic stroke disease states and various disorders of cerebrovascular origin.  Lately, positron emission tomog. studies proved that vinpocetine has a rapid uptake in the primate and human brain with a heterogenous distribution pattern (preference areas: thalamus, basal ganglia, and visual cortex) both after i.v. and oral administration.  Vinpocetine exerts beneficial effects in cerebral glucose metab. and regional cerebral blood flow in chronic post-stroke patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLyDJ8hXTg5rVg90H21EOLACvtfcHk0lj-XAfQnF6jug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Sru7fL&md5=105e483bb41cebbb36c513785da4492a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fmed.20043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20043%26sid%3Dliteratum%253Aachs%26aulast%3DVas%26aufirst%3DA.%26aulast%3DGulyas%26aufirst%3DB.%26atitle%3DEburnamine%2520derivatives%2520and%2520the%2520brain%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2005%26volume%3D25%26spage%3D737%26epage%3D757%26doi%3D10.1002%2Fmed.20043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedi, K. L.</span></span> <span> </span><span class="NLM_article-title">Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>620</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2009.08.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejphar.2009.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=19699735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGlt73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=620&publication_year=2009&pages=49-56&author=R.+Deshmukhauthor=V.+Sharmaauthor=S.+Mehanauthor=N.+Sharmaauthor=K.+L.+Bedi&title=Amelioration+of+intracerebroventricular+streptozotocin+induced+cognitive+dysfunction+and+oxidative+stress+by+vinpocetine+-+a+PDE1+inhibitor&doi=10.1016%2Fj.ejphar.2009.08.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor</span></div><div class="casAuthors">Deshmukh, Rahul; Sharma, Vivek; Mehan, Sidharth; Sharma, Nidhi; Bedi, K. L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">620</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enhancing cyclic nucleotides signaling by inhibition of phosphodiesterases (PDEs) is known to be beneficial in disorders assocd. with cognitive decline.  The present study was designed to investigate the effect of vinpocetine (PDE1 inhibitor) on intracerebroventricular (i.c.v.) streptozotocin induced exptl. sporadic dementia of Alzheimer's type.  Infusion of streptozotocin impaired learning and memory, increased oxidative-nitritive stress and induced cholinergic hypofunction in rats.  Chronic treatment with vinpocetine (5, 10 and 20 mg/kg i.p.) for 21 days following first i.c.v. streptozotocin infusion significantly improved learning and memory in Morris water maze and passive avoidance paradigms.  Further, vinpocetine significantly reduced the oxidative-nitritive stress, as evidenced by decrease in malondialdehyde (MDA) and nitrite levels, and restored the reduced glutathione (GSH) levels.  Significant increase in acetylcholinesterase activity and lactate dehydrogenase levels was obsd. in the present model indicating cholinergic hypofunction and increase in neuronal cell damage.  Chronic treatment with vinpocetine also reduced significantly the increase in acetylcholinesterase activity and lactate dehydrogenase levels indicating restorative capacity of vinpocetine with respect to cholinergic functions and preventing the neuronal damage.  The obsd. beneficial effects of vinpocetine on spatial memory may be due to its ability to favorably modulate cholinergic functions, prevent neuronal cell damage and possibly through its antioxidant mechanism also.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokMQmZ9Cf3ybVg90H21EOLACvtfcHk0lj-XAfQnF6jug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGlt73L&md5=59b849a1799de087fe52b8eb62605be5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DDeshmukh%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DMehan%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DBedi%26aufirst%3DK.%2BL.%26atitle%3DAmelioration%2520of%2520intracerebroventricular%2520streptozotocin%2520induced%2520cognitive%2520dysfunction%2520and%2520oxidative%2520stress%2520by%2520vinpocetine%2520-%2520a%2520PDE1%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D620%26spage%3D49%26epage%3D56%26doi%3D10.1016%2Fj.ejphar.2009.08.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polgar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vereczkey, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyary, I.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of vinpocetine and its metabolite, apovincaminic acid, in plasma and cerebrospinal fluid after intravenous infusion</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/0731-7085(85)80016-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2F0731-7085%2885%2980016-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16867695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BD28vksVGnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1985&pages=131-139&author=M.+Polgarauthor=L.+Vereczkeyauthor=I.+Nyary&title=Pharmacokinetics+of+vinpocetine+and+its+metabolite%2C+apovincaminic+acid%2C+in+plasma+and+cerebrospinal+fluid+after+intravenous+infusion&doi=10.1016%2F0731-7085%2885%2980016-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of vinpocetine and its metabolite, apovincaminic acid, in plasma and cerebrospinal fluid after intravenous infusion</span></div><div class="casAuthors">Polgar M; Vereczkey L; Nyary I</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmaceutical and biomedical analysis</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-9</span>
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    </div><div class="casAbstract">The pharmacokinetics of vinpocetine (ethyl apovincaminate, Cavinton) and its metabolite, apovincaminic acid, was studied in patients with cerebrovascular disorders.  Vinpocetine (1 mg/kg) was infused intravenously over 25 min.  The elimination half-life of the parent drug in plasma was 4.7+/-2.13 h.  Total clearance of vinpocetine was 0.79+/-0.1 1 h(-1) kg(-1).  The presence of vinpocetine in cerebrospinal fluid shows that the drug is able to pass through the blood-brain barrier and reach the central nervous system which is a possible site of action.  The maximum increase of cerebral blood flow (25%) was measured at 32 min after the start of the infusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlCzlURmC27dbHMBt0mMIXfW6udTcc2eamMwHyBV7BYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vksVGnsQ%253D%253D&md5=0c6b445421738cae19542472523a807f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0731-7085%2885%2980016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0731-7085%252885%252980016-9%26sid%3Dliteratum%253Aachs%26aulast%3DPolgar%26aufirst%3DM.%26aulast%3DVereczkey%26aufirst%3DL.%26aulast%3DNyary%26aufirst%3DI.%26atitle%3DPharmacokinetics%2520of%2520vinpocetine%2520and%2520its%2520metabolite%252C%2520apovincaminic%2520acid%252C%2520in%2520plasma%2520and%2520cerebrospinal%2520fluid%2520after%2520intravenous%2520infusion%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D1985%26volume%3D3%26spage%3D131%26epage%3D139%26doi%3D10.1016%2F0731-7085%2885%2980016-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hindmarch, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erzigkeit, H.</span></span> <span> </span><span class="NLM_article-title">Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes</span>. <i>Int. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1097/00004850-199100610-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1097%2F00004850-199100610-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=2071888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADyaK3Mzgt1Oktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=31-43&author=I.+Hindmarchauthor=H.+H.+Fuchsauthor=H.+Erzigkeit&title=Efficacy+and+tolerance+of+vinpocetine+in+ambulant+patients+suffering+from+mild+to+moderate+organic+psychosyndromes&doi=10.1097%2F00004850-199100610-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes</span></div><div class="casAuthors">Hindmarch I; Fuchs H H; Erzigkeit H</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-43</span>
        ISSN:<span class="NLM_cas:issn">0268-1315</span>.
    </div><div class="casAbstract">The efficacy and tolerance of orally administered vinpocetine was investigated in patients suffering from mild to moderate organic psychosyndromes including primary dementia.  Two hundred and three patients were included in a placebo-controlled, randomized double-blind, multicentre trial and received every day for 16 weeks either: 3 x 10 mg doses of vinpocetine, 3 x 20 mg doses of vinpocetine, or 3 x placebo.  Patients were assessed on ratings of clinical global impression, cognitive performance and on measures of the quality of life including depressive illness.  There were no clinically relevant side-effects reported and the frequencies of adverse events between patients treated with vinpocetine (30 mg or 60 mg) and placebo were comparable.  Statistically significant improvements were found in favour of both active treatment groups compared to placebo in both confirmatory evaluations of efficacy of treatment: the "Global Improvement" (on the CGI scale) and cognitive performance (SKT).  Vinpocetine was also superior to placebo in ratings of the "severity of illness".  This study demonstrates the usefulness and efficacy of vinpocetine in the management of patients with moderate organic psychosyndromes.  An apparently greater therapeutic efficacy of 3 x 10 mg vinpocetine compared with the higher vinpocetine dosage is statistically not significant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRImv0le3k4vOR_TJajKxJDfW6udTcc2eamMwHyBV7BYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3Mzgt1Oktg%253D%253D&md5=73e08f92c644e8ae2bc16e96652ff720</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1097%2F00004850-199100610-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004850-199100610-00005%26sid%3Dliteratum%253Aachs%26aulast%3DHindmarch%26aufirst%3DI.%26aulast%3DFuchs%26aufirst%3DH.%2BH.%26aulast%3DErzigkeit%26aufirst%3DH.%26atitle%3DEfficacy%2520and%2520tolerance%2520of%2520vinpocetine%2520in%2520ambulant%2520patients%2520suffering%2520from%2520mild%2520to%2520moderate%2520organic%2520psychosyndromes%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D1991%26volume%3D6%26spage%3D31%26epage%3D43%26doi%3D10.1097%2F00004850-199100610-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyser, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1164</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1149-1164&author=P.+Liauthor=H.+Zhengauthor=J.+Zhaoauthor=L.+Zhangauthor=W.+Yaoauthor=H.+Zhuauthor=J.+D.+Beardauthor=K.+Idaauthor=W.+Laneauthor=G.+Snellauthor=S.+Sogabeauthor=C.+J.+Heyserauthor=G.+L.+Snyderauthor=J.+P.+Hendrickauthor=K.+E.+Vanoverauthor=R.+E.+Davisauthor=L.+P.+Wennogle&title=Discovery+of+potent+and+selective+inhibitors+of+phosphodiesterase+1+for+the+treatment+of+cognitive+impairment+associated+with+neurodegenerative+and+neuropsychiatric+diseases&doi=10.1021%2Facs.jmedchem.5b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases</span></div><div class="casAuthors">Li, Peng; Zheng, Hailin; Zhao, Jun; Zhang, Lei; Yao, Wei; Zhu, Hongwen; Beard, J. David; Ida, Koh; Lane, Weston; Snell, Gyorgy; Sogabe, Satoshi; Heyser, Charles J.; Snyder, Gretchen L.; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert E.; Wennogle, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1149-1164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A diverse set of 3-aminopyrazolo[3,4-d]pyrimidinones was designed and synthesized.  The structure-activity relationships of these polycyclic compds. as phosphodiesterase 1 (PDE1) inhibitors were studied along with their physicochem. and pharmacokinetic properties.  Systematic optimizations of this novel scaffold culminated in the identification of a clin. candidate I, which exhibited picomolar inhibitory potency for PDE1, demonstrated excellent selectivity against all other PDE families and showed good efficacy in vivo.  Currently, this investigational new drug is in Phase I clin. development and being considered for the treatment of several indications including cognitive deficits assocd. with schizophrenia and Alzheimer's disease, movement disorders, attention deficit and hyperactivity disorders, and other central nervous system (CNS) and non-CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiqQuMoLsXnbVg90H21EOLACvtfcHk0liaYJ5YLW3yhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D&md5=73741521722dc906869ffa3504ceaf2e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01751%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBeard%26aufirst%3DJ.%2BD.%26aulast%3DIda%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DHeyser%26aufirst%3DC.%2BJ.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520phosphodiesterase%25201%2520for%2520the%2520treatment%2520of%2520cognitive%2520impairment%2520associated%2520with%2520neurodegenerative%2520and%2520neuropsychiatric%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1149%26epage%3D1164%26doi%3D10.1021%2Facs.jmedchem.5b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadenberg, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkerman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mates, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L. P.</span></span> <span> </span><span class="NLM_article-title">Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>233</i></span>,  <span class="NLM_fpage">3113</span>– <span class="NLM_lpage">3124</span>, <span class="refDoi"> DOI: 10.1007/s00213-016-4346-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1007%2Fs00213-016-4346-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=27342643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=2016&pages=3113-3124&author=G.+L.+Snyderauthor=J.+Prickaertsauthor=M.+L.+Wadenbergauthor=L.+Zhangauthor=H.+Zhengauthor=W.+Yaoauthor=S.+Akkermanauthor=H.+Zhuauthor=J.+P.+Hendrickauthor=K.+E.+Vanoverauthor=R.+Davisauthor=P.+Liauthor=S.+Matesauthor=L.+P.+Wennogle&title=Preclinical+profile+of+ITI-214%2C+an+inhibitor+of+phosphodiesterase+1%2C+for+enhancement+of+memory+performance+in+rats&doi=10.1007%2Fs00213-016-4346-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats</span></div><div class="casAuthors">Snyder, Gretchen L.; Prickaerts, Jos; Wadenberg, Marie-Louise; Zhang, Lei; Zheng, Hailin; Yao, Wei; Akkerman, Sven; Zhu, Hongwen; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert; Li, Peng; Mates, Sharon; Wennogle, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3113-3124</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Therapeutic agents for memory enhancement in psychiatric disorders, such as schizophrenia, are urgently needed.  Objective: The aim of this study is to characterize the preclin. profile of ITI-214, a potent inhibitor of phosphodiesterase 1 (PDE1).  Methods: ITI-214 was assayed for inhibition of PDE1 vs. other PDE enzyme families using recombinant human PDE enzymes and for off-target binding to 70 substrates (General SEP II diversity panel; Caliper Life Sciences).  Effects of ITI-214 (0.1-10 mg/kg, po) on memory performance were assayed in rats using the novel object recognition (NOR) paradigm, with drug given at specified time points prior to or following exposure to objects in an open field.  ITI-214 was evaluated for potential drug-drug interaction with risperidone in rats using conditioned avoidance response (CAR) and pharmacokinetic assessments.  Results: ITI-214 inhibited PDE1A (Ki = 33 pmol) with >1000-fold selectivity for the nearest other PDE family (PDE4D) and displayed minimal off-target binding interactions in a 70-substrate selectivity profile.  By using specific timing of oral ITI-214 administration, it was demonstrated in the NOR that ITI-214 is able to enhance acquisition, consolidation, and retrieval memory processes.  All memory effects were in the absence of effects on exploratory behavior.  ITI-214 did not disrupt the risperidone pharmacokinetic profile or effects in CAR.  Conclusions: ITI-214 improved the memory processes of acquisition, consolidation, and retrieval across a broad dose range (0.1-10 mg/kg, po) without disrupting the antipsychotic-like activity of a clin. antipsychotic medication, specifically risperidone.  Clin. development of ITI-214 is currently in progress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7eUb8S0yISLVg90H21EOLACvtfcHk0lh2vUYwuiMydw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnsLrF&md5=90f1653bd30aaf1ffe5a543f0181e4c1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00213-016-4346-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-016-4346-2%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DWadenberg%26aufirst%3DM.%2BL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DAkkerman%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DMates%26aufirst%3DS.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DPreclinical%2520profile%2520of%2520ITI-214%252C%2520an%2520inhibitor%2520of%2520phosphodiesterase%25201%252C%2520for%2520enhancement%2520of%2520memory%2520performance%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2016%26volume%3D233%26spage%3D3113%26epage%3D3124%26doi%3D10.1007%2Fs00213-016-4346-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span>Clinical trial study found in clinical trials for ITI-214:
NCT01900522. <a href="https://clinicaltrials.gov/ct2/show/NCT01900522?term=NCT01900522&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01900522?term=NCT01900522&rank=1</a> (accessed <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+ITI-214%3A%0ANCT01900522.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01900522%3Fterm%3DNCT01900522%26rank%3D1+%28accessed+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dyck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branstetter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharbaoui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitenbucher, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cedervall, E. P.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discovery of selective phosphodiesterase 1 inhibitors with memory enhancing properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3472</span>– <span class="NLM_lpage">3483</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvF2jsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3472-3483&author=B.+Dyckauthor=B.+Branstetterauthor=T.+Gharbaouiauthor=A.+R.+Hudsonauthor=J.+G.+Breitenbucherauthor=L.+Gomezauthor=E.+P.+Cedervall&title=Discovery+of+selective+phosphodiesterase+1+inhibitors+with+memory+enhancing+properties&doi=10.1021%2Facs.jmedchem.7b00302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties</span></div><div class="casAuthors">Dyck, Brian; Branstetter, Bryan; Gharbaoui, Tawfik; Hudson, Andrew R.; Breitenbucher, J. Guy; Gomez, Laurent; Botrous, Iriny; Marrone, Tami; Barido, Richard; Allerston, Charles K.; Cedervall, E. Peder; Xu, Rui; Sridhar, Vandana; Barker, Ryan; Aertgeerts, Kathleen; Schmelzer, Kara; Neul, David; Lee, Dong; Massari, Mark Eben; Andersen, Carsten B.; Sebring, Kristen; Zhou, Xianbo; Petroski, Robert; Limberis, James; Augustin, Martin; Chun, Lawrence E.; Edwards, Thomas E.; Peters, Marco; Tabatabaei, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3472-3483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of potent thienotriazolopyrimidinone-based PDE1 inhibitors was discovered.  X-ray crystal structures of example compds. from this series in complex with the catalytic domain of PDE1B and PDE10A were detd., allowing optimization of PDE1B potency and PDE selectivity.  Redn. of hERG affinity led to greater than a 3000-fold selectivity for PDE1B over hERG. 6-(4-Methoxybenzyl)-9-((tetrahydro-2H-pyran-4-yl)methyl)-8,9,10,11-tetrahydropyrido[4',3':4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one was identified as an orally bioavailable and brain penetrating PDE1B enzyme inhibitor with potent memory-enhancing effects in a rat model of object recognition memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX2wxwLW-OPLVg90H21EOLACvtfcHk0lh2vUYwuiMydw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvF2jsLk%253D&md5=ff7c3c08432646621c8d2cc32693e75f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00302%26sid%3Dliteratum%253Aachs%26aulast%3DDyck%26aufirst%3DB.%26aulast%3DBranstetter%26aufirst%3DB.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DHudson%26aufirst%3DA.%2BR.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26aulast%3DGomez%26aufirst%3DL.%26aulast%3DCedervall%26aufirst%3DE.%2BP.%26atitle%3DDiscovery%2520of%2520selective%2520phosphodiesterase%25201%2520inhibitors%2520with%2520memory%2520enhancing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3472%26epage%3D3483%26doi%3D10.1021%2Facs.jmedchem.7b00302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stangherlin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesellchen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoccarato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surdo, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaccolo, M.</span></span> <span> </span><span class="NLM_article-title">cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.110.230698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1161%2FCIRCRESAHA.110.230698" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=929-939&author=A.+Stangherlinauthor=F.+Gesellchenauthor=A.+Zoccaratoauthor=A.+Terrinauthor=L.+A.+Fieldsauthor=M.+Berreraauthor=N.+C.+Surdoauthor=M.+A.+Craigauthor=G.+Smithauthor=G.+Hamiltonauthor=M.+Zaccolo&title=cGMP+signals+modulate+cAMP+levels+in+a+compartment-specific+manner+to+regulate+catecholamine-dependent+signaling+in+cardiac+myocytes&doi=10.1161%2FCIRCRESAHA.110.230698"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.110.230698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.110.230698%26sid%3Dliteratum%253Aachs%26aulast%3DStangherlin%26aufirst%3DA.%26aulast%3DGesellchen%26aufirst%3DF.%26aulast%3DZoccarato%26aufirst%3DA.%26aulast%3DTerrin%26aufirst%3DA.%26aulast%3DFields%26aufirst%3DL.%2BA.%26aulast%3DBerrera%26aufirst%3DM.%26aulast%3DSurdo%26aufirst%3DN.%2BC.%26aulast%3DCraig%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DG.%26aulast%3DHamilton%26aufirst%3DG.%26aulast%3DZaccolo%26aufirst%3DM.%26atitle%3DcGMP%2520signals%2520modulate%2520cAMP%2520levels%2520in%2520a%2520compartment-specific%2520manner%2520to%2520regulate%2520catecholamine-dependent%2520signaling%2520in%2520cardiac%2520myocytes%26jtitle%3DCirc.%2520Res.%26date%3D2011%26volume%3D108%26spage%3D929%26epage%3D939%26doi%3D10.1161%2FCIRCRESAHA.110.230698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boss, F. G.</span>; <span class="NLM_string-name">Hendrix, M.</span>; <span class="NLM_string-name">Konig, G.</span>; <span class="NLM_string-name">Niewohner, U.</span>; <span class="NLM_string-name">Schlemmer, K.-H.</span>; <span class="NLM_string-name">Schreiber, R.</span>; <span class="NLM_string-name">Van Der Staay, F. J.</span>; <span class="NLM_string-name">Schauss, D.</span></span> <span> </span><span class="NLM_article-title">Selective Phosphodiesterase 2 Inhibitors Used as Medicaments for Improving Cognition</span>. <span class="NLM_patent">WO2002009713 A2</span>, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=F.+G.+Boss&author=M.+Hendrix&author=G.+Konig&author=U.+Niewohner&author=K.-H.+Schlemmer&author=R.+Schreiber&author=F.+J.+Van+Der+Staay&author=D.+Schauss&title=Selective+Phosphodiesterase+2+Inhibitors+Used+as+Medicaments+for+Improving+Cognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoss%26aufirst%3DF.%2BG.%26atitle%3DSelective%2520Phosphodiesterase%25202%2520Inhibitors%2520Used%2520as%2520Medicaments%2520for%2520Improving%2520Cognition%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boess, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Staay, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Staveren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vente, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, G.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2004.07.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2004.07.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1081-1092&author=F.+G.+Boessauthor=M.+Hendrixauthor=F.+J.+van+der+Staayauthor=C.+Erbauthor=R.+Schreiberauthor=W.+van+Staverenauthor=J.+de+Venteauthor=J.+Prickaertsauthor=A.+Bloklandauthor=G.+Koenig&title=Inhibition+of+phosphodiesterase+2+increases+neuronal+cGMP%2C+synaptic+plasticity+and+memory+performance&doi=10.1016%2Fj.neuropharm.2004.07.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2004.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2004.07.040%26sid%3Dliteratum%253Aachs%26aulast%3DBoess%26aufirst%3DF.%2BG.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3Dvan%2BStaveren%26aufirst%3DW.%26aulast%3Dde%2BVente%26aufirst%3DJ.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520phosphodiesterase%25202%2520increases%2520neuronal%2520cGMP%252C%2520synaptic%2520plasticity%2520and%2520memory%2520performance%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D47%26spage%3D1081%26epage%3D1092%26doi%3D10.1016%2Fj.neuropharm.2004.07.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Staay, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span> <span> </span><span class="NLM_article-title">Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>558</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2006.11.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejphar.2006.11.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=17207788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVGgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=558&publication_year=2007&pages=107-112&author=K.+Ruttenauthor=J.+Prickaertsauthor=M.+Hendrixauthor=F.+J.+van+der+Staayauthor=A.+Sikauthor=A.+Blokland&title=Time-dependent+involvement+of+cAMP+and+cGMP+in+consolidation+of+object+memory%3A+studies+using+selective+phosphodiesterase+type+2%2C+4+and+5+inhibitors&doi=10.1016%2Fj.ejphar.2006.11.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Time-dependent involvement of cAMP and cGMP in consolidation of object memory: Studies using selective phosphodiesterase type 2, 4 and 5 inhibitors</span></div><div class="casAuthors">Rutten, Kris; Prickaerts, Jos; Hendrix, Martin; van der Staay, F. Josef; Sik, Ayhan; Blokland, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">558</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">107-112</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study investigated the time-dependent memory enhancing properties of three selective phosphodiesterase inhibitors (PDE-I) vardenafil (PDE5-I), rolipram (PDE4-I) and BAY 60-7550 (PDE2-I) in the object recognition task.  In particular, the time-dependent involvement of cAMP and cGMP in memory consolidation was assessed by altering the time points of drug administration.  Vardenafil (1 mg/kg, p.o.), rolipram (0.03 mg/kg, i.p.), and BAY 60-7550 (3 mg/kg, p.o.) were tested in rats with a 24 h delay between the learning and the test trial.  The PDE-Is were administered at different time points, i.e. directly after, 1 h, 3 h and 6 h after the first trial.  Using a 24 h interval, vardenafil only showed an effect on object memory when injected directly after trial 1, rolipram only showed an improvement when injected 3 h after trial 1 and BAY 60-7550 improved memory when injected either directly after or 3 h after trial 1.  No treatment effects were found when the compds. were administered 1 h or 6 h after the first trial.  Our results extend our previous data that different types of PDE-Is affect different stages of memory consolidation.  Moreover, the present study provides further support that selective PDE-Is can influence memory consolidation in a time-dependent manner, assumingly by elevating central cAMP and cGMP levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEtk2Ty9RwdbVg90H21EOLACvtfcHk0lhWf9YVBDBWuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVGgtbs%253D&md5=cdfabbc2dc208ca9279d6804f626e0a3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.11.041%26sid%3Dliteratum%253Aachs%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DSik%26aufirst%3DA.%26aulast%3DBlokland%26aufirst%3DA.%26atitle%3DTime-dependent%2520involvement%2520of%2520cAMP%2520and%2520cGMP%2520in%2520consolidation%2520of%2520object%2520memory%253A%2520studies%2520using%2520selective%2520phosphodiesterase%2520type%25202%252C%25204%2520and%25205%2520inhibitors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D558%26spage%3D107%26epage%3D112%26doi%3D10.1016%2Fj.ejphar.2006.11.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domek-Lopacinska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strosznajder, J. B.</span></span> <span> </span><span class="NLM_article-title">The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1216</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2008.02.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.brainres.2008.02.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=18499090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVKku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1216&publication_year=2008&pages=68-77&author=K.+Domek-Lopacinskaauthor=J.+B.+Strosznajder&title=The+effect+of+selective+inhibition+of+cyclic+GMP+hydrolyzing+phosphodiesterases+2+and+5+on+learning+and+memory+processes+and+nitric+oxide+synthase+activity+in+brain+during+aging&doi=10.1016%2Fj.brainres.2008.02.108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging</span></div><div class="casAuthors">Domek-Lopacinska, K.; Strosznajder, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1216</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">68-77</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Our previous studies have shown that there is a lower cGMP concn. in the aged brain as well as an alteration in the activity of cGMP-hydrolyzing phosphodiesterases (PDEs) and nitric oxide synthase (NOS).  The aim of this study was to investigate the effect of specific inhibitors of selected PDEs on object recognition memory and locomotor activity during aging, and to correlate their action with NOS activity in the following brain regions: hippocampus, striatum, and cerebral cortex.  The study was carried out using 3, 12, and 24 mo-old rats.  Inhibitors of PDE2 and PDE5 (Bayer 60-7550 and zaprinast, resp.) were used.  Evaluation of memory and locomotor activity was carried out using an object recognition task and the open field test.  NOS activity was detd. using a radiochem. method after behavioral anal. in the cytosolic fraction from all brain areas investigated.  We have found that the inhibitor of PDE2, Bayer 60-7550, improves object recognition memory in all age groups investigated and increases basal constitutive NOS activity in the hippocampus and striatum.  Moreover, in 3 mo-old rats, addnl. inhibition of PDE5 by zaprinast improves object memory and elevates NOS activity in all brain regions studied.  Specific inhibition of nNOS eliminates the effect of Bayer 60-7550 on memory function and on NOS activity in 24 mo-old rats.  In summary, our results indicate that inhibition of PDE2 is able to improve cognition and memory function in 3, 12, and 24 mo-old rats through the enhancement of nNOS activity in the brain, whereas inhibition of PDE5 is effective only in 3 mo-old animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroSn1Uayy6qrVg90H21EOLACvtfcHk0ljhUzLzlSyyHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVKku7c%253D&md5=bbc77008c158141527bb046db313f6bf</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2008.02.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2008.02.108%26sid%3Dliteratum%253Aachs%26aulast%3DDomek-Lopacinska%26aufirst%3DK.%26aulast%3DStrosznajder%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520effect%2520of%2520selective%2520inhibition%2520of%2520cyclic%2520GMP%2520hydrolyzing%2520phosphodiesterases%25202%2520and%25205%2520on%2520learning%2520and%2520memory%2520processes%2520and%2520nitric%2520oxide%2520synthase%2520activity%2520in%2520brain%2520during%2520aging%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1216%26spage%3D68%26epage%3D77%26doi%3D10.1016%2Fj.brainres.2008.02.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Donkelaar, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrington, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbusch, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J. H.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1914</span>– <span class="NLM_lpage">1925</span>, <span class="refDoi"> DOI: 10.1038/npp.2009.24</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnpp.2009.24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=19262466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFSju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=1914-1925&author=K.+Ruttenauthor=E.+L.+Van+Donkelaarauthor=L.+Ferringtonauthor=A.+Bloklandauthor=E.+Bollenauthor=H.+W.+Steinbuschauthor=P.+A.+Kellyauthor=J.+H.+Prickaerts&title=Phosphodiesterase+inhibitors+enhance+object+memory+independent+of+cerebral+blood+flow+and+glucose+utilization+in+rats&doi=10.1038%2Fnpp.2009.24"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats</span></div><div class="casAuthors">Rutten, Kris; Van Donkelaar, Eva L.; Ferrington, Linda; Blokland, Arjan; Bollen, Eva; Steinbusch, Harry W. M.; Kelly, Paul A. T.; Prickaerts, Jos H. H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1914-1925</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) inhibitors prevent the breakdown of the second messengers, cAMP (cAMP) and cyclic GMP (cGMP), and are currently studied as possible targets for cognitive enhancement.  Earlier studies indicated beneficial effects of PDE inhibitors in object recognition.  In this study we tested the effects of three PDE inhibitors on spatial memory as assessed in a place and object recognition task.  Furthermore, as both cAMP and cGMP are known vasodilators, the effects of PDE inhibition on cognitive functions could be explained by enhancement of cerebrovascular function.  We examd. this possibility by measuring the effects of PDE5 and PDE4 inhibitor treatment on local cerebral blood flow and glucose utilization in rats using [14C]-iodoantipyrine and [14C]-2-deoxyglucose quant. autoradiog., resp.  In the spatial location task, PDE5 inhibition (cGMP) with vardenafil enhanced only early phase consolidation, PDE4 inhibition (cAMP) with rolipram enhanced only late phase consolidation, and PDE2 inhibition (cAMP and cGMP) with Bay 60-7550 enhanced both consolidation processes.  Furthermore, PDE5 inhibition had no cerebrovascular effects in hippocampal or rhinal areas.  PDE4 inhibition increased rhinal, but not hippocampal blood flow, whereas it decreased glucose utilization in both areas.  In general, PDE5 inhibition decreased the ratio between blood flow and glucose utilization, indicative of general oligemia; whereas PDE4 inhibition increased this ratio, indicative of general hyperemia.  Both oligemic and hyperemic conditions are detrimental for brain function and do not explain memory enhancement.  These results underscore the specific effects of cAMP and cGMP on memory consolidation (object and spatial memory) and provide evidence that the underlying mechanisms of PDE inhibition on cognition are independent of cerebrovascular effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfAElwT0GL1rVg90H21EOLACvtfcHk0ljhUzLzlSyyHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFSju7c%253D&md5=506d0fbcb1b4a7a0c25bf92ab08fc270</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2009.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2009.24%26sid%3Dliteratum%253Aachs%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DVan%2BDonkelaar%26aufirst%3DE.%2BL.%26aulast%3DFerrington%26aufirst%3DL.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DBollen%26aufirst%3DE.%26aulast%3DSteinbusch%26aufirst%3DH.%2BW.%26aulast%3DKelly%26aufirst%3DP.%2BA.%26aulast%3DPrickaerts%26aufirst%3DJ.%2BH.%26atitle%3DPhosphodiesterase%2520inhibitors%2520enhance%2520object%2520memory%2520independent%2520of%2520cerebral%2520blood%2520flow%2520and%2520glucose%2520utilization%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D1914%26epage%3D1925%26doi%3D10.1038%2Fnpp.2009.24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sierksma, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sydlik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostamian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbusch, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Hove, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer’s disease</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2012.06.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=124-136&author=A.+S.+Sierksmaauthor=K.+Ruttenauthor=S.+Sydlikauthor=S.+Rostamianauthor=H.+W.+Steinbuschauthor=D.+L.+van+den+Hoveauthor=J.+Prickaerts&title=Chronic+phosphodiesterase+type+2+inhibition+improves+memory+in+the+APPswe%2FPS1dE9+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuropharm.2012.06.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.048%26sid%3Dliteratum%253Aachs%26aulast%3DSierksma%26aufirst%3DA.%2BS.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DSydlik%26aufirst%3DS.%26aulast%3DRostamian%26aufirst%3DS.%26aulast%3DSteinbusch%26aufirst%3DH.%2BW.%26aulast%3Dvan%2Bden%2BHove%26aufirst%3DD.%2BL.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DChronic%2520phosphodiesterase%2520type%25202%2520inhibition%2520improves%2520memory%2520in%2520the%2520APPswe%252FPS1dE9%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D124%26epage%3D136%26doi%3D10.1016%2Fj.neuropharm.2012.06.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klabnik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">955</span>– <span class="NLM_lpage">970</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neurobiolaging.2014.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=25442113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsF2mu7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=955-970&author=Y.+Xuauthor=J.+Panauthor=J.+Sunauthor=L.+Dingauthor=L.+Ruanauthor=M.+Reedauthor=X.+Yuauthor=J.+Klabnikauthor=D.+Linauthor=J.+Liauthor=L.+Chenauthor=C.+Zhangauthor=H.+Zhangauthor=J.+M.+O%E2%80%99Donnell&title=Inhibition+of+phosphodiesterase+2+reverses+impaired+cognition+and+neuronal+remodeling+caused+by+chronic+stress&doi=10.1016%2Fj.neurobiolaging.2014.08.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress</span></div><div class="casAuthors">Xu, Ying; Pan, Jianchun; Sun, Jiao; Ding, Lianshu; Ruan, Lina; Reed, Miranda; Yu, Xuefeng; Klabni, Jonathan; Lin, Dan; Li, Jianxin; Chen, Ling; Zhang, Chong; Zhang, Hanting; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">955-970</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chronic stress and neuronal vulnerability have recently been recognized as factors contributing to cognitive disorders.  One way to modify neuronal vulnerability is through mediation of phosphodiesterase 2 (PDE2), an enzyme that exerts its action on cognitive processes via the control of intracellular second messengers, cGMP and, to a lesser extent, cAMP.  This study explored the effects of a PDE2 inhibitor, Bay 60-7550, on stress-induced learning and memory dysfunction in terms of its ramification on behavioral, morphol., and mol. changes.  Bay 60-7550 reversed stress-induced cognitive impairment in the Morris water maze, novel object recognition, and location tasks (object recognition test and/or object location test), effects prevented by treatment with 7-NI, a selective inhibitor of neuronal nitric oxide synthase; MK801, a glutamate receptor (NMDAR) inhibitor; myr-AIP, a CaMKII inhibitor; and KT5823, a protein kinase G inhibitor.  Bay 60-7550 also ameliorated stress-induced structural remodeling in the CA1 of the hippocampus, leading to increases in dendritic branching, length, and spine d.  However, the neuroplasticity initiated by Bay 60-7550 was not seen in the presence of 7-NI, MK801, myr-AIP, or KT5823.  PDE2 inhibition reduced stress-induced extracellular-regulated protein kinase activation and attenuated stress-induced decreases in transcription factors (e.g., Elk-1, TORC1, and CREB phosphorylation) and plasticity-related proteins (e.g., Egr-1 and brain-derived neurotrophic factor).  Pretreatment with inhibitors of NMDA, CaMKII, neuronal nitric oxide synthase, and protein kinase G (or protein kinase A) blocked the effects of Bay 60-7550 on cGMP or cAMP signaling.  These findings indicate that the effect of PDE2 inhibition on stress-induced memory impairment is potentially mediated via modulation of neuroplasticity-related NMDAR-CaMKII-cGMP/cAMP signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC4VvV9CfvU7Vg90H21EOLACvtfcHk0lixX5zFgjSy5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsF2mu7rL&md5=bd201c08a67c20c036958d7ed02cd25f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DRuan%26aufirst%3DL.%26aulast%3DReed%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DKlabnik%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520phosphodiesterase%25202%2520reverses%2520impaired%2520cognition%2520and%2520neuronal%2520remodeling%2520caused%2520by%2520chronic%2520stress%26jtitle%3DNeurobiol.%2520Aging%26date%3D2015%26volume%3D36%26spage%3D955%26epage%3D970%26doi%3D10.1016%2Fj.neurobiolaging.2014.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reneerkens, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hage, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbusch, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>236</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2012.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bbr.2012.08.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2013&pages=16-22&author=O.+A.+Reneerkensauthor=K.+Ruttenauthor=E.+Bollenauthor=T.+Hageauthor=A.+Bloklandauthor=H.+W.+Steinbuschauthor=J.+Prickaerts&title=Inhibition+of+phoshodiesterase+type+2+or+type+10+reverses+object+memory+deficits+induced+by+scopolamine+or+MK-801&doi=10.1016%2Fj.bbr.2012.08.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2012.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2012.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DReneerkens%26aufirst%3DO.%2BA.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBollen%26aufirst%3DE.%26aulast%3DHage%26aufirst%3DT.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DSteinbusch%26aufirst%3DH.%2BW.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520phoshodiesterase%2520type%25202%2520or%2520type%252010%2520reverses%2520object%2520memory%2520deficits%2520induced%2520by%2520scopolamine%2520or%2520MK-801%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2013%26volume%3D236%26spage%3D16%26epage%3D22%26doi%3D10.1016%2Fj.bbr.2012.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abarghaz, M.</span>; <span class="NLM_string-name">Biondi, S.</span>; <span class="NLM_string-name">Duranton, J.</span>; <span class="NLM_string-name">Limanton, E.</span>; <span class="NLM_string-name">Mondadori, C.</span>; <span class="NLM_string-name">Wagner, P.</span></span> <span> </span><span class="NLM_article-title">Benzo-1,4-diazepin-2-one Derivatives as Phosphodiesterase 2 Inhibitors, Preparation and Therapeutic Use Thereof</span>. <span class="NLM_patent">WO2005063723</span>, <span class="NLM_year">2005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+Abarghaz&author=S.+Biondi&author=J.+Duranton&author=E.+Limanton&author=C.+Mondadori&author=P.+Wagner&title=Benzo-1%2C4-diazepin-2-one+Derivatives+as+Phosphodiesterase+2+Inhibitors%2C+Preparation+and+Therapeutic+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAbarghaz%26aufirst%3DM.%26atitle%3DBenzo-1%252C4-diazepin-2-one%2520Derivatives%2520as%2520Phosphodiesterase%25202%2520Inhibitors%252C%2520Preparation%2520and%2520Therapeutic%2520Use%2520Thereof%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitenbucher, J. G.</span></span> <span> </span><span class="NLM_article-title">PDE2 inhibition: potential for the treatment of cognitive disorders</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6522</span>– <span class="NLM_lpage">6527</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bmcl.2013.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=24189054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslartbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6522-6527&author=L.+Gomezauthor=J.+G.+Breitenbucher&title=PDE2+inhibition%3A+potential+for+the+treatment+of+cognitive+disorders&doi=10.1016%2Fj.bmcl.2013.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">PDE2 inhibition: Potential for the treatment of cognitive disorders</span></div><div class="casAuthors">Gomez, Laurent; Breitenbucher, J. Guy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6522-6527</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase inhibition has received much attention in the past 20 years for the potential treatment of CNS disorders.  A primary focus of this work is the enhancement of memory and/or cognitive functioning.  The role of PDEs in the augmentation of cyclic nucleotide signaling makes these enzymes attractive targets for enhancing the effects of neuronal communication.  This review focuses on recent findings with respect to the role of PDE2 inhibition in cognitive functioning.  Special attention is paid to recently disclosed, selective tool compds. and the use of these tool compds. to support the role of PDE2 inhibition in cognition.  Recently reported SAR and modeling work will be presented along with discussion of the entry of new PDE2 inhibitors into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGUUFzh2-kTrVg90H21EOLACvtfcHk0lixX5zFgjSy5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslartbjL&md5=04ca2bdc35dc0b436a228ba62934b91e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%26aufirst%3DL.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DPDE2%2520inhibition%253A%2520potential%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6522%26epage%3D6527%26doi%3D10.1016%2Fj.bmcl.2013.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span>; <span class="NLM_string-name">Chappie, T. A.</span>; <span class="NLM_string-name">Humphrey, J. M.</span>; <span class="NLM_string-name">Verhoest, P. R.</span>; <span class="NLM_string-name">Yang, E.</span></span> <span> </span><span class="NLM_article-title">Imidazo[5,1-f][1,2,4]triazines for the Treatment of Neurological Disorders</span>. <span class="NLM_patent">US 20120214791</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+J.+Helal&author=T.+A.+Chappie&author=J.+M.+Humphrey&author=P.+R.+Verhoest&author=E.+Yang&title=Imidazo%5B5%2C1-f%5D%5B1%2C2%2C4%5Dtriazines+for+the+Treatment+of+Neurological+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26atitle%3DImidazo%255B5%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2520for%2520the%2520Treatment%2520of%2520Neurological%2520Disorders%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Fernandez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroker, K. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1002/syn.21840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1002%2Fsyn.21840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26178667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1elu7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=484-496&author=D.+Fernandez-Fernandezauthor=H.+Rosenbrockauthor=K.+S.+Kroker&title=Inhibition+of+PDE2A%2C+but+not+PDE9A%2C+modulates+presynaptic+short-term+plasticity+measured+by+paired-pulse+facilitation+in+the+CA1+region+of+the+hippocampus&doi=10.1002%2Fsyn.21840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus</span></div><div class="casAuthors">Fernandez-Fernandez, Diego; Rosenbrock, Holger; Kroker, Katja S.</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">484-496</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) inhibitors are currently considered promising therapeutic targets for treatment of cognitive impairment in diseases such as Schizophrenia and Alzheimer's disease.  Inhibitors of PDE2A and PDE9A have emerged as potential candidates shown to improve synaptic plasticity and memory function in animals.  However, the functional relevance of their putative different localization in the neuron is not understood.  Thus, this study aims at elucidating potential presynaptic effects of PDE2A inhibition in comparison to the inhibition of PDE9A.  For this purpose, we used paired-pulse facilitation (PPF), a model of short-term synaptic plasticity related to presynaptic function.  First, we performed a series of expts. to validate the model in acute rat hippocampal slices using several ref. substances including calcium channel blockers, glutamatergic receptor antagonists, and GPCR agonists.  Second, we analyzed the effect of PDE2A and PDE9A inhibition and their role regulating the influence that the second messengers cAMP and cGMP exert on basal transmission.  Our results show that the interplay between the adenylyl cyclase activator forskolin, the sol. guanylyl cyclase activator BAY 41-8543 and the PDE2A inhibitor PF-999 reveals a primarily presynaptic mechanism of action of PDE2A inhibition.  On the contrary, inhibition of PDE9A did not alter PPF under similar conditions.  In conclusion, these data provide new evidence supporting a role of PDE2A modulating short-term synaptic plasticity.  Moreover, this function of PDE2A is suggested to rely on an active modulation of the cAMP hydrolysis as a response to changes in cGMP levels at the presynaptic level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMx3KC2TNDKrVg90H21EOLACvtfcHk0lhB7nTW88_new"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1elu7vI&md5=990c6e54c53f4d8a08ae91d2fbdcef83</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21840%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Fernandez%26aufirst%3DD.%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DKroker%26aufirst%3DK.%2BS.%26atitle%3DInhibition%2520of%2520PDE2A%252C%2520but%2520not%2520PDE9A%252C%2520modulates%2520presynaptic%2520short-term%2520plasticity%2520measured%2520by%2520paired-pulse%2520facilitation%2520in%2520the%2520CA1%2520region%2520of%2520the%2520hippocampus%26jtitle%3DSynapse%26date%3D2015%26volume%3D69%26spage%3D484%26epage%3D496%26doi%3D10.1002%2Fsyn.21840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span> <span> </span><span class="NLM_article-title">Identification of a brain penetrant, highly selective phosphodiesterase 2A inhibitor for the treatment of cognitive impairment associated with schizophrenia (CIAS)</span>.  <i>Abstracts of Papers</i>, 244th National Meeting & Exposition of the American Chemical Society, Philadelphia, PA, U.S., August 19–23, 2012; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+J.+Helal&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26atitle%3DIdentification%2520of%2520a%2520brain%2520penetrant%252C%2520highly%2520selective%2520phosphodiesterase%25202A%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cognitive%2520impairment%2520associated%2520with%2520schizophrenia%2520%2528CIAS%2529%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span>Clinical
trial study found in clinical trials for PF-05180999: NCT01429740. <a href="https://clinicaltrials.gov/ct2/show/NCT01429740?term=PF-05180999&amp;rank=2" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01429740?term=PF-05180999&rank=2</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+PF-05180999%3A+NCT01429740.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01429740%3Fterm%3DPF-05180999%26rank%3D2+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span>Clinical trial study
found in clinical trials for PF-05180999: NCT01530529. <a href="https://clinicaltrials.gov/ct2/show/NCT01530529?term=PF-05180999&amp;rank=3" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01530529?term=PF-05180999&rank=3</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+PF-05180999%3A+NCT01530529.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01530529%3Fterm%3DPF-05180999%26rank%3D3+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyden, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kormos, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maklad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piotrowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. X.</span></span> <span> </span><span class="NLM_article-title">Application of structure-based design and parallel chemistry to identify a potent, selective, and brain penetrant phosphodiesterase 2A inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5673</span>– <span class="NLM_lpage">5698</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00397</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00397" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1Sitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5673-5698&author=C.+J.+Helalauthor=E.+P.+Arnoldauthor=T.+L.+Boydenauthor=C.+Changauthor=T.+A.+Chappieauthor=K.+F.+Fennellauthor=M.+D.+Formanauthor=M.+Hajosauthor=J.+F.+Harmsauthor=W.+E.+Hoffmanauthor=J.+M.+Humphreyauthor=Z.+Kangauthor=R.+J.+Kleimanauthor=B.+L.+Kormosauthor=C.+W.+Leeauthor=J.+Luauthor=N.+Makladauthor=L.+McDowellauthor=S.+Menteauthor=R.+E.+O%E2%80%99Connorauthor=J.+Panditauthor=M.+Piotrowskiauthor=A.+W.+Schmidtauthor=C.+J.+Schmidtauthor=H.+Uenoauthor=P.+R.+Verhoestauthor=E.+X.+Yang&title=Application+of+structure-based+design+and+parallel+chemistry+to+identify+a+potent%2C+selective%2C+and+brain+penetrant+phosphodiesterase+2A+inhibitor&doi=10.1021%2Facs.jmedchem.7b00397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor</span></div><div class="casAuthors">Helal, Christopher J.; Arnold, Eric P.; Boyden, Tracey L.; Chang, Cheng; Chappie, Thomas A.; Fennell, Kimberly F.; Forman, Michael D.; Hajos, Mihaly; Harms, John F.; Hoffman, William E.; Humphrey, John M.; Kang, Zhijun; Kleiman, Robin J.; Kormos, Bethany L.; Lee, Che-Wah; Lu, Jiemin; Maklad, Noha; McDowell, Laura; Mente, Scot; O'Connor, Rebecca E.; Pandit, Jayvardhan; Piotrowski, Mary; Schmidt, Anne W.; Schmidt, Christopher J.; Ueno, Hirokazu; Verhoest, Patrick R.; Yang, Edward X.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5673-5698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 2A (PDE2A) inhibitors have been reported to demonstrate in vivo activity in preclin. models of cognition.  To more fully explore the biol. of PDE2A inhibition, we sought to identify potent PDE2A inhibitors with improved brain penetration as compared to current literature compds.  Applying estd. human dose calcns. while simultaneously leveraging synthetically enabled chem. and structure-based drug design has resulted in a highly potent, selective, brain penetrant compd. 71 (PF-05085727) that effects in vivo biochem. changes commensurate with PDE2A inhibition along with behavioral and electrophysiol. reversal of the effects of NMDA antagonists in rodents.  This data supports the ability of PDE2A inhibitors to potentiate NMDA signaling and their further development for clin. cognition indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpZdZgTF6GMLVg90H21EOLACvtfcHk0lhB7nTW88_new"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1Sitb4%253D&md5=e1c3c778fc622ac2f5917625a983323f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00397%26sid%3Dliteratum%253Aachs%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DArnold%26aufirst%3DE.%2BP.%26aulast%3DBoyden%26aufirst%3DT.%2BL.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DFennell%26aufirst%3DK.%2BF.%26aulast%3DForman%26aufirst%3DM.%2BD.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DKang%26aufirst%3DZ.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DMcDowell%26aufirst%3DL.%26aulast%3DMente%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BE.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DPiotrowski%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DYang%26aufirst%3DE.%2BX.%26atitle%3DApplication%2520of%2520structure-based%2520design%2520and%2520parallel%2520chemistry%2520to%2520identify%2520a%2520potent%252C%2520selective%252C%2520and%2520brain%2520penetrant%2520phosphodiesterase%25202A%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5673%26epage%3D5698%26doi%3D10.1021%2Facs.jmedchem.7b00397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span>Clinical trial study found in clinical trials for TAK-915: NCT02584569. <a href="https://clinicaltrials.gov/ct2/show/NCT02584569?term=TAK-915&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02584569?term=TAK-915&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+TAK-915%3A+NCT02584569.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02584569%3Fterm%3DTAK-915%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span>Clinical trial study
found in clinical trials for TAK-915: NCT02461160. <a href="https://clinicaltrials.gov/ct2/show/NCT02461160?term=NCT02461160&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02461160?term=NCT02461160&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+TAK-915%3A+NCT02461160.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02461160%3Fterm%3DNCT02461160%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Movsesian, M.</span></span> <span> </span><span class="NLM_article-title">Novel approaches to targeting PDE3 in cardiovascular disease</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.pharmthera.2016.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=27108947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVOms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2016&pages=74-81&author=M.+Movsesian&title=Novel+approaches+to+targeting+PDE3+in+cardiovascular+disease&doi=10.1016%2Fj.pharmthera.2016.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Novel approaches to targeting PDE3 in cardiovascular disease</span></div><div class="casAuthors">Movsesian, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-81</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Inhibitors of PDE3, a family of dual-specificity cyclic nucleotide phosphodiesterases, are used clin. to increase cardiac contractility by raising intracellular cAMP content in cardiac myocytes and to reduce vascular resistance by increasing intracellular cGMP content in vascular smooth muscle myocytes.  When used in the treatment of patients with heart failure, PDE3 inhibitors are effective in the acute setting but increase sudden cardiac death with long-term administration, possibly reflecting pro-apoptotic and pro-hypertrophic consequences of increased cAMP-mediated signaling in cardiac myocytes.  CAMP-mediated signaling in cardiac myocytes is highly compartmentalized, and different phosphodiesterases, by controlling cAMP content in functionally discrete intracellular microcompartments, regulate different cAMP-mediated pathways.  Four variants/isoforms of PDE3 (PDE3A1, PDE3A2, PDE3A3, and PDE3B) are expressed in cardiac myocytes, and new exptl. results have demonstrated that these isoforms, which are differentially localized intracellularly through unique protein-protein interactions, control different physiol. responses.  While the catalytic regions of these isoforms may be too similar to allow the catalytic activity of each isoform to be selectively inhibited, targeting their unique protein-protein interactions may allow desired responses to be elicited without the adverse consequences that limit the usefulness of existing PDE3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpySUN0pntSI7Vg90H21EOLACvtfcHk0lhMRL7Q2Y-PFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVOms7g%253D&md5=6e933dbd53f91fb96ad1664b273d8d99</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DMovsesian%26aufirst%3DM.%26atitle%3DNovel%2520approaches%2520to%2520targeting%2520PDE3%2520in%2520cardiovascular%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D163%26spage%3D74%26epage%3D81%26doi%3D10.1016%2Fj.pharmthera.2016.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tokuchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hishikawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, K.</span></span> <span> </span><span class="NLM_article-title">Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer’s disease and reverting to normal cognition</span>. <i>J. Neurol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>346</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.jns.2014.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.jns.2014.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=25248955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BC2M7jvFKquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2014&pages=288-292&author=R.+Tokuchiauthor=N.+Hishikawaauthor=T.+Kurataauthor=K.+Satoauthor=S.+Konoauthor=T.+Yamashitaauthor=K.+Deguchiauthor=K.+Abe&title=Clinical+and+demographic+predictors+of+mild+cognitive+impairment+for+converting+to+Alzheimer%E2%80%99s+disease+and+reverting+to+normal+cognition&doi=10.1016%2Fj.jns.2014.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition</span></div><div class="casAuthors">Tokuchi Ryo; Hishikawa Nozomi; Sato Kota; Kono Syoichiro; Yamashita Toru; Deguchi Kentaro; Kurata Tomoko; Abe Koji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the neurological sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">288-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To identify clinical and demographic predictors for mild cognitive impairment (MCI) conversion to Alzheimer's disease (AD) or reversion to normal cognition, and sustained MCI.  METHODS:  In total, 74 baseline MCI subjects were retrospectively investigated and categorized into three subgroups: conversion to AD, sustained MCI, or reversion to normal cognition during one year.  The clinical and demographic characteristics assessed were age, gender, educational attainment, vascular risk factors, white matter lesions (WMLs), and parahippocampal gyrus atrophy (PGA), analyzed by magnetic resonance imaging (MRI) using the voxel-based specific regional analysis system for AD (VSRAD).  RESULTS:  Of the 74 MCI subjects, 29 (39.2%) were classified as "converters", 39 (52.7%) as "sustained MCI", and 6 (8.1%) as "reverters".  Among the three subgroups, there were significant differences in educational attainment (years) (*p = 0.03), baseline mini-mental state examination (MMSE) scores (***p<0.001), and periventricular and deep white matter hyperintensity grades (*p = 0.02 and *p = 0.03, respectively).  Baseline PGA showed a significant increasing trend among the three subgroups (reverters<sustained MCI<converters, (###)p<0.001).  MCI subjects with higher educational attainment and low VSRAD Z-scores without WMLs were associated with reversion to normal cognitive function.  CONCLUSIONS:  Risk factors for MCI conversion to AD were low educational attainment, low baseline MMSE scores, high grade WMLs, and high VSRAD Z-scores.  High educational attainment, low VSRAD Z-scores, and no WMLs characterized reversion to normal cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDOQFApSkp6lZoq0fPSOTvfW6udTcc2ebZITgiyHHKdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7jvFKquw%253D%253D&md5=71ce876e1635cd1b5ae8ffe4b3bc5c84</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.jns.2014.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jns.2014.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DTokuchi%26aufirst%3DR.%26aulast%3DHishikawa%26aufirst%3DN.%26aulast%3DKurata%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DKono%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DDeguchi%26aufirst%3DK.%26aulast%3DAbe%26aufirst%3DK.%26atitle%3DClinical%2520and%2520demographic%2520predictors%2520of%2520mild%2520cognitive%2520impairment%2520for%2520converting%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520reverting%2520to%2520normal%2520cognition%26jtitle%3DJ.%2520Neurol.%2520Sci.%26date%3D2014%26volume%3D346%26spage%3D288%26epage%3D292%26doi%3D10.1016%2Fj.jns.2014.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jellinger, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attems, J.</span></span> <span> </span><span class="NLM_article-title">Prevalence of dementia disorders in the oldest-old: an autopsy study</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1007/s00401-010-0654-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1007%2Fs00401-010-0654-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2010&pages=421-433&author=K.+A.+Jellingerauthor=J.+Attems&title=Prevalence+of+dementia+disorders+in+the+oldest-old%3A+an+autopsy+study&doi=10.1007%2Fs00401-010-0654-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs00401-010-0654-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-010-0654-5%26sid%3Dliteratum%253Aachs%26aulast%3DJellinger%26aufirst%3DK.%2BA.%26aulast%3DAttems%26aufirst%3DJ.%26atitle%3DPrevalence%2520of%2520dementia%2520disorders%2520in%2520the%2520oldest-old%253A%2520an%2520autopsy%2520study%26jtitle%3DActa%2520Neuropathol.%26date%3D2010%26volume%3D119%26spage%3D421%26epage%3D433%26doi%3D10.1007%2Fs00401-010-0654-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanzi, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moir, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S. L.</span></span> <span> </span><span class="NLM_article-title">Clearance of Alzheimer’s Abeta peptide: the many roads to perdition</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2004.08.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuron.2004.08.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=605-608&author=R.+E.+Tanziauthor=R.+D.+Moirauthor=S.+L.+Wagner&title=Clearance+of+Alzheimer%E2%80%99s+Abeta+peptide%3A+the+many+roads+to+perdition&doi=10.1016%2Fj.neuron.2004.08.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2004.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2004.08.024%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DMoir%26aufirst%3DR.%2BD.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DClearance%2520of%2520Alzheimer%25E2%2580%2599s%2520Abeta%2520peptide%253A%2520the%2520many%2520roads%2520to%2520perdition%26jtitle%3DNeuron%26date%3D2004%26volume%3D43%26spage%3D605%26epage%3D608%26doi%3D10.1016%2Fj.neuron.2004.08.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalaria, R. N.</span></span> <span> </span><span class="NLM_article-title">The role of cerebral ischemia in Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1016/S0197-4580(00)00125-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2FS0197-4580%2800%2900125-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10867217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BD3cvgs1eltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=321-330&author=R.+N.+Kalaria&title=The+role+of+cerebral+ischemia+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0197-4580%2800%2900125-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The role of cerebral ischemia in Alzheimer's disease</span></div><div class="casAuthors">Kalaria R N</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of aging</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-30</span>
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    </div><div class="casAbstract">The Alzheimer type of dementia and stroke are known to increase at comparable rates with age.  Recent advances suggest that vascular risk factors linked to cerebrovascular disease and stroke in the elderly significantly increase the risk of developing Alzheimer's disease (AD).  These include atherosclerosis, atrial fibrillation, coronary artery disease, hypertension, and diabetes mellitus.  Moreover, review of various autopsy series shows that 60-90% of AD cases exhibit variable cerebrovascular pathology.  Although some vascular lesions such as cerebral amyloid angiopathy, endothelial degeneration, and periventricular white matter lesions are evident in most cases of AD, a third will exhibit cerebral infarction.  Despite the interpretation of pathological evidence, longitudinal clinical studies suggest that the co-existence of stroke and AD occurs more than by chance alone.  Strokes known to occur in patients with Alzheimer syndrome and most frequently in the oldest old substantially worsen cognitive decline and outcome, implicating some interaction between the disorders.  Nevertheless, the nature of a true relationship between the two disorders seems little explored.  What predisposes to strokes in underlying cognitive decline or AD? Is it possible that cerebral ischemia is a causal factor for AD? I examined several vascular factors and the vascular pathophysiology implicated in stroke and AD, and propose that cerebral ischemia or oligemia may promote Alzheimer type of changes in the aging brain.  Irrespective of the ultimate pathogenetic mechanism, these approaches implicate that management of peripheral vascular disease is important in the treatment or prevention of Alzheimer's disease or mixed dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtwE-qlOsc2aqcneEtCi92fW6udTcc2ea9ifhYSehrlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3cvgs1eltg%253D%253D&md5=8a852961b34f99767becbf60a8b74bdd</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2800%2900125-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252800%252900125-1%26sid%3Dliteratum%253Aachs%26aulast%3DKalaria%26aufirst%3DR.%2BN.%26atitle%3DThe%2520role%2520of%2520cerebral%2520ischemia%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2000%26volume%3D21%26spage%3D321%26epage%3D330%26doi%3D10.1016%2FS0197-4580%2800%2900125-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. S.</span></span> <span> </span><span class="NLM_article-title">Cilostazol: therapeutic potential against focal cerebral ischemic damage</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.2174/138161206775474323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.2174%2F138161206775474323" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=565-573&author=K.+W.+Hongauthor=J.+H.+Leeauthor=K.+Y.+Kimauthor=S.+Y.+Parkauthor=W.+S.+Lee&title=Cilostazol%3A+therapeutic+potential+against+focal+cerebral+ischemic+damage&doi=10.2174%2F138161206775474323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2174%2F138161206775474323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775474323%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DK.%2BY.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DW.%2BS.%26atitle%3DCilostazol%253A%2520therapeutic%2520potential%2520against%2520focal%2520cerebral%2520ischemic%2520damage%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D565%26epage%3D573%26doi%3D10.2174%2F138161206775474323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takiguchi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span> <span> </span><span class="NLM_article-title">Cilostazol prevents amyloid beta peptide(25-35)-induced memory impairment and oxidative stress in mice</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">1899</span>– <span class="NLM_lpage">1912</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.01014.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fj.1476-5381.2010.01014.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20825411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWhsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2010&pages=1899-1912&author=M.+Hiramatsuauthor=O.+Takiguchiauthor=A.+Nishiyamaauthor=H.+Mori&title=Cilostazol+prevents+amyloid+beta+peptide%2825-35%29-induced+memory+impairment+and+oxidative+stress+in+mice&doi=10.1111%2Fj.1476-5381.2010.01014.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol prevents amyloid β peptide25-35-induced memory impairment and oxidative stress in mice</span></div><div class="casAuthors">Hiramatsu, Masayuki; Takiguchi, Osanao; Nishiyama, Aki; Mori, Hiromasa</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1899-1912</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Cilostazol may be effective in dementia assocd. with a cerebral ischemia.  In this study, we examd. whether it exerts beneficial effects on learning and/or memory impairment induced by Aβ25-35 in mice, and compared its effects with those of aspirin.  Aβ25-35 (9 nmol) was administered to mice i.c.v.  Learning and memory behavior were evaluated by measuring spontaneous alternation in a Y-maze and a step-down type passive avoidance test, on the 5th and 8th days after injection resp.  Levels of lipid peroxidn. (malondialdehyde) and cytokines in the frontal cortex and hippocampus were measured 2, 3, 5 and 7 days after the Aβ25-35 injection.  The effects of repeated administration of cilostazol and aspirin (both at 30 and 100 mg/kg-1, p.o.) on any changes induced by Aβ25-35 were evaluated.  Repeated administration of cilostazol significantly attenuated the impairment of spontaneous alternation and the shortened step-down latency induced by Aβ25-35.  Aspirin did not show any beneficial effect.  A significant increase in the levels of malondialdehyde (MDA) and IL-1β (only measured in hippocampus) was obsd. 2, 3 and 5 days after the Aβ25-35 injection in the frontal cortex and hippocampus.  Repeated administration of cilostazol (100 mg/kg-1) completely prevented the increase in MDA levels but failed to antagonize the increase in the expression of IL-1β induced by Aβ25-35.  These results suggest that the protective effect of cilostazol on Aβ25-35-induced memory impairment may be related to oxidative stress in the frontal cortex and the hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo29phkvEihHLVg90H21EOLACvtfcHk0liMjhH5U4Iu0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWhsb%252FK&md5=d3e02a6445fdea4e98b023cf78f4c2a0</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.01014.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.01014.x%26sid%3Dliteratum%253Aachs%26aulast%3DHiramatsu%26aufirst%3DM.%26aulast%3DTakiguchi%26aufirst%3DO.%26aulast%3DNishiyama%26aufirst%3DA.%26aulast%3DMori%26aufirst%3DH.%26atitle%3DCilostazol%2520prevents%2520amyloid%2520beta%2520peptide%252825-35%2529-induced%2520memory%2520impairment%2520and%2520oxidative%2520stress%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D161%26spage%3D1899%26epage%3D1912%26doi%3D10.1111%2Fj.1476-5381.2010.01014.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leem, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H. K.</span></span> <span> </span><span class="NLM_article-title">Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid beta-induced cognitive deficits associated with decreased amyloid beta accumulation</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2011.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bbrc.2011.04.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2011&pages=602-608&author=S.+H.+Parkauthor=J.+H.+Kimauthor=S.+S.+Baeauthor=K.+W.+Hongauthor=D.+S.+Leeauthor=J.+Y.+Leemauthor=B.+T.+Choiauthor=H.+K.+Shin&title=Protective+effect+of+the+phosphodiesterase+III+inhibitor+cilostazol+on+amyloid+beta-induced+cognitive+deficits+associated+with+decreased+amyloid+beta+accumulation&doi=10.1016%2Fj.bbrc.2011.04.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2011.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2011.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DBae%26aufirst%3DS.%2BS.%26aulast%3DHong%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DLeem%26aufirst%3DJ.%2BY.%26aulast%3DChoi%26aufirst%3DB.%2BT.%26aulast%3DShin%26aufirst%3DH.%2BK.%26atitle%3DProtective%2520effect%2520of%2520the%2520phosphodiesterase%2520III%2520inhibitor%2520cilostazol%2520on%2520amyloid%2520beta-induced%2520cognitive%2520deficits%2520associated%2520with%2520decreased%2520amyloid%2520beta%2520accumulation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D408%26spage%3D602%26epage%3D608%26doi%3D10.1016%2Fj.bbrc.2011.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span> <span> </span><span class="NLM_article-title">A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study</span>. <i>Am. J. Geriatr. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1097/JGP.0b013e31819431ea</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1097%2FJGP.0b013e31819431ea" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=19307864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ivVCgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=353-354&author=H.+Araiauthor=T.+Takahashi&title=A+combination+therapy+of+donepezil+and+cilostazol+for+patients+with+moderate+Alzheimer+disease%3A+pilot+follow-up+study&doi=10.1097%2FJGP.0b013e31819431ea"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study</span></div><div class="casAuthors">Arai Heii; Takahashi Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCx1PkgV5nGvEeosoOnpOLfW6udTcc2ea9ifhYSehrlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ivVCgsw%253D%253D&md5=722b0e9a3896ed1fcc3161ff5ec31d93</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1097%2FJGP.0b013e31819431ea&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJGP.0b013e31819431ea%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DT.%26atitle%3DA%2520combination%2520therapy%2520of%2520donepezil%2520and%2520cilostazol%2520for%2520patients%2520with%2520moderate%2520Alzheimer%2520disease%253A%2520pilot%2520follow-up%2520study%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Psychiatry%26date%3D2009%26volume%3D17%26spage%3D353%26epage%3D354%26doi%3D10.1097%2FJGP.0b013e31819431ea" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, M.</span></span> <span> </span><span class="NLM_article-title">Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e89516</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0089516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1371%2Fjournal.pone.0089516" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e89516&author=M.+Iharaauthor=M.+Nishinoauthor=A.+Taguchiauthor=Y.+Yamamotoauthor=Y.+Hattoriauthor=S.+Saitoauthor=Y.+Takahashiauthor=M.+Tsujiauthor=Y.+Kasaharaauthor=Y.+Takataauthor=M.+Okada&title=Cilostazol+add-on+therapy+in+patients+with+mild+dementia+receiving+donepezil%3A+a+retrospective+study&doi=10.1371%2Fjournal.pone.0089516"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0089516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0089516%26sid%3Dliteratum%253Aachs%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DNishino%26aufirst%3DM.%26aulast%3DTaguchi%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DM.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DTakata%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DM.%26atitle%3DCilostazol%2520add-on%2520therapy%2520in%2520patients%2520with%2520mild%2520dementia%2520receiving%2520donepezil%253A%2520a%2520retrospective%2520study%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De89516%26doi%3D10.1371%2Fjournal.pone.0089516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, M.</span></span> <span> </span><span class="NLM_article-title">Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis</span>. <i>Psychogeriatrics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1111/psyg.12021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fpsyg.12021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=25707423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BC2Mrot1ajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=164-169&author=A.+Taguchiauthor=Y.+Takataauthor=M.+Iharaauthor=Y.+Kasaharaauthor=M.+Tsujiauthor=M.+Nishinoauthor=D.+Sternauthor=M.+Okada&title=Cilostazol+improves+cognitive+function+in+patients+with+mild+cognitive+impairment%3A+a+retrospective+analysis&doi=10.1111%2Fpsyg.12021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis</span></div><div class="casAuthors">Taguchi Akihiko; Takata Yu; Ihara Masafumi; Kasahara Yukiko; Tsuji Masahiro; Nishino Madoka; Stern David; Okada Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">164-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Cerebral ischemia and accumulation of amyloid β (Aβ) are major risk factors for the development of dementia, including vascular dementia and Alzheimer's disease.  Cilostazol, an antiplatelet drug, has been shown to improve cerebral circulation and reduce accumulation of Aβ.  In this study, the long-term effect of cilostazol on cognitive function was investigated retrospectively.  METHODS:  Medical records at Sumotoitsuki Hospital were surveyed to find all patients treated with cilostazol and evaluated by the Mini-Mental State Examination (MMSE) during at least two visits separated by an interval of more than 6 months.  Patients receiving anti-dementia drugs were excluded.  Temporal changes in MMSE scores were compared between patients treated with cilostazol (n = 70) and those who ceased administration of this drug (n = 22).  The mean follow-up period was 691 days.  RESULTS:  Decrease in MMSE score was significantly ameliorated by administration of cilostazol.  Subgroup analysis revealed that cilostazol significantly improved MMSE score in patients with mild cognitive impairment, though no significant effect was observed in patients with normal cognitive function or dementia.  CONCLUSIONS:  Although there are limitations to such a retrospective study, these results significantly encourage undertaking a prospective cohort study to determine the effect of cilostazol on mild cognitive impairment where no treatments currently exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkwhSfdrbgnCXXDYhVZBdlfW6udTcc2eZ5d1Vb9RzwX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mrot1ajsw%253D%253D&md5=96c6a6e5803056c9a9c96d4f28376871</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1111%2Fpsyg.12021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpsyg.12021%26sid%3Dliteratum%253Aachs%26aulast%3DTaguchi%26aufirst%3DA.%26aulast%3DTakata%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DM.%26aulast%3DNishino%26aufirst%3DM.%26aulast%3DStern%26aufirst%3DD.%26aulast%3DOkada%26aufirst%3DM.%26atitle%3DCilostazol%2520improves%2520cognitive%2520function%2520in%2520patients%2520with%2520mild%2520cognitive%2520impairment%253A%2520a%2520retrospective%2520analysis%26jtitle%3DPsychogeriatrics%26date%3D2013%26volume%3D13%26spage%3D164%26epage%3D169%26doi%3D10.1111%2Fpsyg.12021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hishikawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, K.</span></span> <span> </span><span class="NLM_article-title">Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer’s disease with asymptomatic lacunar infarction</span>. <i>Geriatr. Gerontol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1384</span>– <span class="NLM_lpage">1391</span>, <span class="refDoi"> DOI: 10.1111/ggi.12870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fggi.12870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=27578455" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=1384-1391&issue=10&author=N.+Hishikawaauthor=Y.+Fukuiauthor=K.+Satoauthor=Y.+Ohtaauthor=T.+Yamashitaauthor=K.+Abe&title=Comprehensive+effects+of+galantamine+and+cilostazol+combination+therapy+on+patients+with+Alzheimer%E2%80%99s+disease+with+asymptomatic+lacunar+infarction&doi=10.1111%2Fggi.12870"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1111%2Fggi.12870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fggi.12870%26sid%3Dliteratum%253Aachs%26aulast%3DHishikawa%26aufirst%3DN.%26aulast%3DFukui%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DOhta%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DAbe%26aufirst%3DK.%26atitle%3DComprehensive%2520effects%2520of%2520galantamine%2520and%2520cilostazol%2520combination%2520therapy%2520on%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520asymptomatic%2520lacunar%2520infarction%26jtitle%3DGeriatr.%2520Gerontol.%2520Int.%26date%3D2016%26volume%3D17%26issue%3D10%26spage%3D1384%26epage%3D1391%26doi%3D10.1111%2Fggi.12870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tai, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. H.</span></span> <span> </span><span class="NLM_article-title">Cilostazol use is associated with reduced risk of dementia: a nationwide cohort study</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">784</span>, <span class="refDoi"> DOI: 10.1007/s13311-017-0512-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1007%2Fs13311-017-0512-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=28194663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVaqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=784&author=S.+Y.+Taiauthor=C.+Y.+Chienauthor=Y.+H.+Changauthor=Y.+H.+Yang&title=Cilostazol+use+is+associated+with+reduced+risk+of+dementia%3A+a+nationwide+cohort+study&doi=10.1007%2Fs13311-017-0512-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study</span></div><div class="casAuthors">Tai, Shu-Yu; Chien, Chen-Yu; Chang, Yu-Han; Yang, Yuan-Han</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">784-791</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Whether antiplatelet agents have a preventive effect on cognitive function remains unknown.  We examd. the potential assocn. between the use of cilostazol, an antiplatelet agent and cyclic adenosine monophosphate phosphodiesterase 3 inhibitor, and the risk of dementia in an Asian population.  Patients initiating cilostazol therapy between 1 Jan. 2004 and 31 Dec. 2009 without a prior history of dementia were identified from Taiwan's National Health Insurance database.  Participants were stratified by age, sex, comorbidities, and comedication.  The outcome of interest was all-cause dementia (ICD-9-CM codes 290.0, 290.4, 294.1, 331.0).  Cox regression models were used to est. the hazard ratio (HR) of dementia.  The cumulative cilostazol dosage was stratified by quartile of defined daily doses using no cilostazol use as a ref.  A total of 9148 participants 40 years of age or older and free of dementia at baseline were analyzed.  Patients using cilostazol (n = 2287) had a significantly decreased risk of incident dementia compared with patients not using the drug [n = 6861; adjusted HR (aHR) 0.75; 95% confidence interval (CI) 0.61-0.92].  Notably, cilostazol use was found to have a dose-dependent assocn. with reduced rate of dementia emergence (p for trend = 0.001).  Subgroup anal. identified a decline of dementia in cilostazol users with diagnosed ischemic heart disease (aHR 0.44, 95% CI 0.24-0.83) and cerebral vascular disease (aHR 0.34, 95% CI 0.21-0.54).  These observations suggest that cilostazol use may reduce the risk to develop dementia, and a high cumulative dose further decreases the risk of dementia.  These findings should be examd. further in randomized clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ZP4x682GkLVg90H21EOLACvtfcHk0lgU46_jl06oCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVaqs78%253D&md5=d5867d3221d14af26c08fe9d65fc8cca</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1007%2Fs13311-017-0512-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-017-0512-4%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DS.%2BY.%26aulast%3DChien%26aufirst%3DC.%2BY.%26aulast%3DChang%26aufirst%3DY.%2BH.%26aulast%3DYang%26aufirst%3DY.%2BH.%26atitle%3DCilostazol%2520use%2520is%2520associated%2520with%2520reduced%2520risk%2520of%2520dementia%253A%2520a%2520nationwide%2520cohort%2520study%26jtitle%3DNeurotherapeutics%26date%3D2017%26volume%3D14%26spage%3D784%26doi%3D10.1007%2Fs13311-017-0512-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span>Clinical trial study found in clinical trials for Cilostazol:
NCT01409564. <a href="https://clinicaltrials.gov/ct2/show/NCT01409564?term=Cilostazol&amp;draw=3&amp;rank=12" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01409564?term=Cilostazol&draw=3&rank=12</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+Cilostazol%3A%0ANCT01409564.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01409564%3Fterm%3DCilostazol%26draw%3D3%26rank%3D12+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span>Clinical trial study
found in clinical trials for Cilostazol: NCT02491268. <a href="https://clinicaltrials.gov/ct2/show/NCT02491268?term=Cilostazol&amp;draw=3&amp;rank=37" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02491268?term=Cilostazol&draw=3&rank=37</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+Cilostazol%3A+NCT02491268.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02491268%3Fterm%3DCilostazol%26draw%3D3%26rank%3D37+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLachlan, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynex, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S. K.</span></span> <span> </span><span class="NLM_article-title">Changes in PDE4D isoforms in the hippocampus of a patient with advanced Alzheimer disease</span>. <i>Arch. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1001/archneur.64.3.456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1001%2Farchneur.64.3.456" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=17353396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ltlWhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=456-457&author=C.+S.+McLachlanauthor=M.+L.+Chenauthor=C.+N.+Lynexauthor=D.+L.+Gohauthor=S.+Brennerauthor=S.+K.+Tay&title=Changes+in+PDE4D+isoforms+in+the+hippocampus+of+a+patient+with+advanced+Alzheimer+disease&doi=10.1001%2Farchneur.64.3.456"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in PDE4D isoforms in the hippocampus of a patient with advanced Alzheimer disease</span></div><div class="casAuthors">McLachlan Craig S; Chen Melissa L; Lynex Clare N; Goh Denise L M; Brenner Sydney; Tay Stacey K H</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">456-7</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR80keTmBw1i4hLSh9fo81bfW6udTcc2eaQC_kz0UttU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ltlWhtw%253D%253D&md5=54ff9fefa37f74e59ae19d4c1c092795</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1001%2Farchneur.64.3.456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.64.3.456%26sid%3Dliteratum%253Aachs%26aulast%3DMcLachlan%26aufirst%3DC.%2BS.%26aulast%3DChen%26aufirst%3DM.%2BL.%26aulast%3DLynex%26aufirst%3DC.%2BN.%26aulast%3DGoh%26aufirst%3DD.%2BL.%26aulast%3DBrenner%26aufirst%3DS.%26aulast%3DTay%26aufirst%3DS.%2BK.%26atitle%3DChanges%2520in%2520PDE4D%2520isoforms%2520in%2520the%2520hippocampus%2520of%2520a%2520patient%2520with%2520advanced%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2007%26volume%3D64%26spage%3D456%26epage%3D457%26doi%3D10.1001%2Farchneur.64.3.456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spina, D.</span></span> <span> </span><span class="NLM_article-title">PDE4 inhibitors: current status</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1038/bjp.2008.307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fbjp.2008.307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=18660825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFKkurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2008&pages=308-315&author=D.+Spina&title=PDE4+inhibitors%3A+current+status&doi=10.1038%2Fbjp.2008.307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">PDE4 inhibitors: current status</span></div><div class="casAuthors">Spina, D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-315</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 4 (PDE4) inhibitors are currently under development for the treatment of respiratory diseases including asthma and chronic obstructive pulmonary disease.  The rationale for the development of this drug class stems from our understanding of the role of PDE4 in suppressing the function of a range of inflammatory and resident cells thought to contribute toward the pathogenesis of these diseases.  Similarly, numerous preclin. in vivo studies have shown that PDE4 inhibitors suppress characteristic features of these diseases, namely, cell recruitment, activation of inflammatory cells and physiol. changes in lung function in response to a range of insults to the airways.  These potentially beneficial actions of PDE4 inhibitors have been successfully translated in phase II and III clin. trials with roflumilast and cilomilast.  However, dose limiting side effects of nausea, diarrhea and headache have tempered the enthusiasm of this drug class for the treatment of these respiratory diseases.  A no. of strategies are currently being pursued in attempts to improve clin. efficacy and reduce side effects, including delivery via the inhaled route, and/or development of non-emetic PDE4 inhibitors and mixed PDE inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWb9EsDIbiDbVg90H21EOLACvtfcHk0lj5-QJerPF5dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFKkurbM&md5=6d540b4fc5da7ed20c5df9b73120a6c0</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.307%26sid%3Dliteratum%253Aachs%26aulast%3DSpina%26aufirst%3DD.%26atitle%3DPDE4%2520inhibitors%253A%2520current%2520status%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D155%26spage%3D308%26epage%3D315%26doi%3D10.1038%2Fbjp.2008.307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krause, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kühne, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.3109/00498258809041693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.3109%2F00498258809041693" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=561-571&author=W.+Krauseauthor=G.+K%C3%BChne&title=Pharmacokinetics+of+rolipram+in+the+rhesus+and+cynomolgus+monkeys%2C+the+rat+and+the+rabbit.+Studies+on+species+differences&doi=10.3109%2F00498258809041693"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.3109%2F00498258809041693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498258809041693%26sid%3Dliteratum%253Aachs%26aulast%3DKrause%26aufirst%3DW.%26aulast%3DK%25C3%25BChne%26aufirst%3DG.%26atitle%3DPharmacokinetics%2520of%2520rolipram%2520in%2520the%2520rhesus%2520and%2520cynomolgus%2520monkeys%252C%2520the%2520rat%2520and%2520the%2520rabbit.%2520Studies%2520on%2520species%2520differences%26jtitle%3DXenobiotica%26date%3D1998%26volume%3D18%26spage%3D561%26epage%3D571%26doi%3D10.3109%2F00498258809041693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitolo, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinchese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">1624</span>– <span class="NLM_lpage">1634</span>, <span class="refDoi"> DOI: 10.1172/JCI22831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1172%2FJCI22831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=15578094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2004&pages=1624-1634&author=B.+Gongauthor=O.+V.+Vitoloauthor=F.+Trincheseauthor=S.+Liuauthor=M.+Shelanskiauthor=O.+Arancio&title=Persistent+improvement+in+synaptic+and+cognitive+functions+in+an+Alzheimer+mouse+model+after+rolipram+treatment&doi=10.1172%2FJCI22831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment</span></div><div class="casAuthors">Gong, Bing; Vitolo, Ottavio V.; Trinchese, Fabrizio; Liu, Shumin; Shelanski, Michael; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1624-1634</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Evidence suggests that Alzheimer disease (AD) begins as a disorder of synaptic function, caused in part by increased levels of amyloid β-peptide 1-42 (Aβ42).  Both synaptic and cognitive deficits are reproduced in mice double transgenic for amyloid precursor protein (AA substitution K670N,M671L) and presenilin-1 (AA substitution M146V).  Here the authors demonstrate that brief treatment with the phosphodiesterase 4 inhibitor rolipram ameliorates deficits in both long-term potentiation (LTP) and contextual learning in the double-transgenic mice.  Most importantly, this beneficial effect can be extended beyond the duration of the administration.  One course of long-term systemic treatment with rolipram improves LTP and basal synaptic transmission as well as working, ref., and associative memory deficits for at least 2 mo after the end of the treatment.  This protective effect is possibly due to stabilization of synaptic circuitry via alterations in gene expression by activation of the cAMP-dependent protein kinase (PKA)/cAMP regulatory element-binding protein (CREB) signaling pathway that make the synapses more resistant to the insult inflicted by Aβ.  Thus, agents that enhance the cAMP/PKA/CREB pathway have potential for the treatment of AD and other diseases assocd. with elevated Aβ42 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI79h3DC1rU7Vg90H21EOLACvtfcHk0lj5-QJerPF5dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhur3I&md5=72e43d10754678b58a452160fe7142e2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1172%2FJCI22831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI22831%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DB.%26aulast%3DVitolo%26aufirst%3DO.%2BV.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DShelanski%26aufirst%3DM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPersistent%2520improvement%2520in%2520synaptic%2520and%2520cognitive%2520functions%2520in%2520an%2520Alzheimer%2520mouse%2520model%2520after%2520rolipram%2520treatment%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2004%26volume%3D114%26spage%3D1624%26epage%3D1634%26doi%3D10.1172%2FJCI22831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozueta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelanski, M.</span></span> <span> </span><span class="NLM_article-title">Reversal of long-term dendritic spine alterations in Alzheimer disease models</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">16877</span>– <span class="NLM_lpage">16882</span>, <span class="refDoi"> DOI: 10.1073/pnas.0908706106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1073%2Fpnas.0908706106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=16877-16882&author=D.+L.+Smithauthor=J.+Pozuetaauthor=B.+Gongauthor=O.+Arancioauthor=M.+Shelanski&title=Reversal+of+long-term+dendritic+spine+alterations+in+Alzheimer+disease+models&doi=10.1073%2Fpnas.0908706106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908706106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908706106%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DPozueta%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DB.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DShelanski%26aufirst%3DM.%26atitle%3DReversal%2520of%2520long-term%2520dendritic%2520spine%2520alterations%2520in%2520Alzheimer%2520disease%2520models%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D16877%26epage%3D16882%26doi%3D10.1073%2Fpnas.0908706106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ<sub>25–35</sub> or Aβ<sub>1–40</sub> peptide in rats</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>212</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1007/s00213-010-1943-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1007%2Fs00213-010-1943-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20640406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFCgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2010&pages=181-191&author=Y.+F.+Chengauthor=C.+Wangauthor=H.+B.+Linauthor=Y.+F.+Liauthor=Y.+Huangauthor=J.+P.+Xuauthor=H.+T.+Zhang&title=Inhibition+of+phosphodiesterase-4+reverses+memory+deficits+produced+by+A%CE%B225%E2%80%9335+or+A%CE%B21%E2%80%9340+peptide+in+rats&doi=10.1007%2Fs00213-010-1943-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats</span></div><div class="casAuthors">Cheng, Yu-Fang; Wang, Chuang; Lin, Huan-Bing; Li, Yun-Feng; Huang, Ying; Xu, Jiang-Ping; Zhang, Han-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-191</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">CAMP signaling plays an important role in memory loss assocd. with Alzheimer's disease (AD).  However, little is known about whether inhibition of phosphodiesterase-4 (PDE4), which increases intracellular cAMP, reverses β-amyloid peptide (Aβ)-induced memory deficits.  Expts. were performed to demonstrate the effect of the PDE4 inhibitor rolipram on memory impairment produced by Aβ1-40 (Aβ40) or its core fragment Aβ25-35.  We tested memory using Morris water-maze and passive avoidance tasks and examd. expression of phosphorylated cAMP response-element binding protein (pCREB) in the hippocampus in rats treated with Aβ25-35 or Aβ40 into bilateral CA1 subregions, with or without rolipram administration.  Aβ25-35 (10 μg/side) increased escape latency during acquisition training and decreased swimming time and distance in the target quadrant in the water-maze probe trial; it also decreased 24-h retention in the passive avoidance paradigm.  All these were reversed by chronic administration of rolipram (0.5 mg/kg).  Similarly, Aβ40 (4 μg/side) produced memory impairment, as demonstrated by decreased retention in passive avoidance; this was also reversed by repeated treatment with rolipram.  In addn., rolipram blocked extinction of memory during the 32-day testing period in the passive avoidance test.  Further, Aβ40 decreased pCREB expression in the hippocampus, which was also reversed by rolipram; the changes in pCREB were highly correlated with those in memory.  These results suggest that the PDE4 inhibitor rolipram reverses cognitive deficits assocd. with AD most likely via increased cAMP/CREB signaling in the hippocampus; PDE4 could be a target for drugs that improve cognition in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgj5q7VduLnrVg90H21EOLACvtfcHk0ljkCdGOClEpvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFCgu7g%253D&md5=47deb157f2d749f9d8801731b5a63cea</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1007%2Fs00213-010-1943-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-010-1943-3%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%2BF.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DH.%2BB.%26aulast%3DLi%26aufirst%3DY.%2BF.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26atitle%3DInhibition%2520of%2520phosphodiesterase-4%2520reverses%2520memory%2520deficits%2520produced%2520by%2520A%25CE%25B225%25E2%2580%259335%2520or%2520A%25CE%25B21%25E2%2580%259340%2520peptide%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2010%26volume%3D212%26spage%3D181%26epage%3D191%26doi%3D10.1007%2Fs00213-010-1943-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. T.</span></span> <span> </span><span class="NLM_article-title">The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats</span>. <i>Int. J. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1017/S1461145711000836</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1017%2FS1461145711000836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=21733236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVWgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=749-766&author=C.+Wangauthor=X.+M.+Yangauthor=Y.+Y.+Zhuoauthor=H.+Zhouauthor=H.+B.+Linauthor=Y.+F.+Chengauthor=J.+P.+Xuauthor=H.+T.+Zhang&title=The+phosphodiesterase-4+inhibitor+rolipram+reverses+A%CE%B2-induced+cognitive+impairment+and+neuroinflammatory+and+apoptotic+responses+in+rats&doi=10.1017%2FS1461145711000836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats</span></div><div class="casAuthors">Wang, Chuang; Yang, Xue-Mei; Zhuo, Ye-Ye; Zhou, Heng; Lin, Huan-Bing; Cheng, Yu-Fang; Xu, Jiang-Ping; Zhang, Han-Ting</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">749-766</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">β-Amyloid (Aβ) peptides play an important role in cognition deficits, neuroinflammation, and apoptosis obsd. in Alzheimer's disease (AD).  Activation of cAMP signaling enhances memory and inhibits inflammatory and apoptotic responses.  However, it is not known whether inhibition of phosphodiesterase-4 (PDE4), a crit. controller of intracellular cAMP concns., affects AD-assocd. neuroinflammatory and apoptotic responses and whether these responses contribute to deficits of memory mediated by cAMP signaling.  We addressed these issues using memory tests and neurochem. measures.  Specifically, rats microinfused with aggregated Aβ25-35 (10 μg/side) into bilateral CA1 subregions displayed deficits in learning ability and memory, as evidenced by decreases in escape latency during acquisition trials and exploratory activities in the probe trial in the water-maze task and 24-h retention in the passive avoidance test.  These effects were reversed by rolipram (0.1, 0.25 and 0.5 mg/kg.d i.p.), a prototypic PDE4 inhibitor, in a dose-dependent manner.  Interestingly, Aβ25-35-treated rats also displayed decreases in expression of phosphorylated cAMP response-element binding protein (pCREB) and Bcl-2, but increases in expression of NF-κB p65 and Bax in the hippocampus; these effects were also reversed by rolipram in a dose-dependent manner.  Similar neurochem. results were obsd. by replacing Aβ25-35 with Aβ1-42, a full-length amyloid peptide that quickly forms toxic oligomers.  These results suggest that PDE4 inhibitors such as rolipram may reverse Aβ-induced memory deficits at least in part via the attenuation of neuronal inflammation and apoptosis mediated by cAMP/CREB signaling.  PDE4 could be a target for treatment of memory loss assocd. with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdUA81iV8V8bVg90H21EOLACvtfcHk0ljkCdGOClEpvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVWgurk%253D&md5=aeddc1b317c45f05990b7f4dd564106e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1017%2FS1461145711000836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145711000836%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DX.%2BM.%26aulast%3DZhuo%26aufirst%3DY.%2BY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DH.%2BB.%26aulast%3DCheng%26aufirst%3DY.%2BF.%26aulast%3DXu%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26atitle%3DThe%2520phosphodiesterase-4%2520inhibitor%2520rolipram%2520reverses%2520A%25CE%25B2-induced%2520cognitive%2520impairment%2520and%2520neuroinflammatory%2520and%2520apoptotic%2520responses%2520in%2520rats%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2012%26volume%3D15%26spage%3D749%26epage%3D766%26doi%3D10.1017%2FS1461145711000836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span> <span> </span><span class="NLM_article-title">Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action</span>. <i>Neurobiol. Learn. Mem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1016/j.nlm.2005.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.nlm.2005.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16242977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsF2nt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2006&pages=132-138&author=K.+Ruttenauthor=J.+Prickaertsauthor=A.+Blokland&title=Rolipram+reverses+scopolamine-induced+and+time-dependent+memory+deficits+in+object+recognition+by+different+mechanisms+of+action&doi=10.1016%2Fj.nlm.2005.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action</span></div><div class="casAuthors">Rutten, K.; Prickaerts, J.; Blokland, A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Learning and Memory</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-138</span>CODEN:
                <span class="NLM_cas:coden">NLMEFR</span>;
        ISSN:<span class="NLM_cas:issn">1074-7427</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In this study, the effect of the selective phosphodiesterase type 4 (PDE4) inhibitor rolipram on memory performance was investigated using the object recognition task.  First, three doses of rolipram (0.01, 0.03 or 0.1 mg/kg) were tested with a 24 h delay between the learning (T1) and the test (T2) trial.  Doses of rolipram were injected at different time points (30 min before T1, immediately after T1 or 3 h after T1).  In a second expt., the effects of rolipram (0.03, 0.1 or 0.3 mg/kg) were tested in combination with scopolamine (0.1 mg/kg) applying a 1 h delay between trials.  Both substances were administered 30 min before T1.  Using a 24 h interval, rolipram showed an improvement in long-term memory performance when injected 3 h after T1 at a dose of 0.03 mg/kg.  Further, rolipram reversed the scopolamine-induced short-term memory deficit at a dose of 0.1 mg/kg.  Although the improved memory performance in both conditions is likely to be explained by elevated cAMP levels, two sep. working mechanisms might explain these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPmOMfSpMePLVg90H21EOLACvtfcHk0liF37rApvdJcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsF2nt7o%253D&md5=1bbb751b6dcbb187d08cea3eaa1ad693</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.nlm.2005.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nlm.2005.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26atitle%3DRolipram%2520reverses%2520scopolamine-induced%2520and%2520time-dependent%2520memory%2520deficits%2520in%2520object%2520recognition%2520by%2520different%2520mechanisms%2520of%2520action%26jtitle%3DNeurobiol.%2520Learn.%2520Mem.%26date%3D2006%26volume%3D85%26spage%3D132%26epage%3D138%26doi%3D10.1016%2Fj.nlm.2005.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by Abeta<sub>25–35</sub> in rats</span>. <i>Metab. Brain Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1007/s11011-016-9814-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1007%2Fs11011-016-9814-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26920899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslCrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=779-791&author=Y.+Zhuoauthor=H.+Guoauthor=Y.+Chengauthor=C.+Wangauthor=C.+Wangauthor=J.+Wuauthor=Z.+Zouauthor=D.+Ganauthor=Y.+Liauthor=J.+Xu&title=Inhibition+of+phosphodiesterase-4+reverses+the+cognitive+dysfunction+and+oxidative+stress+induced+by+Abeta25%E2%80%9335+in+rats&doi=10.1007%2Fs11011-016-9814-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by Aβ25-35 in rats</span></div><div class="casAuthors">Zhuo, Yeye; Guo, Haibiao; Cheng, Yufang; Wang, Chuang; Wang, Canmao; Wu, Jingang; Zou, Zhengqiang; Gan, Danna; Li, Yiwen; Xu, Jiangping</div><div class="citationInfo"><span class="NLM_cas:title">Metabolic Brain Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">779-791</span>CODEN:
                <span class="NLM_cas:coden">MBDIEE</span>;
        ISSN:<span class="NLM_cas:issn">0885-7490</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Phosphodiesterase-4 (PDE4) inhibitors prevent the breakdown of the second messenger cAMP and have been demonstrated to improve learning in several animal models of cognition.  In this study, we explored the antioxidative effects of rolipram in Alzheimer's disease (AD) by using bilateral Aβ25-35 injection into the hippocampus of rats, which were used as an AD model.  Rats received 3 i.p. (i.p.) doses of rolipram (0.1, 0.5 and 1.25 mg/kg) daily after the injection of Aβ25-35 for 25 days.  Chronic administration of rolipram prevented the memory impairments induced by Aβ25-35, as assessed using the passive avoidance test and the Morris water maze test.  Furthermore, rolipram significantly reduced the oxidative stress induced by Aβ25-35, as evidenced by the decrease in the levels of reactive oxygen species (ROS) and malondialdehyde (MDA), and restored the reduced GSH levels and superoxide dismutase (SOD) activity.  Moreover, western blotting and real-time reverse transcription polymerase chain reaction (RT-PCR) anal. showed that rolipram remarkably upregulated thioredoxin (Trx) and inhibited the inducible nitric oxide synthase/nitric oxide (iNOS/NO) pathway in the hippocampus.  These results demonstrated that rolipram improved the learning and memory abilities in an Aβ25-35-induced AD rat model.  The mechanism underlying these effects may be due to the noticeable antioxidative effects of rolipram.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXJjU2lmgtrLVg90H21EOLACvtfcHk0liF37rApvdJcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslCrt7o%253D&md5=ce1b7dcb4a859d07fb5c4e6bd2c6f1e5</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1007%2Fs11011-016-9814-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11011-016-9814-1%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DZ.%26aulast%3DGan%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520phosphodiesterase-4%2520reverses%2520the%2520cognitive%2520dysfunction%2520and%2520oxidative%2520stress%2520induced%2520by%2520Abeta25%25E2%2580%259335%2520in%2520rats%26jtitle%3DMetab.%2520Brain%2520Dis.%26date%3D2016%26volume%3D31%26spage%3D779%26epage%3D791%26doi%3D10.1007%2Fs11011-016-9814-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer’s Type</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2017.01.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.biopha.2017.01.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=28152479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVSlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2017&pages=698-707&author=A.+Kumarauthor=N.+Singh&title=Inhibitor+of+phosphodiestearse-4+improves+memory+deficits%2C+oxidative+stress%2C+neuroinflammation+and+neuropathological+alterations+in+mouse+models+of+dementia+of+Alzheimer%E2%80%99s+Type&doi=10.1016%2Fj.biopha.2017.01.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's Type</span></div><div class="casAuthors">Kumar, Amit; Singh, Nirmal</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">698-707</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The study investigates the potential of Rolipram a phosphodiesterase-4 inhibitor in cognitive deficits induced by streptozotocin (STZ, 3 mg/kg intracerebroventricularly) and natural ageing in mice.  Morris water maze (MWM) test was employed to evaluate learning and memory of the animals.  Extent of oxidative stress was measured by estg. the levels of brain glutathione (GSH) and thiobarbituric acid reactive species (TBARS).  Brain acetylcholinestrase (AChE) activity was also estd.  The brain activity of myeloperoxidase (MPO) was measured as a marker of inflammation.  STZ and ageing results in marked decline in MWM performance of the animals, reflecting impairment of learning and memory.  STZ treated mice and aged mice exhibited a marked accentuation of AChE activity, TBARS and MPO activity along with fall in GSH level.  Further the stained micrographs of STZ treated mice and aged mice indicate pathol. changes, severe neutrophilic infiltration and amyloid deposition.  Rolipram treatment significantly attenuated STZ induced and age related memory deficits, biochem. and histopathol. alterations.  The findings demonstrate the potential of Rolipram in memory dysfunctions which may probably be attributed to its anti-cholinesterase, anti-amyloid, anti-oxidative and anti-inflammatory effects.  The study concludes that PDE-4 can be explored as a potential therapeutic target in dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolyQDD1R3sxrVg90H21EOLACvtfcHk0liF37rApvdJcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVSlt7w%253D&md5=283d145e47d12940a38df6cfe8ae5b00</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.01.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.01.059%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DInhibitor%2520of%2520phosphodiestearse-4%2520improves%2520memory%2520deficits%252C%2520oxidative%2520stress%252C%2520neuroinflammation%2520and%2520neuropathological%2520alterations%2520in%2520mouse%2520models%2520of%2520dementia%2520of%2520Alzheimer%25E2%2580%2599s%2520Type%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D88%26spage%3D698%26epage%3D707%26doi%3D10.1016%2Fj.biopha.2017.01.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Lima, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Presti-Torres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimaraes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalco, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, N.</span></span> <span> </span><span class="NLM_article-title">Amelioration of recognition memory impairment associated with iron loading or aging by the type 4-specific phosphodiesterase inhibitor rolipram in rats</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2008.06.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=788-792&author=M.+N.+de+Limaauthor=J.+Presti-Torresauthor=V.+A.+Garciaauthor=M.+R.+Guimaraesauthor=F.+S.+Scalcoauthor=R.+Roeslerauthor=N.+Schroder&title=Amelioration+of+recognition+memory+impairment+associated+with+iron+loading+or+aging+by+the+type+4-specific+phosphodiesterase+inhibitor+rolipram+in+rats&doi=10.1016%2Fj.neuropharm.2008.06.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.06.025%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLima%26aufirst%3DM.%2BN.%26aulast%3DPresti-Torres%26aufirst%3DJ.%26aulast%3DGarcia%26aufirst%3DV.%2BA.%26aulast%3DGuimaraes%26aufirst%3DM.%2BR.%26aulast%3DScalco%26aufirst%3DF.%2BS.%26aulast%3DRoesler%26aufirst%3DR.%26aulast%3DSchroder%26aufirst%3DN.%26atitle%3DAmelioration%2520of%2520recognition%2520memory%2520impairment%2520associated%2520with%2520iron%2520loading%2520or%2520aging%2520by%2520the%2520type%25204-specific%2520phosphodiesterase%2520inhibitor%2520rolipram%2520in%2520rats%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D788%26epage%3D792%26doi%3D10.1016%2Fj.neuropharm.2008.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabe, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bredenbröker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethke, T. D.</span></span> <span> </span><span class="NLM_article-title">Roflumilast-an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(05)67100-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2FS0140-6736%2805%2967100-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2005&pages=563-571&author=K.+F.+Rabeauthor=E.+D.+Batemanauthor=D.+O%E2%80%99Donnellauthor=S.+Witteauthor=D.+Bredenbr%C3%B6kerauthor=T.+D.+Bethke&title=Roflumilast-an+oral+anti-inflammatory+treatment+for+chronic+obstructive+pulmonary+disease%3A+a+randomised+controlled+trial&doi=10.1016%2FS0140-6736%2805%2967100-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2967100-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252967100-0%26sid%3Dliteratum%253Aachs%26aulast%3DRabe%26aufirst%3DK.%2BF.%26aulast%3DBateman%26aufirst%3DE.%2BD.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DD.%26aulast%3DWitte%26aufirst%3DS.%26aulast%3DBredenbr%25C3%25B6ker%26aufirst%3DD.%26aulast%3DBethke%26aufirst%3DT.%2BD.%26atitle%3DRoflumilast-an%2520oral%2520anti-inflammatory%2520treatment%2520for%2520chronic%2520obstructive%2520pulmonary%2520disease%253A%2520a%2520randomised%2520controlled%2520trial%26jtitle%3DLancet%26date%3D2005%26volume%3D366%26spage%3D563%26epage%3D571%26doi%3D10.1016%2FS0140-6736%2805%2967100-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanmierlo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creemers, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkerman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Duinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambeth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2016.01.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bbr.2016.01.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2016&pages=26-33&author=T.+Vanmierloauthor=P.+Creemersauthor=S.+Akkermanauthor=M.+van+Duinenauthor=A.+Sambethauthor=J.+De+Vryauthor=T.+Uzauthor=A.+Bloklandauthor=J.+Prickaerts&title=The+PDE4+inhibitor+roflumilast+improves+memory+in+rodents+at+non-emetic+doses&doi=10.1016%2Fj.bbr.2016.01.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2016.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2016.01.031%26sid%3Dliteratum%253Aachs%26aulast%3DVanmierlo%26aufirst%3DT.%26aulast%3DCreemers%26aufirst%3DP.%26aulast%3DAkkerman%26aufirst%3DS.%26aulast%3Dvan%2BDuinen%26aufirst%3DM.%26aulast%3DSambeth%26aufirst%3DA.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26aulast%3DUz%26aufirst%3DT.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DThe%2520PDE4%2520inhibitor%2520roflumilast%2520improves%2520memory%2520in%2520rodents%2520at%2520non-emetic%2520doses%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D303%26spage%3D26%26epage%3D33%26doi%3D10.1016%2Fj.bbr.2016.01.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span>Clinical trial study
found in clinical trials for roflumilast, NCT01433666. <a href="https://clinicaltrials.gov/ct2/show/NCT01433666?term=NCT01433666&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01433666?term=NCT01433666&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+roflumilast%2C+NCT01433666.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01433666%3Fterm%3DNCT01433666%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span>Clinical trial study
found in clinical trials for roflumilast, NCT02051335. <a href="https://clinicaltrials.gov/ct2/show/NCT02051335?term=NCT02051335&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02051335?term=NCT02051335&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+roflumilast%2C+NCT02051335.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02051335%3Fterm%3DNCT02051335%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span>Clinical trial study
found in clinical trials for roflumilast, NCT02835716. <a href="https://clinicaltrials.gov/ct2/show/NCT02835716?term=NCT02835716&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02835716?term=NCT02835716&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+roflumilast%2C+NCT02835716.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02835716%3Fterm%3DNCT02835716%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jabaris, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumathy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girish, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugumar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saravana Babu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanikachalam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanikachalam, M.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/ CREB signaling system</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1622</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2015.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.brainres.2015.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26168894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOktrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1622&publication_year=2015&pages=279-291&author=S.+S.+Jabarisauthor=H.+Sumathyauthor=R.+Girishauthor=S.+Narayananauthor=M.+Sugumarauthor=C.+Saravana+Babuauthor=S.+Thanikachalamauthor=M.+Thanikachalam&title=Phosphodiesterase-4+inhibitors+ameliorates+cognitive+deficits+in+deoxycorticosterone+acetate+induced+hypertensive+rats+via+cAMP%2F+CREB+signaling+system&doi=10.1016%2Fj.brainres.2015.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/CREB signaling system</span></div><div class="casAuthors">Jabaris, S. Sugin Lal; Sumathy, Haridass; Girish, Ramesh; Narayanan, Shridhar; Sugumar, Mani; Saravana Babu, Chidambaram; Thanikachalam, Sadagopan; Thanikachalam, Mohan</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1622</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">279-291</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphodiesterase-4 (PDE-4) inhibitors promote memory by blocking the degrdn. of cAMP.  Existing evidence also shows that neuronal survival and plasticity are dependent on the phosphorylation of cAMP-response element-binding protein.  In this regard, PDE-4 inhibitors have also been shown to reverse pharmacol. and genetically induced memory impairment in animal models.  In the present study, the authors examd. the effect of both rolipram and roflumilast (PDE-4 inhibitors) on the impairment of learning and memory obsd. in hypertensive rats.  Deoxycorticosterone acetate (DOCA) salt hypertensive model was used to induce learning and memory deficits.  The mRNA expression of different PDE-4 subtypes along with the protein levels of pCREB and BDNF in the hippocampus was quantified.  Systolic blood pressure was significantly increased in DOCA salt hypertensive rats when compared to sham operated rats.  This effect was reversed by clonidine, an α2 receptor agonist, while PDE-4 inhibitors did not.  PDE-4 inhibitors significantly improved the time-induced memory deficits in object recognition task (ORT).  In DOCA salt hypertensive rats, the gene expression of PDE-4B and PDE-4D was significantly increased.  Furthermore, both pCREB and BDNF showed decreased levels of expression in hypertensive rats in comparison to sham operated rats.  Repeated administration of PDE-4 inhibitors significantly decreased both PDE-4B and PDE-4D with an increase in the expression of pCREB and BDNF in hypersensitive rats.  Also, rolipram, roflumilast and roflumilast N-oxide showed a linear increase in the plasma and brain concns. after ORT.  Our present findings suggested that PDE-4 inhibitors ameliorate hypertension-induced learning impairment via cAMP/CREB signaling that regulates BDNF expression downstream in the rat hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor2T-qJ90KbrVg90H21EOLACvtfcHk0lgKGrIgJSqs6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOktrjP&md5=de346d07555e0ae055e5c27d3d85cb4b</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2015.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2015.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DJabaris%26aufirst%3DS.%2BS.%26aulast%3DSumathy%26aufirst%3DH.%26aulast%3DGirish%26aufirst%3DR.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DSugumar%26aufirst%3DM.%26aulast%3DSaravana%2BBabu%26aufirst%3DC.%26aulast%3DThanikachalam%26aufirst%3DS.%26aulast%3DThanikachalam%26aufirst%3DM.%26atitle%3DPhosphodiesterase-4%2520inhibitors%2520ameliorates%2520cognitive%2520deficits%2520in%2520deoxycorticosterone%2520acetate%2520induced%2520hypertensive%2520rats%2520via%2520cAMP%252F%2520CREB%2520signaling%2520system%26jtitle%3DBrain%2520Res.%26date%3D2015%26volume%3D1622%26spage%3D279%26epage%3D291%26doi%3D10.1016%2Fj.brainres.2015.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jabaris, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumathy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanikachalam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, C. S.</span></span> <span> </span><span class="NLM_article-title">Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>746</i></span>,  <span class="NLM_fpage">138</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2014.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejphar.2014.10.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=25446433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSmsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=746&publication_year=2015&pages=138-147&author=S.+G.+Jabarisauthor=H.+Sumathyauthor=R.+S.+Kumarauthor=S.+Narayananauthor=S.+Thanikachalamauthor=C.+S.+Babu&title=Effects+of+rolipram+and+roflumilast%2C+phosphodiesterase-4+inhibitors%2C+on+hypertension-induced+defects+in+memory+function+in+rats&doi=10.1016%2Fj.ejphar.2014.10.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats</span></div><div class="casAuthors">Jabaris, Sobhana George Sugin Lal; Sumathy, Haridass; Kumar, Ramadass Satiesh; Narayanan, Shridhar; Thanikachalam, Sadagopan; Babu, Chidambaram Saravana</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">746</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138-147</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypertension (HT) is a prevailing risk factor for cognitive impairment, the most common cause of vascular dementia; yet, no possible mechanism underlying the cognitive impairment induced by hypertension has been identified so far.  Inhibition of PDE-4 has been shown to increase phosphorylation of cAMP-response element binding protein in the hippocampus and enhance the memory performance.  Here, we examd. the effects of PDE-4 inhibitors, rolipram and roflumilast, on the impairment of learning and memory obsd. in hypertensive rats.  We used 2k-1c hypertensive model to induce learning and memory defects.  In addn., mRNA expression of PDE-4 sub-types A-D was also assessed in the hippocampus tissue.  Systolic blood pressure (SBP) was measured by tail-cuff method was significantly increased in 2k-1c rats when compared to sham operated rats; this effect was reversed by clonidine, whereas, PDE-4 inhibitors did not.  PDE-4 inhibitors significantly reversed time induced memory deficit in novel object recognition task (NORT).  Further, the retention latency on the second day in the elevated plus maze model was significantly shortened after repeated administration of rolipram and roflumilast.  Plasma and brain concns. of rolipram, roflumilast and roflumilast N-oxide were also measured after the NORT and showed linear increase in plasma and brain concns.  The PDE4B and PDE4D gene expression was significantly enhanced in hypertensive rats compared with sham operated however PDE4A and PDE4C remained unaltered.  Repeated treatment with PDE-4 inhibitors caused down regulation of PDE4B and PDE4D in hypertensive rats.  These results suggest that inhibition of PDE-4 ameliorates HT-induced impairment of learning and memory functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKT6L29U_H4bVg90H21EOLACvtfcHk0lgKGrIgJSqs6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSmsLnO&md5=7a461c0debc0b3e2c32ec304846aed55</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2014.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2014.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DJabaris%26aufirst%3DS.%2BG.%26aulast%3DSumathy%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DR.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DThanikachalam%26aufirst%3DS.%26aulast%3DBabu%26aufirst%3DC.%2BS.%26atitle%3DEffects%2520of%2520rolipram%2520and%2520roflumilast%252C%2520phosphodiesterase-4%2520inhibitors%252C%2520on%2520hypertension-induced%2520defects%2520in%2520memory%2520function%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D746%26spage%3D138%26epage%3D147%26doi%3D10.1016%2Fj.ejphar.2014.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bourtchouladze, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lidge, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catapano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gossweiler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romashko, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, T.</span></span> <span> </span><span class="NLM_article-title">A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">10518</span>– <span class="NLM_lpage">10522</span>, <span class="refDoi"> DOI: 10.1073/pnas.1834280100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1073%2Fpnas.1834280100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=10518-10522&author=R.+Bourtchouladzeauthor=R.+Lidgeauthor=R.+Catapanoauthor=J.+Stanleyauthor=S.+Gossweilerauthor=D.+Romashkoauthor=R.+Scottauthor=T.+Tully&title=A+mouse+model+of+Rubinstein-Taybi+syndrome%3A+defective+long-term+memory+is+ameliorated+by+inhibitors+of+phosphodiesterase+4&doi=10.1073%2Fpnas.1834280100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1834280100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1834280100%26sid%3Dliteratum%253Aachs%26aulast%3DBourtchouladze%26aufirst%3DR.%26aulast%3DLidge%26aufirst%3DR.%26aulast%3DCatapano%26aufirst%3DR.%26aulast%3DStanley%26aufirst%3DJ.%26aulast%3DGossweiler%26aufirst%3DS.%26aulast%3DRomashko%26aufirst%3DD.%26aulast%3DScott%26aufirst%3DR.%26aulast%3DTully%26aufirst%3DT.%26atitle%3DA%2520mouse%2520model%2520of%2520Rubinstein-Taybi%2520syndrome%253A%2520defective%2520long-term%2520memory%2520is%2520ameliorated%2520by%2520inhibitors%2520of%2520phosphodiesterase%25204%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D10518%26epage%3D10522%26doi%3D10.1073%2Fpnas.1834280100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bletsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, T.</span></span> <span> </span><span class="NLM_article-title">The PDE4 inhibitor HT-0712 improves hippocampus-dependent memory in aged mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2938</span>– <span class="NLM_lpage">2948</span>, <span class="refDoi"> DOI: 10.1038/npp.2014.154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnpp.2014.154" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=2938-2948&author=M.+Petersauthor=M.+Bletschauthor=J.+Stanleyauthor=D.+Wheelerauthor=R.+Scottauthor=T.+Tully&title=The+PDE4+inhibitor+HT-0712+improves+hippocampus-dependent+memory+in+aged+mice&doi=10.1038%2Fnpp.2014.154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.154%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DM.%26aulast%3DBletsch%26aufirst%3DM.%26aulast%3DStanley%26aufirst%3DJ.%26aulast%3DWheeler%26aufirst%3DD.%26aulast%3DScott%26aufirst%3DR.%26aulast%3DTully%26aufirst%3DT.%26atitle%3DThe%2520PDE4%2520inhibitor%2520HT-0712%2520improves%2520hippocampus-dependent%2520memory%2520in%2520aged%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D2938%26epage%3D2948%26doi%3D10.1038%2Fnpp.2014.154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span>Clinical trial study found in clinical trials for HT-0712,
NCT02013310. <a href="https://clinicaltrials.gov/ct2/show/NCT02013310?term=NCT02013310&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02013310?term=NCT02013310&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+HT-0712%2C%0ANCT02013310.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02013310%3Fterm%3DNCT02013310%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aspiotis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesen, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacombe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laliberte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Styhler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairment</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6387</span>– <span class="NLM_lpage">6393</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bmcl.2010.09.087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6387-6393&author=M.+Gallantauthor=R.+Aspiotisauthor=S.+Dayauthor=R.+Diasauthor=D.+Dubeauthor=L.+Dubeauthor=R.+W.+Friesenauthor=M.+Girardauthor=D.+Guayauthor=P.+Hamelauthor=Z.+Huangauthor=P.+Lacombeauthor=S.+Laliberteauthor=J.+F.+Levesqueauthor=S.+Liuauthor=D.+Macdonaldauthor=J.+Manciniauthor=D.+W.+Nicholsonauthor=A.+Styhlerauthor=K.+Townsonauthor=K.+Watersauthor=R.+N.+Youngauthor=Y.+Girard&title=Discovery+of+MK-0952%2C+a+selective+PDE4+inhibitor+for+the+treatment+of+long-term+memory+loss+and+mild+cognitive+impairment&doi=10.1016%2Fj.bmcl.2010.09.087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.087%26sid%3Dliteratum%253Aachs%26aulast%3DGallant%26aufirst%3DM.%26aulast%3DAspiotis%26aufirst%3DR.%26aulast%3DDay%26aufirst%3DS.%26aulast%3DDias%26aufirst%3DR.%26aulast%3DDube%26aufirst%3DD.%26aulast%3DDube%26aufirst%3DL.%26aulast%3DFriesen%26aufirst%3DR.%2BW.%26aulast%3DGirard%26aufirst%3DM.%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DHamel%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLacombe%26aufirst%3DP.%26aulast%3DLaliberte%26aufirst%3DS.%26aulast%3DLevesque%26aufirst%3DJ.%2BF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMacdonald%26aufirst%3DD.%26aulast%3DMancini%26aufirst%3DJ.%26aulast%3DNicholson%26aufirst%3DD.%2BW.%26aulast%3DStyhler%26aufirst%3DA.%26aulast%3DTownson%26aufirst%3DK.%26aulast%3DWaters%26aufirst%3DK.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DGirard%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520MK-0952%252C%2520a%2520selective%2520PDE4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520long-term%2520memory%2520loss%2520and%2520mild%2520cognitive%2520impairment%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6387%26epage%3D6393%26doi%3D10.1016%2Fj.bmcl.2010.09.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span>Clinical trial study
found in clinical trials for MK-0952, NCT00362024. <a href="https://clinicaltrials.gov/ct2/show/NCT00362024?term=MK-0952&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT00362024?term=MK-0952&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study%0Afound+in+clinical+trials+for+MK-0952%2C+NCT00362024.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00362024%3Fterm%3DMK-0952%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drouin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pando, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haun, F.</span></span> <span> </span><span class="NLM_article-title">Etazolate improves performance in a foraging and homing task in aged rats</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>634</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2010.02.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejphar.2010.02.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20223232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1WmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=634&publication_year=2010&pages=95-100&author=J.+Drottauthor=L.+Desireauthor=D.+Drouinauthor=M.+Pandoauthor=F.+Haun&title=Etazolate+improves+performance+in+a+foraging+and+homing+task+in+aged+rats&doi=10.1016%2Fj.ejphar.2010.02.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Etazolate improves performance in a foraging and homing task in aged rats</span></div><div class="casAuthors">Drott, Jason; Desire, L.; Drouin, D.; Pando, M.; Haun, Forrest</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">634</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">95-100</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Etazolate is a phosphodiesterase 4 (PDE4) inhibitor and GABAA receptor modulator that also stimulates alpha-secretase activity and neurotrophic sol. amyloid precursor protein (sAPPα) prodn., currently developed as a possible Alzheimer's disease therapeutic.  In this study two doses of etazolate were tested for cognitive effects in normally aged rats, using a complex spatial learning and memory task that emphasized two naturally occurring behaviors in rodents, foraging for food and returning large pieces of found food to a safe home location.  Both etazolate doses completely prevented both (1) a foraging deficit that developed in untreated aged rats over the course of the test, as well as (2) a trial-specific deficit in memory for previously visited food locations that also developed over the course of the test in untreated aged rats.  Both doses also significantly reduced a sep. memory deficit for changing locations of the animals' home box, plus completely prevented a significant tendency for untreated aged animals to attempt entry into similar-appearing but incorrect home boxes.  The combined behavioral data demonstrate pos. effects of etazolate on sep. age-related cognitive deficits, using a complex task based on naturally occurring rodent behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBSaIGIW7gI7Vg90H21EOLACvtfcHk0ljgl8hr9om_Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1WmtL0%253D&md5=b7ad137dde90330fa736bebe0104787f</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2010.02.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2010.02.036%26sid%3Dliteratum%253Aachs%26aulast%3DDrott%26aufirst%3DJ.%26aulast%3DDesire%26aufirst%3DL.%26aulast%3DDrouin%26aufirst%3DD.%26aulast%3DPando%26aufirst%3DM.%26aulast%3DHaun%26aufirst%3DF.%26atitle%3DEtazolate%2520improves%2520performance%2520in%2520a%2520foraging%2520and%2520homing%2520task%2520in%2520aged%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D634%26spage%3D95%26epage%3D100%26doi%3D10.1016%2Fj.ejphar.2010.02.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span> <span> </span><span class="NLM_article-title">Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons</span>. <i>J. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1002/neu.480250409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1002%2Fneu.480250409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=7915758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADyaK2cXktVWmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=439-450&author=M.+P.+Mattson&title=Secreted+forms+of+%CE%B2-amyloid+precursor+protein+modulate+dendrite+outgrowth+and+calcium+responses+to+glutamate+in+cultured+embryonic+hippocampal+neurons&doi=10.1002%2Fneu.480250409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons</span></div><div class="casAuthors">Mattson, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurobiology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">439-50</span>CODEN:
                <span class="NLM_cas:coden">JNEUBZ</span>;
        ISSN:<span class="NLM_cas:issn">0022-3034</span>.
    </div><div class="casAbstract">In addn. to being the major excitatory neurotransmitter in the mammalian brain, glutamate is believed to play a key role in the regulation of neurite outgrowth and synaptogenesis during development.  In cultured embryonic hippocampal pyramidal neurons, glutamate inhibits dendrite outgrowth by a mechanism involving elevation of intracellular-free calcium levels ([Ca2+]i).  In the present study, secreted forms of the β-amyloid precursor protein (APPss) counteracted the inhibitory effect of glutamate on dendrite outgrowth in cultured embryonic hippocampal neurons.  The prolonged elevation of [Ca2+]i normally induced by glutamate was significantly attenuated in neurons that had been pretreated with 2-10 nM of APPs695 or APPs751.  Immunocytochem. with β-amyloid precursor protein antibodies showed that immunoreactivity was concd. in axons and, particularly, in their growth cones.  Because β-amyloid precursor proteins are axonally transported, and APPss can be released from axon terminals/growth cones in response to elec. activity, the present findings suggest that APPss may play a role in developmental and synaptic plasticity by modulating dendritic responses to glutamate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVPyu96qthDLVg90H21EOLACvtfcHk0lgRrZEGhy-O_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktVWmu7w%253D&md5=49392b043f8f14f9d8dd2318fd5e59cc</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2Fneu.480250409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fneu.480250409%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26atitle%3DSecreted%2520forms%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein%2520modulate%2520dendrite%2520outgrowth%2520and%2520calcium%2520responses%2520to%2520glutamate%2520in%2520cultured%2520embryonic%2520hippocampal%2520neurons%26jtitle%3DJ.%2520Neurobiol.%26date%3D1994%26volume%3D25%26spage%3D439%26epage%3D450%26doi%3D10.1002%2Fneu.480250409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span>Clinical trial study found in clinical trials for Etazolate,
NCT00880412. <a href="https://clinicaltrials.gov/ct2/results?cond=&amp;term=NCT00880412&amp;cntry1=&amp;state1=&amp;Search=Search" class="extLink">https://clinicaltrials.gov/ct2/results?cond=&term=NCT00880412&cntry1=&state1=&Search=Search</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+Etazolate%2C%0ANCT00880412.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fresults%3Fcond%3D%26term%3DNCT00880412%26cntry1%3D%26state1%3D%26Search%3DSearch+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sol, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ousset, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemarie, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">P. Pando, M.</span></span> <span> </span><span class="NLM_article-title">EHT0202 in Alzheimer’s disease: a 3-month, randomized, placebo-controlled, double-blind study</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.2174/156720511795256053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.2174%2F156720511795256053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=21222604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslOisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=203-212&author=B.+Vellasauthor=O.+Solauthor=P.+J.+Snyderauthor=P.+J.+Oussetauthor=R.+Haddadauthor=M.+Maurinauthor=J.+C.+Lemarieauthor=L.+Desireauthor=M.+P.+Pando&title=EHT0202+in+Alzheimer%E2%80%99s+disease%3A+a+3-month%2C+randomized%2C+placebo-controlled%2C+double-blind+study&doi=10.2174%2F156720511795256053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">EHT0202 in Alzheimer's disease: a 3-month, randomized, placebo-controlled, double-blind study</span></div><div class="casAuthors">Vellas, B.; Sol, O.; Snyder, P. J.; Ousset, P.-J.; Haddad, R.; Maurin, M.; Lemarie, J.-C.; Desire, L.; Pando, M. P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-212</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: EHT0202 (etazolate hydrochloride) is a new compd. exhibiting both potential diseasemodifying and symptomatic treatment properties in Alzheimer's Disease increasing alpha-secretase activity and sAPP alpha secretion, as well as acting as a GABA-A receptor modulator and as a PDE-4 inhibitor.  Methods: This pilot, randomized, double-blind, placebo-controlled, parallel group, multicentre, Phase IIA study was conducted in 159 randomized patients suffering from mild to moderate Alzheimer's Disease.  EHT0202 (40 or 80mg bid) or placebo was administered as adjunctive therapy to one acetylcholinesterase inhibitor over a 3-mo period.  This study was designed to assess the clin. safety and tolerability of EHT0202 as a primary objective, with secondary endpoints (cognitive function, daily living activities, behavior, caregiver burden and global functioning) included to explore clin. efficacy of EHT0202 vs. placebo.  Results: EHT0202 was shown to be safe and generally well tolerated.  Dose-dependent nos. of early withdrawal and central nervous system related adverse events were obsd.  As expected, since the study was not powered and not designed to show drug efficacy, and except for ratings on the ADCS-ADL scale, no significant differences were seen between treatment groups.  Conclusions: These first encouraging safety results do support further development of EHT0202 in order to assess its clin. efficacy and to confirm its tolerability in a larger cohort of Alzheimer patients and for a longer period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGT7btT8TzVrVg90H21EOLACvtfcHk0lgRrZEGhy-O_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslOisLk%253D&md5=b48e7cc084616eb4d81bd4d7c25763de</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.2174%2F156720511795256053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720511795256053%26sid%3Dliteratum%253Aachs%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DSol%26aufirst%3DO.%26aulast%3DSnyder%26aufirst%3DP.%2BJ.%26aulast%3DOusset%26aufirst%3DP.%2BJ.%26aulast%3DHaddad%26aufirst%3DR.%26aulast%3DMaurin%26aufirst%3DM.%26aulast%3DLemarie%26aufirst%3DJ.%2BC.%26aulast%3DDesire%26aufirst%3DL.%26aulast%3DP.%2BPando%26aufirst%3DM.%26atitle%3DEHT0202%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%25203-month%252C%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%2520study%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2011%26volume%3D8%26spage%3D203%26epage%3D212%26doi%3D10.2174%2F156720511795256053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macnaughtan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prestegard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and structure-activity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7673</span>– <span class="NLM_lpage">7688</span>, <span class="refDoi"> DOI: 10.1021/jm701635j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701635j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKlu7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7673-7688&author=S.+Zhengauthor=G.+Kaurauthor=H.+Wangauthor=M.+Liauthor=M.+Macnaughtanauthor=X.+Yangauthor=S.+Reidauthor=J.+Prestegardauthor=B.+Wangauthor=H.+Ke&title=Design%2C+synthesis%2C+and+structure-activity+relationship%2C+molecular+modeling%2C+and+NMR+studies+of+a+series+of+phenyl+alkyl+ketones+as+highly+potent+and+selective+phosphodiesterase-4+inhibitors&doi=10.1021%2Fjm701635j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and structure-activity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors</span></div><div class="casAuthors">Zheng, Shilong; Kaur, Gurpreet; Wang, Huanchen; Li, Minyong; Macnaughtan, Megan; Yang, Xiaochuan; Reid, Suazette; Prestegard, James; Wang, Binghe; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7673-7688</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 4 catalyzes the hydrolysis of cAMP and is a target for the development of anti-inflammatory agents.  We have designed and synthesized a series of Ph alkyl ketones as PDE4 inhibitors.  Among them, 13 compds. were identified as having submicromolar IC50 values.  The most potent compds. have IC50 values of in the mid- to low-nanomolar range.  Compd. I (R = i-Pr, X = O)also showed preference for PDE4 with selectivity of >2000-fold over PDE7, PDE9, PDE2, and PDE5.  Docking of I, II (R = i-Pr, X = CH2), and III (R = n-Pr, X = O) into the binding pocket of the PDE4 catalytic domain revealed a similar binding profile to PDE4 with rolipram except that the fluorine atoms of the difluoromethyl groups of I, II, and III are within a reasonable range for hydrogen bond formation with the amide hydrogen of Thr 333 and the long alkyl chain bears addnl. van der Waals interactions with His 160, Asp 318, and Tyr 159.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkyBtbusd487Vg90H21EOLACvtfcHk0lgRrZEGhy-O_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKlu7vN&md5=cc9e4b0a1e090e8bead52686da67d047</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm701635j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701635j%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DMacnaughtan%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DReid%26aufirst%3DS.%26aulast%3DPrestegard%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationship%252C%2520molecular%2520modeling%252C%2520and%2520NMR%2520studies%2520of%2520a%2520series%2520of%2520phenyl%2520alkyl%2520ketones%2520as%2520highly%2520potent%2520and%2520selective%2520phosphodiesterase-4%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7673%26epage%3D7688%26doi%3D10.1021%2Fjm701635j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2017.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=28065587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFakt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=260-269&author=H.+Guoauthor=Y.+Chengauthor=C.+Wangauthor=J.+Wuauthor=Z.+Zouauthor=B.+Niuauthor=H.+Yuauthor=H.+Wangauthor=J.+Xu&title=FFPM%2C+a+PDE4+inhibitor%2C+reverses+learning+and+memory+deficits+in+APP%2FPS1+transgenic+mice+via+cAMP%2FPKA%2FCREB+signaling+and+anti-inflammatory+effects&doi=10.1016%2Fj.neuropharm.2017.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects</span></div><div class="casAuthors">Guo, Haibiao; Cheng, Yufang; Wang, Canmao; Wu, Jingang; Zou, Zhengqiang; Niu, Bo; Yu, Hui; Wang, Haitao; Xu, Jiangping</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">260-269</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Thus far, phosphodiesterase-4 (PDE4) inhibitors have not been approved for application in Alzheimer's disease (AD) in a clin. setting due to severe side effects, such as nausea and vomiting.  In this study, we investigated the effect of FFPM, a novel PDE4 inhibitor, on learning and memory abilities, as well as the underlying mechanism in the APP/PS1 mouse model of AD.  Pharmacokinetic studies have revealed that FFPM efficiently permeates into the brain, and reached peak values in plasma 2 h after orally dosing.  A 3-wk treatment with FFPM, at doses of 0.25 mg/kg and 0.5 mg/kg, significantly improved the learning and memory abilities of APP/PS1 transgenic mice in the Morris water maze and the Step-down passive avoidance task.  Interestingly, we found that while rolipram (0.5 mg/kg) reduced the duration of the α2 adrenergic receptor-mediated anesthesia induced by xylazine/ketamine, FFPM (0.5 mg/kg) or the vehicle did not have an evident effect.  FFPM increased the cAMP, PKA and CREB phosphorylation and BDNF levels, and reduced the NF-κB p65, iNOS, TNF-α and IL-1β levels in the hippocampi of APP/PS1 trangenic mice, as obsd. by ELISA and Western blot anal.  Taken together, our data demonstrated that the reversal effect of FFPM on cognitive deficits in APP/PS1 transgenic mice might be related to stimulation of the cAMP/PKA/CREB/BDNF pathway and anti-inflammatory effects.  Moreover, FFPM appears to have potential as an effective PDE4 inhibitor in AD treatment with little emetic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqueQvekWB9CbVg90H21EOLACvtfcHk0lhFmDbiRP4gEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFakt70%253D&md5=024f56897208ce4c5c36e3a89d90c407</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DZ.%26aulast%3DNiu%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DFFPM%252C%2520a%2520PDE4%2520inhibitor%252C%2520reverses%2520learning%2520and%2520memory%2520deficits%2520in%2520APP%252FPS1%2520transgenic%2520mice%2520via%2520cAMP%252FPKA%252FCREB%2520signaling%2520and%2520anti-inflammatory%2520effects%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D116%26spage%3D260%26epage%3D269%26doi%3D10.1016%2Fj.neuropharm.2017.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. T.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">172</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.5236-10.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1523%2FJNEUROSCI.5236-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=21209202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1ygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=172-183&author=Y.+F.+Liauthor=Y.+F.+Chengauthor=Y.+Huangauthor=M.+Contiauthor=S.+P.+Wilsonauthor=J.+M.+O%E2%80%99Donnellauthor=H.+T.+Zhang&title=Phosphodiesterase-4D+knock-out+and+RNA+interference-mediated+knock-down+enhance+memory+and+increase+hippocampal+neurogenesis+via+increased+cAMP+signaling&doi=10.1523%2FJNEUROSCI.5236-10.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling</span></div><div class="casAuthors">Li, Yun-Feng; Cheng, Yu-Fang; Huang, Ying; Conti, Marco; Wilson, Steven P.; O'Donnell, James M.; Zhang, Han-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-183</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Phosphodiesterase-4 (PDE4) plays an important role in mediating memory via the control of intracellular cAMP signaling; inhibition of PDE4 enhances memory.  However, development of PDE4 inhibitors as memory enhancers has been hampered by their major side effect of emesis.  PDE4 has four subtypes (PDE4A-D) consisting of 25 splice variants.  Mice deficient in PDE4D displayed memory enhancement in radial arm maze, water maze, and object recognition tests.  These effects were mimicked by repeated treatment with rolipram in wild-type mice.  In addn., similarly as rolipram-treated wild-type mice, PDE4D-deficient mice also displayed increased hippocampal neurogenesis and phosphorylated cAMP response element-binding protein (pCREB).  Furthermore, microinfusion of lentiviral vectors that contained microRNAs (miRNAs) targeting long-form PDE4D isoforms into bilateral dentate gyri of the mouse hippocampus down-regulated PDE4D4 and PDE4D5, enhanced memory, and increased hippocampal neurogenesis and pCREB.  Finally, while rolipram and PDE4D deficiency shortened α2 adrenergic receptor-mediated anesthesia, a surrogate measure of emesis, miRNA-mediated PDE4D knock-down in the hippocampus did not.  The present results suggest that PDE4D, in particular long-form PDE4D, plays a crit. role in the mediation of memory and hippocampal neurogenesis, which are mediated by cAMP/CREB signaling; reduced expression of PDE4D, or at least PDE4D4 and PDE4D5, in the hippocampus enhances memory but appears not to cause emesis.  These novel findings will aid in the development of PDE4 subtype- or variant-selective inhibitors for treatment of disorders involving impaired cognition, including Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonKG03_qqdl7Vg90H21EOLACvtfcHk0lhFmDbiRP4gEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1ygsg%253D%253D&md5=928836c09ff122681fdf11db58885b79</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5236-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5236-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BF.%26aulast%3DCheng%26aufirst%3DY.%2BF.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DConti%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DS.%2BP.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26atitle%3DPhosphodiesterase-4D%2520knock-out%2520and%2520RNA%2520interference-mediated%2520knock-down%2520enhance%2520memory%2520and%2520increase%2520hippocampal%2520neurogenesis%2520via%2520increased%2520cAMP%2520signaling%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D172%26epage%3D183%26doi%3D10.1523%2FJNEUROSCI.5236-10.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamatiou, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S. L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachance, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laliberté, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.-C.</span></span> <span> </span><span class="NLM_article-title">Deletion of phosphodiesterase 4D in mice shortens α2-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1045</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1172/JCI0215506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1172%2FJCI0215506" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2002&pages=1045-1052&author=A.+Robichaudauthor=P.+B.+Stamatiouauthor=S.+L.+C.+Jinauthor=N.+Lachanceauthor=D.+MacDonaldauthor=F.+Lalibert%C3%A9author=S.+Liuauthor=Z.+Huangauthor=M.+Contiauthor=C.-C.+Chan&title=Deletion+of+phosphodiesterase+4D+in+mice+shortens+%CE%B12-adrenoceptor-mediated+anesthesia%2C+a+behavioral+correlate+of+emesis&doi=10.1172%2FJCI0215506"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1172%2FJCI0215506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI0215506%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DA.%26aulast%3DStamatiou%26aufirst%3DP.%2BB.%26aulast%3DJin%26aufirst%3DS.%2BL.%2BC.%26aulast%3DLachance%26aufirst%3DN.%26aulast%3DMacDonald%26aufirst%3DD.%26aulast%3DLalibert%25C3%25A9%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DConti%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DC.-C.%26atitle%3DDeletion%2520of%2520phosphodiesterase%25204D%2520in%2520mice%2520shortens%2520%25CE%25B12-adrenoceptor-mediated%2520anesthesia%252C%2520a%2520behavioral%2520correlate%2520of%2520emesis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D110%26spage%3D1045%26epage%3D1052%26doi%3D10.1172%2FJCI0215506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savoie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamatiou, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachance, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolicoeur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.-C.</span></span> <span> </span><span class="NLM_article-title">Assessing the emetic potential of PDE4 inhibitors in rats</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0704457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fsj.bjp.0704457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=11786486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVegug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2002&pages=113-118&author=A.+Robichaudauthor=C.+Savoieauthor=P.+B.+Stamatiouauthor=N.+Lachanceauthor=P.+Jolicoeurauthor=R.+Rasoriauthor=C.-C.+Chan&title=Assessing+the+emetic+potential+of+PDE4+inhibitors+in+rats&doi=10.1038%2Fsj.bjp.0704457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the emetic potential of PDE4 inhibitors in rats</span></div><div class="casAuthors">Robichaud, A.; Savoie, C.; Stamatiou, P. B.; Lachance, N.; Jolicoeur, P.; Rasori, R.; Chan, C. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-118</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Type 4 phosphodiesterase (PDE4) inhibitors mimic the pharmacol. actions of alpha2-adrenoceptor antagonists.  This has been postulated as the mechanism by which PDE4 inhibitors induce emesis and was also demonstrated by their ability to reverse xylazine/ketamine-induced anesthesia.  We further characterized this latter effect since it appears to reflect the emetic potential of PDE4 inhibitors.  Selective inhibitors of PDE 1, 2, 3, 4 and 5 were studied in rats, on the duration of anesthesia induced by the combination of xylazine (10 mg kg-1, i.m.) and ketamine (10 mg kg-1, i.m.).  PMNPQ ((i.e. 6-(4-pyridylmethyl)-8-(3-nitrophenyl)quinoline) - PDE4 inhibitor 0.01-3 mg kg-1), like MK-912 (alpha2-adrenoceptor antagonist: 0.01-3 mg kg-1), dose-dependently reduced the duration of anesthesia.  In contrast, vinpocetine (PDE1 inhibitor), EHNA (PDE2 inhibitor), milrinone (PDE3 inhibitor) and zaprinast (PDE5 inhibitor) had no significant effect at the doses tested (1-10 mg kg-1).  Anal. of plasma and cerebrospinal fluid (CSF) of treated animals confirmed the absorption and distribution to the brain of the inactive inhibitors.  Neither MK-912 (3 mg kg-1) nor PMNPQ (0.1-1 mg kg-1) altered the duration of anesthesia induced via a non-alpha2-adrenoceptor pathway (sodium pentobarbitone 50 mg kg-1, i.p.).  Central NK1 receptors are involved in PDE4 inhibitor-induced emesis.  Consistently, [sar9, Met(O2)11]-substance P (NK1 receptor agonist, 6 μg i.c.v.) reduced the duration of anesthesia induced by xylazine/ketamine.  In summary, this model is functionally coupled to PDE4, specific to alpha2-adrenoceptors and relevant to PDE4 inhibitor-induced emesis.  It therefore provides a novel way of evaluating the emetic potential of PDE4 inhibitors in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhFBpxwaft4bVg90H21EOLACvtfcHk0lgtjAqX2TD_vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVegug%253D%253D&md5=ce6141bb9867f3b9e469bc72393d33e7</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704457%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DA.%26aulast%3DSavoie%26aufirst%3DC.%26aulast%3DStamatiou%26aufirst%3DP.%2BB.%26aulast%3DLachance%26aufirst%3DN.%26aulast%3DJolicoeur%26aufirst%3DP.%26aulast%3DRasori%26aufirst%3DR.%26aulast%3DChan%26aufirst%3DC.-C.%26atitle%3DAssessing%2520the%2520emetic%2520potential%2520of%2520PDE4%2520inhibitors%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D135%26spage%3D113%26epage%3D118%26doi%3D10.1038%2Fsj.bjp.0704457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romussi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spallarossa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brullo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondavalli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanthuyne, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roussel, C.</span></span> <span> </span><span class="NLM_article-title">New selective phosphodiesterase 4D inhibitors differently acting on long, short, and supershort isoforms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6546</span>– <span class="NLM_lpage">6557</span>, <span class="refDoi"> DOI: 10.1021/jm900977c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900977c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6546-6557&author=O.+Brunoauthor=A.+Romussiauthor=A.+Spallarossaauthor=C.+Brulloauthor=S.+Schenoneauthor=F.+Bondavalliauthor=N.+Vanthuyneauthor=C.+Roussel&title=New+selective+phosphodiesterase+4D+inhibitors+differently+acting+on+long%2C+short%2C+and+supershort+isoforms&doi=10.1021%2Fjm900977c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">New Selective Phosphodiesterase 4D Inhibitors Differently Acting on Long, Short, and Supershort Isoforms</span></div><div class="casAuthors">Bruno, Olga; Romussi, Alessia; Spallarossa, Andrea; Brullo, Chiara; Schenone, Silvia; Bondavalli, Francesco; Vanthuyne, Nicolas; Roussel, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6546-6557</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lack of selective inhibitors toward the long, short, or supershort phosphodiesterases (PDE4s) prevented researchers from carefully defining the connection between different enzyme isoforms, their brain localization, and their role in neurodegenerative diseases such as Alzheimer's disease (AD).  In the search for new therapeutic agents for treating memory and learning disorders, we synthesized new rolipram related PDE4 inhibitors, which had some selectivity toward the long form PDE4D3.  The first series was synthesized as racemate and then resolved by semipreparative HPLC on chiral supports.  Herein we report the synthetic pathways to obtain rolipram related compds. and their biol. activities and some SAR considerations that provide some insights and hints for the structural requirements for PDE4D subtype selectivity and enzyme inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrp9k6gslEYrVg90H21EOLACvtfcHk0lgtjAqX2TD_vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtL3M&md5=db19da5da1e6781c62dd6b6415ca68c3</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjm900977c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900977c%26sid%3Dliteratum%253Aachs%26aulast%3DBruno%26aufirst%3DO.%26aulast%3DRomussi%26aufirst%3DA.%26aulast%3DSpallarossa%26aufirst%3DA.%26aulast%3DBrullo%26aufirst%3DC.%26aulast%3DSchenone%26aufirst%3DS.%26aulast%3DBondavalli%26aufirst%3DF.%26aulast%3DVanthuyne%26aufirst%3DN.%26aulast%3DRoussel%26aufirst%3DC.%26atitle%3DNew%2520selective%2520phosphodiesterase%25204D%2520inhibitors%2520differently%2520acting%2520on%2520long%252C%2520short%252C%2520and%2520supershort%2520isoforms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6546%26epage%3D6557%26doi%3D10.1021%2Fjm900977c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canepa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brullo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardella, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domenicotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijselaers, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanmierlo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limebeer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argellati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinari, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pronzato, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricciarelli, R.</span></span> <span> </span><span class="NLM_article-title">GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">2054</span>– <span class="NLM_lpage">2063</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01524.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fj.1476-5381.2011.01524.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=21649644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2011&pages=2054-2063&author=O.+Brunoauthor=E.+Fedeleauthor=J.+Prickaertsauthor=L.+A.+Parkerauthor=E.+Canepaauthor=C.+Brulloauthor=A.+Cavalleroauthor=E.+Gardellaauthor=A.+Balbiauthor=C.+Domenicottiauthor=E.+Bollenauthor=H.+J.+Gijselaersauthor=T.+Vanmierloauthor=K.+Erbauthor=C.+L.+Limebeerauthor=F.+Argellatiauthor=U.+M.+Marinariauthor=M.+A.+Pronzatoauthor=R.+Ricciarelli&title=GEBR-7b%2C+a+novel+PDE4D+selective+inhibitor+that+improves+memory+in+rodents+at+non-emetic+doses&doi=10.1111%2Fj.1476-5381.2011.01524.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses</span></div><div class="casAuthors">Bruno, O.; Fedele, E.; Prickaerts, J.; Parker, L. A.; Canepa, E.; Brullo, C.; Cavallero, A.; Gardella, E.; Balbi, A.; Domenicotti, C.; Bollen, E.; Gijselaers, H. J. M.; Vanmierlo, T.; Erb, K.; Limebeer, C. L.; Argellati, F.; Marinari, U. M.; Pronzato, M. A.; Ricciarelli, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2054-2063</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: Strategies designed to enhance cerebral cAMP have been proposed as symptomatic treatments to counteract cognitive deficits.  However, pharmacol. therapies aimed at reducing PDE4, the main class of cAMP catabolizing enzymes in the brain, produce severe emetic side effects.  We have recently synthesized a 3-cyclopentyloxy-4-methoxybenzaldehyde deriv., structurally related to rolipram, and endowed with selective PDE4D inhibitory activity.  The aim of the present study was to investigate the effect of the new drug, namely GEBR-7b, on memory performance, nausea, hippocampal cAMP and amyloid-β (Aβ) levels.  Exptl. Approach: To measure memory performance, we performed object recognition tests on rats and mice treated with GEBR-7b or rolipram.  The emetic potential of the drug, again compared with rolipram, was evaluated in rats using the taste reactivity test and in mice using the xylazine/ketamine anesthesia test.  Extracellular hippocampal cAMP was evaluated by intracerebral microdialysis in freely moving rats.  Levels of sol. Aβ peptides were measured in hippocampal tissues and cultured N2a cells by ELISA.  Key Results: GEBR-7b increased hippocampal cAMP, did not influence Aβ levels and improved spatial, as well as object memory performance in the object recognition tests.  The effect of GEBR-7b on memory was 3 to 10 times more potent than that of rolipram, and its EDs had no effect on surrogate measures of emesis in rodents.  Conclusion and Implications: Our results demonstrate that GEBR-7b enhances memory functions at doses that do not cause emesis-like behavior in rodents, thus offering a promising pharmacol. perspective for the treatment of memory impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpATGYg_M20rVg90H21EOLACvtfcHk0lgtjAqX2TD_vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsLrN&md5=3cb12b993944a55d6052b10bd07c9c09</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01524.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01524.x%26sid%3Dliteratum%253Aachs%26aulast%3DBruno%26aufirst%3DO.%26aulast%3DFedele%26aufirst%3DE.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DParker%26aufirst%3DL.%2BA.%26aulast%3DCanepa%26aufirst%3DE.%26aulast%3DBrullo%26aufirst%3DC.%26aulast%3DCavallero%26aufirst%3DA.%26aulast%3DGardella%26aufirst%3DE.%26aulast%3DBalbi%26aufirst%3DA.%26aulast%3DDomenicotti%26aufirst%3DC.%26aulast%3DBollen%26aufirst%3DE.%26aulast%3DGijselaers%26aufirst%3DH.%2BJ.%26aulast%3DVanmierlo%26aufirst%3DT.%26aulast%3DErb%26aufirst%3DK.%26aulast%3DLimebeer%26aufirst%3DC.%2BL.%26aulast%3DArgellati%26aufirst%3DF.%26aulast%3DMarinari%26aufirst%3DU.%2BM.%26aulast%3DPronzato%26aufirst%3DM.%2BA.%26aulast%3DRicciarelli%26aufirst%3DR.%26atitle%3DGEBR-7b%252C%2520a%2520novel%2520PDE4D%2520selective%2520inhibitor%2520that%2520improves%2520memory%2520in%2520rodents%2520at%2520non-emetic%2520doses%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D164%26spage%3D2054%26epage%3D2063%26doi%3D10.1111%2Fj.1476-5381.2011.01524.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brullo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricciarelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotolo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Hagen, B. T.</span></span> <span> </span><span class="NLM_article-title">New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2, 6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejmech.2016.08.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=82-102&author=C.+Brulloauthor=R.+Ricciarelliauthor=J.+Prickaertsauthor=O.+Arancioauthor=M.+Massaauthor=C.+Rotoloauthor=B.+T.+van+Hagen&title=New+insights+into+selective+PDE4D+inhibitors%3A+3-%28Cyclopentyloxy%29-4-methoxybenzaldehyde+O-%282-%282%2C+6-dimethylmorpholino%29-2-oxoethyl%29+oxime+%28GEBR-7b%29+structural+development+and+promising+activities+to+restore+memory+impairment&doi=10.1016%2Fj.ejmech.2016.08.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DBrullo%26aufirst%3DC.%26aulast%3DRicciarelli%26aufirst%3DR.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DMassa%26aufirst%3DM.%26aulast%3DRotolo%26aufirst%3DC.%26aulast%3Dvan%2BHagen%26aufirst%3DB.%2BT.%26atitle%3DNew%2520insights%2520into%2520selective%2520PDE4D%2520inhibitors%253A%25203-%2528Cyclopentyloxy%2529-4-methoxybenzaldehyde%2520O-%25282-%25282%252C%25206-dimethylmorpholino%2529-2-oxoethyl%2529%2520oxime%2520%2528GEBR-7b%2529%2520structural%2520development%2520and%2520promising%2520activities%2520to%2520restore%2520memory%2520impairment%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D82%26epage%3D102%26doi%3D10.1016%2Fj.ejmech.2016.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staker, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsteinsdottir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrafnsdottir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselyov, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span> <span> </span><span class="NLM_article-title">Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1038/nbt.1598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnbt.1598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=20037581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SktbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=63-70&author=A.+B.+Burginauthor=O.+T.+Magnussonauthor=J.+Singhauthor=P.+Witteauthor=B.+L.+Stakerauthor=J.+M.+Bjornssonauthor=M.+Thorsteinsdottirauthor=S.+Hrafnsdottirauthor=T.+Hagenauthor=A.+S.+Kiselyovauthor=L.+J.+Stewartauthor=M.+E.+Gurney&title=Design+of+phosphodiesterase+4D+%28PDE4D%29+allosteric+modulators+for+enhancing+cognition+with+improved+safety&doi=10.1038%2Fnbt.1598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety</span></div><div class="casAuthors">Burgin, Alex B.; Magnusson, Olafur T.; Singh, Jasbir; Witte, Pam; Staker, Bart L.; Bjornsson, Jon M.; Thorsteinsdottir, Margret; Hrafnsdottir, Sigrun; Hagen, Timothy; Kiselyov, Alex S.; Stewart, Lance J.; Gurney, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-70</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphodiesterase 4 (PDE4), the primary cAMP-hydrolyzing enzyme in cells, is a promising drug target for a wide range of conditions.  Here we present seven co-crystal structures of PDE4 and bound inhibitors that show the regulatory domain closed across the active site, thereby revealing the structural basis of PDE4 regulation.  This structural insight, together with supporting mutagenesis and kinetic studies, allowed us to design small-mol. allosteric modulators of PDE4D that do not completely inhibit enzymic activity (Imax ∼ 80-90%).  These allosteric modulators have reduced potential to cause emesis, a dose-limiting side effect of existing active site-directed PDE4 inhibitors, while maintaining biol. activity in cellular and in vivo models.  Our results may facilitate the design of CNS therapeutics modulating cAMP signaling for the treatment of Alzheimer's disease, Huntington's disease, schizophrenia and depression, where brain distribution is desired for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr18KdQE2oVsbVg90H21EOLACvtfcHk0ljS43f3Ps5Iag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SktbzJ&md5=1e8651a7116206eefddb9fa6b79d5112</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1598%26sid%3Dliteratum%253Aachs%26aulast%3DBurgin%26aufirst%3DA.%2BB.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DWitte%26aufirst%3DP.%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DBjornsson%26aufirst%3DJ.%2BM.%26aulast%3DThorsteinsdottir%26aufirst%3DM.%26aulast%3DHrafnsdottir%26aufirst%3DS.%26aulast%3DHagen%26aufirst%3DT.%26aulast%3DKiselyov%26aufirst%3DA.%2BS.%26aulast%3DStewart%26aufirst%3DL.%2BJ.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DDesign%2520of%2520phosphodiesterase%25204D%2520%2528PDE4D%2529%2520allosteric%2520modulators%2520for%2520enhancing%2520cognition%2520with%2520improved%2520safety%26jtitle%3DNat.%2520Biotechnol.%26date%3D2010%26volume%3D28%26spage%3D63%26epage%3D70%26doi%3D10.1038%2Fnbt.1598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J.</span></span> <span> </span><span class="NLM_article-title">Role of phosphodiesterase 4D in memory and cognition</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">662.4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=662.4&author=C.+Zhangauthor=Y.+Xuauthor=M.+Gurneyauthor=J.+O%E2%80%99Donnell&title=Role+of+phosphodiesterase+4D+in+memory+and+cognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DGurney%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%26atitle%3DRole%2520of%2520phosphodiesterase%25204D%2520in%2520memory%2520and%2520cognition%26jtitle%3DFASEB%2520J.%26date%3D2017%26volume%3D31%26spage%3D662.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span>Clinical
trial study found in clinical trials for BPN14770, NCT02648672. <a href="https://clinicaltrials.gov/ct2/show/NCT02648672?term=BPN14770&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02648672?term=BPN14770&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+BPN14770%2C+NCT02648672.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02648672%3Fterm%3DBPN14770%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span>Clinical
trial study found in clinical trials for BPN14770, NCT02840279. <a href="https://clinicaltrials.gov/ct2/show/NCT02840279?term=BPN14770&amp;rank=2" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02840279?term=BPN14770&rank=2</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+BPN14770%2C+NCT02840279.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02840279%3Fterm%3DBPN14770%26rank%3D2+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span>Clinical
trial study found in clinical trials for BPN14770, NCT03030105. <a href="https://clinicaltrials.gov/ct2/show/NCT03030105?term=BPN14770&amp;rank=3" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03030105?term=BPN14770&rank=3</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+BPN14770%2C+NCT03030105.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03030105%3Fterm%3DBPN14770%26rank%3D3+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, P. J.</span></span> <span> </span><span class="NLM_article-title"><i>Comparison</i> of phosphodiesterase type 5 (PDE5) inhibitors</span>. <i>Int. J. Clin. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.1111/j.1742-1241.2006.01049.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fj.1742-1241.2006.01049.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16780568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVemsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2006&pages=967-975&author=P.+J.+Wright&title=Comparison+of+phosphodiesterase+type+5+%28PDE5%29+inhibitors&doi=10.1111%2Fj.1742-1241.2006.01049.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of phosphodiesterase type 5 (PDE5) inhibitors</span></div><div class="casAuthors">Wright, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">967-975</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Of the current options available to treat erectile dysfunction, oral phosphodiesterase type 5 (PDE5) inhibitors are the recommended first-line treatment.  This review compares the three currently licensed PDE5 inhibitors: sildenafil citrate (sildenafil), vardenafil HCl (vardenafil) and tadalafil.  All three drugs have similar efficacy and toxicity profiles.  Sildenafil and vardenafil have similar mol. structures, but tadalafil is structurally different, which is reflected in its pharmacokinetic profile.  With regard to the onset of action, achievement of an erection that leads to successful intercourse has been reported for 35% of patients treated with sildenafil within 14 min, 21% of patients treated with vardenafil within 10 min and 16% of patients treated with tadalafil within 16 min.  Sildenafil and vardenafil both have half-lives of approx. 4 h but the half-life of tadalafil is 17.5 h.  Another difference between the PDE5 inhibitors is that food, esp. fatty food, affects the pharmacokinetic profiles of sildenafil and vardenafil, but not that of tadalafil.  These pharmacokinetic differences among the PDE5 inhibitors may underlie patient preference, an important and emerging aspect of ED therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq23EQj8sircbVg90H21EOLACvtfcHk0ljS43f3Ps5Iag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVemsb0%253D&md5=7a1da0d485aee821949c1e373032b590</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2006.01049.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2006.01049.x%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DP.%2BJ.%26atitle%3DComparison%2520of%2520phosphodiesterase%2520type%25205%2520%2528PDE5%2529%2520inhibitors%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2006%26volume%3D60%26spage%3D967%26epage%3D975%26doi%3D10.1111%2Fj.1742-1241.2006.01049.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoraghi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Multiple conformations of phosphodiesterase-5: implications for enzyme function and drug development</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">21469</span>– <span class="NLM_lpage">21479</span>, <span class="refDoi"> DOI: 10.1074/jbc.M512527200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1074%2Fjbc.M512527200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16735511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1KjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=21469-21479&author=H.+Wangauthor=Y.+Liuauthor=Q.+Huaiauthor=J.+Caiauthor=R.+Zoraghiauthor=S.+H.+Francisauthor=J.+D.+Corbinauthor=H.+Robinsonauthor=Z.+Xinauthor=G.+Linauthor=H.+Ke&title=Multiple+conformations+of+phosphodiesterase-5%3A+implications+for+enzyme+function+and+drug+development&doi=10.1074%2Fjbc.M512527200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Conformations of Phosphodiesterase-5: implications for enzyme function and drug development</span></div><div class="casAuthors">Wang, Huanchen; Liu, Yudong; Huai, Qing; Cai, Jiwen; Zoraghi, Roya; Francis, Sharron H.; Corbin, Jackie D.; Robinson, Howard; Xin, Zhongcheng; Lin, Guiting; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">21469-21479</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Phosphodiesterase-5 (PDE5) is the target for sildenafil, vardenafil, and tadalafil, which are drugs for treatment of erectile dysfunction and pulmonary hypertension.  We report here the crystal structures of a fully active catalytic domain of unliganded PDE5A1 and its complexes with sildenafil or icarisid II.  These structures together with the PDE5A1-isobutyl-1-methylxanthine complex show that the H-loop (residues 660-683) at the active site of PDE5A1 has four different conformations and migrates 7-35 Å upon inhibitor binding.  In addn., the conformation of sildenafil reported herein differs significantly from those in the previous structures of chimerically hybridized or almost inactive PDE5.  Mutagenesis and kinetic analyses confirm that the H-loop is particularly important for substrate recognition and that invariant Gly659, which immediately precedes the H-loop, is crit. for optimal substrate affinity and catalytic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplF9ohkT9ogLVg90H21EOLACvtfcHk0lgxskGunpnrnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1KjsLs%253D&md5=3a5ac86273a74da4a559bc6efc647181</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M512527200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M512527200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHuai%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DZoraghi%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DS.%2BH.%26aulast%3DCorbin%26aufirst%3DJ.%2BD.%26aulast%3DRobinson%26aufirst%3DH.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DMultiple%2520conformations%2520of%2520phosphodiesterase-5%253A%2520implications%2520for%2520enzyme%2520function%2520and%2520drug%2520development%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D21469%26epage%3D21479%26doi%3D10.1074%2Fjbc.M512527200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puzzo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniszewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privitera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leznik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer’s disease mouse model</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">8075</span>– <span class="NLM_lpage">8086</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0864-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1523%2FJNEUROSCI.0864-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=19553447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=8075-8086&author=D.+Puzzoauthor=A.+Staniszewskiauthor=S.+X.+Dengauthor=L.+Priviteraauthor=E.+Leznikauthor=S.+Liuauthor=H.+Zhangauthor=Y.+Fengauthor=A.+Palmeriauthor=D.+W.+Landryauthor=O.+Arancio&title=Phosphodiesterase+5+inhibition+improves+synaptic+function%2C+memory%2C+and+amyloid-%CE%B2+load+in+an+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1523%2FJNEUROSCI.0864-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer's disease mouse model</span></div><div class="casAuthors">Puzzo, Daniela; Staniszewski, Agnieszka; Deng, Shi Xian; Privitera, Lucia; Leznik, Elena; Liu, Shumin; Zhang, Hong; Feng, Yan; Palmeri, Agostino; Landry, Donald W.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8075-8086</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Memory loss, synaptic dysfunction, and accumulation of amyloid β-peptides (Aβ) are major hallmarks of Alzheimer's disease (AD).  Downregulation of the nitric oxide/cGMP/cGMP-dependent protein kinase/c-AMP responsive element-binding protein (CREB) cascade has been linked to the synaptic deficits after Aβ elevation.  Here, we report that the phosphodiesterase 5 inhibitor (PDE5) sildenafil (Viagra), a mol. that enhances phosphorylation of CREB, a mol. involved in memory, through elevation of cGMP levels, is beneficial against the AD phenotype in a mouse model of amyloid deposition.  We demonstrate that the inhibitor produces an immediate and long-lasting amelioration of synaptic function, CREB phosphorylation, and memory.  This effect is also assocd. with a long-lasting redn. of Aβ levels.  Given that side effects of PDE5 inhibitors are widely known and do not preclude their administration to a senile population, these drugs have potential for the treatment of AD and other diseases assocd. with elevated Aβ levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69pOrzfjxY7Vg90H21EOLACvtfcHk0lgxskGunpnrnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D&md5=5aead1f7c92b6166b8591c3e7951f78d</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0864-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0864-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DPrivitera%26aufirst%3DL.%26aulast%3DLeznik%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPhosphodiesterase%25205%2520inhibition%2520improves%2520synaptic%2520function%252C%2520memory%252C%2520and%2520amyloid-%25CE%25B2%2520load%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D8075%26epage%3D8086%26doi%3D10.1523%2FJNEUROSCI.0864-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>250</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2013.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.bbr.2013.05.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=2013&pages=230-237&author=J.+Zhangauthor=J.+Guoauthor=X.+Zhaoauthor=Z.+Chenauthor=G.+Wangauthor=A.+Liuauthor=Q.+Wangauthor=W.+Zhouauthor=Y.+Xueauthor=C.+Wang&title=Phosphodiesterase-5+inhibitor+sildenafil+prevents+neuroinflammation%2C+lowers+beta-amyloid+levels+and+improves+cognitive+performance+in+APP%2FPS1+transgenic+mice&doi=10.1016%2Fj.bbr.2013.05.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2013.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2013.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DPhosphodiesterase-5%2520inhibitor%2520sildenafil%2520prevents%2520neuroinflammation%252C%2520lowers%2520beta-amyloid%2520levels%2520and%2520improves%2520cognitive%2520performance%2520in%2520APP%252FPS1%2520transgenic%2520mice%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2013%26volume%3D250%26spage%3D230%26epage%3D237%26doi%3D10.1016%2Fj.bbr.2013.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervias, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricobaraza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puerta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Roldán, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Osta, A.</span></span> <span> </span><span class="NLM_article-title">sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer’s disease</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">2029</span>– <span class="NLM_lpage">2041</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01517.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fj.1476-5381.2011.01517.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=21627640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2011&pages=2029-2041&author=M.+Cuadrado-Tejedorauthor=I.+Herviasauthor=A.+Ricobarazaauthor=E.+Puertaauthor=J.+M.+P%C3%A9rez-Rold%C3%A1nauthor=C.+Garc%C3%ADa-Barrosoauthor=R.+Francoauthor=N.+Aguirreauthor=A.+Garc%C3%ADa-Osta&title=sildenafil+restores+cognitive+function+without+affecting+%CE%B2-amyloid+burden+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1476-5381.2011.01517.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Cuadrado-Tejedor, M.; Hervias, I.; Ricobaraza, A.; Puerta, E.; Perez-Roldan, J. M.; Garcia-Barroso, C.; Franco, R.; Aguirre, N.; Garcia-Osta, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2029-2041</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Inhibitors of phosphodiesterase 5 (PDE5) affect signalling pathways by elevating cGMP, which is a second messenger involved in processes of neuroplasticity.  In the present study, the effects of the PDE5 inhibitor, sildenafil, on the pathol. features of Alzheimer's disease and on memory-related behavior were investigated.  Exptl. Approach Sildenafil was administered to the Tg2576 transgenic mouse model of Alzheimer's disease and to age-matched neg. littermates (controls).  Memory function was analyzed using the Morris water maze test and fear conditioning tasks.  Biochem. analyses were performed in brain lysates from animals treated with saline or with sildenafil.  Key Results Treatment of aged Tg2576 animals with sildenafil completely reversed their cognitive impairment.  Such changes were accompanied in the hippocampus by a redn. of tau hyperphosphorylation and a decrease in the activity of glycogen synthase kinase 3β (GSK3β) and of cyclin-dependent kinase 5 (CDK5) (p25/p35 ratio).  Moreover, sildenafil also increased levels of brain-derived neurotrophic factor (BDNF) and the activity-regulated cytoskeletal-assocd. protein (Arc) in the hippocampus without any detectable modification of brain amyloid burden.  Conclusions and Implications Sildenafil improved cognitive functions in Tg2576 mice and the effect was not related to changes in the amyloid burden.  These data further strengthen the potential of sildenafil as a therapeutic agent for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSIHZg2HFLZbVg90H21EOLACvtfcHk0lgycGHvYl_gFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsL3F&md5=5bda5d02186b430428a2d7ce8c354696</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01517.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01517.x%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DHervias%26aufirst%3DI.%26aulast%3DRicobaraza%26aufirst%3DA.%26aulast%3DPuerta%26aufirst%3DE.%26aulast%3DP%25C3%25A9rez-Rold%25C3%25A1n%26aufirst%3DJ.%2BM.%26aulast%3DGarc%25C3%25ADa-Barroso%26aufirst%3DC.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DAguirre%26aufirst%3DN.%26aulast%3DGarc%25C3%25ADa-Osta%26aufirst%3DA.%26atitle%3Dsildenafil%2520restores%2520cognitive%2520function%2520without%2520affecting%2520%25CE%25B2-amyloid%2520burden%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D164%26spage%3D2029%26epage%3D2041%26doi%3D10.1111%2Fj.1476-5381.2011.01517.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orejana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros-Minones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puerta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, N.</span></span> <span> </span><span class="NLM_article-title">Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">625.e11</span>– <span class="NLM_lpage">625.e20</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2011.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neurobiolaging.2011.03.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=625.e11-625.e20&author=L.+Orejanaauthor=L.+Barros-Minonesauthor=J.+Jordanauthor=E.+Puertaauthor=N.+Aguirre&title=Sildenafil+ameliorates+cognitive+deficits+and+tau+pathology+in+a+senescence-accelerated+mouse+model&doi=10.1016%2Fj.neurobiolaging.2011.03.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2011.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2011.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DOrejana%26aufirst%3DL.%26aulast%3DBarros-Minones%26aufirst%3DL.%26aulast%3DJordan%26aufirst%3DJ.%26aulast%3DPuerta%26aufirst%3DE.%26aulast%3DAguirre%26aufirst%3DN.%26atitle%3DSildenafil%2520ameliorates%2520cognitive%2520deficits%2520and%2520tau%2520pathology%2520in%2520a%2520senescence-accelerated%2520mouse%2520model%26jtitle%3DNeurobiol.%2520Aging%26date%3D2012%26volume%3D33%26spage%3D625.e11%26epage%3D625.e20%26doi%3D10.1016%2Fj.neurobiolaging.2011.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orejana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros-Minones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cedazo-Minguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tordera, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puerta, E.</span></span> <span> </span><span class="NLM_article-title">Sildenafil decreases BACE1 and cathepsin B levels and reduces APP Amyloidogenic processing in the SAMP8 Mouse</span>. <i>J. Gerontol., Ser. A</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1093/gerona/glu106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1093%2Fgerona%2Fglu106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=25063079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvFCqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=675-685&author=L.+Orejanaauthor=L.+Barros-Minonesauthor=J.+Jordanauthor=A.+Cedazo-Minguezauthor=R.+M.+Torderaauthor=N.+Aguirreauthor=E.+Puerta&title=Sildenafil+decreases+BACE1+and+cathepsin+B+levels+and+reduces+APP+Amyloidogenic+processing+in+the+SAMP8+Mouse&doi=10.1093%2Fgerona%2Fglu106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Sildenafil decreases BACE1 and cathepsin B levels and reduces app amyloidogenic processing in the SAMP8 mouse</span></div><div class="casAuthors">Orejana, Lourdes; Barros-Minones, Lucia; Cedazo-Minguez, Joaquin Jordan Angel; Tordera, Rosa M.; Aguirre, Norberto; Puerta, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Journals of Gerontology, Series A: Biological Sciences and Medical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">675-685</span>CODEN:
                <span class="NLM_cas:coden">JGASFW</span>;
        ISSN:<span class="NLM_cas:issn">1079-5006</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The senescence-accelerated mouse-prone 8 (SAMP8), used as a model of aging, displays many established pathol. features of Alzheimer's disease.  Cognitive impairments and increased levels of hyperphosphorylated tau are found in the hippocampus of SAMP8 mice along with an increased β-secretase activity and amyloid-β (Aβ) depositions that increase in no. and extent with age.  Based on a previous study from our lab. showing an amelioration of cognitive impairments and tau pathol. by sildenafil, in this study we tested whether this drug could also modulate the amyloid precursor protein amyloidogenic processing in this mouse model.  Our results show that the protein levels of the β-secretases β-site amyloid precursor protein cleaving enzyme 1 and cathepsin B are higher in the hippocampus of 9-mo-old SAMP8 mice than those of age-matched senescence-resistant-1.  Sildenafil (7.5mg/kg for 4 wk) attenuated learning and memory impairments shown by SAMP8 mice in the passive avoidance test.  The increased expression of β-site amyloid precursor protein cleaving enzyme 1 was also reduced by sildenafil, an effect paralleled to decreases in the activities of two β-site amyloid precursor protein cleaving enzyme 1 modulators, calpain and cyclin-dependent kinase 5 protein.  Interestingly, sildenafil enhanced both Akt and glycogen synthase kinase-3β (ser9) phosphorylation, which could be mediating the redn. in cathepsin B levels found in the hippocampus of sildenafil-treated SAMP8 mice.  Sildenafil-induced redn. in β-site amyloid precursor protein cleaving enzyme 1 and cathepsin B expression in SAMP8 mice was assocd. with a decrease in hippocampal Aβ42 levels which, in turn, could mediate the parallel decline in glial fibrillary acidic protein expression obsd. in these animals.  These findings highlight the therapeutic potential of sildenafil in Alzheimer's disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgbd3y0L5j67Vg90H21EOLACvtfcHk0lgycGHvYl_gFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvFCqs7w%253D&md5=3df8df3da69c8e04d5e4ceecb2e0a98f</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1093%2Fgerona%2Fglu106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fgerona%252Fglu106%26sid%3Dliteratum%253Aachs%26aulast%3DOrejana%26aufirst%3DL.%26aulast%3DBarros-Minones%26aufirst%3DL.%26aulast%3DJordan%26aufirst%3DJ.%26aulast%3DCedazo-Minguez%26aufirst%3DA.%26aulast%3DTordera%26aufirst%3DR.%2BM.%26aulast%3DAguirre%26aufirst%3DN.%26aulast%3DPuerta%26aufirst%3DE.%26atitle%3DSildenafil%2520decreases%2520BACE1%2520and%2520cathepsin%2520B%2520levels%2520and%2520reduces%2520APP%2520Amyloidogenic%2520processing%2520in%2520the%2520SAMP8%2520Mouse%26jtitle%3DJ.%2520Gerontol.%252C%2520Ser.%2520A%26date%3D2015%26volume%3D70%26spage%3D675%26epage%3D685%26doi%3D10.1093%2Fgerona%2Fglu106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span>Clinical
trial study found in clinical trials for sildenafil, NCT00455715. <a href="https://clinicaltrials.gov/ct2/show/NCT00455715?term=sildenafil&amp;draw=3&amp;rank=12" class="extLink">https://clinicaltrials.gov/ct2/show/NCT00455715?term=sildenafil&draw=3&rank=12</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+sildenafil%2C+NCT00455715.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00455715%3Fterm%3Dsildenafil%26draw%3D3%26rank%3D12+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span>Clinical
trial study found in clinical trials for sildenafil, NCT01941732. <a href="https://clinicaltrials.gov/ct2/show/NCT01941732?term=sildenafil&amp;draw=3&amp;rank=28" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01941732?term=sildenafil&draw=3&rank=28</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+sildenafil%2C+NCT01941732.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01941732%3Fterm%3Dsildenafil%26draw%3D3%26rank%3D28+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Arrastia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devous, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womack, K. B.</span></span> <span> </span><span class="NLM_article-title">Sildenafil improves vascular and metabolic function in patients with Alzheimer’s Disease</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1351</span>– <span class="NLM_lpage">1364</span>, <span class="refDoi"> DOI: 10.3233/JAD-161006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.3233%2FJAD-161006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=29036811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2gtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1351-1364&author=M.+Shengauthor=H.+Luauthor=P.+Liuauthor=Y.+Liauthor=H.+Raviauthor=S.+L.+Pengauthor=R.+Diaz-Arrastiaauthor=M.+D.+Devousauthor=K.+B.+Womack&title=Sildenafil+improves+vascular+and+metabolic+function+in+patients+with+Alzheimer%E2%80%99s+Disease&doi=10.3233%2FJAD-161006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease</span></div><div class="casAuthors">Sheng, Min; Lu, Hanzhang; Liu, Peiying; Li, Yang; Ravi, Harshan; Peng, Shin-Lei; Diaz-Arrastia, Ramon; Devous, Michael D.; Womack, Kyle B.; Claassen, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1351-1364</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Background: : Alzheimer's disease (AD) is the leading cause of degenerative dementia in the aging population.  Patients with AD have alterations in cerebral hemodynamic function including reduced cerebral blood flow (CBF) and cerebral metabolic rate.  Therefore, improved cerebrovascular function may be an attractive goal for pharmaceutical intervention in AD.  Objective: : We wished to observe the acute effects of sildenafil on cerebrovascular function and brain metab. in patients with AD.  Methods: : We used several novel non-invasive MRI techniques to investigate the alterations of CBF, cerebral metabolic rate of oxygen (CMRO2), and cerebrovascular reactivity (CVR) after a single dose of sildenafil administration in order to assess its physiol. effects in patients with AD.  CBF, CMRO2, and CVR measurements using MRI were performed before and one hour after the oral administration of 50mg sildenafil.  Baseline Montreal Cognitive Assessment score was also obtained.  Results: : Complete CBF and CMRO2 data were obtained in twelve patients.  Complete CVR data were obtained in eight patients.  Global CBF and CMRO2 significantly increased (p=0.03, p=0.05, resp.) following sildenafil administration.  Voxel-wise analyses of CBF maps showed that increased CBF was most pronounced in the bilateral medial temporal lobes.  CVR significantly decreased after administration of sildenafil.  Conclusion: : Our data suggest that a single dose of sildenafil improves cerebral hemodynamic function and increases cerebral oxygen metab. in patients with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQe1EPHEsy_LVg90H21EOLACvtfcHk0lgycGHvYl_gFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2gtLnE&md5=3ce96e3a5346d3e536a22bc9a7fdcdcb</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.3233%2FJAD-161006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-161006%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DRavi%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DS.%2BL.%26aulast%3DDiaz-Arrastia%26aufirst%3DR.%26aulast%3DDevous%26aufirst%3DM.%2BD.%26aulast%3DWomack%26aufirst%3DK.%2BB.%26atitle%3DSildenafil%2520improves%2520vascular%2520and%2520metabolic%2520function%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2017%26volume%3D60%26spage%3D1351%26epage%3D1364%26doi%3D10.3233%2FJAD-161006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forgue, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedding, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrishko, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M. I.</span></span> <span> </span><span class="NLM_article-title">Tadalafil pharmacokinetics in healthy subjects</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">280</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.2005.02553.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1111%2Fj.1365-2125.2005.02553.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=16487221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD28XislKhsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2006&pages=280-288&author=S.+T.+Forgueauthor=B.+E.+Pattersonauthor=A.+W.+Beddingauthor=C.+D.+Payneauthor=D.+L.+Phillipsauthor=R.+E.+Wrishkoauthor=M.+I.+Mitchell&title=Tadalafil+pharmacokinetics+in+healthy+subjects&doi=10.1111%2Fj.1365-2125.2005.02553.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Tadalafil pharmacokinetics in healthy subjects</span></div><div class="casAuthors">Forgue, S. Thomas; Patterson, Beverley E.; Bedding, Alun W.; Payne, Christopher D.; Phillips, Diane L.; Wrishko, Rebecca E.; Mitchell, Malcolm I.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">280-288</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aims To characterize tadalafil plasma pharmacokinetics in healthy subjects following single and multiple doses.  Methods Noncompartmental parameters were calcd. for healthy subjects receiving a single 2.5-20-mg tadalafil does in 13 clin. pharmacol. studies.  An integrated statistical anal. of results in 237 subjects provided global avs. and an assessment of effects of body mass index (BMI), age, gender and smoking status.  Diurnal variation, food effects and proportionality of exposure to dose were analyzed in three studies.  Multiple-dose pharmacokinetics were evaluated in a sep. study in which parallel groups of 15 subjects received 10 or 20 mg tadalafil once daily for 10 days.  Results Tadalafil was absorbed rapidly with mean Cmax (378 μg l-1 for 20 mg) obsd. at 2 h; thereafter, concns. declined nearly monoexponentially with a mean (5th, 95th percentiles) t1/2 of 17.5 (11.5, 29.6) hours.  Mean oral clearance (CL/F) was 2.48 (1.35, 4.35) l h-1 and apparent vol. of distribution (Vz/F) was 62.6 (39.5, 92.1) l.  No clin. meaningful effect of BMI, age, gender or smoking was identified.  Exposure was not substantially affected by time of dosing.  Food had negligible effects on bioavailability as assessed by 90% confidence intervals for Cmax and AUC mean ratios.  Parameters were proportional to dose, indicating that doubling the dose doubled exposure.  Steady state was attained by day 5 following once-daily administration, and accumulation (1.6-fold) was consistent with the t1/2.  Conclusions Tadalafil pharmacokinetics are linear with respect to dose and time, and are not affected by food.  Systemic clearance is low relative to other phosphodiesterase 5 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw0ePo3xDnD7Vg90H21EOLACvtfcHk0lgU7hJWioFyrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislKhsLc%253D&md5=a9dfc7d0d0d3aa07619a42c5c79b7495</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2005.02553.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2005.02553.x%26sid%3Dliteratum%253Aachs%26aulast%3DForgue%26aufirst%3DS.%2BT.%26aulast%3DPatterson%26aufirst%3DB.%2BE.%26aulast%3DBedding%26aufirst%3DA.%2BW.%26aulast%3DPayne%26aufirst%3DC.%2BD.%26aulast%3DPhillips%26aufirst%3DD.%2BL.%26aulast%3DWrishko%26aufirst%3DR.%2BE.%26aulast%3DMitchell%26aufirst%3DM.%2BI.%26atitle%3DTadalafil%2520pharmacokinetics%2520in%2520healthy%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D61%26spage%3D280%26epage%3D288%26doi%3D10.1111%2Fj.1365-2125.2005.02553.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricobaraza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual-Lucas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unceta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rico, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goicolea, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanciego, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2012.06.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=114-123&author=C.+Garcia-Barrosoauthor=A.+Ricobarazaauthor=M.+Pascual-Lucasauthor=N.+Uncetaauthor=A.+J.+Ricoauthor=M.+A.+Goicoleaauthor=J.+Sallesauthor=J.+L.+Lanciegoauthor=J.+Oyarzabalauthor=R.+Francoauthor=M.+Cuadrado-Tejedorauthor=A.+Garcia-Osta&title=Tadalafil+crosses+the+blood-brain+barrier+and+reverses+cognitive+dysfunction+in+a+mouse+model+of+AD&doi=10.1016%2Fj.neuropharm.2012.06.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.052%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DRicobaraza%26aufirst%3DA.%26aulast%3DPascual-Lucas%26aufirst%3DM.%26aulast%3DUnceta%26aufirst%3DN.%26aulast%3DRico%26aufirst%3DA.%2BJ.%26aulast%3DGoicolea%26aufirst%3DM.%2BA.%26aulast%3DSalles%26aufirst%3DJ.%26aulast%3DLanciego%26aufirst%3DJ.%2BL.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DTadalafil%2520crosses%2520the%2520blood-brain%2520barrier%2520and%2520reverses%2520cognitive%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520AD%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D114%26epage%3D123%26doi%3D10.1016%2Fj.neuropharm.2012.06.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span>Clinical trial study found in clinical  <i>trials</i> for sildenafil, NCT02450253. <a href="https://clinicaltrials.gov/ct2/show/NCT02450253?term=tadalafil&amp;cond=vascular+dementia&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02450253?term=tadalafil&cond=vascular+dementia&rank=1</a> (accessed Dec. 18, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+sildenafil%2C+NCT02450253.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02450253%3Fterm%3Dtadalafil%26cond%3Dvascular%2Bdementia%26rank%3D1+%28accessed+Dec.+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3Dtrials%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniszewski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, Y. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakkar, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejmech.2012.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=23313637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVemsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=285-294&author=J.+Fioritoauthor=F.+Saeedauthor=H.+Zhangauthor=A.+Staniszewskiauthor=Y.+Fengauthor=Y.+I.+Francisauthor=S.+Raoauthor=D.+M.+Thakkarauthor=S.+X.+Dengauthor=D.+W.+Landryauthor=O.+Arancio&title=Synthesis+of+quinoline+derivatives%3A+discovery+of+a+potent+and+selective+phosphodiesterase+5+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2012.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Fiorito, Jole; Saeed, Faisal; Zhang, Hong; Staniszewski, Agnieszka; Feng, Yan; Francis, Yitshak I.; Rao, Sudha; Thakkar, Devarshi M.; Deng, Shi-Xian; Landry, Donald W.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">285-294</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Phosphodiesterase type 5 (PDE5) mediates the degrdn. of cGMP in a variety of tissues including brain.  Recent studies have demonstrated the importance of the nitric oxide/cGMP/cAMP-responsive element-binding protein (CREB) pathway to the process of learning and memory.  Thus, PDE5 inhibitors (PDE5Is) are thought to be promising new therapeutic agents for the treatment of Alzheimer's disease (AD), a neurodegenerative disorder characterized by memory loss.  To explore this possibility, a series of quinoline derivs. were synthesized and evaluated.  We found that compd. I selectively inhibits PDE5 with an IC50 of 0.27 nM and readily crosses the blood brain barrier.  In an in vivo mouse model of AD, compd. I rescues synaptic and memory defects.  Quinoline-based, CNS-permeant PDE5Is have potential for AD therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6B39cj4LBh7Vg90H21EOLACvtfcHk0lgU7hJWioFyrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVemsrg%253D&md5=335f11f0576ec3fe8dc1bcf5df2cebdc</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DSaeed%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFrancis%26aufirst%3DY.%2BI.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DThakkar%26aufirst%3DD.%2BM.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DSynthesis%2520of%2520quinoline%2520derivatives%253A%2520discovery%2520of%2520a%2520potent%2520and%2520selective%2520phosphodiesterase%25205%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D60%26spage%3D285%26epage%3D294%26doi%3D10.1016%2Fj.ejmech.2012.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanzhez-Arias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mederos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual-Lucas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perea, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer’s disease</span>. <i>Clin. Epigenet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">108</span>, <span class="refDoi"> DOI: 10.1186/s13148-015-0142-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1186%2Fs13148-015-0142-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26457123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVOksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=108&author=M.+Cuadrado-Tejedorauthor=C.+Garcia-Barrosoauthor=J.+Sanzhez-Ariasauthor=S.+Mederosauthor=O.+Rabalauthor=A.+Ugarteauthor=R.+Francoauthor=M.+Pascual-Lucasauthor=V.+Seguraauthor=G.+Pereaauthor=J.+Oyarzabalauthor=A.+Garcia-Osta&title=Concomitant+histone+deacetylase+and+phosphodiesterase+5+inhibition+synergistically+prevents+the+disruption+in+synaptic+plasticity+and+it+reverses+cognitive+impairment+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs13148-015-0142-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Cuadrado-Tejedor, M.; Garcia-Barroso, C.; Sanzhez-Arias, J.; Mederos, S.; Rabal, O.; Ugarte, A.; Franco, R.; Pascual-Lucas, M.; Segura, V.; Perea, G.; Oyarzabal, J.; Garcia-Osta, A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Epigenetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108/1-108/11</span>CODEN:
                <span class="NLM_cas:coden">CELPCI</span>;
        ISSN:<span class="NLM_cas:issn">1868-7083</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Given the implication of histone acetylation in memory processes, histone deacetylase inhibitors (HDACIs) have been postulated as potential modulators of cognitive impairment in Alzheimer's disease (AD).  However, dose-dependent side effects have been described in patients with the currently available broad-spectrum HDACIs, explaining why their therapeutic potential has not been realized for chronic diseases.  Here, by simultaneously targeting two independent enzyme activities, histone deacetylase (HDAC) and phosphodiesterase-5 (PDE5), we propose a novel mode of inhibitory action that might increase the therapeutic specificity of HDACIs.  Results: The combination of vorinostat, a pan-HDACI, and tadalafil, a PDE5 inhibitor, rescued the long-term potentiation impaired in slices from APP/PS1 mice.  When administered in vivo, the combination of these drugs alleviated the cognitive deficits in AD mice, as well as the amyloid and tau pathol., and it reversed the reduced dendritic spine d. on hippocampal neurons.  Significantly, the combination of vorinostat and tadalafil was more effective than each drug alone, both against the symptoms and in terms of disease modification, and importantly, these effects persisted after a 4-wk washout period.  Conclusions: The results highlight the pharmacol. potential of a combination of mols. that inhibit HDAC and PDE5 as a therapeutic approach for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMSYuXPnR9SLVg90H21EOLACvtfcHk0liZip-jIm9n1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVOksbw%253D&md5=bb0f0702afbc1ac3fe7867bd037ca09e</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1186%2Fs13148-015-0142-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13148-015-0142-9%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DSanzhez-Arias%26aufirst%3DJ.%26aulast%3DMederos%26aufirst%3DS.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DPascual-Lucas%26aufirst%3DM.%26aulast%3DSegura%26aufirst%3DV.%26aulast%3DPerea%26aufirst%3DG.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DConcomitant%2520histone%2520deacetylase%2520and%2520phosphodiesterase%25205%2520inhibition%2520synergistically%2520prevents%2520the%2520disruption%2520in%2520synaptic%2520plasticity%2520and%2520it%2520reverses%2520cognitive%2520impairment%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DClin.%2520Epigenet.%26date%3D2015%26volume%3D7%26spage%3D108%26doi%3D10.1186%2Fs13148-015-0142-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Miguel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estella-Hermoso de Mendoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sáez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espelosin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haizhong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of first-in-class dual acting histone deacetylases (HDACs) and phosphodiesterase 5 (PDE5) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8967</span>– <span class="NLM_lpage">9004</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00908</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00908" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyqtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8967-9004&author=O.+Rabalauthor=J.+A.+S%C3%A1nchez-Ariasauthor=M.+Cuadrado-Tejedorauthor=I.+De+Miguelauthor=M.+P%C3%A9rez-Gonz%C3%A1lezauthor=C.+Garcia-Barrosoauthor=A.+Ugarteauthor=A.+Estella-Hermoso+de+Mendozaauthor=E.+S%C3%A1ezauthor=M.+Espelosinauthor=S.+Ursuaauthor=T.+Haizhongauthor=W.+Weiauthor=X.+Mushengauthor=A.+Garcia-Ostaauthor=J.+Oyarzabal&title=Design%2C+synthesis%2C+and+biological+evaluation+of+first-in-class+dual+acting+histone+deacetylases+%28HDACs%29+and+phosphodiesterase+5+%28PDE5%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Rabal, Obdulia; Sanchez-Arias, Juan A.; Cuadrado-Tejedor, Mar; de Miguel, Irene; Perez-Gonzalez, Marta; Garcia-Barroso, Carolina; Ugarte, Ana; Estella-Hermoso de Mendoza, Ander; Saez, Elena; Espelosin, Maria; Ursua, Susana; Haizhong, Tan; Wei, Wu; Musheng, Xu; Garcia-Osta, Ana; Oyarzabal, Julen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8967-9004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Simultaneous inhibition of phosphodiesterase 5 (PDE5) and histone deacetylases (HDAC) has recently been validated as a potentially novel therapeutic approach for Alzheimer's Disease (AD).  To further extend this concept, the authors designed and synthesized the first chem. series of dual acting PDE5 and HDAC inhibitors, and the authors validated this systems therapeutics approach.  Following the implementation of structure- and knowledge-based approaches, initial hits were designed and were shown to validate the hypothesis of dual in vitro inhibition.  Then, an optimization strategy was pursued to obtain a proper tool compd. for in vivo testing in AD models.  Initial hits were translated into mols. with adequate cellular functional responses (histone acetylation and cAMP/cGMP response element-binding (CREB) phosphorylation in the nanomolar range), an acceptable therapeutic window (>1 log unit) and the ability to cross the blood-brain barrier, leading to the identification of 7 as a candidate for in vivo proof-of-concept testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbHBoJlefNEbVg90H21EOLACvtfcHk0liZip-jIm9n1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyqtL7O&md5=756a252809f05f5d7fc59e828736cfba</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00908%26sid%3Dliteratum%253Aachs%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DS%25C3%25A1nchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DDe%2BMiguel%26aufirst%3DI.%26aulast%3DP%25C3%25A9rez-Gonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DEstella-Hermoso%2Bde%2BMendoza%26aufirst%3DA.%26aulast%3DS%25C3%25A1ez%26aufirst%3DE.%26aulast%3DEspelosin%26aufirst%3DM.%26aulast%3DUrsua%26aufirst%3DS.%26aulast%3DHaizhong%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DMusheng%26aufirst%3DX.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DOyarzabal%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520first-in-class%2520dual%2520acting%2520histone%2520deacetylases%2520%2528HDACs%2529%2520and%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8967%26epage%3D9004%26doi%3D10.1021%2Facs.jmedchem.6b00908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mederos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perea, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">A first-in-class small-molecule that acts as a dual inhibitor of HDAC and PDE5 and that rescues hippocampal synaptic impairment in Alzheimer’s Disease mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1038/npp.2016.163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnpp.2016.163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=27550730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOntLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=524-539&author=M.+Cuadrado-Tejedorauthor=C.+Garcia-Barrosoauthor=J.+A.+Sanchez-Ariasauthor=O.+Rabalauthor=M.+Perez-Gonzalezauthor=S.+Mederosauthor=A.+Ugarteauthor=R.+Francoauthor=V.+Seguraauthor=G.+Pereaauthor=J.+Oyarzabalauthor=A.+Garcia-Osta&title=A+first-in-class+small-molecule+that+acts+as+a+dual+inhibitor+of+HDAC+and+PDE5+and+that+rescues+hippocampal+synaptic+impairment+in+Alzheimer%E2%80%99s+Disease+mice&doi=10.1038%2Fnpp.2016.163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice</span></div><div class="casAuthors">Cuadrado-Tejedor, Mar; Garcia-Barroso, Carolina; Sanchez-Arias, Juan A.; Rabal, Obdulia; Perez-Gonzalez, Marta; Mederos, Sara; Ugarte, Ana; Franco, Rafael; Segura, Victor; Perea, Gertrudis; Oyarzabal, Julen; Garcia-Osta, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">524-539</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The targeting of two independent but synergistic enzymic activities, histone deacetylases (HDACs, class I and HDAC6) and phosphodiesterase 5 (PDE5), has recently been validated as a potentially novel therapeutic approach for Alzheimer's disease (AD).  Here we report the discovery of a new first-in-class small-mol. (CM-414) that acts as a dual inhibitor of PDE5 and HDACs.  We have used this compd. as a chem. probe to validate this systems therapeutics strategy, where an increase in the activation of cAMP/cGMP-responsive element-binding protein (CREB) induced by PDE5 inhibition, combined with moderate HDAC class I inhibition, leads to efficient histone acetylation.  This mol. rescued the impaired long-term potentiation evident in hippocampal slices from APP/PS1 mice.  Chronic treatment of Tg2576 mice with CM-414 diminished brain Aβ and tau phosphorylation (pTau) levels, increased the inactive form of GSK3β, reverted the decrease in dendritic spine d. on hippocampal neurons, and reversed their cognitive deficits, at least in part by inducing the expression of genes related to synaptic transmission.  Thus, CM-414 may serve as the starting point to discover balanced dual inhibitors with an optimal efficacy and safety profile for clin. testing on AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrel_KiPL5177Vg90H21EOLACvtfcHk0lhqrfLGMDO_Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOntLfP&md5=26482df7c58696a362ca1e73bab12264</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.163%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DSanchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DPerez-Gonzalez%26aufirst%3DM.%26aulast%3DMederos%26aufirst%3DS.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DSegura%26aufirst%3DV.%26aulast%3DPerea%26aufirst%3DG.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DA%2520first-in-class%2520small-molecule%2520that%2520acts%2520as%2520a%2520dual%2520inhibitor%2520of%2520HDAC%2520and%2520PDE5%2520and%2520that%2520rescues%2520hippocampal%2520synaptic%2520impairment%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2017%26volume%3D42%26spage%3D524%26epage%3D539%26doi%3D10.1038%2Fnpp.2016.163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Torres, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolnay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Probst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengod, G.</span></span> <span> </span><span class="NLM_article-title">Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer’s disease brains examined by in situ hybridization</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1016/S0014-4886(03)00042-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2FS0014-4886%2803%2900042-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=12895443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVCrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2003&pages=322-334&author=S.+Perez-Torresauthor=R.+Cortesauthor=M.+Tolnayauthor=A.+Probstauthor=J.+M.+Palaciosauthor=G.+Mengod&title=Alterations+on+phosphodiesterase+type+7+and+8+isozyme+mRNA+expression+in+Alzheimer%E2%80%99s+disease+brains+examined+by+in+situ+hybridization&doi=10.1016%2FS0014-4886%2803%2900042-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization</span></div><div class="casAuthors">Perez-Torres, S.; Cortes, R.; Tolnay, M.; Probst, A.; Palacios, J. M.; Mengod, G.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">322-334</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) play a central role in signal transduction by regulating intracellular levels of cAMP and cGMP.  It has been suggested that cAMP pathways could be upregulated in Alzheimer's disease.  By in situ hybridization histochem. we have detd. the expression pattern of two newly described cAMP-specific phosphodiesterases families, PDE7 and PDE8, in several brain areas in control subjects.  The hybridization levels of PDE8A mRNA were very low in all brain areas examd.  High PDE7B and PDE8B mRNA signal intensities were found in the hippocampal formation.  PDE7A was found to be present in both neuronal and non-neuronal cell populations.  When the expression of these isoenzymes in control brains was compared with that in Alzheimer's disease brains staged according to Braak and Braak we found that PDE8B was the only isoenzyme showing a significant increase, in cortical areas and parts of the hippocampal formation, at Braak stages III-VI.  Our results show that the expression of specific cAMP PDE isoforms is selectively regulated in Alzheimer's disease and assocd. with the stages of the disease.  The availability of animal models of Alzheimer's disease and of new pharmacol. tools such as selective PDE inhibitors will allow study of the therapeutic potential of the control of cAMP levels in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM6l4bt6haRbVg90H21EOLACvtfcHk0lhqrfLGMDO_Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVCrtbw%253D&md5=3ce70d806673af55de7c0d8f32411320</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2FS0014-4886%2803%2900042-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-4886%252803%252900042-6%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Torres%26aufirst%3DS.%26aulast%3DCortes%26aufirst%3DR.%26aulast%3DTolnay%26aufirst%3DM.%26aulast%3DProbst%26aufirst%3DA.%26aulast%3DPalacios%26aufirst%3DJ.%2BM.%26aulast%3DMengod%26aufirst%3DG.%26atitle%3DAlterations%2520on%2520phosphodiesterase%2520type%25207%2520and%25208%2520isozyme%2520mRNA%2520expression%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brains%2520examined%2520by%2520in%2520situ%2520hybridization%26jtitle%3DExp.%2520Neurol.%26date%3D2003%26volume%3D182%26spage%3D322%26epage%3D334%26doi%3D10.1016%2FS0014-4886%2803%2900042-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span> <span> </span><span class="NLM_article-title">PDE7 inhibitors as new drugs for neurological and inflammatory disorders</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1127</span>– <span class="NLM_lpage">1139</span>, <span class="refDoi"> DOI: 10.1517/13543776.18.10.1127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1517%2F13543776.18.10.1127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1127-1139&author=C.+Gilauthor=N.+E.+Campilloauthor=D.+I.+Perezauthor=A.+Martinez&title=PDE7+inhibitors+as+new+drugs+for+neurological+and+inflammatory+disorders&doi=10.1517%2F13543776.18.10.1127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">PDE7 inhibitors as new drugs for neurological and inflammatory disorders</span></div><div class="casAuthors">Gil, Carmen; Campillo, Nuria E.; Perez, Daniel I.; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1127-1139</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 7 (PDE7) is a high affinity cAMP-specific PDE whose functional role in T cells has been the subject of some controversy.  Recent findings on tissue distribution, however, support the hypothesis that PDE7 could be a good target for the treatment of airway diseases, T-cell related diseases or even CNS disorders.  This review discloses recent discoveries of selective PDE7 and PDE4/PDE7 dual inhibitors with special emphasis on their potential for neurol. and inflammatory diseases.  PDE7 inhibitors constitute a new approach to be explored for the treatment of neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDb9sjzbO67Vg90H21EOLACvtfcHk0lhqrfLGMDO_Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nO&md5=e1a3797094e7f79bc798198c110007ca</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.10.1127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.10.1127%26sid%3Dliteratum%253Aachs%26aulast%3DGil%26aufirst%3DC.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DPDE7%2520inhibitors%2520as%2520new%2520drugs%2520for%2520neurological%2520and%2520inflammatory%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D1127%26epage%3D1139%26doi%3D10.1517%2F13543776.18.10.1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domenech, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nueda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span> <span> </span><span class="NLM_article-title">CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application example</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1349</span>– <span class="NLM_lpage">1359</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2007.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.ejmech.2007.10.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1349-1359&author=A.+Castroauthor=M.+J.+Jerezauthor=C.+Gilauthor=F.+Calderonauthor=T.+Domenechauthor=A.+Nuedaauthor=A.+Martinez&title=CODES%2C+a+novel+procedure+for+ligand-based+virtual+screening%3A+PDE7+inhibitors+as+an+application+example&doi=10.1016%2Fj.ejmech.2007.10.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DJerez%26aufirst%3DM.%2BJ.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DCalderon%26aufirst%3DF.%26aulast%3DDomenech%26aufirst%3DT.%26aulast%3DNueda%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DCODES%252C%2520a%2520novel%2520procedure%2520for%2520ligand-based%2520virtual%2520screening%253A%2520PDE7%2520inhibitors%2520as%2520an%2520application%2520example%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1349%26epage%3D1359%26doi%3D10.1016%2Fj.ejmech.2007.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paterniti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Impellizzeri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span> <span> </span><span class="NLM_article-title">PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e15937</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0015937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1371%2Fjournal.pone.0015937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=21297958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFaitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e15937&author=I.+Paternitiauthor=E.+Mazzonauthor=C.+Gilauthor=D.+Impellizzeriauthor=V.+Palomoauthor=M.+Redondoauthor=D.+I.+Perezauthor=E.+Espositoauthor=A.+Martinezauthor=S.+Cuzzocrea&title=PDE+7+inhibitors%3A+new+potential+drugs+for+the+therapy+of+spinal+cord+injury&doi=10.1371%2Fjournal.pone.0015937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury</span></div><div class="casAuthors">Paterniti, Irene; Mazzon, Emanuela; Gil, Carmen; Impellizzeri, Daniela; Palomo, Valle; Redondo, Myriam; Perez, Daniel I.; Esposito, Emanuela; Martinez, Ana; Cuzzocrea, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e15937</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Primary traumatic mech. injury to the spinal cord (SCI) causes the death of a no. of neurons that to date can neither be recovered nor regenerated.  During the last years our group has been involved in the design, synthesis and evaluation of PDE7 inhibitors as new innovative drugs for several neurol. disorders.  Our working hypothesis is based on two different facts.  Firstly, neuroinflammation is modulated by cAMP levels, thus the key role for phosphodiesterases (PDEs), which hydrolyze cAMP, is undoubtedly demonstrated.  On the other hand, PDE7 is expressed simultaneously on leukocytes and on the brain, highlighting the potential crucial role of PDE7 as drug target for neuroinflammation.  Methodol./Principal Findings: Here we present two chem. diverse families of PDE7 inhibitors, designed using computational techniques such as virtual screening and neuronal networks.  We report their biol. profile and their efficacy in an exptl. SCI model induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy.  We have selected two candidates, namely S14 and VP1.15, as PDE7 inhibitors.  These compds. increase cAMP prodn. both in macrophage and neuronal cell lines.  Regarding drug-like properties, compds. were able to cross the blood brain barrier using parallel artificial membranes (PAMPA) methodol.  SCI in mice resulted in severe trauma characterized by edema, neutrophil infiltration, and prodn. of a range of inflammatory mediators, tissue damage, and apoptosis.  Treatment of the mice with S14 and VP1.15, two PDE7 inhibitors, significantly reduced the degree of spinal cord inflammation, tissue injury (histol. score), and TNF-α, IL-6, COX-2 and iNOS expression.  Conclusions/Significance: All these data together led us to propose PDE7 inhibitors, and specifically S14 and VP1.15, as potential drug candidates to be further studied for the treatment of SCI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvbyBbaYiCy7Vg90H21EOLACvtfcHk0liWiehhlPIFsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFaitb0%253D&md5=57658a377f69fd7040dee1d4492946ee</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0015937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0015937%26sid%3Dliteratum%253Aachs%26aulast%3DPaterniti%26aufirst%3DI.%26aulast%3DMazzon%26aufirst%3DE.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DImpellizzeri%26aufirst%3DD.%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DRedondo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCuzzocrea%26aufirst%3DS.%26atitle%3DPDE%25207%2520inhibitors%253A%2520new%2520potential%2520drugs%2520for%2520the%2520therapy%2520of%2520spinal%2520cord%2520injury%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De15937%26doi%3D10.1371%2Fjournal.pone.0015937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Gonzalez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antequera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Grijalba, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krzyzanowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarasa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carro, E.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2133</span>– <span class="NLM_lpage">2145</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2013.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neurobiolaging.2013.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=23582662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlslWmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=2133-2145&author=R.+Perez-Gonzalezauthor=C.+Pascualauthor=D.+Antequeraauthor=M.+Bolosauthor=M.+Redondoauthor=D.+I.+Perezauthor=V.+Perez-Grijalbaauthor=A.+Krzyzanowskaauthor=M.+Sarasaauthor=C.+Gilauthor=I.+Ferrerauthor=A.+Martinezauthor=E.+Carro&title=Phosphodiesterase+7+inhibitor+reduced+cognitive+impairment+and+pathological+hallmarks+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2013.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Perez-Gonzalez, Rocio; Pascual, Consuelo; Antequera, Desiree; Bolos, Marta; Redondo, Miriam; Perez, Daniel I.; Perez-Grijalba, Virginia; Krzyzanowska, Agnieszka; Sarasa, Manuel; Gil, Carmen; Ferrer, Isidro; Martinez, Ana; Carro, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2133-2145</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Elevated levels of amyloid beta (Aβ) peptide, hyperphosphorylation of tau protein, and inflammation are pathol. hallmarks in Alzheimer's disease (AD).  Phosphodiesterase 7 (PDE7) regulates the inflammatory response through the cyclic adenosine monophosphate signaling cascade, and thus plays a central role in AD.  The aim of this study was to evaluate the efficacy of an inhibitor of PDE7, named S14, in a mouse model of AD.  We report that APP/Ps1 mice treated daily for 4 wk with S14 show: (1) significant attenuation in behavioral impairment; (2) decreased brain Aβ deposition; (3) enhanced astrocyte-mediated Aβ degrdn.; and (4) decreased tau phosphorylation.  These effects are mediated via the cyclic adenosine monophosphate/cyclic adenosine monophosphate response element-binding protein signaling pathway, and inactivation of glycogen synthase kinase (GSK)3.  Our data support the use of PDE7 inhibitors, and specifically S14, as effective therapeutic agents for the prevention and treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJq9wIJNY9n7Vg90H21EOLACvtfcHk0liWiehhlPIFsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslWmt74%253D&md5=5d7deb7766409e1f27dd671b67bb5fbc</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2013.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2013.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Gonzalez%26aufirst%3DR.%26aulast%3DPascual%26aufirst%3DC.%26aulast%3DAntequera%26aufirst%3DD.%26aulast%3DBolos%26aufirst%3DM.%26aulast%3DRedondo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DPerez-Grijalba%26aufirst%3DV.%26aulast%3DKrzyzanowska%26aufirst%3DA.%26aulast%3DSarasa%26aufirst%3DM.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DFerrer%26aufirst%3DI.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCarro%26aufirst%3DE.%26atitle%3DPhosphodiesterase%25207%2520inhibitor%2520reduced%2520cognitive%2520impairment%2520and%2520pathological%2520hallmarks%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D2133%26epage%3D2145%26doi%3D10.1016%2Fj.neurobiolaging.2013.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soderling, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayuga, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">15553</span>– <span class="NLM_lpage">15558</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.25.15553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1074%2Fjbc.273.25.15553" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=15553-15558&author=S.+H.+Soderlingauthor=S.+J.+Bayugaauthor=J.+A.+Beavo&title=Identification+and+characterization+of+a+novel+family+of+cyclic+nucleotide+phosphodiesterases&doi=10.1074%2Fjbc.273.25.15553"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.25.15553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.25.15553%26sid%3Dliteratum%253Aachs%26aulast%3DSoderling%26aufirst%3DS.%2BH.%26aulast%3DBayuga%26aufirst%3DS.%2BJ.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520novel%2520family%2520of%2520cyclic%2520nucleotide%2520phosphodiesterases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D15553%26epage%3D15558%26doi%3D10.1074%2Fjbc.273.25.15553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wunder, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tersteegen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahrig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, M.</span></span> <span> </span><span class="NLM_article-title">Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1775</span>– <span class="NLM_lpage">1781</span>, <span class="refDoi"> DOI: 10.1124/mol.105.017608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1124%2Fmol.105.017608" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=1775-1781&author=F.+Wunderauthor=A.+Tersteegenauthor=A.+Rebmannauthor=C.+Erbauthor=T.+Fahrigauthor=M.+Hendrix&title=Characterization+of+the+first+potent+and+selective+PDE9+inhibitor+using+a+cGMP+reporter+cell+line&doi=10.1124%2Fmol.105.017608"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.017608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.017608%26sid%3Dliteratum%253Aachs%26aulast%3DWunder%26aufirst%3DF.%26aulast%3DTersteegen%26aufirst%3DA.%26aulast%3DRebmann%26aufirst%3DA.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DFahrig%26aufirst%3DT.%26aulast%3DHendrix%26aufirst%3DM.%26atitle%3DCharacterization%2520of%2520the%2520first%2520potent%2520and%2520selective%2520PDE9%2520inhibitor%2520using%2520a%2520cGMP%2520reporter%2520cell%2520line%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D1775%26epage%3D1781%26doi%3D10.1124%2Fmol.105.017608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van der Staay, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barfacker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erb, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckroth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karthaus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tersteegen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kampen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, M.</span></span> <span> </span><span class="NLM_article-title">The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2008.07.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=908-918&author=F.+J.+van+der+Staayauthor=K.+Ruttenauthor=L.+Barfackerauthor=J.+Devryauthor=C.+Erbauthor=H.+Heckrothauthor=D.+Karthausauthor=A.+Tersteegenauthor=M.+van+Kampenauthor=A.+Bloklandauthor=J.+Prickaertsauthor=K.+G.+Reymannauthor=U.+H.+Schroderauthor=M.+Hendrix&title=The+novel+selective+PDE9+inhibitor+BAY+73-6691+improves+learning+and+memory+in+rodents&doi=10.1016%2Fj.neuropharm.2008.07.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.07.005%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBarfacker%26aufirst%3DL.%26aulast%3DDevry%26aufirst%3DJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DHeckroth%26aufirst%3DH.%26aulast%3DKarthaus%26aufirst%3DD.%26aulast%3DTersteegen%26aufirst%3DA.%26aulast%3Dvan%2BKampen%26aufirst%3DM.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DReymann%26aufirst%3DK.%2BG.%26aulast%3DSchroder%26aufirst%3DU.%2BH.%26aulast%3DHendrix%26aufirst%3DM.%26atitle%3DThe%2520novel%2520selective%2520PDE9%2520inhibitor%2520BAY%252073-6691%2520improves%2520learning%2520and%2520memory%2520in%2520rodents%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D908%26epage%3D918%26doi%3D10.1016%2Fj.neuropharm.2008.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroker, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rast, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorner-Ciossek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1964</span>– <span class="NLM_lpage">1974</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2011.12.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=1964-1974&author=K.+S.+Krokerauthor=G.+Rastauthor=R.+Giovanniniauthor=A.+Martiauthor=C.+Dorner-Ciossekauthor=H.+Rosenbrock&title=Inhibition+of+acetylcholinesterase+and+phosphodiesterase-9A+has+differential+effects+on+hippocampal+early+and+late+LTP&doi=10.1016%2Fj.neuropharm.2011.12.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DKroker%26aufirst%3DK.%2BS.%26aulast%3DRast%26aufirst%3DG.%26aulast%3DGiovannini%26aufirst%3DR.%26aulast%3DMarti%26aufirst%3DA.%26aulast%3DDorner-Ciossek%26aufirst%3DC.%26aulast%3DRosenbrock%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520acetylcholinesterase%2520and%2520phosphodiesterase-9A%2520has%2520differential%2520effects%2520on%2520hippocampal%2520early%2520and%2520late%2520LTP%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D1964%26epage%3D1974%26doi%3D10.1016%2Fj.neuropharm.2011.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroker, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorner-Ciossek, C.</span></span> <span> </span><span class="NLM_article-title">PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2072</span>– <span class="NLM_lpage">2078</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neurobiolaging.2014.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=24746365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlCgtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=2072-2078&author=K.+S.+Krokerauthor=C.+Mathisauthor=A.+Martiauthor=J.+C.+Casselauthor=H.+Rosenbrockauthor=C.+Dorner-Ciossek&title=PDE9A+inhibition+rescues+amyloid+beta-induced+deficits+in+synaptic+plasticity+and+cognition&doi=10.1016%2Fj.neurobiolaging.2014.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition</span></div><div class="casAuthors">Kroker, Katja S.; Mathis, Chantal; Marti, Anelise; Cassel, Jean-Christophe; Rosenbrock, Holger; Dorner-Ciossek, Cornelia</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2072-2078</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The cyclic nucleotide cGMP is an important intracellular messenger for synaptic plasticity and memory function in rodents.  Therefore, inhibition of cGMP degrading phosphodiesterases, like PDE9A, has gained interest as potential target for treatment of cognition deficits in indications like Alzheimer's disease (AD).  In fact, PDE9A inhibition results in increased hippocampal long-term potentiation and exhibits procognitive effects in rodents.  To date, however, no evidence has been published linking PDE9A inhibition to the pathol. hallmarks of AD such as amyloid beta (Aβ) deposition.  Therefore, we investigated the role of PDE9A inhibition in an AD relevant context by testing its effects on Aβ-related deficits in synaptic plasticity and cognition.  The PDE9A inhibitor BAY 73-6691 was found to restore long-term potentiation impaired by Aβ42 oligomers.  Furthermore, we demonstrated that BAY 73-6691 enhanced cGMP levels in the hippocampus of APP transgenic tg2576 mice and improved memory performance of these mice.  Altogether, our results support the hypothesis that inhibition of PDE9A could be a beneficial approach for the treatment of memory impairment in AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraWP3yArit6LVg90H21EOLACvtfcHk0lhGuupYn-4oTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlCgtrk%253D&md5=d5942494c3143f65ff6c8e19141cfbce</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DKroker%26aufirst%3DK.%2BS.%26aulast%3DMathis%26aufirst%3DC.%26aulast%3DMarti%26aufirst%3DA.%26aulast%3DCassel%26aufirst%3DJ.%2BC.%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DDorner-Ciossek%26aufirst%3DC.%26atitle%3DPDE9A%2520inhibition%2520rescues%2520amyloid%2520beta-induced%2520deficits%2520in%2520synaptic%2520plasticity%2520and%2520cognition%26jtitle%3DNeurobiol.%2520Aging%26date%3D2014%26volume%3D35%26spage%3D2072%26epage%3D2078%26doi%3D10.1016%2Fj.neurobiolaging.2014.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y. J.</span></span> <span> </span><span class="NLM_article-title">Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-beta peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer’s disease</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1642</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2016.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.brainres.2016.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=27071547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtFCltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1642&publication_year=2016&pages=327-335&author=J.+Liauthor=C.+N.+Liuauthor=N.+Weiauthor=X.+D.+Liauthor=Y.+Y.+Liuauthor=R.+Yangauthor=Y.+J.+Jia&title=Protective+effects+of+BAY+73-6691%2C+a+selective+inhibitor+of+phosphodiesterase+9%2C+on+amyloid-beta+peptides-induced+oxidative+stress+in+in-vivo+and+in-vitro+models+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.brainres.2016.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-β peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease</span></div><div class="casAuthors">Li, Jian; Liu, Chun-Na; Wei, Ning; Li, Xi-Dong; Liu, Yuan-Yuan; Yang, Rui; Jia, Yu-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1642</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">327-335</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is accompanied by enhanced oxidative stress and excess free radicals.  Phosphodiesterase 9 inhibitors (PDE-9Is) showed memory improving effects in many pharmacol. deficit models.  However, whether BAY 73-6691 (a selective PDE-9I) may attenuate the oxidative stress during the development of AD is still unclear.  For this purpose, primary cultures of SH-SY5Y cells were incubated with 20 μM beta-amyloid25-35 (Aβ25-35), followed by exposure to different concns. (50, 100, 150 and 200 μg/mL) of BAY 73-6691.  Furthermore, the antioxidant effect of BAY 73-6691 was evaluated in mice subjected to intracerebroventricular injection of Aβ25-35 (day 0) and treatment with BAY 73-6691 by i.p. injection once daily (days 1-10).  Our results elucidated that treatment with BAY 73-6691 attenuated the Aβ25-35-induced cytotoxicity and oxidative stress in SH-SY5Y cells.  In vivo, BAY 73-6691 protected Aβ25-35-induced oxidative damage in hippocampus, assocd. with the attenuation of impairments in hippocampal neurons.  Administration of BAY 73-6691 improved learning and memory in the Morris water maze test, and restored several hippocampal memory-assocd. proteins.  Our study identified a neuroprotective role for BAY 73-6691 against Aβ25-35-induced oxidative stress in vivo and in vitro, harboring therapeutic potential for the treatment of AD by alleviating the impairments in spatial memory and hippocampal neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg-SItR1ICPrVg90H21EOLACvtfcHk0lhGuupYn-4oTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtFCltb8%253D&md5=e4a386b4336a0be7ca6d55a536655b41</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2016.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2016.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%2BN.%26aulast%3DWei%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DX.%2BD.%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DJia%26aufirst%3DY.%2BJ.%26atitle%3DProtective%2520effects%2520of%2520BAY%252073-6691%252C%2520a%2520selective%2520inhibitor%2520of%2520phosphodiesterase%25209%252C%2520on%2520amyloid-beta%2520peptides-induced%2520oxidative%2520stress%2520in%2520in-vivo%2520and%2520in-vitro%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Res.%26date%3D2016%26volume%3D1642%26spage%3D327%26epage%3D335%26doi%3D10.1016%2Fj.brainres.2016.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proulx-Lafrance, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span> <span> </span><span class="NLM_article-title">Design and discovery of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943), a selective brain penetrant PDE9A inhibitor for the treatment of cognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9045</span>– <span class="NLM_lpage">9054</span>, <span class="refDoi"> DOI: 10.1021/jm3007799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3007799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9045-9054&author=P.+R.+Verhoestauthor=K.+R.+Fonsecaauthor=X.+Houauthor=C.+Proulx-Lafranceauthor=M.+Cormanauthor=C.+J.+Helalauthor=M.+M.+Claffeyauthor=J.+B.+Tuttleauthor=K.+J.+Coffmanauthor=S.+Liuauthor=F.+Nelsonauthor=R.+J.+Kleimanauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+Vanase-Frawleyauthor=S.+Liras&title=Design+and+discovery+of+6-%5B%283S%2C4S%29-4-methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one+%28PF-04447943%29%2C+a+selective+brain+penetrant+PDE9A+inhibitor+for+the+treatment+of+cognitive+disorders&doi=10.1021%2Fjm3007799"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm3007799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3007799%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DProulx-Lafrance%26aufirst%3DC.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDesign%2520and%2520discovery%2520of%25206-%255B%25283S%252C4S%2529-4-methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2520%2528PF-04447943%2529%252C%2520a%2520selective%2520brain%2520penetrant%2520PDE9A%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9045%26epage%3D9054%26doi%3D10.1021%2Fjm3007799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vardigan, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Converso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uslaner, J. M.</span></span> <span> </span><span class="NLM_article-title">The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task</span>. <i>J. Neurogenet.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.3109/01677063.2011.630494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.3109%2F01677063.2011.630494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=22070409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=120-126&author=J.+D.+Vardiganauthor=A.+Conversoauthor=P.+H.+Hutsonauthor=J.+M.+Uslaner&title=The+selective+phosphodiesterase+9+%28PDE9%29+inhibitor+PF-04447943+attenuates+a+scopolamine-induced+deficit+in+a+novel+rodent+attention+task&doi=10.3109%2F01677063.2011.630494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task</span></div><div class="casAuthors">Vardigan, Joshua D.; Converso, Antonella; Hutson, Pete H.; Uslaner, Jason M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">120-126</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Numerous changes occur during aging and Alzheimer's disease (AD) progression, including a decline in cholinergic functioning and cognition, as well as alterations in gene expression and activity in the nitric oxide/cyclic guanosine monophosphate (NO/cGMP) pathway.  Donepezil, the current std. of care for Alzheimer's disease, improves cholinergic functioning and has demonstrated effects on multiple domains of cognition, including memory and attention in both preclin. species and patients.  We previously found that increasing activation of the NO/cGMP pathway via phosphodiesterase 9 (PDE9) inhibition also improves memory in rodents and suggested that PDE9 might be a promising target for novel treatments for AD.  Here we investigated whether PDE9 inhibition also enhances attention using a novel attention task in rats.  We validated this task using several pharmacol. manipulations and showed that the selective PDE9 inhibitor PF-04447943 produced effects similar to those of donepezil.  These data confirm and extend the hypothesis that PDE9 inhibition might serve as a novel treatment for AD and age-related cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJa-1clww9LrVg90H21EOLACvtfcHk0lj9HK5Xq5I2UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF&md5=1d03e024134e690d1765bd4ee8576aad</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.630494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.630494%26sid%3Dliteratum%253Aachs%26aulast%3DVardigan%26aufirst%3DJ.%2BD.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520selective%2520phosphodiesterase%25209%2520%2528PDE9%2529%2520inhibitor%2520PF-04447943%2520attenuates%2520a%2520scopolamine-induced%2520deficit%2520in%2520a%2520novel%2520rodent%2520attention%2520task%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D120%26epage%3D126%26doi%3D10.3109%2F01677063.2011.630494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magliaro, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Converso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eschle, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rindgen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivian, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eddins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uslaner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le-Mair, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachs, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier-Batteur, S.</span></span> <span> </span><span class="NLM_article-title">The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1 -(pyrimidin-2 -ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuropharm.2011.05.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=665-676&author=P.+H.+Hutsonauthor=E.+N.+Fingerauthor=B.+C.+Magliaroauthor=S.+M.+Smithauthor=A.+Conversoauthor=P.+E.+Sandersonauthor=D.+Mullinsauthor=L.+A.+Hydeauthor=B.+K.+Eschleauthor=Z.+Turnbullauthor=H.+Sloanauthor=M.+Guzziauthor=X.+Zhangauthor=A.+Wangauthor=D.+Rindgenauthor=R.+Mazzolaauthor=J.+A.+Vivianauthor=D.+Eddinsauthor=J.+M.+Uslanerauthor=R.+Bednarauthor=C.+Gamboneauthor=W.+Le-Mairauthor=M.+J.+Marinoauthor=N.+Sachsauthor=G.+Xuauthor=S.+Parmentier-Batteur&title=The+selective+phosphodiesterase+9+%28PDE9%29+inhibitor+PF-04447943+%286-%5B%283S%2C4S%29-4-methyl-1+-%28pyrimidin-2+-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one%29+enhances+synaptic+plasticity+and+cognitive+function+in+rodents&doi=10.1016%2Fj.neuropharm.2011.05.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26aulast%3DMullins%26aufirst%3DD.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DEschle%26aufirst%3DB.%2BK.%26aulast%3DTurnbull%26aufirst%3DZ.%26aulast%3DSloan%26aufirst%3DH.%26aulast%3DGuzzi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRindgen%26aufirst%3DD.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26aulast%3DEddins%26aufirst%3DD.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DBednar%26aufirst%3DR.%26aulast%3DGambone%26aufirst%3DC.%26aulast%3DLe-Mair%26aufirst%3DW.%26aulast%3DMarino%26aufirst%3DM.%2BJ.%26aulast%3DSachs%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DParmentier-Batteur%26aufirst%3DS.%26atitle%3DThe%2520selective%2520phosphodiesterase%25209%2520%2528PDE9%2529%2520inhibitor%2520PF-04447943%2520%25286-%255B%25283S%252C4S%2529-4-methyl-1%2520-%2528pyrimidin-2%2520-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2529%2520enhances%2520synaptic%2520plasticity%2520and%2520cognitive%2520function%2520in%2520rodents%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D665%26epage%3D676%26doi%3D10.1016%2Fj.neuropharm.2011.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanz, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bove, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majchrzak, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal-Gonzales, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, D. T.</span></span> <span> </span><span class="NLM_article-title">Dendritic spine density deficits in the hippocampal CA1 region of young Tg2576 mice are ameliorated with the PDE9A inhibitor PF-04447943</span>. <i>Alzheimer's Dementia</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">S563</span>– <span class="NLM_lpage">S564</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2010.05.1922</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.jalz.2010.05.1922" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S563-S564&author=R.+J.+Kleimanauthor=T.+A.+Lanzauthor=J.+E.+Finleyauthor=S.+E.+Boveauthor=M.+J.+Majchrzakauthor=S.+L.+Beckerauthor=S.+Carvajal-Gonzalesauthor=A.+M.+Kuhnauthor=K.+M.+Woodauthor=A.+Marigaauthor=F.+R.+Nelsonauthor=P.+R.+Verhoestauthor=P.+A.+Seymourauthor=D.+T.+Stephenson&title=Dendritic+spine+density+deficits+in+the+hippocampal+CA1+region+of+young+Tg2576+mice+are+ameliorated+with+the+PDE9A+inhibitor+PF-04447943&doi=10.1016%2Fj.jalz.2010.05.1922"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.05.1922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.05.1922%26sid%3Dliteratum%253Aachs%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DLanz%26aufirst%3DT.%2BA.%26aulast%3DFinley%26aufirst%3DJ.%2BE.%26aulast%3DBove%26aufirst%3DS.%2BE.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DCarvajal-Gonzales%26aufirst%3DS.%26aulast%3DKuhn%26aufirst%3DA.%2BM.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DMariga%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26atitle%3DDendritic%2520spine%2520density%2520deficits%2520in%2520the%2520hippocampal%2520CA1%2520region%2520of%2520young%2520Tg2576%2520mice%2520are%2520ameliorated%2520with%2520the%2520PDE9A%2520inhibitor%2520PF-04447943%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS563%26epage%3DS564%26doi%3D10.1016%2Fj.jalz.2010.05.1922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span>Clinical trial study found in clinical trials for PF-04447943,
NCT00988598. <a href="https://clinicaltrials.gov/ct2/show/NCT00988598?term=PF-04447943&amp;rank=6" class="extLink">https://clinicaltrials.gov/ct2/show/NCT00988598?term=PF-04447943&rank=6</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+PF-04447943%2C%0ANCT00988598.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00988598%3Fterm%3DPF-04447943%26rank%3D6+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span>Clinical
trial study found in clinical trials for PF-04447943, NCT00930059. <a href="https://clinicaltrials.gov/ct2/show/NCT00930059?term=PF-04447943&amp;rank=3" class="extLink">https://clinicaltrials.gov/ct2/show/NCT00930059?term=PF-04447943&rank=3</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+PF-04447943%2C+NCT00930059.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00930059%3Fterm%3DPF-04447943%26rank%3D3+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span>Clinical
trial study found in clinical trials for BI-409306, NCT02337907. <a href="https://clinicaltrials.gov/ct2/show/NCT02337907?term=BI-409306&amp;draw=3&amp;rank=12" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02337907?term=BI-409306&draw=3&rank=12</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+BI-409306%2C+NCT02337907.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02337907%3Fterm%3DBI-409306%26draw%3D3%26rank%3D12+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span>Clinical
trial study found in clinical trials for BI-409306, NCT02240693. <a href="https://clinicaltrials.gov/ct2/show/NCT02240693?term=BI-409306&amp;draw=3&amp;rank=13" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02240693?term=BI-409306&draw=3&rank=13</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+BI-409306%2C+NCT02240693.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02240693%3Fterm%3DBI-409306%26draw%3D3%26rank%3D13+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of highly selective phosphodiesterase-9A inhibitors and implications for inhibitor design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8549</span>– <span class="NLM_lpage">8558</span>, <span class="refDoi"> DOI: 10.1021/jm301189c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301189c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8549-8558&author=F.+Mengauthor=J.+Houauthor=Y.-X.+Shaoauthor=P.-Y.+Wuauthor=M.+Huangauthor=X.+Zhuauthor=Y.+Caiauthor=Z.+Liauthor=J.+Xuauthor=P.+Liuauthor=H.-B.+Luoauthor=Y.+Wanauthor=H.+Ke&title=Structure-based+discovery+of+highly+selective+phosphodiesterase-9A+inhibitors+and+implications+for+inhibitor+design&doi=10.1021%2Fjm301189c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design</span></div><div class="casAuthors">Meng, Fei; Hou, Jing; Shao, Yong-Xian; Wu, Pei-Ying; Huang, Manna; Zhu, Xinhai; Cai, Yonghong; Li, Zhe; Xu, Jie; Liu, Peiqing; Luo, Hai-Bin; Wan, Yiqian; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8549-8558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of phosphodiesterase-9 (PDE9) inhibitors that contain a scaffold of 6-amino-pyrazolopyrimidinone have been discovered by a combination of structure-based design and computational docking.  This procedure significantly saved the load of chem. synthesis and is an effective method for the discovery of inhibitors.  The best compd. 28 (I) has an IC50 of 21 nM and 3.3 μM, resp., for PDE9 and PDE5 and about 3 orders of magnitude of selectivity against other PDE families.  The crystal structure of the PDE9 catalytic domain in complex with 28 has been detd. and shows a hydrogen bond between 28 and Tyr424.  This hydrogen bond may account for the 860-fold selectivity of 28 against PDE1B, in comparison with about 30-fold selectivity of BAY73-6691.  Thus, our studies suggest that Tyr424, a unique residue of PDE8 and PDE9, is a potential target for improvement of selectivity of PDE9 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXPtJ-cQVCabVg90H21EOLACvtfcHk0lhFwp5Ce8QPAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ&md5=ed8c37d784c80b040c51c9e2b40e2d99</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Fjm301189c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301189c%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DY.-X.%26aulast%3DWu%26aufirst%3DP.-Y.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DH.-B.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DStructure-based%2520discovery%2520of%2520highly%2520selective%2520phosphodiesterase-9A%2520inhibitors%2520and%2520implications%2520for%2520inhibitor%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8549%26epage%3D8558%26doi%3D10.1021%2Fjm301189c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery of a phosphodiesterase 9A inhibitor as a potential hypoglycemic agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10304</span>– <span class="NLM_lpage">10313</span>, <span class="refDoi"> DOI: 10.1021/jm500836h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500836h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSju73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10304-10313&author=Y.+X.+Shaoauthor=M.+Huangauthor=W.+Cuiauthor=L.+J.+Fengauthor=Y.+Wuauthor=Y.+Caiauthor=Z.+Liauthor=X.+Zhuauthor=P.+Liuauthor=Y.+Wanauthor=H.+Keauthor=H.-B.+Luo&title=Discovery+of+a+phosphodiesterase+9A+inhibitor+as+a+potential+hypoglycemic+agent&doi=10.1021%2Fjm500836h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent</span></div><div class="casAuthors">Shao, Yong-xian; Huang, Manna; Cui, Wenjun; Feng, Ling-Jun; Wu, Yinuo; Cai, Yinghong; Li, Zhe; Zhu, Xinhai; Liu, Peiqing; Wan, Yiqian; Ke, Hengming; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10304-10313</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 9 (PDE9) inhibitors have been studied as potential therapeutics for treatment of diabetes and Alzheimer's disease.  Here we report a potent PDE9 inhibitor 3r that has an IC50 of 0.6 nM and >150-fold selectivity over other PDEs.  The HepG2 cell-based assay shows that 3r inhibits the mRNA expression of phosphoenolpyruvate carboxykinase and glucose 6-phosphatase.  These activities of 3r, together with the reasonable pharmacokinetic properties and no acute toxicity at 1200 mg/kg dosage, suggest its potential as a hypoglycemic agent.  The crystal structure of PDE9-3r reveals significantly different conformation and hydrogen bonding pattern of 3r from those of previously published 28s.  Both 3r and 28s form a hydrogen bond with Tyr424, a unique PDE9 residue (except for PDE8), but 3r shows an addnl. hydrogen bond with Ala452.  This structure information might be useful for design of PDE9 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo41BAQ4bJwqbVg90H21EOLACvtfcHk0lhFwp5Ce8QPAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSju73E&md5=71b59f683cfbd1b6620d507e654e231f</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjm500836h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500836h%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DY.%2BX.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DL.%2BJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DDiscovery%2520of%2520a%2520phosphodiesterase%25209A%2520inhibitor%2520as%2520a%2520potential%2520hypoglycemic%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10304%26epage%3D10313%26doi%3D10.1021%2Fjm500836h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Structural asymmetry of phosphodiesterase-9A and a unique pocket for selective binding of a potent enantiomeric inhibitor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">836</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.1124/mol.115.099747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1124%2Fmol.115.099747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26316540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=836-845&author=M.+Huangauthor=Y.+Shaoauthor=J.+Houauthor=W.+Cuiauthor=B.+Liangauthor=Y.+Huangauthor=Z.+Liauthor=Y.+Wuauthor=X.+Zhuauthor=P.+Liuauthor=Y.+Wanauthor=H.+Keauthor=H.-B.+Luo&title=Structural+asymmetry+of+phosphodiesterase-9A+and+a+unique+pocket+for+selective+binding+of+a+potent+enantiomeric+inhibitor&doi=10.1124%2Fmol.115.099747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Structural asymmetry of phosphodiesterase-9A and a unique pocket for selective binding of a potent enantiomeric inhibitor</span></div><div class="casAuthors">Huang, Manna; Shao, Yongxian; Hou, Jianying; Cui, Wenjun; Liang, Beibei; Huang, Yingchun; Li, Zhe; Wu, Yinuo; Zhu, Xinhai; Liu, Peiqing; Wan, Yiqian; Ke, Hengming; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">836-845</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphodiesterase-9 (PDE9) inhibitors have been studied as potential therapeutics for treatment of central nervous system diseases and diabetes.  Here, we report the discovery of a new category of PDE9 inhibitors by rational design on the basis of the crystal structures.  The best compd., (S)-6-((1-(4-chlorophenyl)ethyl)amino)-1-cyclopentyl-1,5,6,7-tetrahydro-4H-pyrazolo[3,4-day]pyrimidin-4-one [(S)-C33], has an IC50 value of 11 nM against PDE9 and the racemic C33 has bioavailability of 56.5% in the rat pharmacokinetic model.  The crystal structures of PDE9 in the complex with racemic C33, (R)-C33, and (S)-C33 reveal subtle conformational asymmetry of two M-loops in the PDE9 dimer and different conformations of two C33 enantiomers.  The structures also identified a small hydrophobic pocket that interacts with the tyrosyl tail of (S)-C33 but not with (R)-C33, and is thus possibly useful for improvement of selectivity of PDE9 inhibitors.  The asymmetry of the M-loop and the different interactions of the C33 enantiomers imply the necessity to consider the whole PDE9 dimer in the design of inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsftx1vMJFUbVg90H21EOLACvtfcHk0lhoBZsABZ4itQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSnur8%253D&md5=2e6884812e3b703a74cf1495b5a5a9a3</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.099747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.099747%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DStructural%2520asymmetry%2520of%2520phosphodiesterase-9A%2520and%2520a%2520unique%2520pocket%2520for%2520selective%2520binding%2520of%2520a%2520potent%2520enantiomeric%2520inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D836%26epage%3D845%26doi%3D10.1124%2Fmol.115.099747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1039/C4MB00389F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1039%2FC4MB00389F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=25328054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslert73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=115-125&author=Z.+Liauthor=X.+Luauthor=L.-J.+Fengauthor=Y.+Guauthor=X.+Liauthor=Y.+Wuauthor=H.-B.+Luo&title=Molecular+dynamics-based+discovery+of+novel+phosphodiesterase-9A+inhibitors+with+non-pyrazolopyrimidinone+scaffolds&doi=10.1039%2FC4MB00389F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds</span></div><div class="casAuthors">Li, Zhe; Lu, Xiao; Feng, Ling-Jun; Gu, Ying; Li, Xingshu; Wu, Yinuo; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-125</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Phosphodiesterase-9A (PDE9A) is a promising therapeutic target for the treatment of diabetes and Alzheimer's disease (AD).  The Pfizer PDE9A inhibitor PF-04447943 has completed Phase II clin. trials in subjects with mild to moderate AD in 2013.  However, most of the reported PDE9A inhibitors share the same scaffold as pyrazolopyrimidinone, which lacks structural diversity and is unfavorable for the development of novel PDE9A inhibitors.  In the present study, a combinatorial method including pharmacophores, mol. docking, mol. dynamics simulations, binding free energy calcns., and bioassay was used to discover novel PDE9A inhibitors with new scaffolds rather than pyrazolopyrimidinones from the SPECS database contg. about 200,000 compds.  As a result, 15 hits out of 29 mols. (a hit rate of 52%) with five novel scaffolds were identified to be PDE9A inhibitors with inhibitory affinities no more than 50 μM to enrich the structural diversity, different from the pyrazolopyrimidinone-derived family.  The high hit ratio of 52% for this virtual screening method indicated that the combinatorial method is a good compromise between computational cost and accuracy.  Binding pattern analyses indicate that those hits with non-pyrazolopyrimidinone scaffolds can bind the same active site pocket of PDE9A as classical PDE9A inhibitors.  In addn., structural modification of compd. AG-690/40135604 (IC50 = 8.0 μM) led to a new one, 16, with an improved inhibitory affinity of 2.1 μM as expected.  The five novel scaffolds discovered in the present study can be used for the rational design of PDE9A inhibitors with higher affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6UunPMCOV57Vg90H21EOLACvtfcHk0lhoBZsABZ4itQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslert73L&md5=761bc5740f8a65cf23c2bd0e1bf7eccc</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1039%2FC4MB00389F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MB00389F%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DL.-J.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DMolecular%2520dynamics-based%2520discovery%2520of%2520novel%2520phosphodiesterase-9A%2520inhibitors%2520with%2520non-pyrazolopyrimidinone%2520scaffolds%26jtitle%3DMol.%2520BioSyst.%26date%3D2015%26volume%3D11%26spage%3D115%26epage%3D125%26doi%3D10.1039%2FC4MB00389F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soderling, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayuga, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span> <span> </span><span class="NLM_article-title">Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">7071</span>– <span class="NLM_lpage">7076</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.12.7071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1073%2Fpnas.96.12.7071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=7071-7076&author=S.+H.+Soderlingauthor=S.+J.+Bayugaauthor=J.+A.+Beavo&title=Isolation+and+characterization+of+a+dual-substrate+phosphodiesterase+gene+family%3A+PDE10A&doi=10.1073%2Fpnas.96.12.7071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.12.7071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.12.7071%26sid%3Dliteratum%253Aachs%26aulast%3DSoderling%26aufirst%3DS.%2BH.%26aulast%3DBayuga%26aufirst%3DS.%2BJ.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DIsolation%2520and%2520characterization%2520of%2520a%2520dual-substrate%2520phosphodiesterase%2520gene%2520family%253A%2520PDE10A%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D7071%26epage%3D7076%26doi%3D10.1073%2Fpnas.96.12.7071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hebb, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denovan-Wright, E. M.</span></span> <span> </span><span class="NLM_article-title">Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington’s disease transgenic mice prior to the onset of motor symptoms</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2003.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2Fj.neuroscience.2003.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=14751289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFKgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2004&pages=967-981&author=A.+L.+Hebbauthor=H.+A.+Robertsonauthor=E.+M.+Denovan-Wright&title=Striatal+phosphodiesterase+mRNA+and+protein+levels+are+reduced+in+Huntington%E2%80%99s+disease+transgenic+mice+prior+to+the+onset+of+motor+symptoms&doi=10.1016%2Fj.neuroscience.2003.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms</span></div><div class="casAuthors">Hebb, A. L. O.; Robertson, H. A.; Denovan-Wright, E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">967-981</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Inheritance of a single copy of the gene encoding huntingtin (HD) with an expanded polyglutamine-encoding CAG repeat leads to neuronal dysfunction, neurodegeneration and the development of the symptoms of Huntington's disease (HD).  The authors have found that the steady-state mRNA levels of two members of the phosphodiesterase (PDE) multi-gene family decrease over time in the striatum of R6 transgenic HD mice relative to age-matched wild-type littermates.  Phosphodiesterase 10A (PDE10A) mRNA and protein levels decline in the striatum of R6/1 and R6/2 HD mice prior to motor symptom development.  The rate of redn. in PDE10A protein correlates with the rate of decline of the message and the decrease in PDE10A mRNA and protein is more rapid in R6/2 compared with R6/1 mice.  Both PDE10A protein and mRNA, therefore, decline to min. levels prior to the onset of overt phys. symptoms in both strains of transgenic mice.  Moreover, protein levels of PDE10A are decreased in the caudate-putamen of grade 3 HD patients compared with age-matched neuropathol. normal controls.  Striatal PDE1B mRNA levels also decline in R6/1 and R6/2 HD mice; however, the decrease in striatal PDE10A levels (>60%) was greater than that obsd. for PDE1B and immediately preceded the onset of motor symptoms.  In contrast, PDE4A mRNA levels are relatively low in the striatum and do not differ between age-matched wild-type and transgenic HD mice.  This suggests that the regulation of PDE10A and PDE1B, but not PDE4A, mRNA levels is dependent on the relative expression of or no. of CAG repeats within the human HD transgene.  The loss of phosphodiesterase activity may lead to dysregulation of cAMP and cGMP levels in the striatum, a region of the brain that contributes to the control of movement and cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq097hFgJMexbVg90H21EOLACvtfcHk0lhoBZsABZ4itQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFKgsg%253D%253D&md5=f274758b2f39ce57fae14cb76d61ff50</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2003.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2003.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DHebb%26aufirst%3DA.%2BL.%26aulast%3DRobertson%26aufirst%3DH.%2BA.%26aulast%3DDenovan-Wright%26aufirst%3DE.%2BM.%26atitle%3DStriatal%2520phosphodiesterase%2520mRNA%2520and%2520protein%2520levels%2520are%2520reduced%2520in%2520Huntington%25E2%2580%2599s%2520disease%2520transgenic%2520mice%2520prior%2520to%2520the%2520onset%2520of%2520motor%2520symptoms%26jtitle%3DNeuroscience%26date%3D2004%26volume%3D123%26spage%3D967%26epage%3D981%26doi%3D10.1016%2Fj.neuroscience.2003.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapin, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marr, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proulx-LaFrance, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suiciak, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1<i>H</i>-pyrazol-3- yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of Schizophrenia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5188</span>– <span class="NLM_lpage">5196</span>, <span class="refDoi"> DOI: 10.1021/jm900521k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900521k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5188-5196&author=P.+R.+Verhoestauthor=D.+S.+Chapinauthor=M.+Cormanauthor=K.+Fonsecaauthor=J.+F.+Harmsauthor=X.+Houauthor=E.+S.+Marrauthor=F.+S.+Mennitiauthor=F.+Nelsonauthor=R.+O%E2%80%99Connorauthor=J.+Panditauthor=C.+Proulx-LaFranceauthor=A.+W.+Schmidtauthor=C.+J.+Schmidtauthor=J.+A.+Suiciakauthor=S.+Liras&title=Discovery+of+a+novel+class+of+phosphodiesterase+10A+inhibitors+and+identification+of+clinical+candidate+2-%5B4-%281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-+yl%29-phenoxymethyl%5D-quinoline+%28PF-2545920%29+for+the+treatment+of+Schizophrenia&doi=10.1021%2Fjm900521k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fjm900521k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900521k%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DProulx-LaFrance%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSuiciak%26aufirst%3DJ.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520phosphodiesterase%252010A%2520inhibitors%2520and%2520identification%2520of%2520clinical%2520candidate%25202-%255B4-%25281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-%2520yl%2529-phenoxymethyl%255D-quinoline%2520%2528PF-2545920%2529%2520for%2520the%2520treatment%2520of%2520Schizophrenia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5188%26epage%3D5196%26doi%3D10.1021%2Fjm900521k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span>Clinical trial study found in clinical trials for PF-02545920,
NCT02197130. <a href="https://clinicaltrials.gov/ct2/show/NCT02197130?term=PF-02545920&amp;draw=1&amp;rank=6" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02197130?term=PF-02545920&draw=1&rank=6</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+PF-02545920%2C%0ANCT02197130.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02197130%3Fterm%3DPF-02545920%26draw%3D1%26rank%3D6+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span>Clinical
trial study found in clinical trials for PF-02545920, NCT02342548. <a href="https://clinicaltrials.gov/ct2/show/NCT02342548?term=PF-02545920&amp;draw=1&amp;rank=4" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02342548?term=PF-02545920&draw=1&rank=4</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+PF-02545920%2C+NCT02342548.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02342548%3Fterm%3DPF-02545920%26draw%3D1%26rank%3D4+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kunitomo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fushimi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokubo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin- 4(1H)-one (TAK-063), a highly potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9627</span>– <span class="NLM_lpage">9643</span>, <span class="refDoi"> DOI: 10.1021/jm5013648</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5013648" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9627-9643&author=J.+Kunitomoauthor=M.+Yoshikawaauthor=M.+Fushimiauthor=A.+Kawadaauthor=J.+F.+Quinnauthor=H.+Okiauthor=H.+Kokuboauthor=M.+Kondoauthor=K.+Nakashimaauthor=N.+Kamiguchiauthor=K.+Suzukiauthor=H.+Kimuraauthor=T.+Taniguchi&title=Discovery+of+1-%5B2-fluoro-4-%281H-pyrazol-1-yl%29phenyl%5D-5-methoxy-3-%281-phenyl-1H-pyrazol-5-yl%29pyridazin-+4%281H%29-one+%28TAK-063%29%2C+a+highly+potent%2C+selective%2C+and+orally+active+phosphodiesterase+10A+%28PDE10A%29+inhibitor&doi=10.1021%2Fjm5013648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm5013648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5013648%26sid%3Dliteratum%253Aachs%26aulast%3DKunitomo%26aufirst%3DJ.%26aulast%3DYoshikawa%26aufirst%3DM.%26aulast%3DFushimi%26aufirst%3DM.%26aulast%3DKawada%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DKokubo%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DM.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520of%25201-%255B2-fluoro-4-%25281H-pyrazol-1-yl%2529phenyl%255D-5-methoxy-3-%25281-phenyl-1H-pyrazol-5-yl%2529pyridazin-%25204%25281H%2529-one%2520%2528TAK-063%2529%252C%2520a%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9627%26epage%3D9643%26doi%3D10.1021%2Fjm5013648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span> <span> </span><span class="NLM_article-title">TAK-063, a PDE10A inhibitor with balanced activation of direct and indirect pathways, provides potent antipsychotic-like effects in multiple paradigms</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2252</span>– <span class="NLM_lpage">2262</span>, <span class="refDoi"> DOI: 10.1038/npp.2016.20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fnpp.2016.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26849714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFGktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=2252-2262&author=K.+Suzukiauthor=A.+Haradaauthor=H.+Suzukiauthor=M.+Miyamotoauthor=H.+Kimura&title=TAK-063%2C+a+PDE10A+inhibitor+with+balanced+activation+of+direct+and+indirect+pathways%2C+provides+potent+antipsychotic-like+effects+in+multiple+paradigms&doi=10.1038%2Fnpp.2016.20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms</span></div><div class="casAuthors">Suzuki, Kazunori; Harada, Akina; Suzuki, Hirobumi; Miyamoto, Maki; Kimura, Haruhide</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2252-2262</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) inhibitors are expected to be novel drugs for schizophrenia through activation of both direct and indirect pathway medium spiny neurons.  However, excess activation of the direct pathway by a dopamine D1 receptor agonist SKF82958 canceled antipsychotic-like effects of a dopamine D2 receptor antagonist haloperidol in methamphetamine (METH)-induced hyperactivity in rats.  Thus, balanced activation of these pathways may be crit. for PDE10A inhibitors.  Current antipsychotics and the novel PDE10A inhibitor TAK-063, but not the selective PDE10A inhibitor MP-10, produced dose-dependent antipsychotic-like effects in METH-induced hyperactivity and prepulse inhibition in rodents.  TAK-063 and MP-10 activated the indirect pathway to a similar extent; however, MP-10 caused greater activation of the direct pathway than did TAK-063.  Interestingly, the off-rate of TAK-063 from PDE10A in rat brain sections was faster than that of MP-10, and a slower off-rate PDE10A inhibitor with TAK-063-like chem. structure showed an MP-10-like pharmacol. profile.  In general, faster off-rate enzyme inhibitors are more sensitive than slower off-rate inhibitors to binding inhibition by enzyme substrates.  As expected, TAK-063 was more sensitive than MP-10 to binding inhibition by cyclic nucleotides.  Moreover, an immunohistochem. study suggested that cyclic adenosine monophosphate levels in the direct pathway were higher than those in the indirect pathway.  These data can explain why TAK-063 showed partial activation of the direct pathway compared with MP-10.  The findings presented here suggest that TAK-063's antipsychotic-like efficacy may be attributable to its unique pharmacol. properties, resulting in balanced activation of the direct and indirect striatal pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI0rSbqykBcbVg90H21EOLACvtfcHk0ljvLOw56pwEIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFGktbo%253D&md5=794c9b5aa0a0040f749d50db79c25446</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.20%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DH.%26atitle%3DTAK-063%252C%2520a%2520PDE10A%2520inhibitor%2520with%2520balanced%2520activation%2520of%2520direct%2520and%2520indirect%2520pathways%252C%2520provides%2520potent%2520antipsychotic-like%2520effects%2520in%2520multiple%2520paradigms%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26volume%3D41%26spage%3D2252%26epage%3D2262%26doi%3D10.1038%2Fnpp.2016.20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiraishi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span> <span> </span><span class="NLM_article-title">The phosphodiesterase 10A selective inhibitor TAK-063 improves cognitive functions associated with Schizophrenia in rodent models</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">587</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.230482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1124%2Fjpet.115.230482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=26675680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtF2ksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=587-595&author=E.+Shiraishiauthor=K.+Suzukiauthor=A.+Haradaauthor=N.+Suzukiauthor=H.+Kimura&title=The+phosphodiesterase+10A+selective+inhibitor+TAK-063+improves+cognitive+functions+associated+with+Schizophrenia+in+rodent+models&doi=10.1124%2Fjpet.115.230482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">The Phosphodiesterase 10A Selective Inhibitor TAK-063 Improves Cognitive Functions Associated with Schizophrenia in Rodent Models</span></div><div class="casAuthors">Shiraishi Eri; Suzuki Kazunori; Harada Akina; Suzuki Noriko; Kimura Haruhide</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">587-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cognitive deficits in various domains, including recognition memory, attention, impulsivity, working memory, and executive function, substantially affect functional outcomes in patients with schizophrenia.  TAK-063 [1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one] is a potent and selective phosphodiesterase 10A inhibitor that produces antipsychotic-like effects in rodent models of schizophrenia.  We evaluated the effects of TAK-063 on multiple cognitive functions associated with schizophrenia using naive and drug-perturbed rodents.  TAK-063 at 0.1 and 0.3 mg/kg p.o. improved time-dependent memory decay in object recognition in naive rats.  TAK-063 at 0.1 and 0.3 mg/kg p.o. increased accuracy rate, and TAK-063 at 0.3 mg/kg p.o. reduced impulsivity in a five-choice serial reaction time task in naive rats.  N-methyl-d-aspartate receptor antagonists, such as phencyclidine and MK-801 [(5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine], were used to induce working memory deficits relevant to schizophrenia in animals.  TAK-063 at 0.3 mg/kg p.o. attenuated both phencyclidine-induced working memory deficits in a Y-maze test in mice and MK-801-induced working memory deficits in an eight-arm radial maze task in rats.  An attentional set-shifting task using subchronic phencyclidine-treated rats was used to assess the executive function.  TAK-063 at 0.3 mg/kg p.o. reversed cognitive deficits in extradimensional shifts.  These findings suggest that TAK-063 has a potential to ameliorate deficits in multiple cognitive domains impaired in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZGT27-BUcZ0H3Rlp_k91zfW6udTcc2eZtolQXg_nEB7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtF2ksg%253D%253D&md5=a66911d6a23b448aafe7b9277ffebc2e</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230482%26sid%3Dliteratum%253Aachs%26aulast%3DShiraishi%26aufirst%3DE.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DKimura%26aufirst%3DH.%26atitle%3DThe%2520phosphodiesterase%252010A%2520selective%2520inhibitor%2520TAK-063%2520improves%2520cognitive%2520functions%2520associated%2520with%2520Schizophrenia%2520in%2520rodent%2520models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D587%26epage%3D595%26doi%3D10.1124%2Fjpet.115.230482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span>Clinical trial study found in clinical trials for TAK-063,
NCT02477020. <a href="https://clinicaltrials.gov/ct2/show/NCT02477020?term=NCT02477020&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02477020?term=NCT02477020&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in+clinical+trials+for+TAK-063%2C%0ANCT02477020.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02477020%3Fterm%3DNCT02477020%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span>; <span class="NLM_string-name">Donello, J. E.</span>; <span class="NLM_string-name">Chauvignac, C.</span>; <span class="NLM_string-name">Taverne, T.</span>; <span class="NLM_string-name">Beausoleil, E.</span>; <span class="NLM_string-name">Casagrande, A. S.</span>; <span class="NLM_string-name">Yang, R.</span></span> <span> </span><span class="NLM_article-title">PDE10 Inhibitors and Related Compositions and Methods</span>. <span class="NLM_patent">WO2011112828 A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=B.+Leblond&author=J.+E.+Donello&author=C.+Chauvignac&author=T.+Taverne&author=E.+Beausoleil&author=A.+S.+Casagrande&author=R.+Yang&title=PDE10+Inhibitors+and+Related+Compositions+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLeblond%26aufirst%3DB.%26atitle%3DPDE10%2520Inhibitors%2520and%2520Related%2520Compositions%2520and%2520Methods%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span>Clinical trial study found in
clinical trials for OMS643762, NCT01952132. <a href="https://clinicaltrials.gov/ct2/show/NCT01952132?term=NCT01952132&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01952132?term=NCT01952132&rank=1</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical+trial+study+found+in%0Aclinical+trials+for+OMS643762%2C+NCT01952132.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01952132%3Fterm%3DNCT01952132%26rank%3D1+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span>Clinical
trial study found in clinical trials for EVP-6308, NCT02037074. <a href="https://clinicaltrials.gov/ct2/show/NCT02037074?term=NCT02037074&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02037074?term=NCT02037074&rank=1</a>(accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinical%0Atrial+study+found+in+clinical+trials+for+EVP-6308%2C+NCT02037074.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02037074%3Fterm%3DNCT02037074%26rank%3D1%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cote, R. H.</span></span> <span> </span><span class="NLM_article-title">Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5</span>. <i>Int. J. Impotence Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">S28</span>– <span class="NLM_lpage">S33</span>, <span class="refDoi"> DOI: 10.1038/sj.ijir.3901212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1038%2Fsj.ijir.3901212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=15224133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=S28-S33&author=R.+H.+Cote&title=Characteristics+of+photoreceptor+PDE+%28PDE6%29%3A+similarities+and+differences+to+PDE5&doi=10.1038%2Fsj.ijir.3901212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5</span></div><div class="casAuthors">Cote, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Impotence Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S28-S33</span>CODEN:
                <span class="NLM_cas:coden">IJIRFB</span>;
        ISSN:<span class="NLM_cas:issn">0955-9930</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 6 (PDE6) is highly concd. in the retina.  It is most abundant in the internal membranes of retinal photoreceptors, where it reduces cytoplasmic levels of cGMP in rod and cone outer segments in response to light.  The rod PDE6 holoenzyme comprises α and β catalytic subunits and two identical inhibitory γ subunits.  Each catalytic subunit contains three distinct globular domains corresponding to the catalytic domain and two GAF domains (responsible for allosteric cGMP binding).  The PDE6 catalytic subunits resemble PDE5 in amino-acid sequence as well as in three-dimensional structure of the catalytic dimer; preference for cGMP over cAMP (cAMP) as a substrate; and the ability to bind cGMP at the regulatory GAF domains.  Most PDE5 inhibitors inhibit PDE6 with similar potency, and electroretinogram studies show modest effects of PDE5 inhibitors on visual function-an observation potentially important in designing PDE5-specific therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwrGvfie0U1bVg90H21EOLACvtfcHk0lhtQfZVIVFTrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsbs%253D&md5=7700b18905668782047be0bbdd461726</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1038%2Fsj.ijir.3901212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ijir.3901212%26sid%3Dliteratum%253Aachs%26aulast%3DCote%26aufirst%3DR.%2BH.%26atitle%3DCharacteristics%2520of%2520photoreceptor%2520PDE%2520%2528PDE6%2529%253A%2520similarities%2520and%2520differences%2520to%2520PDE5%26jtitle%3DInt.%2520J.%2520Impotence%2520Res.%26date%3D2004%26volume%3D16%26spage%3DS28%26epage%3DS33%26doi%3D10.1038%2Fsj.ijir.3901212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boolell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, S. A.</span></span> <span> </span><span class="NLM_article-title">Sildenafil, an inhibitor of phosphodiesterase type 5, enhances nitric oxide mediated relaxation of human corpus cavernosum</span>. <i>Int. J. Impotence Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=103&author=M.+Boolellauthor=M.+J.+Allenauthor=S.+A.+Ballard&title=Sildenafil%2C+an+inhibitor+of+phosphodiesterase+type+5%2C+enhances+nitric+oxide+mediated+relaxation+of+human+corpus+cavernosum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoolell%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DBallard%26aufirst%3DS.%2BA.%26atitle%3DSildenafil%252C%2520an%2520inhibitor%2520of%2520phosphodiesterase%2520type%25205%252C%2520enhances%2520nitric%2520oxide%2520mediated%2520relaxation%2520of%2520human%2520corpus%2520cavernosum%26jtitle%3DInt.%2520J.%2520Impotence%2520Res.%26date%3D1996%26volume%3D8%26spage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gamanuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuasa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, K.</span></span> <span> </span><span class="NLM_article-title">Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1016/S0898-6568(02)00146-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1016%2FS0898-6568%2802%2900146-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=12681444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislemsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=565-574&author=M.+Gamanumaauthor=K.+Yuasaauthor=T.+Sasakiauthor=N.+Sakuraiauthor=J.+Koteraauthor=K.+Omori&title=Comparison+of+enzymatic+characterization+and+gene+organization+of+cyclic+nucleotide+phosphodiesterase+8+family+in+humans&doi=10.1016%2FS0898-6568%2802%2900146-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans</span></div><div class="casAuthors">Gamanuma, Michiko; Yuasa, Keizo; Sasaki, Takashi; Sakurai, Naoki; Kotera, Jun; Omori, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-574</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Full-length cDNAs of human cyclic nucleotide phosphodiesterase 8B (PDE8B) were isolated.  Enzymic characteristics of a dominant variant encoding a protein of 885 residues (PDE8B1) were compared with those of PDE8A1.  The recombinant PDE8A1 and PDE8B1 proteins of an entire form were produced in both cytosolic and membrane fractions of the transfected COS cells.  The human PDE8B1 was a high-affinity cAMP-PDE with Km value of 101±12 nM for cAMP, which is greater than that of PDE8A1 (40±1 nM).  Relative Vmax value of PDE8A1 was 57±8% compared with that of PDE8B1 (100±12%).  Although PDE8A1 was moderately inhibited by dipyridamole with IC50 value of 8±2 μM, the compd. antagonized the PDE8B1 activity at three-fold higher concn. (IC50=23±2 μM).  The human PDE8B gene was composed of 22 exons, spanning over 217 kb.  Although overall sequence identity between PDE8A1 and PDE8B1 was 68%, positions of junctions of each exon between the PDE8A1 and PDE8B1 sequences were well matched, indicating evolutionary relatedness of both genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp35CEEyORktrVg90H21EOLACvtfcHk0lhtQfZVIVFTrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislemsbs%253D&md5=c47dd94b28601e42b6b9353401b92fe4</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2FS0898-6568%2802%2900146-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0898-6568%252802%252900146-8%26sid%3Dliteratum%253Aachs%26aulast%3DGamanuma%26aufirst%3DM.%26aulast%3DYuasa%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DN.%26aulast%3DKotera%26aufirst%3DJ.%26aulast%3DOmori%26aufirst%3DK.%26atitle%3DComparison%2520of%2520enzymatic%2520characterization%2520and%2520gene%2520organization%2520of%2520cyclic%2520nucleotide%2520phosphodiesterase%25208%2520family%2520in%2520humans%26jtitle%3DCell.%2520Signalling%26date%3D2003%26volume%3D15%26spage%3D565%26epage%3D574%26doi%3D10.1016%2FS0898-6568%2802%2900146-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu-Albergine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span> <span> </span><span class="NLM_article-title">The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">639</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1124/mol.110.069104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1124%2Fmol.110.069104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=639-648&author=L.+C.+Tsaiauthor=M.+Shimizu-Albergineauthor=J.+A.+Beavo&title=The+high-affinity+cAMP-specific+phosphodiesterase+8B+controls+steroidogenesis+in+the+mouse+adrenal+gland&doi=10.1124%2Fmol.110.069104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.069104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.069104%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DL.%2BC.%26aulast%3DShimizu-Albergine%26aufirst%3DM.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520high-affinity%2520cAMP-specific%2520phosphodiesterase%25208B%2520controls%2520steroidogenesis%2520in%2520the%2520mouse%2520adrenal%2520gland%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D639%26epage%3D648%26doi%3D10.1124%2Fmol.110.069104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu-Albergine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrucco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span> <span> </span><span class="NLM_article-title">cAMP-specific phosphodiesterases 8A and 8B, essential regulators of Leydig cell steroidogenesis</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">556</span>– <span class="NLM_lpage">566</span>, <span class="refDoi"> DOI: 10.1124/mol.111.076125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1124%2Fmol.111.076125" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=556-566&author=M.+Shimizu-Albergineauthor=L.+C.+Tsaiauthor=E.+Patruccoauthor=J.+A.+Beavo&title=cAMP-specific+phosphodiesterases+8A+and+8B%2C+essential+regulators+of+Leydig+cell+steroidogenesis&doi=10.1124%2Fmol.111.076125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1124%2Fmol.111.076125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.111.076125%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu-Albergine%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DL.%2BC.%26aulast%3DPatrucco%26aufirst%3DE.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DcAMP-specific%2520phosphodiesterases%25208A%2520and%25208B%252C%2520essential%2520regulators%2520of%2520Leydig%2520cell%2520steroidogenesis%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D81%26spage%3D556%26epage%3D566%26doi%3D10.1124%2Fmol.111.076125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vang, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Sasson, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kream, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNinno, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Housley, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brocke, S.</span></span> <span> </span><span class="NLM_article-title">PDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e12011</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0012011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;key=10.1371%2Fjournal.pone.0012011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e12011&author=A.+G.+Vangauthor=S.+Z.+Ben-Sassonauthor=H.+Dongauthor=B.+Kreamauthor=M.+P.+DeNinnoauthor=M.+M.+Claffeyauthor=W.+Housleyauthor=R.+B.+Clarkauthor=P.+M.+Epsteinauthor=S.+Brocke&title=PDE8+regulates+rapid+Teff+cell+adhesion+and+proliferation+independent+of+ICER&doi=10.1371%2Fjournal.pone.0012011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0012011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0012011%26sid%3Dliteratum%253Aachs%26aulast%3DVang%26aufirst%3DA.%2BG.%26aulast%3DBen-Sasson%26aufirst%3DS.%2BZ.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DKream%26aufirst%3DB.%26aulast%3DDeNinno%26aufirst%3DM.%2BP.%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DHousley%26aufirst%3DW.%26aulast%3DClark%26aufirst%3DR.%2BB.%26aulast%3DEpstein%26aufirst%3DP.%2BM.%26aulast%3DBrocke%26aufirst%3DS.%26atitle%3DPDE8%2520regulates%2520rapid%2520Teff%2520cell%2520adhesion%2520and%2520proliferation%2520independent%2520of%2520ICER%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De12011%26doi%3D10.1371%2Fjournal.pone.0012011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i17"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01370">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_57502"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01370">10.1021/acs.jmedchem.7b01370</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figures showing expression of mRNA for PDEs in human tissues (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01370/suppl_file/jm7b01370_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01370/suppl_file/jm7b01370_si_001.pdf">jm7b01370_si_001.pdf (421.43 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01370%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-13%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01370" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799237a5edd3c28","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
